Conditions: Biliary Tract Neoplasms Liver Cancer Hepatocellular Carcinoma Cholangiocarcinoma Bile Duct Cancer
Keywords: PDL1-Mediated Adaptive Resistance Monoclonal Antibody CTLA-4 Ablative Therapy Combination of Tremelimumab and Durvalumab
Allocation: NON_RANDOMIZED | Intervention model: PARALLEL
Enrollment: 54
Healthy volunteers: no

Brief summary:
BACKGROUND:

* Various tumor ablative procedures and techniques have been shown to result in immunogenic cell death and induction of a peripheral immune response. The term ablative therapies applies to trans-arterial catheter chemoembolization (TACE), radiofrequency ablation (RFA) and cryoablation (CA).
* The underlying hypothesis of this study is that the effect of immune checkpoint inhibition can be enhanced by TACE, CA and RFA in patients with advanced hepatocellular carcinoma (HCC) and biliary tract carcinomas (BTC). We have already demonstrated proof of principle as well as safety and feasibility of this approach with anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) therapy.
* Based on the concept of programmed death-ligand 1 (PDL1)-mediated adaptive resistance and the emerging role of programmed cell death protein 1 (PD1) therapy in HCC, we would like to evaluate the combination of tremelimumab and durvalumab (with ablative therapies) in HCC and BTC.

Objectives:

\- To preliminarily evaluate the 6-month progression free survival (PFS) of combining tremelimumab and durvalumab in patients with advanced HCC (either alone or with cryoablation, TACE or RFA) and in patients with advanced biliary tract carcinoma (BTC) (either alone or with cryoablation or RFA).

ELIGIBILITY:

* Histologically or cytologically confirmed diagnosis of HCC or biliary tract carcinoma OR histopathological confirmation of carcinoma in the setting of clinical and radiological characteristics which, together with the pathology, are highly suggestive of a diagnosis of HCC (or biliary tract carcinoma).
* Childs-Pugh A/B7 cirrhosis only is allowed. If patient does not have cirrhosis, this limitation does not apply.
* Patients must have disease that is not amenable to potentially curative resection, radiofrequency ablation, or liver transplantation.

DESIGN:

We will evaluate the combination of tremelimumab and durvalumab (with ablative therapies) in cohorts A (HCC; N=40) and B (BTC; N=30). The first N=10 patients in both cohorts will receive tremelimumab and durvalumab only (i.e. No interventional radiologic procedures).

* A: Advanced HCC, BCLC# Stage B/C

  * N= 1st 10 pts: No ablative procedure Cryoablation/RFA/TACE##
  * Tremelimumab 75mg flat dose every (q)28 days for 4 doses; Durvalumab 1500mg flat dose q28 days until end of study (EOS)###
  * 40 total: 10 trem+ dur alone; 10 trem+ dur + TACE; 10 trem + dur + RFA; 10 trem + dur + cryo
* B: Intra/extra-hepatic cholangiocarcinoma

  * N= 1st 10 patients (pts): No ablative procedure; RFA/ cryoablation
  * Tremelimumab 75mg flat dose q28 days for 4 doses; Durvalumab 1500mg flat dose q28 days until EOS###
  * 30 total: 10 trem+ dur alone; 10 trem + dur + RFA; 10 trem

    * BCLC = Barcelona clinic liver cancer staging system

      * For BCLC stage B patients TACE may be repeated as per standard of care

        * EOS = End of study treatment or meeting any of the off-treatment or off study criteria.

Detailed description:
BACKGROUND:

* Various tumor ablative procedures and techniques have been shown to result in immunogenic cell death and induction of a peripheral immune response. The term ablative therapies applies to trans-arterial catheter chemoembolization (TACE), radiofrequency ablation (RFA) and cryoablation (CA).
* The underlying hypothesis of this study is that the effect of immune checkpoint inhibition can be enhanced by TACE, CA and RFA in patients with advanced hepatocellular carcinoma (HCC) and biliary tract carcinomas (BTC). We have already demonstrated proof of principle as well as safety and feasibility of this approach with anti-CTLA4 therapy.
* Based on the concept of PDL1-mediated adaptive resistance and the emerging role of PD1 therapy in HCC, we would like to evaluate the combination of tremelimumab and durvalumab (with ablative therapies) in HCC and BTC.

Objectives:

\- To preliminarily evaluate the 6-month progression free survival (PFS) of combining tremelimumab and durvalumab in patients with advanced HCC (either alone or with cryoablation, TACE or RFA) and in patients with advanced biliary tract carcinoma (BTC) (either alone or with cryoablation or RFA).

ELIGIBILITY:

* Histologically or cytologically confirmed diagnosis of HCC or biliary tract carcinoma OR histopathological confirmation of carcinoma in the setting of clinical and radiological characteristics which, together with the pathology, are highly suggestive of a diagnosis of HCC (or biliary tract carcinoma).
* Childs-Pugh A/B7 cirrhosis only is allowed. If patient does not have cirrhosis, this limitation does not apply.
* Patients must have disease that is not amenable to potentially curative resection, radiofrequency ablation, or liver transplantation.

DESIGN:

We will evaluate the combination of tremelimumab and durvalumab (with ablative therapies) in cohorts A1 (HCC; Barcelona clinic liver cancer staging system (BCLC) stage C; N=10), A2 (HCC; BCLC stages B/C; N=30) and B (BTC; N=30). The patients in cohort A1 and first 10 patients in cohort B will receive tremelimumab and durvalumab only (i.e. no interventional radiologic procedures).

Arms:
arm 1: Durvalumab + Tremelimumab arm 2: Durvalumab + Tremelimumab + TACE arm 3: Durvalumab + Tremelimumab+ RFA arm 4: Durvalumab + Tremelimumab+ Cryoablation

Interventions: intervention 1: Durvalumab intervention 2: Tremelimumab intervention 3: Trans-arterial Catheter Chemoembolization (TACE) intervention 4: Radiofrequency Ablation (RFA) intervention 5: Cryoablation
Intervention descriptions: intervention 1: Flat dose of 1500 mg every 4 weeks. intervention 2: Flat dose of 75 mg every 4 weeks for up to 4 doses. intervention 3: TACE will be performed on Day 36 (+/-96hrs). intervention 4: RFA will be performed on Day 36 (+/-96hrs). intervention 5: Cryoablation will be performed on Day 36 (+/-96hrs).

Protocol document:
ICF_002.pdf: 
MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
INSTITUTE: 
National Cancer Institute 
STUDY NUMBER: 
16-C-0135 
PRINCIPAL INVESTIGATOR: 
Tim Greten, M.D. 
STUDY TITLE:  
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination with 
Ablative Therapies in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract 
Carcinomas (BTC) 
 
Continuing Review Approved by the IRB on 05/08/17 
Amendment Approved by the IRB on 06/26/17 (C) 
 
Date posted to web:  07/18/17 
Drug Only 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent (1) 
 
 
INTRODUCTION 
We invite you to take part in a research study at the National Institutes of Health (NIH). 
First, we want you to know that: 
Taking part in NIH research is entirely voluntary.  
You may choose not to take part, or you may withdraw from the study at any time.  In 
either case, you will not lose any benefits to which you are otherwise entitled.  However, 
to receive care at the NIH, you must be taking part in a study or be under evaluation for 
study participation. 
You may receive no benefit from taking part.  The research may give us knowledge that 
may help people in the future. 
Second, some people have personal, religious or ethical beliefs that may limit the kinds of 
medical or research treatments they would want to receive (such as blood transfusions).  If you 
have such beliefs, please discuss them with your NIH doctors or research team before you agree 
to the study. 
Now we will describe this research study.  Before you decide to take part, please take as much 
time as you need to ask any questions and discuss this study with anyone at NIH, or with family, 
friends or your personal physician or other health professional.   
Why is this study being done?  
This research is being done to study the safety and effectiveness of the combination of 
durvalumab (formerly known as MEDI4736) and tremelimumab with and without trans-arterial 
catheter chemoembolization (TACE), radiofrequency ablation (RFA), or cryoablation. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 2 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
As you are among the first group of ~ 20 subjects enrolling on the study, you will be assigned to 
take durvalumab and tremelimumab. The second group of 50 subjects will be will be assigned to 
take durvalumab and tremelimumab with TACE, RFA or cryoablation. 
Tremelimumab is an experimental drug that has not been approved by the U.S. Food and Drug 
Administration (FDA). Although tremelimumab is not approved by the FDA, it has been 
evaluated in a number of clinical studies, and over 1000 patients, most of whom had melanoma. 
Tremelimumab is similar in how it works to another drug (called ipilimumab) which was 
recently approved by the FDA. Tremelimumab has been tested in a small group of patients with 
liver cancer or hepatocellular cancer (HCC) and in general was well tolerated.  
Durvalumab is an investigational drug designed to boost the body’s immune system by targeting 
a protein on tumor cells called PDL-1. PDL-1 normally maintains the balance of the immune 
system. In cancer, PDL-1 helps tumors evade detection and elimination by the immune system. 
Durvalumab may increase the immune system’s ability to identify and destroy cancer cells. 
“Investigational” means that durvalumab has not been approved by the Food and Drug 
Administration (FDA) as either a prescription or over-the-counter drug.  
TACE, RFA, and cryoablation are standard procedures that are used to treat tumors. 
This is the first study in which both drugs taken together will be tested in combination with 
TACE, RFA, or cryoablation, which is the main goal of this study. 
Why are you being asked to take part in this study? 
You are being asked to take part in this study because you have advanced hepatocellular cancer 
(HCC) or biliary tract cancer that has not responded to other types of therapy, and your doctor 
has determined that you are not a candidate for liver transplantation. 
How many people will take part in this study?  
About 90 people will take part in this study. 
Description of Research Study 
Before you begin the study 
Before you begin this study, you will have several exams and tests to make sure you are eligible 
for this study.  The exams and tests are part of regular cancer care and may be done even if you 
do not join the study.  If you recently had some of the tests, they may not need to be repeated. 
The research team will explain these exams and tests to you. You will have: 
• Confirmation of diagnosis (You must provide a sample tumor tissue for an NCI lab to 
evaluate.  The tissue may be from a previous surgery or biopsy.  If none is available, we 
will ask you to undergo a biopsy to provide a fresh sample.) 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 3 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• History and physical exam 
• Review of current medications and past treatments 
• Blood work 
• Urine laboratory tests 
• Tumor measurements using special x-rays called computerized tomography (CT or CAT 
scans) or magnetic resonance imaging (MRI) of your chest, stomach, and pelvis areas 
• A heart test called an electrocardiogram or ECG to check your heart 
• Urine or blood pregnancy test 
During the study 
If the exams, tests and procedures show that you can be in the study, and you choose to take part, 
then you will begin treatment.  
Before you begin treatment, you will have a biopsy of your tumor using a needle. 
In this study, study therapy will be divided into cycles, each lasting 28 days. Treatment involves 
receiving tremelimumab and durvalumab through an IV on day 1 of each cycle. You will be 
asked to undergo optional tumor biopsies during cycle 2 on day 8 (day 36) and after you have 
completed the third cycle (day 85) of tremelimumab and durvalumab. You will receive 
tremelimumab for up to 4 cycles.  You will continue to receive durvalumab until your disease 
worsens, you experience intolerable side effects or you have completed 12 months of study 
therapy, whichever comes first.  
When you are finished taking the drugs (treatment) 
You will be seen within 60 days after completion of the study treatment to assess for possible 
delayed or ongoing side effects and overall clinical status. At this visit, you will have basic blood 
tests as well as blood collected for research purposes. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 4 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Study Calendar 
Cycle 1 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab* 
• Tumor biopsy 
• Tremelimumab infusion 
• Durvalumab infusion 
Day 8 
• Routine and research blood tests 
Day 15 
• Routine and research blood tests 
Day 22 
• Routine blood tests 
Cycle 2 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab* 
• Tremelimumab infusion 
• Durvalumab infusion 
Day 8  
(Day 36) 
• Routine and research blood tests 
• Tumor biopsy (optional) 
Day 15 
• Routine blood tests 
Day 22 
• Routine blood tests 
Cycle 3 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Tremelimumab infusion 
• Durvalumab infusion  
• CT Scan or MRI 
Day 8 
• Routine and research blood tests 
Day 15 
• Routine blood tests 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 5 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Day 22 
• Routine blood tests 
Cycle 4 
Day 1 
(Day 85) 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab*  
• Tumor Biopsy (optional) 
• Tremelimumab infusion 
• Durvalumab infusion  
Day 8 
• Routine and research blood tests 
Day 15 
• Routine blood tests 
Day 22 
• Routine blood tests 
Subsequent Cycles 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Durvalumab infusion 
• CT scan or MRI (every 8 weeks from third cycle) 
* Rectal swabs will be used to study microbes living in your gut, including sequence of 
microbial genes.  
Birth Control 
If you are a woman who is breast feeding or pregnant, you may not take part in the study because 
we don’t know how this medicine would affect your baby or your unborn child. If you are a 
woman who can become pregnant, or are the partner of a woman who can become pregnant, you 
will need to practice at least two effective forms of birth control before starting study treatment, 
during study treatment, and for 6 months after you finish study treatment. If you are a man, you 
should not donate sperm before, during and for 6 months after you finish study treatment.  If you 
think that you or your partner is pregnant, you should tell your study doctor or nurse at once.   
Effective forms of birth control include:  
• abstinence  
• intrauterine device (IUD) 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 6 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• hormonal [birth control pills, injections, or implants] 
• tubal ligation 
• vasectomy 
Risks or Discomforts of Participation 
What side effects or risks can I expect from being in this study? 
Tremelimumab: 
The following are side effects that have been associated with Tremelimumab: 
• Diarrhea 
• Rash 
• Pruritus (itching) 
• Fatigue 
• Nausea 
• Vomiting 
• Anorexia (loss of appetite) 
• Headache 
• Abdominal Pain 
• Auto-immune changes to the pituitary gland leading to hormonal changes. 
• Inflammation of the part of the intestine known as the colon which can lead to infection, 
blood in the stools and abdominal pain. This is also known as ‘colitis’.  Colitis has the 
potential to be life threatening and require prolonged hospitalizations. As part of its 
management it may require treatment with steroids which may place you at increased risk 
for severe infections.  
• Inflammation of the liver which is also known as hepatitis. In extreme cases this may 
result in liver failure and death.   
• Occasionally you can also get a skin rash related to the treatment and this can also result 
in severe and life threatening symptoms.  
• Problems related to Tremelimumab infusion 
• There is a remote chance that you may have a serious allergic reaction (anaphylaxis) to 
Tremelimumab. Anaphylaxis may cause a serious drop in blood pressure, difficulty in 
breathing, severe hives, and sometimes death. Your doctor will monitor you very closely 
after you receive the Tremelimumab, and will have medications available to treat any 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 7 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
allergic reactions that might occur. Less serious allergic reactions, such as skin rash with 
or without itching and swelling, may also occur within hours to days after receiving the 
Tremelimumab. These effects usually get better without treatment.  
Durvalumab 
Likely 
• Diarrhea 
• Rash/dry itchy skin 
• Liver problems: Increases in the blood level of substances called enzymes found within 
your liver cells may occur. The enzyme changes are unlikely to make you feel unwell. 
However, if these blood enzyme levels become very high, your study doctor may need to 
stop the study medication. A patient may develop inflammation of the liver called 
hepatitis, however this is uncommon. Signs and symptoms of this include yellowing of 
the skin or whites of the eyes, dark urine, severe nausea and vomiting, pain in the upper 
right side of your abdomen, skin itchiness, not feeling hungry and bleeding or bruising 
more easily than normal. 
• Fatigue 
• Difficulty breathing 
• Nausea 
• Constipation 
• Decreased appetite 
• Vomiting 
• Fever 
• Pain in muscles and joints 
Less Likely 
• Inflammation in the lungs (pneumonitis): Symptoms may include but are not limited to a 
new or worsening cough, shortness of breath possibly with fever. Preliminary data 
suggested that there may be the tendency of higher frequency and severity in Japanese 
patients compared with non-Japanese patients: Tell your study doctor right away if you 
have any of these symptoms as it may need to be treated urgently. 
• Low thyroid (Hypothyroidism): This is when the thyroid gland produces less thyroid 
hormone than it should which causes the metabolism to run too slow. Symptoms may 
include but are not limited to fatigue, increased sensitivity to cold, constipation, dry skin, 
unexplained weight gain, puffy face, muscle weakness, slow heart rate, thinning hair, 
impaired memory. The condition can be treated with replacement thyroid hormone. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 8 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• High thyroid (Hyperthyroidism): This is when the thyroid gland produces too much 
thyroid hormone. Symptoms include anxiety or nervousness, weight loss, frequent and 
loose bowel movements, breathlessness, feeling hot and possibly having heart 
palpitations. Depending on the severity of the symptoms treatment may include just 
monitoring the symptoms, treating the symptoms themselves and/or giving medicine to 
block the thyroid hormone. 
• Kidney problems: You may have an increase of creatinine levels in a blood test 
(creatinine is a protein marker that measures kidney function) but not have any symptoms 
or feel unwell. Less commonly a patient may experience nephritis which is an 
inflammation of the kidneys that stops the kidneys from working properly.  
• Nervous system problems: Symptoms can include unusual weakness of legs, arms, or 
face, numbness or tingling in hands or feet. In rare situations, there is the potential for the 
inflammation of the nervous system to be severe: Tell your study doctor right away if you 
have problems swallowing, if you start to feel weak very quickly and you are having 
trouble breathing. 
• Infusion Related Reactions: Reactions may occur during or after the infusion of study 
medication.  The reaction may cause fever or chills and a change in blood pressure or 
difficulty in breathing which might be serious. Tell your study doctor right away if you 
experience any of these symptoms even if it has been several days after the infusion has 
been completed.   
• Inflammation of the intestine (colitis). It may cause abdominal pain and diarrhea with or 
without blood. Fever may be present. It may require you to receive additional fluids. If 
left untreated, this may lead to a tear in the wall of the intestine which can be serious and 
life threatening. Tell your study doctor right away if you have any of these symptoms.  
Rare 
• Problems with your adrenal glands (Adrenal Insufficiency): May cause stomach pains, 
vomiting, muscle weakness and fatigue, depression, low blood pressure, weight loss, 
kidney problems, and changes in mood and personality. This event can occur commonly 
in patients who receive a combination of durvalumab and tremelimumab but has been 
reported uncommonly in patients who received durvalumab on its own. These 
complications may be permanent and may require hormone replacement. 
• Inflammation of the pancreas (pancreatitis). Pancreatitis usually causes symptoms of 
persistent upper abdominal pain (sometimes made worse by eating and drinking), nausea, 
vomiting and general weakness. Pancreatitis usually settles with simple measures but it 
can be a serious condition and can be fatal. You should immediately tell your study 
doctor if you develop any unusual symptoms. You may get an increase of lipase and 
amylase levels in a blood test (related to the pancreas) but not have any symptoms or feel 
unwell. Lipase and amylase are enzymes or protein markers that measure the function of 
your pancreas. Uncommonly these increases may be associated with pancreatitis. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 9 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• Type 1 Diabetes mellitus which may cause increased blood glucose levels (called 
‘hyperglycaemia’):  Symptoms may include weight loss, increased urination, increased 
thirst, and increased hunger. Type 1 diabetes will require replacement of insulin through 
injection. Tell your study doctor right away if you have any of these symptoms.    
• Allergic reactions: These can cause swelling of the face, lips and throat, breathing 
difficulties along with hives or nettle like rash. You should immediately tell your study 
doctor if you develop any of these symptoms.  
• Problems with the pituitary gland (hypopituitarism): Hypopituitarism refers to decreased 
output of hormones from the pituitary gland in the brain and may be caused by 
inflammation of the pituitary gland (hypophysitis). Symptoms may include headaches, 
thirstiness, and trouble seeing or double vision, leakage of breast milk or irregular periods 
in women. These complications may be permanent and may require hormone 
replacement. 
• Inflammation of the heart muscle (myocarditis). Symptoms can include chest pain, rapid 
or abnormal heart beat, shortness of breath and swelling of your legs. Tell your study 
doctor right away if you experience any of these symptoms. 
A new drug may show an increase in side effects or unexpected effects as more studies are 
conducted. For your safety, you will be followed closely by your Study Doctor and the study 
staff for any undesirable or unexpected side effects during your participation in this study and 
each time you receive durvalumab. 
There may be other side effects of durvalumab that are unknown. Other immune-mediated side 
effects are possible that have not been observed, and can result in inflammatory side effects in 
any organ or tissue. You will be told about any new findings that develop during the course of 
this study that may affect your decision to stay in the study. 
There is a remote chance that you may develop new allergies to previously exposed substances, 
other than Durvalumab or Tremelimumab. For example, it is possible that you could develop an 
allergy to shellfish or IV contrast while taking Durvalumab or Tremelimumab. These allergies 
may be severe and life threatening. 
Blood Sampling  
Bruising or bleeding at the needle site; rarely infection. This is treated with bandages, pressure 
and, if infection, antibiotic medicines. For more information about risks and side effects, ask 
your study team. 
Tumor Biopsy 
If your doctor determines it is safe we will obtain a piece of your tumor (biopsy) before you 
begin any study therapy, and on day 36 and day 85 using a needle with minimal risk to you.  You 
will be given local anesthesia (numbing medicine) and a sedative prior to the biopsy.  The biopsy 
will be taken through a needle put through the skin into your tumor.  After the procedure, the 
nurses will watch your blood pressure and other vital signs.  The baseline biopsy is mandatory 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 10 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
and you cannot participate in this study if you do not agree to this biopsy. The day 36 and day 85 
biopsies are optional. If the first biopsy is too difficult or if you experience too much discomfort 
as a result of it, you will be able to continue on the protocol without undergoing the second 
biopsy. However, an attempt at the first biopsy is needed to enter this study. There are other 
studies at NIH which may also be options for you and which do not involve biopsies.  
Radiation 
The tumor biopsy will be done by a specialist using an ultrasound or CT scanner to guide the 
biopsy needle into the tumor to ensure accuracy. To collect the research biopsies, you might be 
exposed to three CT scans. This radiation exposure is not required for your medical care and is 
for research purposes only. The amount of radiation you will receive in these procedures is 2.4 
rem which is below the guideline of 5 rem per year allowed for research subjects by the NIH 
Radiation Safety Committee.  The average person in the United States receives a radiation 
exposure of 0.3 rem per year from natural sources, such as the sun, outer space, and the earth's 
air and soil.  If you would like more information about radiation, please ask the investigator for a 
copy of the pamphlet, An Introduction to Radiation for NIH Research Subjects. 
Potential Benefits of Participation 
Are there benefits to taking part in this study? 
The aim of this study is to see if this experimental treatment will cause your tumors to shrink.  
We do not know if you will receive personal, medical benefit from taking part in this study.  
These potential benefits could include shrinking of your tumor or lessening of your symptoms, 
such as pain, that are caused by the cancer.  Because there is not much information about the 
drug’s effect on your cancer, we do not know if you will benefit from taking part in this study, 
although the knowledge gained from this study may help others in the future who have cancer.   
Alternative Approaches or Treatments 
Instead of being in this study, you have these options: 
• Getting treatment or care for your cancer without being in a study 
• Taking part in another study 
• Getting comfort care, also called palliative care.  This type of care helps reduce pain, 
tiredness, appetite problems and other problems caused by the cancer.  It does not treat 
the cancer directly.  Instead, it tries to improve how you feel.  Comfort care tries to keep 
you as active and comfortable as possible. 
Please talk to your doctor about these and other options. 
Research Subject’s Rights 
What are the costs of taking part in this study?  
If you choose to take part in the study, the following will apply, in keeping with the NIH policy: 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 11 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• 
You will receive study treatment at no charge to you. This may include 
surgery, medicines, laboratory testing, x-rays or scans done at the 
Clinical Center, National Institutes of Health (NIH), or arranged for you 
by the research team to be done outside the Clinical Center, NIH if the 
study related treatment is not available at the NIH.  
• 
There are limited funds available to cover the cost of some tests and 
procedures performed outside the Clinical Center, NIH.  You may have 
to pay for these costs if they are not covered by your insurance company. 
• 
Medicines that are not part of the study treatment will not be provided or 
paid for by the Clinical Center, NIH. 
• 
Once you have completed taking part in the study, medical care will no 
longer be provided by the Clinical Center, NIH. 
Will your medical information be kept private? 
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Organizations that may look at 
and/or copy your medical records for research, quality assurance, and data analysis include: 
• The National Cancer Institute (NCI) and other government agencies, like the Food and 
Drug Administration (FDA), which are involved in keeping research safe for people. 
• National Cancer Institute Institutional Review Board 
• Qualified representatives from MedImmune, Inc, the pharmaceutical company who 
produces tremelimumab and durvalumab. 
A description of this clinical trial will be available on http://www.Clinicaltrials.gov, as required 
by U.S. Law.  This Web site will not include information that can identify you.  At most the 
Web site will include a summary of the results.  You can search this Web site at any time.  
Genomic data of your microbes and your health information will be put in a controlled-access 
database.  This means that only researchers who apply for and get permission to use the 
information for a specific research project will be able to access the information.  Your 
microbial genomic data and health information will not be labeled with your name or other 
information that could be used to identify you.  Researchers approved to access information in 
the database have agreed not to attempt to identify you. 
Stopping Therapy  
Your doctor may decide to stop your therapy for the following reasons: 
• if he/she believes that it is in your best interest 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 12 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• if your disease comes back during treatment 
• if you have side effects from the treatment that your doctor thinks are too severe 
• if new information shows that another treatment would be better for you 
In this case, you will be informed of the reason therapy is being stopped. 
You can stop taking part in the study at any time. However, if you decide to stop taking part in 
the study, we would like you to talk to the study doctor and your regular doctor first. 
If you decide at any time to withdraw your consent to participate in the trial, we will not collect 
any additional medical information about you. However, according to FDA guidelines, 
information collected on you up to that point may still be provided to MedImmune, Inc. or 
designated representatives. If you withdraw your consent and leave the trial, any samples of 
yours that have been obtained for the study and stored at the NCI can be destroyed upon request. 
However, any samples and data generated from the samples that have already been distributed to 
other researchers or placed in the research databases cannot be recalled and destroyed. 
Conflict of Interest  
The National Institutes of Health (NIH) reviews NIH staff researchers at least yearly for conflicts 
of interest.  This process is detailed in a Protocol Review Guide.  You may ask your research 
team for a copy of the Protocol Review Guide or for more information.  Members of the research 
team who do not work for NIH are expected to follow these guidelines but they do not need to 
report their personal finances to the NIH. 
Members of the research team working on this study may have up to $15,000 of stock in the 
companies that make products used in this study.  This is allowed under federal rules and is not a 
conflict of interest.  
The National Institutes of Health and the research team for this study are using tremelimumab 
and durvalumab developed by MedImmune, Inc. through a joint study with your researchers and 
the company.   The company also provides financial support for this study.  
Use of Specimens and Data for Future Research 
To advance science, it is helpful for researchers to share information they get from studying 
human samples.  They do this by putting it into one or more scientific databases, where it is 
stored along with information from other studies. A researcher who wants to study the 
information must apply to the database and be approved.  Researchers use specimens and data 
stored in scientific databases to advance science and learn about health and disease.   
We plan to keep some of your specimens and data that we collect and use them for future 
research and share them with other researchers. We will not contact you to ask about each of 
these future uses.  These specimens and data will be stripped of identifiers such as name, address 
or account number, so that they may be used for future research on any topic and shared broadly 
for research purposes. Your specimens and data will be used for research purposes only and will 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 13 of 15 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
not benefit you.  It is also possible that the stored specimens and data may never be used.  
Results of research done on your specimens and data will not be available to you or your doctor.  
It might help people who have cancer and other diseases in the future.   
If you do not want your stored specimens and data used for future research, please contact us in 
writing and let us know that you do not want us to use your specimens and/or data.  Then any 
specimens that have not already been used or shared will be destroyed and your data will not be 
used for future research. However, it may not be possible to withdraw or delete materials or data 
once they have been shared with other researchers. 
 


MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 14 of 15 pages 
 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH 
STUDY (Continuation Sheet) 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
 
File in Section 4:  Protocol Consent 
 
 
 
OTHER PERTINENT INFORMATION 
1. 
Confidentiality.  When results of an NIH research study are reported in medical journals 
or at scientific meetings, the people who take part are not named and identified.  In most cases, 
the NIH will not release any information about your research involvement without your written 
permission.  However, if you sign a release of information form, for example, for an insurance 
company, the NIH will give the insurance company information from your medical record.  This 
information might affect (either favorably or unfavorably) the willingness of the insurance 
company to sell you insurance. 
The Federal Privacy Act protects the confidentiality of your NIH medical records.  However, you 
should know that the Act allows release of some information from your medical record without 
your permission, for example, if it is required by the Food and Drug Administration (FDA), 
members of Congress, law enforcement officials, or authorized hospital accreditation 
organizations. 
2. 
Policy Regarding Research-Related Injuries.  The Clinical Center will provide short-
term medical care for any injury resulting from your participation in research here.  In general, 
no long-term medical care or financial compensation for research-related injuries will be 
provided by the National Institutes of Health, the Clinical Center, or the Federal Government.  
However, you have the right to pursue legal remedy if you believe that your injury justifies such 
action. 
3. 
Payments.  The amount of payment to research volunteers is guided by the National 
Institutes of Health policies.  In general, patients are not paid for taking part in research studies at 
the National Institutes of Health.  Reimbursement of travel and subsistence will be offered 
consistent with NIH guidelines. 
4. 
Problems or Questions.  If you have any problems or questions about this study, or 
about your rights as a research participant, or about any research-related injury, contact the 
Principal Investigator, Tim Greten, M.D., Building 10, Room 12N226, Telephone:  240-760-
6114. You may also call the Clinical Center Patient Representative at 301-496-2626. If you have 
any questions about the use of your specimens or data for future research studies, you may also 
contact the Office of the Clinical Director, Telephone:  240-760-6070.  
5. 
Consent Document.  Please keep a copy of this document in case you want to read it 
again. 


MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 15 of 15 pages 
 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH 
STUDY (Continuation Sheet) 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
 
File in Section 4:  Protocol Consent 
 
 
 
 
COMPLETE APPROPRIATE ITEM(S) BELOW: 
A. Adult Patient’s Consent 
B. Parent’s Permission for Minor Patient. 
I have read the explanation about this study 
and have been given the opportunity to discuss 
it and to ask questions.  I hereby consent to 
take part in this study. 
I have read the explanation about this study 
and have been given the opportunity to discuss 
it and to ask questions.  I hereby give 
permission for my child to take part in this 
study.   
(Attach NIH 2514-2, Minor’s Assent, if 
applicable.) 
 
  
  
 
 
 
Signature of Adult Patient/ 
Legal Representative 
Date 
Signature of Parent(s)/ Guardian Date 
 
 
Print Name 
 
 
Print Name 
C. Child’s Verbal Assent (If Applicable) 
The information in the above consent was described to my child and my child agrees to 
participate in the study. 
 
  
  
 
Signature of Parent(s)/Guardian 
Date 
Print Name 
THIS CONSENT DOCUMENT HAS BEEN APPROVED FOR USE  
FROM MAY 8, 2017 THROUGH MAY 7, 2018.  
 
 
 
 
 
 
 
 
Signature of Investigator 
Date 
Signature of Witness 
Date 
 
 
Print Name 
 
 
Print Name 
 

Prot_SAP_000.pdf: 









 
!""#$%&'($)
+&(,$-
/00123
4536789:2;
/25:<:;:92
=>?@#A(ABA,-
 D4E FG
H$#I&AJK'($-
ELMNOMNEN 
=P+=QR"$#-
S4TENON UGL
+&(,$-VW:X9;
Y;1Z[
9\
490<:23Z
/00123
4536789:2;
/25:<:;:92
:2
690<:2];:92
^:;5
]<X];:_3
;53`]8:3a:2
Y1<b36;a
^:;5
c38];963XX1X]`
4]`6:290]
dc44e
9`
f:X:]`[
T`]6;
4]`6:290]a
dfT4e
=P>@#&JB&g',
>J%$I(&h'(A#-


 




T:0
i`3;32j
kl





T59`]6:6
m
i/
k]X:n2]26:3a
f`]265





S];:92]X
4]263`
/2a;:;1;3





f1:XZ:2n
 Ej
o990
NfFOf





pEEE
o967_:XX3
W:73





f3;53aZ]j
kl
NEOpN





NLEqUDEqD  L





n`3;32;\r0]:Xs2:5sn9_
>J%$I(&h'(&AJ',
!h$J(I-



l`1nS]03t
T`303X:010]<
l1`_]X10]<
dkul/LUFDe
/SlS10<3`t  NFG O
 NFG O
Y892a9`t
432;3`
\9`
4]263`
o3a3]`65j
S];:92]X
4]263`
/2a;:;1;3
432;3`
\9`
4]263`
o3a3]`65j
S];:92]X
4]263`
/2a;:;1;3
k]21\]6;1`3`t k3Z/00123j
/26s
k3Z/00123j
/26s
Y188X:3`t
k3Z/00123j
/26s
k3Z/00123j
/26s











 
!"#$%&
()*+,-./012
3 456789:
<9=86
5>?5<7@A
B68CAD96A:
5ED
<ACFE7G9A:
F5@A
>AAE
:F8HE
<8
6A:9?<
7E
7==9E8IAE7C
CA??
DA5<F
5ED
7ED9C<78E
8J
5
BA67BFA65?
7==9EA
6A:B8E:AK
LFA
<A6=
5>?5<7@A
<FA65B7A:
5BB?M
<8
<65E:N56<A675?
C5<FA<A6
CFA=8A=>8?7O5<78E
PLQRSTU
65D78J6AG9AECM
5>?5<78E
PVWQT
5ED
C6M85>?5<78E
PRQTK
3 LFA
9EDA6?M7EI
FMB8<FA:7:
8J
<F7:
:<9DM
7:
<F5<
<FA
AJJAC<
8J
7==9EA
CFACXB87E<
7EF7>7<78E
C5E
>A
AEF5ECAD
>M
LQRSU
RQ
5ED
VWQ
7E
B5<7AE<:
H7<F
5D@5ECAD
FAB5<8CA??9?56
C56C7E8=5
PYRRT
5ED
>7?756M
<65C<
C56C7E8=5:
PZLRTK
[A
F5@A
5?6A5DM
DA=8E:<65<AD
B688J
8J
B67EC7B?A
5:
HA??
5:
:5JA<M
5ED
JA5:7>7?7<M
8J
<F7:
5BB685CF
H7<F
5E<7NRL\Q]
<FA65BMK
3 Z5:AD
8E
<FA
C8ECAB<
8J
^_`\aN=AD75<AD
5D5B<7@A
6A:7:<5ECAb
5ED
<FA
A=A6I7EI
68?A
8J
_`a
<FA65BM
7E
YRRU
HA
H89?D
?7XA
<8
A@5?95<A
<FA
C8=>7E5<78E
8J
<6A=A?7=9=5>
5ED
D96@5?9=5>
PH7<F
5>?5<7@A
<FA65B7A:T
7E
YRR
5ED
ZLRK
defg*hijgk2
3 L8
B6A?7=7E567?M
A@5?95<A
<FA
lN=8E<F
B68I6A::78E
J6AA
:96@7@5?
P_WmT
8J
C8=>7E7EI
<6A=A?7=9=5>
5ED
D96@5?9=5>
7E
B5<7AE<:
H7<F
5D@5ECAD
YRR
PA7<FA6
5?8EA
86
H7<F
C6M85>?5<78EU
LQRS
86
VWQT
5ED
7E
B5<7AE<:
H7<F
5D@5ECAD
>7?756M
<65C<
C56C7E8=5
PZLRT
PA7<FA6
5?8EA
86
H7<F
C6M85>?5<78E
86
VWQTK
noi,ieioihp2
3 Y7:<8?8I7C5??M
86
CM<8?8I7C5??M
C8EJ76=AD
D75IE8:7:
8J
YRR
86
>7?756M
<65C<
C56C7E8=5
qV
F7:<8B5<F8?8I7C5?
C8EJ76=5<78E
8J
C56C7E8=5
7E
<FA
:A<<7EI
8J
C?7E7C5?
5ED
65D78?8I7C5?
CF565C<A67:<7C:
HF7CFU
<8IA<FA6
H7<F
<FA
B5<F8?8IMU
56A
F7IF?M
:9IIA:<7@A
8J
5
D75IE8:7:
8J
YRR
P86
>7?756M
<65C<
C56C7E8=5TK
3 RF7?D:N_9IF
QrZs
C766F8:7:
8E?M
7:
5??8HADK
tJ
B5<7AE<
D8A:
E8<
F5@A
C766F8:7:U
<F7:
?7=7<5<78E
D8A:
E8<
5BB?MK
3 _5<7AE<:
=9:<
F5@A
D7:A5:A
<F5<
7:
E8<
5=AE5>?A
<8
B8<AE<75??M
C965<7@A
6A:AC<78EU
65D78J6AG9AECM
5>?5<78EU
86
?7@A6
<65E:B?5E<5<78EK
ugki,02
3 [A
H7??
A@5?95<A
<FA
C8=>7E5<78E
8J
<6A=A?7=9=5>
5ED
D96@5?9=5>
PH7<F
5>?5<7@A
<FA65B7A:T
7E
C8F86<:
Qa
PYRRv
Z56CA?8E5
C?7E7C
?7@A6
C5ECA6
:<5I7EI
:M:<A=
PZR\RT
:<5IA
Rv
wxayTU
Q 
PYRRv
ZR\R
:<5IA:
ZrRv
wxzyT
5ED
Z
PZLRv
wxzyTK
LFA
B5<7AE<:
7EC8F86<
Qa
5ED
J76:<
ay
B5<7AE<:
7E
C8F86<
Z
H7??
6ACA7@A
<6A=A?7=9=5>
5ED
D96@5?9=5>
8E?M
P7KAK
E8
7E<A6@AE<78E5?
65D78?8I7C
B68CAD96A:TK











 
!"#$%'(
)'*!%*!+
,-.)/+00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001
2345689
:8;26;2<0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000 
<2326=6;2
89
:8=>5?3;:6000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A0 ?;2B8CD:2?8;0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A0A
<EFGH
8IJKLEMNKO000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A0A0A
>PMQRPH
8IJKLEMNKS00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A0A01
<KLTUGRPH
8IJKLEMNKOS00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A0A0 
6VWXTPRETPH
8IJKLEMNKOS000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A01
4RLYZPTFUG
RUG
BREMTURXK000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000@
A010A
[::
RUG
E\K
LFPPKUE
E\KPRWKFEML
WRPRGMZQ
]PRGMT^PK_FKULH
RIXREMTU
`B93a
EPRUOb
RPEKPMRX
LRE\KEKP
L\KQTKQITXMcREMTU
`23:6a
RUG
OTPR^KUMId00000000000000000000000000000000000000000000000000@
A0101
BKLKUE
RGNRULKO
MU
MQQFUKbIROKG
RWWPTRL\KO
MU
OTXMG
EFQTP
QRXMZURULMKO000000000AA
A010 
?QQFUK
PKOWTUOK
ET
MUEKPNKUEMTURX
PRGMTXTZMLRX
EPKREQKUEO000000000000000000000000000000000000A1
A010e
2PKQKXMQFQRI000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000Ae
A010f
CFPNRXFQRI0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000Af
A010g
3UEMb:253e
MU
LTQIMUREMTU
hME\
RUEMb>CAi>Cb5A000000000000000000000000000000000000000000000000Ag
A010j
BREMTURXK
^TP
kMPRX
[KWREMEMO
<EFGMKO
RUG
<WKLM^MLRXXH
^TP
[KWREMEMO
4
<FP^RLK
3UEMZKU
RUG
[KWREMEMO
4
?QQFUK
=TUMETPMUZ00000000000000000000000000000000000000000000000000000000000000000000000A@
A010l
mFOEM^MLREMTU
^TP
2FQTP
4MTWOMKO00000000000000000000000000000000000000000000000000000000000000000000000000000A@
A010@
BREMTURX
^TP
QMLPT
IMTQK
RURXHOMO0000000000000000000000000000000000000000000000000000000000000000000000000001n
A010An :FPPKUE
OEREFO
T^
A b:bnA1n
RUG
PREMTURXK
^TP
E\MO
UKh
WPTETLTX
]RO
T^
=RPL\
AAo
1nAgd0 1n
A010AA BKZRPGMUZ
PKOKRPL\
UREFPK
T^
E\K
?B
WPTLKGFPKO0000000000000000000000000000000000000000000000000000001A
1
65?p?4?5?2q
3<<6<<=6;2
3;C
6;B855=6;200000000000000000000000000000000000000000000000000000001A
10A
6XMZMIMXMEH
:PMEKPMR000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001A
10A0A
?ULXFOMTU
:PMEKPMR000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001A
10A01
6VLXFOMTU
:PMEKPMR00000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001 
10A0 
?ULXFOMTU
T^
rTQKU
RUG
=MUTPMEMKO0000000000000000000000000000000000000000000000000000000000000000000000001e
10A0e
BKLPFMEQKUE
<EPREKZMKO0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001e
101
<LPKKUMUZ
6NRXFREMTU0000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000001e
1010A
<LPKKUMUZRLEMNMEMKOWKP^TPQKGWPMTPETTIERMUMUZMU^TPQKGLTUOKUE00000000000000000000001e
10101
<LPKKUMUZRLEMNMEMKOWKP^TPQKGR^EKPRLTUOKUE^TPOLPKKUMUZ\ROIKKUOMZUKG000000001e











 
!"#
$%&'()(*%+'
-./(0'&%'(1+
%+2
3'%'40
5*2%'.
$&1).24&.0""""""""""""""""""""""""""""""""""""""""""""""""""!6
!"#"7
8&.%'9.+'
:00(/+9.+'
$&1).24&.0
;<1&
&./(0'&%'(1+
*4&*10.0
1+=>?@"""""""""""""""""""""!6
!" 
A%0.=(+.
BC%=4%'(1+"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!D
#
385EF
GH$IBHBJ8:8GKJ"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!L
#"7
3'42>
E.0(/+"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!L
#"!
3)M.24=.""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!N
#"!"7
O1M1&'
:7""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!N
#"!"!
O1M1&'
:!""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!N
#"!"#
O1M1&'
A"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!P
#"#
E&4/
:29(+(0'&%'(1+"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#Q
#"#"7
8&.9.=(949%R
E&4/
:29(+(0'&%'(1+""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#Q
#"#"!
E4&C%=49%R
E&4/
:29(+(0'&%'(1+"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#Q
#"#"#
H1+('1&(+/
1S
E10.
:29(+(0'&%'(1+""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#7
#" 
E10(+/
E.=%>0"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#7
#" "7
G994+.T9.2(%'.2
:B0
;(9:B0?"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#7
#" "!
:2C.&0.
BC.+'0
1S
3*.)(%=
G+'.&.0'""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#!
#"6
3*.)(S()
$&1).24&.0
S1&
8:OBU
-<:
%+2
O&>1%R=%'(1+"""""""""""""""""""""""""""""""""""""""""""""""""# 
#"6"7
8&%+0%&'.&(%=
)M.91.9R1=(V%'(1+""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""# 
#"6"!
-%2(1S&.W4.+)>
%R=%'(1+""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#6
#"6"#
O&>1%R=%'(1+""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#6
#"6" 
E.'.&9(+%'(1+
1S
'M.
%914+'
1S
04R'1'%=
%R=%'(1+"""""""""""""""""""""""""""""""""""""""""""""""""""#D
#"D
3'42>
O%=.+2%&""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""#L
XYZ
[\]^
`ab
[\cdea]`^f\a"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
#"L"7
[ghih"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
#"L"!
[gjklmhniogm""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
#"L"#
plojqrshljlmi"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
#"N
O&('.&(%
S1&
-.91C%=
S&19
$&1'1)1=
8M.&%*>
%+2
KSS
3'42>
O&('.&(%""""""""""""""""""""""""""""" !
#"N"7
O&('.&(%
S1&
-.91C%=
S&19
$&1'1)1=
8M.&%*>"""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
#"N"!
KSST3'42>
O&('.&(%"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" #
#"N"#
I10'
'1
<1==1tT4*"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" #
 
OKJOKHG8:J8HBEGO:8GKJ3uHB:35-B3""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" #
 "7
<.9%=.*%'(.+'1S)M(=2TR.%&(+/*1'.+'(%=""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" #











 
!"#
$%&'
)%*+',*-
.+*/
%
0'1%&'
2%3*,'3
45
6/+&78'%3+,9
24*',*+%&"""""""""""""""""""""""""""""""""""""!!
!":
;&447
<4,%*+4,"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""! 
!"!
64,=41+*%,*
>3'%*1',*?-@""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""! 
!" 
2'31+**'7
64,=41+*%,*
$'7+=%*+4,-"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""! 
!"A
BC=&D7'7
64,=41+*%,*
$'7+=%*+4,-"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!A
 
;EFG2B6E$BH
6FIIB6>EFH"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!J
 "K
6433'&%*+L'
G*D7+'-
543
M'-'%3=/N2/%31%=4O+,'*+=
G*D7+'-""""""""""""""""""""""""""""""""""""""""""""!J
 "#
H6E
6433'&%*+L'
G*D7+'-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!P
 "#"K
E11D,'
14,+*43+,9
?Q&&
=4/43*-@""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!P
 "#"#
I+L'3
%D*4%,*+847R
)%,'&
543
%D*4+11D,'
/')%*+*+-
?QES@"""""""""""""""""""""""""""""""""""""!T
 "#":
S')%*+*+-
-'34&49R
%,7
L+3%&
&4%7"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""!T
 "#"!
>D143U-)'=+5+=
VWX
3'-)4,-'-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" Y
 "#" 
$<G6
5D,=*+4,%&
%--%R""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" Y
 "#"A
M'=*%&
G.%8
64&&'=*+4,Z
G*43%9'
%,7
Q,%&R-+-
?4)*+4,%&@""""""""""""""""""""""""""""""""""""""" Y
 "#"J
>D143
;+4)-+'-"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" Y
 ":
$'7E11D,'
2&%,,'7
G*D7+'-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" K
 ":"K
2/%31%=4O+,'*+=-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" K
 ":"#
E11D,49',+=+*R""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" K
 ":":
>
6BII
Q=*+L%*+4,NE6FG
'C)3'--+4,"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" K
 ":"!
2&%-1%U8%-'7
%--%R-
543
=+3=D&%*+,9
3'=')*43-N&+9%,7-
'"9"
2<IK""""""""""""""""""""""""""" #
 "!
G%1)&'
G*43%9'Z
>3%=O+,9
%,7
<+-)4-+*+4,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" #
 "!"K
G%1)&'-
$%,%9'7
8R
<3"
0+99[-
;&447
234='--+,9
643'
?;26@"""""""""""""""""""""""""""" #
 "!"#
<3
\3'*',
I%8
64,*%=*
+,5431%*+4,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" :
 "!":
234*4=4&
641)&'*+4,NG%1)&'
<'-*3D=*+4,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" :
A
<Q>Q
6FIIB6>EFH
QH<
B]QI^Q>EFH""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" :
A"K
<%*%
64&&'=*+4,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" :
A"#
<%*%
G/%3+,9
2&%,-"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
A"#"K
SD1%,
<%*%
G/%3+,9
2&%,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
A"#"#
\',41+=
<%*%
G/%3+,9
2&%,""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
A":
M'-)4,-'
63+*'3+%"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
A":"K
<'5+,+*+4,-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""" !
A":"#
<+-'%-'2%3%1'*'3-""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""  











 
 !"!"
#$%&'()
+',
-./01/%2'3
'+
#$/)1,/40$
52)$/)$!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!6 
 !"!7
8$)9'3)$
:,2%$,2/!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!6;
 !"!6
51,/%2'3
'+
8$)9'3)$!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! <
 !7
#'(2+2$(
2==13$>,$0/%$(
,$)9'3)$
?,2%$,2/
@2,8:A!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! <
 !6
B'C2?2%D
:,2%$,2/!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! <
E
FGH8-IJ8BGFK
8-LMG8-#-FBNO5PBP
PF5
NPQ-BR
#JFGBJ8GFK
ISPF!!!!! <
E!T
5$+232%2'3)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! <
E!U
JHN8I
J++2?$
'+
:'=902/3?$
/3(
B,/2323V
O
G8W
8$9',%23V!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
E!U!T
-C9$(2%$(
8$9',%23V!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
E!U!U
G8W
8$X12,$=$3%)
+',
IG
8$9',%23V
/%
:'3%23123V
8$.2$Y!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
E!"
F:G
:0232?/0
52,$?%',
8$9',%23V!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
E!7
FGH
8$X12,$(
5/%/
/3(
N/+$%D
#'32%',23V
I0/3!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
E!7!T
I,23?29/0
G3.$)%2V/%',O8$)$/,?&
B$/=!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
;
NIJFNJ8
9,'%'?'0ONPQ-BR
8-IJ8BGFK!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
;!T
5$+232%2'3)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
;!T!T
P(.$,)$
-.$3%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! T
;!T!U
N$,2'1)
P(.$,)$
-.$3%
@NP-A!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! U
;!T!"
S2+$>%&,$/%$323V!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! U
;!T!7
N$.$,2%D!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! U
;!T!6
8$0/%2'3)&29
%'
N%1(D
I,'(1?%!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! U
;!T! 
P(.$,)$
-.$3%)
'+
N9$?2/0
G3%$,$)%
@P-NGA!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! "
;!U
P))$))=$3%
'+
N/+$%D
-.$3%)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! "
;!"
8$9',%23V
'+
N$,2'1)
P(.$,)$
-.$3%)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! "
;!7
Z/2.$,
'+
-C9$(2%$(
8$9',%23V
%'
::8!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! "
;!6
8$9',%23V
:,2%$,2/
%'
%&$
I&/,=/?$1%2?/0
:'00/4',/%',)!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 7
;!6!T
-C9$(2%$(
P(.$,)$
-.$3%
8$9',%23V
:,2%$,2/
%'
%&$
GF5
#/31+/?%1,$,!!!!!!!!!!!!!!!!! 7
;!6!U
J%&$,
$.$3%)
,$X12,23V
,$9',%23V!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 6
;! 
8$9',%23V
I,$V3/3?D!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! 6
;! !T
#/%$,3/0
$C9')1,$!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!  
;! !U
I/%$,3/0
$C9')1,$!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!  
;!E
8$V10/%',D8$9',%23V+',N%1(2$):'3(1?%$(M3($,::8>N9'3)',$(GF5!!!!!!!!!!!!!!!!!!!  
[
:SGFG:PS#JFGBJ8GFK!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!  











 
!" #$%$&#$&'%(
'*+#&,-.%$&*+#//////////////////////////////////////////////////////////////////////////////////0 
!! '*((%1*.%$&2-
%3.--4-+$#//////////////////////////////////////////////////////////////////////////////////05
!!/!
'66789:;<=8
.8>8:9?@
:AB
,8=8C67D8A;
%E988D8A;
F'.%,%G////////////////////////////////05
!!/H
4:;89<:C
$9:A>I89
%E988D8A;>
F4$%G////////////////////////////////////////////////////////////////////////05
!H JK4%+
#K1L-'$#
M.*$-'$&*+#////////////////////////////////////////////////////////////////////////////////05
!H/!
-;@<?:C
'6ABN?;
6I
;@8
#;NBO///////////////////////////////////////////////////////////////////////////////////////05
!H/H
.:;<6A:C8
P69
#NQR8?;
#8C8?;<6A//////////////////////////////////////////////////////////////////////////////////05
!H/S
M:9;<?<7:;<6A
6I
'@<CB98A/////////////////////////////////////////////////////////////////////////////////////////////05
!H/T
M%.$&'&M%$&*+
*P
#K1L-'$#
K+%1(-
$*
3&2-
'*+#-+$///////////////////////05
!H/U
-=:CN:;<6A
6I
18A8I<;>
:AB
.<>V>W,<>?6DI69;>
I69
:CC
7:9;<?<7:A;>/////////////////////////////0X
!H/U/! YA6ZA
76;8A;<:C
9<>V>//////////////////////////////////////////////////////////////////////////////////////////////0X
!H/U/H YA6ZA
76;8A;<:C
Q8A8I<;>///////////////////////////////////////////////////////////////////////////////////////// S
!H/U/S .<>V>W18A8I<;>
%A:CO><>/////////////////////////////////////////////////////////////////////////////////////////// S
!H/0
'6A>8A;
M96?8>>
:AB
,6?ND8A;:;<6A////////////////////////////////////////////////////////////////////////// T
!H/0/! '6A>8A;
M96?8>>
I69
%BNC;>
[@6
(:?V
':7:?<;O
;6
'6A>8A;
;6
.8>8:9?@
M:9;<?<7:;<6A/////////////////////////////////////////////////////////////////////////////////////////////////////////////////////////// T
!S .-3K(%$*.\
%+,
*M-.%$&*+%(
'*+#&,-.%$&*+#////////////////////////////////////////// T
!S/!
#;NBO
,<>?6A;<AN:;<6A
:AB
'C6>N98///////////////////////////////////////////////////////////////////////////// T
!S/H
]N:C<;O
%>>N9:A?8
:AB
]N:C<;O
'6A;96C////////////////////////////////////////////////////////////////////// U
!S/S
'6AIC<?;
6I
&A;898>;
M6C<?O/////////////////////////////////////////////////////////////////////////////////////////// U
!S/T
'6AI<B8A;<:C<;O
:AB
M9<=:?O///////////////////////////////////////////////////////////////////////////////////////// U
!T MJ%.4%'-K$&'%(
&+P*.4%$&*+///////////////////////////////////////////////////////////////////////////// 0
!T/!
$98D8C<DND:Q//////////////////////////////////////////////////////////////////////////////////////////////////////////// 0
!T/!/! #6N9?8////////////////////////////////////////////////////////////////////////////////////////////////////////////////////// 0
!T/!/H P69DNC:;<6A
:AB
M987:9:;<6A/////////////////////////////////////////////////////////////////////////////////// 0
!T/!/S %BD<A<>;9:;<6A
M96?8BN98>//////////////////////////////////////////////////////////////////////////////////////  
!T/!/T ,6>8
':C?NC:;<6A//////////////////////////////////////////////////////////////////////////////////////////////////////  
!T/!/U &A=8>;<E:;<6A:C
M96BN?;
&A>78?;<6A////////////////////////////////////////////////////////////////////////// 5
!T/!/0 ,6>8
M987:9:;<6A
#;87>//////////////////////////////////////////////////////////////////////////////////////////// 5
!T/!/ &A=8>;<E:;<6A:C
M96BN?;
%??6NA;:Q<C<;O/////////////////////////////////////////////////////////////////// 5
!T/!/5 .8769;<AE
M96BN?;
'6D7C:<A;>//////////////////////////////////////////////////////////////////////////////// X
!T/H
,N9=:CND:Q///////////////////////////////////////////////////////////////////////////////////////////////////////////////// X











 
!"#$#! %&'()*######################################################################################################################+,
!"#$#$ -&(.'/012&3
035
6(*70(012&3###################################################################################+,
!"#$#8 %1092/21:#################################################################################################################### ;
!"#$#" <&=*
>0/)'/012&3###################################################################################################### !
!"#$#? @3A*=12B012&30/
6(&5')1
6(*70(012&3
%1*7=############################################################### !
!"#$#C @3A*=12B012&30/
6(&5')1
@3=7*)12&3########################################################################## !
!"#$#+ @3A*=12B012&30/
6(&5')1
D))&'31092/21:################################################################### $
!"#$# E*7&(123B
6(&5')1
>&.7/0231=################################################################################ $
!? EF-FEFG>F%###################################################################################################################### "
!C D66FG<@>F%####################################################################################################################### +
!C#!
D77*352H
D
I6*(J&(.03)*
%101'=
>(21*(20################################################################### +
!C#$
D77*352H
K
I
>L2/5I6'BL
>/0==2J2)012&3
%:=1*.######################################################## +
!C#8
D77*352H
>M
N&52J2*5
@..'3*IE*/01*5
E*=7&3=*
>(21*(20
O2(E>P############################ ,
!C#"
D77*352H
<
I
N*5@..'3*
%0.7/*
6(*70(012&3
6(&)*5'(*=######################################,!
!C#?
D77*352H
F
I
<010
>&//*)12&3
F/*.*31=
E*Q'2(*5
9:
N03'J0)1'(*(##########################,$
!C#C
D77*352H
-M
<R%@GS
NR<@-@>DT@RG
DG<
TRU@>@TV
NDGDSFNFGT
SW@<FX@GF%
OTNSP
-RE
@NNWGFINF<@DTF<Y
@G-W%@RGIEFXDTF<Y
DG<
GRGI
@NNWGFZNF<@DTF<
EFD>T@RG%
O<WE[DXWNDK
NRGRT\FED6V
RE
@G
>RNK@GDT@RG
]@T\
RT\FE
6ER<W>T%P
!"
R>TRKFE
$;$;####################################,"
!C#+
D77*352H
SM
-(*Q'*3):
&J
D<E=
J&(
<'(A0/'.09
N&3&1L*(07:
-(&.
6&&/*5
<010
D)(&==N'/127/*
T'.&'(
T:7*=
OG^8;;CP##############################################################################!$?











 
!"#"$%$&"
()
*(%+,-#&*$
./0234567466
80
953340:
;<2
4=
599;3:5=90
742/
>=203=524;=56
?;=@030=90
;=
A53B;=4C524;=
D;;:
?64=4956E3592490
F>?A
D?EG
5=:
2/0
@;66;74=HI
JK=420:
L2520C
FKLG
?;:0
;@
M0:0356
N0H<6524;=C
F?MNG
5OO6495860
2;
964=4956
C2<:40C
FPQ
?MN
E532
PRS
TU
?MN
E532
QVS
TU
?MN
E532
QRS
TU
?MN
E532
WUTS
5=:X;3
TU
?MN
E532
YUTG
Z524;=56>=C242<20C
;@
A0562/
FZ>AG[@<=:0:
4=\0C24H52;3C
5=:
964=4956
23456
C420
C25@@
7/;
530
30CO;=C4860
@;3
2/0
9;=:<92S
B5=5H0B0=2S
;3
;\03C4H/2
;@
Z>A[@<=:0:
964=4956
23456C
/5\0
9;BO6020:
A<B5=
L<8]092C
E3;20924;=
5=:
>?A
D?E
.354=4=H^
./0O3;2;9;6S
4=@;3B0:
9;=C0=2
@;3BFCGS
3093<42B0=2
B5203456CS
5=:
566
O532494O5=2
B5203456C
7466
80C<8B4220:
2;
2/0
>=C242<24;=56
N0\407
_;53:
F>N_G
@;3
30\407
5=:
5OO3;\56^
`OO3;\56
;@
8;2/
2/0O3;2;9;6
5=:
2/0
9;=C0=2
@;3B
B<C2
80
;8254=0:
80@;30
5=a
O532494O5=2
4C
0=3;660:^
`=a
5B0=:B0=2
2;
2/0
O3;2;9;6
7466
30b<430
30\407
5=:
5OO3;\56
8a
2/0
>N_
80@;30
2/0
9/5=H0C
530
4BO60B0=20:
2;
2/0
C2<:a^
>=
5::424;=S
566
9/5=H0C
2;
2/0
9;=C0=2
@;3B
7466
80
>N_[5OO3;\0:c
5=
>N_:0203B4=524;=
7466
80
B5:0
30H53:4=H
7/02/03
5
=07
9;=C0=2
=00:C
2;
80
;8254=0:
@3;B
O532494O5=2C
7/;
O3;\4:0:
9;=C0=2S
<C4=H
5
O30\4;<C6a
5OO3;\0:
9;=C0=2
@;3B^
de-&"f(gh*"-(&
ded !"hgi
(jk$*"-l$!
U^U^U E34B53a
m8]0924\0I
J .;
O3064B4=5346a
0\56<520
2/0
R[B;=2/
O3;H30CC4;=
@300
C<3\4\56
FEMLG
;@
9;B84=4=H
230B064B<B58
5=:
:<3\56<B58
4=
O5240=2C
742/
5:\5=90:
A??
F042/03
56;=0
;3
742/
93a;586524;=S
.`?n
;3
NM`G
5=:
4=
O5240=2C
742/
5:\5=90:
846453a
23592
95394=;B5
F_.?G
F042/03
56;=0
;3
742/
93a;586524;=
;3
NM`G^
U^U^T L09;=:53a
m8]0924\0CI
J .;
5CC0CC
2/0
C5@02a
5=:
@05C484642a
;@
9;B84=4=H
230B064B<B58
5=:
:<3\56<B58
4=
F?;/;32C
`US
`TG
O5240=2C
742/
5:\5=90:
A??
F042/03
56;=0
;3
742/
93a;586524;=S
.`?n
;3NM`G
5=:
F?;/;32
_G
4=
O5240=2C
742/
5:\5=90:
846453a
23592
95394=;B5
F_.?G
F042/03
56;=0
;3
742/
93a;586524;=
;3
NM`G^
U^U^W noO6;352;3a
m8]0924\0CI
J .;
0\56<520
9/5=H0C
4=
4BB<=0
O535B0203C
5C
7066
5C
O/53B59;p4=0249C
4=
2/0
O034O/0356
86;;:
;@
O5240=2C
742/
5:\5=90:
A??
;3
_.?
<=:03H;4=H
586524\0
2/035O40C
4=
9;B84=524;=
742/
9;B84=0:
4BB<=0
9/09pO;4=2
4=/48424;=^
J m\03566
C<3\4\56^
deq j#*rsf(h&g
#&g
f#"-(&#,$
U^T^U A??
5=:
2/0
9<330=2
2/035O0<249
O535:4HB
F35:4;@30b<0=9a
586524;=
tNM`u
235=C[53203456
952/0203
9/0B;0B8;64v524;=
t.`?nu
5=:
C;35@0=48G
w;36:74:0S/0O52;9066<65395394=;B5FA??G4C2/0@4@2/B;C29;BB;=B564H=5=9a742/5
B0:45= C<3\4\56;@R[ B;=2/CtUu^./02/035O0<249O535:4HB x 4=96<:4=H 2/0O;CC4860











 !
"#$%&'%#$"(#)
+#,
$-%"&
"#,".+$"(#)
/
")
(0$1"#%,
2%1(34
5-%
+66&(+.-
$(
7+#+8%7%#$
-+)
$&+,"$"(#+119
.(76&")%,
1(.(:&%8"(#+1
)$&+$%8"%);
)0&8%&9
<6+&$"+1
&%)%.$"(#
(&
$&+#)61+#$+$"(#=
(&
"#$%&'%#$"(#+1
&+,"(1(8".
6&(.%,0&%)>
)0.-
+)
.-%7(%72(1"?+$"(#
(&
+21+$"'%
$%.-#"@0%)4
A%.%#$19>)(&+B%#"2
-+)
2%%#
+,,%,
$(
$-")
6+&+,"87
+#,
"$
")
$-%
(#19
)9)$%7".
,&08
$-%&+69
3-".--+)
,%7(#)$&+$%,
+
)0&'"'+1
2%#%B"$
"#
7(,%&#
&+#,(7"?%,
)$0,"%)4
CDEFGIJ
CKGLDMGNOPQ
MDLDRPST
UVL
WXX
Y#$%&'%#$"(#
Y#,".+$"(#
Z($%#$"+119
.0&+$"'%
Z+&$"+1[%6+$%.$(79
\"7"$%,
1"'%&
,")%+)%
3"$-
8((,
&%)%&'%
]%)
5&+#)61+#$+$"(#
 
1%)"(#
^_.7
(&
`
^
`.7
]%)
Aab
\%)"(#
$(
2%
+21+$%,
+$
1%+)$
 .7
+#,
#($
8&%+$%&
$-+#
_.74
]%)
5bcd
\"'%&
.(#B"#%,e
#(
6(&$+1
'%"#
$-&(72()")
f(
g(&+B%#"2
h%$+)$+$".
,")%+)%
f(
5-%7()$3",%19
0)%,
)$+8"#8
)9)$%7
"#
[cc
")
$-%
i+&.%1(#+
c1"#".
\"'%&
c+#.%&
<ic\c=
g$+8"#8)9)$%7>
$-%
7+j(&
+,'+#$+8%
(B
3-".-
")
$-+$
"#
+,,"$"(#
$(
)$+8"#8
6+$"%#$)
"$
+1)(
,"&%.$)
7+#+8%7%#$klm4
5-%
ic\c
)$+8"#8
)9)$%7
")
)-(3#
"#
nPSNLG
I
2%1(34











  
!"#$%&
()
*+%,&-./+
0-"/",
1"2&%
0+/,&%
3*0104
56+#"/#
,-+55"7",+6"./
+/8
6%&+69&/6
5,:&8$-&;
<=>@ABC>=C=DBE
D@FEGH
IB
IJKK
L=@
JLMKFEB
CN@JBL@D
O=>
IA=P
DF>QJMNK
>BDBM@J=L
=>
@>NLDCKNL@N@J=L
JD
N
C=DDJRJKJ@GS
TB
IJKK
NKD=
BUMKFEB
CN@JBL@D
IJ@A
JD=KN@BE
KBDJ=LD
O=>
IA=P
V<WNK=LB
JD
C=DDJRKBH
QJXBL
@AB
MF>N@JXB
C=@BL@JNK
=O
@AN@
JL@B>XBL@J=LS
YAB
@N>QB@
C=CFKN@J=L
IJKKRB@A=DB
IJ@A
NEXNLMBE
EJDBNDB
O=>
IA=P
@AB
=LKG
NXNJKNRKB
JL@B>XBL@J=LD
N>B
YWZ[
=>
D=>NOBLJRS
 S\S\ VBMBL@
NEXNLMBD
JL
JPPFLB]RNDBE
NCC>=NMABD
JL
D=KJE
@FP=>
PNKJQLNLMJBD
YAB CND@OBI
GBN>D
ANXB
DBBL
C>=Q>BDD
O=>
JPPFLB]RNDBE
NCC>=NMABD
JL
D=KJE
@FP=>
PNKJQLNLMJBDH
IJ@A
<^W
NCC>=XNKD
O=>
@ABDB
NCC>=NMABD
JL
C>=D@N@B
MNLMB>
NLE
KFLQ
MNLMB>
JL
NEEJ@J=L@=
>BLNK
MBKK
MN>MJL=PN
NLE
PBKNL=PN_`]abS
cL
PBKNL=PNH
NL@J]ZYdWe
@AB>NCG
AND
RBBL
DA=IL@=EBP=LD@>N@B
N
PBEJNL
DF>XJXNK
RBLBOJ@
JL
@I=
DBCN>N@B
CANDBD
`
D@FEJBDH
R=@A
=O
IAJMA
IB>BNDD=MJN@BE
IJ@A
K=LQ]@B>P
EJDBNDB
M=L@>=K
JL
NCC>=UJPN@BKG
=LB]OJO@A
=O
CN@JBL@DS
f=>B
>BMBL@KGHNL@J]g^ 
@AB>NCG
AND
EBP=LD@>N@BE
N
DJPJKN>
EBQ>BB
=O
MKJLJMNK
NM@JXJ@G
L=@
=LKG
JL
PBKNL=PN
NLE
hJELBG
MNLMB>
RF@
NKD=
JL
KFLQ
MNLMB>H
N
EJDBNDB
@GCB
C>BXJ=FDKG
@A=FQA@
@=
RB
>BO>NM@=>G@=
NL
JPPFLB
NCC>=NMAS
WCC>BMJN@J=L
=O
@AB
>=KB
JL
EBXBK=CJLQ
@FP=>D
=O
JPPFLB]
BXNDJ=LAND
NKD=
RBBL
BXJEBLMBE
RG
J@D
JLMKFDJ=L
ND
=LB
=O
@AB
iFCEN@BEj
ANKKPN>hD
=O
MNLMB>_kbS
l=@ANL@J]g^ NLENL@J]ZYdWe@AB>NCGBLANLMBNL@J]@FP=>JPPFLJ@GRGRK=MhJLQ@FP=>
JLEFMBEJPPFLBDFCC>BDDJ=L=OMG@=@=UJMY MBKKDNLE@AB>BO=>BBUNQQB>N@JLQ@ABJPPFLB
NM@JXN@J=L@AN@PFD@OJ>D@=MMF>=OJ@D=ILNMM=>ENLEJD@A=FQA@@=RB@AB>BDFK@=O@FP=>LB=]











 !
"#$%&'#(*+,-'.
"(
"
$/-+,
0,+&,'(('(1
23'
,+4'
+*
52678
%#
%#3%9%$%#&
2:;'44
";$%<"$%+#
%(
,'0,'('#$'.
%#
$3'
(;3'-"$%;
%#
=>?@AB
D
9'4+E1
52678:-'.%"$'.
%--/#'
;3';F0+%#$
%(
%#./;'.%#
2
;'44(
"$
$3'
$%-'
+*
$3'%,
%#%$%"4
,'(0+#('
$+
"#$%&'#1
23'
4'<'4
+*
52678
%#./;$%+#
.'0'#.(+#
$3'
"-04%$/.'
+*
$3'
%#%$%"4
2
;'44
,';'0$+,
G25HI:-'.%"$'.
(%&#"4%#&1
7*$',
$3'
25H
%($,%&&','.
9J
"#$%&'#
'#;+/#$',K
52678
%(
$,"#(0+,$'.
$+
$3'
;'44
(/,*";'1
23'
($,+#&',
$3'
($%-/4"$%+#
$3,+/&3
$3'
25H
G"#.
5L!MIK
$3'
&,'"$',
$3'
"-+/#$
+*
52678
$3"$
%(
.'0+(%$'.
+#
$3'2;'44
(/,*";'1
23','*+,'K
52678
*/#;$%+#(
"(
"
(%&#"4
."-0'#',
$+
-"%#$"%#
"
;+#(%($'#$
4'<'4+*2;'44
";$%<"$%+#
%#
$3'
*";'
+*
E%.'4J
<",J%#&
;+#;'#$,"$%+#(
"#.
"**%#%$%'(
+*
4%&"#.
*+,
$3'25H1
=>?@AB
DN
OPQRSTUBV>WXBV
>UU@YB
Z[BZ\]^>YX
>_
>YV@ZBV
>Y
P
ZB``_
WX
X[B
X>UB
^a
X[B>A
>Y>X>W`
AB_]^Y_B
X^
WYX>?BYb
cde
f3%4($$3'('
($/.%'(
.'-+#($,"$'
$3'
0+$'#$%"4
*+,
"#$%:52678
G+,
"#$%
gL I
$3',"0J
$+
'#3"#;'
$3'"#$%:$/-+,
%--/#'
,'(0+#('
"4,'".J
%#
0,+;'((K
%$
;4'",4J
.+'(
#+$
E+,F
%#
$3'
-"h+,%$J
+*
0"$%'#$(123'
i/'($%+#
%(
E3'$3',
$3'
%#%$%"4
%--/#'
";$%<"$%+#
($"&'
;"#
9'
'#3"#;'.1
23'
0+$'#$%"4*+,
$3%(
E"(
%#$,%&/%#&4J
.'-+#($,"$'.
%#
"
,';'#$
0/94%;"$%+#
9J
g+($+E
'$
"4
E3+
,'0+,$'."
;"('
+*
$3'
(+:;"44'.
"9(;+0"4
'**';$
%#
"
0"$%'#$
E%$3
-'4"#+-"
$,'"$'.
E%$3
%0%4%-/-"9
"#.
,".%+$3',"0JjMk1
2'-0+,"4
"((+;%"$%+#(
E','
#+$'.
9'$E''#
$/-+,
(3,%#F"&'
"#.
"#$%9+.J,'(0+#('(
$+
$3'
;"#;',:$'($%(
"#$%&'#
lm:nop: 
%#
"..%$%+#
$+
;3"#&'(
%#
0',%03',"4:
94++.%--/#'
;'44(
"#.
%#;,'"('(
%#
"#$%9+.J
,'(0+#('(
$+
+$3',
"#$%&'#(
"*$',
"
0"$%'#$
9'%#&
$,'"$'.E%$3
"#$%:52678
E"(
$3'#
$,'"$'.
E%$3
'q$',#"4
9'"-
,".%+$3',"0J1
23'
'#3"#;'.
'**';$
*,+-"#$%:52678
(''#
"*$',
,".%"$%+#
"00'",(
$+
3"<'
9''#
./'
$+
"
9++($
'**';$
+*
$/-+,
;'44
.'"$3"#.%--/#'
($%-/4"$%+#
*+44+E%#&
.'4%<',"#;'
+*
"
$/-+,
"#$%&'#
4+".1
r$
%(
$3%(
'#3"#;'.
'**';$E'E%(3
$+
($/.J
%#
$3'
;+#$'q$
+*
%#$',<'#$%+#"4
0,+;'./,'(
*+,
s551
 1!1t r--/#'
,'(0+#('
$+
%#$',<'#$%+#"4
,".%+4+&%;"4
$,'"$-'#$(
23'"%- +*
+/,
0,+0+('.
($/.J
%(
$+
'#3"#;'
$3'
"#$%$/-+,
%--/#'
,'(0+#('
E3%;3
3"(
9''#
(3+E#$++;;/,
*+44+E%#&
%#$',<'#$%+#"4
,".%+4+&%;"4
$,'"$-'#$(1
23'
"$$,";$%<'
"(0';$
+*
$3%(
"00,+";3u
'(0';%"44J
%#
"
.%('"('
"(
0,'<"4'#$
"(
s55
u
%(
$3"$
%$
3"(
$3'
0+$'#$%"4
*+,
'#3"#;%#&
$3''**';$
+*
$,'"$-'#$(
G9+$3
Hv7
"#.
275nI
E3%;3
3"<'
"4,'".J
9''#
"00,+<'.K
3"<'
.'-+#($,"$'.
(/,<%<"4
9'#'*%$
%#
,"#.+-%w'.
($/.%'(
"#.
",'
;+--+#4J
0',*+,-'.
$3,+/&3+/$
$3';+--/#%$J1
v+44+E%#&
Hv7
"#.
275n
#';,+$%;
$/-+,
,'(/4$(
%#
$3'
,'4'"('
+*
$/-+,
"#$%&'#(E3%;3
",'
$"F'#
/0
9J
"#$%&'#:0,'('#$%#&
;'44(
G-"%#4J
.'#.,%$%;
;'44(I
"#.
E3%;3
";$%<"$'"$/-+,:(0';%*%;%--/#','(0+#('jxk1794"$'.$/-+,$%((/'3"(9''#(3+E#$+0,+-+$'
.'#.,%$%;;'44-"$/,"$%+#G"#.,'(/4$"#$2:;'44($%-/4"$+,J0,+0',$%'(Ij yK  k123%("#$%&'#











 !
"#$#%&#(&)*+#,+(%$$-
&(.,(/(0%,+
1#0%2&#3
%$+4*2.4
%1$%+(5#
)"*0#62"#&
%"#
5#"-
#//#0+(5#
(,
#"%6(0%+(,.
5(&(1$#
$#&(*,&3
%
+27*"8&)#0(/(0
(772,#
"#&)*,&#
7%-
)"#5#,+
"#02""#,+
6(&#%&#
(,
%66(+(*,+*
+"#%+(,.
6(&+%,+
7#+%&+%&#&9
:,
*+4#"
;*"6&3
<=>
%,6
?>@A
4%5#
+4#
)*+#,+(%$
+*
+2",
%)%+(#,+B&
+27*"
(,+*
%,
#,6*.#,*2&
5%00(,#9
C#5#"%$&+26(#&
4%5#
6*027#,+#6
%,
(,0"#%&#
(,
)#"()4#"%$
%,+(+27*"
(772,(+-
/*$$*;(,.
(,+#"5#,+(*,%$
"%6(*$*.(0%$
)"*0#62"#&3
)"#6*7(,%,+$-
<=>D E3
 F8 GH9
?4(&
4%&
1##,
6#7*,&+"%+#6
1*+4
(,
%,(7%$
7*6#$&
%,6
(,
427%,
&+26(#&D F3
 I3
 GH9
>-%"2
#+
%$9
#5%$2%+#6
+4#
(772,#"#&)*,&#
(,
J@@
)%+(#,+&
KLM EN
2,6#".*(,.
?>@AD OH9
?4#-
/*2,6
+4%+
>=P8&)#0(/(0
@QI8?0#$$
"#&)*,&#&
;#"#
&(.,(/(0%,+$-
#R)%,6#6
62"(,.
KS
U
E9EEE N
%,6
%/+#"
#71*$(V%+(*,
KS
UE9EEFN9?4#
6#5#$*)7#,+
*/
4(.4#"
/"#W2#,0(#&
*/
>=P8&)#0(/(0
@QI
?
0#$$&
%/+#"
+"#%+7#,+
;#"#&(.,(/(0%,+$-
%&&*0(%+#6
;(+4
+4#
(,620+(*,
*/
XGEY
,#0"*&(&
*/
+27*"
%,6
%,
(7)"*5#6
0$(,(0%$*2+0*7#
KS
U
E9EEZN9
[(V2\*&4(
#+
%$9
7#%&2"#6
0-+*+*R(0
?
0#$$
"#&)*,&#
+*
+27*"
%&&*0(%+#6
%,+(.#,&
K?>>N
(,
J@@
)%+(#,+&
2,6#".*(,.
+"#%+7#,+D ZH9
?4#-
7#%&2"#6
+4#
/"#W2#,0-*/
?>>8&)#0(/(0
?
0#$$&
1#/*"#
%,6
%/+#"
J@@
+"#%+7#,+
1-
A]:CP^?
%&&%-
(,
 F
0%&#&;4*
"#0#(5#6
?>@A3
<=>
*"
04#7*+4#"%)-9
?4#
/"#W2#,0-
*/
?>>8&)#0(/(0
?
0#$$&
;%&
/*2,6+*1#
(,0"#%&#6
(,
%$$
)%+(#,+&9
=2"+4#"7*"#3
(,021%+(*,
*/
?
0#$$&
;(+4
@?]>8I
%,+(1*6(#&
"#&2$+#6(,
%,
(,0"#%&#
*/
+4#
,271#"
*/
?>>8&)#0(/(0
?
0#$$&9
Q"*7(
#+
%$9
#5%$2%+#6
+4#
(,/$2#,0#*/
&21+*+%$
<=>
*,
+27*"8&)#0(/(0
(772,#
"#&)*,&#
(,
%
72"(,#
2"*+4#$(%$
0%"0(,*7%
K[_I`N+27*"
7*6#$D aH9
<=>
"#&2$+#6
(,
#,4%,0#6
&-&+#7(0
%,+(+27*"
?80#$$
(772,#
"#&)*,&#&%,6
+27*"
"#."#&&(*,
+4%+
;%&
%&&*0(%+#6
;(+4
(,0"#%&#6
6#,6"(+(0
0#$$
(,/($+"%+(*,
(,+*
+4#"#7%(,(,.
5(%1$#3
,*,8%1$%+#6
+27*"9
J%,&$#"#+
%$9
%&&#&&#6
+4#
&)#0(/(0
0-+*+*R(0
?
0#$$
"#&)*,&#
(,
)%+(#,+&
;(+4
7%$(.,%,+
$(5#"
+27*"&K1*+4
7#+%&+%+(0
0*$*,
0%,0#"
%,6
J@@N
;4(04
;#"#
+"#%+#6
;(+4
<=>9
C(.,(/(0%,+
+27*"8&)#0(/(0
0-+*+*R(0
?80#$$
&+(72$%+(*,
;%&
&##,3
;(+4
%
6"%7%+(0%$$-
(,0"#%&#6
+27*"
&)#0(/(00-+*$-+(0
%0+(5(+-
*/
@QaKbN
?
0#$$&
%.%(,&+
%2+*$*.*2&
$(5#"
%,6
+27*"
$-&%+#
%/+#"
<=>D FH9J("*(&4(
#+
%$9
%,%$-V#6
+27*"8&)#0(/(0
@QaKbN
?80#$$
"#&)*,&#&
(,
+;#,+-
)%+(#,+&
;(+4
J@@2,6#".*(,.
$*0*8"#.(*,%$
+4#"%)-
K#(+4#"
<=>
*"
?>@AND !H9
?4#-
/*2,6
+4%+
+4#
@QaKbN
?80#$$"#&)*,&#
;%&
(,0"#%&#6
%,63
*,
72$+(5%"(%+#
%,%$-&(&3
+4#
7%.,(+26#
*/
+4#
(772,#
"#&)*,&#;%&
+4#
*,$-
&(.,(/(0%,+
)"*.,*&+(0
/%0+*"
/*"
%
)"*$*,.#6
+27*"8/"##
(,+#"5%$
K4%V%"6
"%+(*E9!IF3
P
M
E9EFFN9
Q#&)(+#+4(&3
*,$-
%
/#;
0%&#&
*/
&)*,+%,#*2&
"#7(&&(*,
*/
7#+%&+%&#&
/*$$*;(,.
<=>
c
+4#
&*8
0%$$#6%1&0*)%$
#//#0+
c
4%5#
1##,
"#)*"+#63
)"#&27%1$-
1#0%2&#
+4(&
(772,#
"#&)*,&#
1-
(+&#$/
(&+**;#%\
+*
1#
0$(,(0%$$-
&(.,(/(0%,+D `8F H9
>
,271#"
*/
&+26(#&
4%5#
+"(#6
+*
1**&+
+4(&
%,+(8
+27*"(772,#
"#&)*,&#
/*$$*;(,.
%1$%+(*,
1-
0*71(,(,.
;(+4
%,
(772,*7*62$%+*"-
%.#,+d
e%(+V#+%$9
)"*5(6#6
)"#0$(,(0%$
)"**/8*/80*,0#)+
/*"
+4(&
(,
%
7*2&#
7*6#$
*/
)"*&+%+#
0%,0#"
2&(,. @?]>8I
1$*0\%6#
+*
%2.7#,+
+4#
(772,#
"#&)*,&#
/"*7
0"-*%1$%+(*,DFFH9
?4#
0*71(,%+(*,
+4#"%)-
"#&2$+#6
(,
XaEY
*/
(,+"%+27*"%$
@Qab
?
0#$$&
1#(,.
%,+(.#,8&)#0(/(09
?4#
#//#0+*,&#0*,6%"-
"#&)*,&#&
;%&
%&&#&&#6
1-
(,f#0+(*,
*/
+4#
&#0*,6%"-
+27*"
*,
+4#
*))*&(+#
/$%,\*/+4#
7*2&#
*,
Q%-
F
/*$$*;(,.
%1$%+(*,9
?4#
."*;+4
*/
&#0*,6%"-
+27*"&
;%&
/*2,6
+*
1#2,%//#0+#6
1-
0"-*%1$%+(*,
%$*,#3
12+
+4#
0*71(,%+(*,
+"#%+7#,+
K%,+(8@?]>I
b
<=>N
;%&
&2//(0(#,++*
&$*;
."*;+4
*"
+"(..#"
"#f#0+(*,9
:,
%66(+(*,3
&#0*,6%"-
+27*"&
;#"#
4(.4$-
(,/($+"%+#61-@QIb?0#$$&%,6@Qab?0#$$&3%,6+4#"#;%&%&(.,(/(0%,+(,0"#%&#(,+4#"%+(**/
(,+"%+27*"%$?#//#0+*"0#$$&+*?"#.2$%+*"-0#$$&30*7)%"#6;(+4#(+4#"<=>*"%,+(8@?]>I
%$*,#9g*4,&*,#+%$9&*2.4++*#,4%,0#+4#%,+(+27*"#//#0+*/<=>1-0*71(,(,.(+;(+442hC8











 !
"#$&''()*+,-*.&)/
0-('*1234/+&5&+
'*)*+6*)76
7)-&8*9,
5(3/9
-*
&)-/16/(.&)2$
:"#$;<
&)
'&+/
8/71&)= >?$@2AB
+*6*)
79/)*+71+&)*'7C
D&+/
E/1/
-1/7-/9
E&-F
GHIJ
F(AB2"#$
K&7
&)-17-('*176
&)L/+-&*)J
*1
+*'8&)7-&*)
-F/174,C
?1/7-'/)-
*5
'&+/
8/71&)=
3(8+(-7)/*(3
-('*13
E&-FGHI
7)9
F(AB2"#$
1/3(6-/9
&)
3&=)&5&+7)-6,
=1/7-/1
-('*1
=1*E-F
3(441/33&*)
7)9
/)F7)+/93(1K&K76
+*'471/9
E&-F
'&+/
-1/7-/9
E&-F
/&-F/1
GHI
*1
F(AB2"#$
76*)/C
MF/)
3(82
-F/174/(-&+
1/=&'/)3
*5
GHI
*1
F(AB2"#$
E/1/
(3/9J
-('*13
41*=1/33/9
&)
766
-1/7-/9
'&+/C
")
+*)-173-J-F/
+*'8&)7-&*)
*5
GHI
7)9
&''()*+,-*.&)/
1/3(6-/9
&)
+*'46/-/
-('*1
1/3*6(-&*)
&)
NOP*5'&+/C
?1/7-'/)-
*5
7
-('*1
E&-F
GHI
7)9
&)-17-('*176
F(AB2"#$
763*
3F*E/9
7)-&-('*1
/55/+-37=7&)3-
7
9&3-7)-
()-1/7-/9
-('*1C
?('*1251//
'&+/
75-/1
-1/7-'/)-
E&-F
GHI
7)9
F(AB2
"#$3F*E/9
&''()*6*=&+
'/'*1,
873/9
*)
-F/&1
78&6&-,
-*
1/L/+-
3(83/Q(/)-
+F766/)=/3
*5
>?$@2AB7)9
-F/
'*1/
7==1/33&K/
471/)-76
>?$@
-('*13C
H6*E
+,-*'/-1,
7)76,3&3
*5
-('*12
1/7+-&K/?
+/663
51*'
'&+/
E&-F
+*'46/-/
-('*1
1/3*6(-&*)
3F*E/9
-F7-
-1/7-'/)-
E&-F
GHI
7)9
F(AB2"#$
1/3(6-/9
&)
7
=1/7-/1
41*4*1-&*)
*5
+,-*.&)/241*9(+&)=
>R!
?
+/663
7)9
>RS
?
+/663
+*'471/9E&-F
'&+/
-1/7-/9
E&-F
GHI
*1
F(AB2"#$
76*)/C
9/)
T1*.
/-
76C
/K76(7-/9
+*'8&)7-&*)
-1/7-'/)-*5
GHI
46(3
?#GU
3-&'(67-&*)
&)
T @
-('*13
7)9
3F*E/9
-F7-
-F/
+*'8&)7-&*)
1/3(6-/9&)
571
'*1/
4*-/)-
7)-&-('*1
&''()/
1/34*)3/3
-F7)
/&-F/1
-1/7-'/)-
'*976&-,
76*)/0$V<C
 C$C! ?1/'/6&'('78
?1/'/6&'('78
:5*1'/16,
>W2@XNJ$O@;
&3
7
F('7)
"=Y$
'I8
9&1/+-/9
7=7&)3-
>?#I2!C
Z4*)?+/66
7+-&K7-&*)J
>?#I2!
/[41/33&*)
7+-3
-*
97'4/)
&''()/
1/34*)3/3
8,
>?#I2!
1/6*+7-&*)-*
-F/
+/66
3(157+/
&)
*19/1
-*
'*9(67-/
7)9
/K/)-(766,
3E&-+F
*55
?
+/66
7+-&K7-&*)C
?1/'/6&'('78
86*+.3
-F/
&)F&8&-*1,
/55/+-
*5
>?#I2!J
7)9
-F/1/5*1/
/)F7)+/3
?
+/66
7+-&K7-&*)C
?F/8&)9&)=
*5
>?#I2!
-*
&-3
-71=/-
6&=7)93
:TXC 
0>RSO<
7)9
TXC$
0>RS@<;
41*K&9/3
7
)/=7-&K/
1/=(67-*1,
3&=)76J
EF&+F
6&'&-3
?
+/66
7+-&K7-&*)C
T6*+.79/
*5
TX
8&)9&)=
-*
>?#I2!
8,
7)-&2
>?#I2!7)-&8*9&/3
763*
1/3(6-3
&)
'71./96,
/)F7)+/9
?
+/66
7+-&K7-&*)
7)9
7)-&-('*1
7+-&K&-,
&)
7)&'76'*9/63J
&)+6(9&)=
.&66&)=
*5
/3-786&3F/9
'(1&)/
3*6&9
-('*13
7)9
&)9(+-&*)
*5
41*-/+-&K/
7)-&-('*1&''()&-,C
I)-&2>?#I2!
-F/174,
F73
1/+/)-6,
8//)
3F*E)
-*
8/
7
K76&97-/9
7441*7+F
-*
+7)+/1
-1/7-'/)-
8,
-F/7441*K76
*5
-F/
'I8
&4&6&'('78
&)
$O  
5*1
-F/
-1/7-'/)-
*5
47-&/)-3
E&-F
'/-73-7-&+
'/67)*'7J
873/9
*)
$
WF73/
"""
3-(9&/3
-F7-
9/'*)3-17-/9
7
3&=)&5&+7)-
&'41*K/'/)-
*)
\B
&)
-F/5&13-27)9
3/+*)926&)/
3/--&)=3C
")
=/)/176J
-('*1
1/34*)3/
17-/3
-*
7)-&2>?#I2!
-F/174,
71/
6*EJ7441*[&'7-/6,
 OPJ
8(-
-F/
9(1786/
1/34*)3/
*1
3-786/
9&3/73/
3//)
&)
7
41*4*1-&*)
*5
47-&/)-3+7)
6/79
-*
7
3&=)&5&+7)-
41*6*)=7-&*)
*5
\BC
")
7
671=/J
3&)=6/271'
WF73/
""
-1/'/6&'('78
-1&76
&)
47-&/)-3
E&-F
79K7)+/9
1/517+-*1,
7)9]*1
1/6743/9
'/67)*'7J
*8L/+-&K/
1/34*)3/3:41&'71,
/)94*&)-;
5*66*E&)=
-1/'/6&'('78
 N
'=].=
^VD
E/1/
*83/1K/9
&)
 @
*5
$! :@C@P;
47-&/)-3
:UNP
>"_
0VCS!J
 OCN@<;C
G/34*)3/3
E/1/
9(1786/
:41/3/)-
7-
`a
'*)-F3
51*'
/)1*66'/)-;
&)
766
 @
1/34*)9/13C
I
WF73/
"""J
*4/)2678/6J
17)9*'&b/9
3-(9,
+*'471&)=
-1/'/6&'('78
 N
'=].=
^VD
:I1'
I;
-*
/&-F/1
97+7187b&)/
*1
-/'*b*6*'&9/
:I1'
T;
&)
47-&/)-3E&-F
79K7)+/9
'/67)*'7
E73
-/1'&)7-/9
5*66*E&)=
7
41/234/+&5&/9
&)-/1&'
5(-&6&-,
7)76,3&3CI-
-F/
-&'/
*5
97-7873/
6*+.J
-F/
'/9&7)
\B
:41&'71,
/)94*&)-;
E73
 $CNS
'*)-F3
&)
I1'I7)9
 OCX 
'*)-F3
&)
I1'
T
:cGd C ! @J
4dOC $X$;C
?F//55&+7+,97-75*1-1/'/6&'('7871/+*)3&3-/)-E&-F-F*3/*5-F/1/67-/9e7)9HRI2
7441*K/927)-&2>?#I2! 7)-&8*9, &4&6&'('78_-('*11/34*)3/ 17-/3 71/ =/)/1766, 6*E











 !
"#$$%&'()#*+,-
 /01
23*
*4+
%+5$&65+5
&25+%7+8
#%+
9+6+%#,,-
83%#2,+:
;4+
($(,()3)#2
)+,#6&)#
8#*#
<,+#%,-
8+)&65*%#*+
*4#*
#
5)#,,
$%&$&%*(&6
&=
$#*(+6*5
>(*4
#6
&2?+<*(7+
%+5$&65+
#68#5)#,,
()$#<*
&6
@AB
%#*+5
<#6
,+#8
*&
#
5(96(=(<#6*
$%&,&69#*(&6
&=
CBD
#68
53$$&%*
8+7+,&$)+6*
&=
*4(5
<,#55
&=
#9+6*
(6
&*4+%
*3)&%5:
E,*4&394
@4#5+
FF
#68
@4#5+
FFF
5*38(+5
&=
*%+)+,()3)#2
(6
)+*#5*#*(<
)+,#6&)#
=#(,+8
*&
)++*
*4+
$%()#%-
+68$&(6*5
&=
%+5$&65+
%#*+
#68
CBD%+5$+<*(7+,-D
*4+
8#*#
<,+#%,-
(68(<#*+
#<*(7(*-
&=
*%+)+,()3)#2
(6
)+,#6&)#D
>(*4
%+5$&65+
%#*+5#68)+8(#6
CB
5()(,#%
*&
*4&5+
&25+%7+8
(6
*4+
($(,()3)#2
*%(#,5:
G&>+7+%D
(6
<&6*%#5*
*&
*%+)+,()3)#2D
*4+%+
#%+
6&
5#=+*-
8#*#
=&%
*4+
35+
&=
($(,()3)#2
(6
GHH:
 :I:J: H,(6(<#,
+'$+%(+6<+
&=
;%+)+,()3)#2
;%+)+,()3)#2
4#5
2++6
+7#,3#*+8
(6
#
63)2+%
&=
<,(6(<#,
5*38(+5
K
#68
&7+%
 ///
$#*(+6*5
K
#68
8+)&65*%#*+8
)#6#9+#2,+
*&'(<(*(+5LIJD
I!M:
;4+EN $%&=(,+
&=
*%+)+,()3)#2
(5
<&65(5*+6*
>(*4
*4#*
&=
($(,()3)#2D
#68
>(*4
*4+
$4#%)#<&,&9-
&=
*4+
*#%9+*:
;&
8#*+D
6&
*3)&%
*-$+
&%
5*#9+
#$$+#%5
*&
2+
#55&<(#*+8
>(*4
36(O3+
EN5"+'<+$*
=&%
7(*(,(9&D
>4(<4
#$$+#%5
*&
2+
<&6=(6+8
*&
$#*(+6*5
>(*4
)+,#6&)#1:
N7+6*5
%+$&%*+8#*
#
=%+O3+6<-
&=
PQR
#68
#55+55+8
2-
*4+
(67+5*(9#*&%
#5
%+,#*+8
*&
*%+#*)+6*
",(5*+8
(6
8+5<+68(69
&%8+%
&=
=%+O3+6<-1
>+%+
8(#%%4+#D
%#54D
$%3%(*35D
=#*(93+D
6#35+#D
7&)(*(69D
#6&%+'(#D
4+#8#<4+D#28&)(6#,
$#(6D
#68
<&,(*(5:
 :I:J:IN'$+%(+6<+
(6
G+$#*(*(5SGHH
;%+)+,()3)#2
4#5
%+<+6*,-
2++6
54&>6
*&
2+
5#=+
(6
#
5*38-
(6
GHH:
;>+6*-T&6+
$#*(+6*5
>(*4
GHUT%+,#*+8
GHH
>+%+
*%+#*+8
>(*4
*%+)+,()3)#2
(6*%#7+6&35,-
#*
#
8&5+
&=
 !
)9SV9
+7+%-
W/8#-5=&%
*>&
<-<,+5:
;&'(<(*-
>#5
)#6#9+#2,+
>(*4
%+$&%*+8
*%+#*)+6*T%+,#*+8
#87+%5+
+7+6*5
#)&69X/0
&=
$#*(+6*5:
Y%#8+
Z
&%
4(94+%
#87+%5+
+7+6*5
(6<,38+8
 
<#5+
&=
$%3%(*35D
 
<#5+
&=
$3%$3%#D#68
!
<#5+5
&=
+,+7#*+8
*%#65#)(6#5+5:
;4+%+
>#5
$%+,()(6#%-
+7(8+6<+
&=
+==(<#<-:
F6
#6(6*+6*(&6T*&T*%+#*
#6#,-5(5D
(67+5*(9#*&%5
&25+%7+8
#
)+8(#6
&7+%#,,
53%7(7#,
&=
[:!
)&6*45
#68
*()+*&$%&9%+55(&6
&=
\:J
)&6*45
#5
>+,,
#5
#
%+83<*(&6
&=
4+$#*(*(5
H
7(%35
"GHU1
(6
*4+
$#*(+6*5]2,&&8D
>4(<4
>#5
#,5&
#<<&)$#6(+8
>(*4
&2?+<*(7+
+64#6<+)+6*5
&=
#6*(7(%#,
())36(*-:
E
5(96(=(<#6*
#68
$%&9%+55(7+
8+<,(6+
(6
5+%3)
GHU
7(%#,
,&#8
>#5
&25+%7+8
")+8(#6
7#,3+5^2#5+,(6+
Z:[X' /+!
<&$(+5S),
75:
8#-
 I/
Z:/I' /+J
<&$(+5S),D
_
a
:/Ib
75:
8#-
I /
 :\W' /+Z
<&$(+5S),D
_
a
:/J1:
 :I:! c3%7#,3)#2
c3%7#,3)#2
(5
#
43)#6
)&6&<,&6#,
#6*(2&8-
&=
*4+
())36&9,&23,(6
Y 
V#$$#
defghij
532<,#55:;4+
=%#9)+6*
<%-5*#,,(k#2,+
"A<1
8&)#(6
&=
83%7#,3)#2
<&6*#(65
#
*%($,+
)3*#*(&6
(6
*4+<&65*#6*
8&)#(6
&=
*4+
F9Y 
4+#7-
<4#(6
*4#*
%+83<+5
2(68(69
*&
*4+
<&)$,+)+6*
<&)$&6+6*
H O#68*4+
A<
9#))#
%+<+$*&%5
%+5$&65(2,+
=&%
)+8(#*(69
#6*(2&8-
8+$+68+6*
<+,,
)+8(#*+8
<-*&*&'(<(*-LI\M:
c3%7#,3)#2
(64(2(*5
2(68(69
&=
$%&9%#))+8
<+,,
8+#*4
,(9#68
 
"@cTl 1
*&
$%&9%#))+8
<+,,
8+#*4
 
"@cT 1
#68
HcX/:
@%&9%#))+8
8+#*4
,(9#68
 
"@cTl 1
(5
#
*%#65)+)2%#6+
())36&%+<+$*&%
>4(<4
<&6*%&,5
$+%($4+%#,
*&,+%#6<+
2-
(64(2(*(69
+==+<*&%
=36<*(&65&=
;
,-)$4&<-*+5
*%&394
+69#9+)+6*
>(*4
@cT 
%+<+$*&%
&6
#6*(9+6
$%+5+6*(69
<+,,:
E6*(T@cTl 
#6*(2&8(+5
8(%+<*,-
*#%9+*
*3)&%
<+,,5
#68
#%+
+'$+<*+8
*&
4#7+
,+55
#87+%5+
+7+6*5
(6
<&)$#%(5&6
>(*4
#6*(T@cT 
#6*(2&8(+5
*4#*
*#%9+*
+==+<*&%
;T<+,,5
(6
*4+
*3)&%
)(<%&+67(%&6)+6*:
m,&<V#8+&=@cTl >(*483%7#,3)#2(5+'$+<*+8*&%+,(+7+@cTl T)+8(#*+853$$%+55(&6&=
43)#6;T<+,,#<*(7#*(&6>(*4(6*3)&%5:F6#'+6&9%#=*)&8+,D83%7#,3)#2(64(2(*+843)#6*3)&%
9%&>*47(##;T<+,,T8+$+68+6*)+<4#6(5):@cTl (53$%+93,#*+8(6#2%&#8%#69+&=<#6<+%5











 !
"#$%'%#(%
)*+,-+./01
"#$%
-2
$3
445
+62*+77#3.
#.
738+
#.9#/'$#3.7:
;.
'
2'./*+'$#/
/'./+*1
$%+
$-83*/+<<
+62*+77#3.
3)
=>?@ 
#7
'773/#'$+9
"#$%
*+9-/+9
7-*A#A'<
'.9
'.
-.)'A3*'B<+
2*3(.37#7:
;.
$%+
2*+/<#.#/'<
7$-9#+7
+))+/$
3)
9-*A'<-8'B
3.
$%+
(*3"$%
3)
%-8'.
2'./*+'$#/
'9+.3/'*/#.38'
$-83*
/+<<
<#.+7
#.
8#/+
"'7
#.A+7$#('$+9:
>-*A'<-8'B
7#(.#)#/'.$<0
#.%#B#$+9
(*3"$%3)
$%+
2'./*+'$#/
'9+.3/'*/#.38'
/+<<
<#.+1
C=DE1
B0
-2
$3
FG5
'7
/382'*+9
$3
$%+
#73$02+?/3.$*3<
'.$#B390:
;.$%+/<#.#/'<
7$-9#+7
$3
9'$+
83*+
$%'.
HHI
7-BJ+/$7
%'A+
B++.
+.*3<<+9
'.9
$*+'$+9:
E-**+.$<0
9-*A'<-8'B
#.A+7$#('$+9
#.
K
3.(3#.(
/<#.#/'<
7$-9#+7
LH
+82<30#.(
>-*A'<-8'B
'7
83.3$%+*'20
'.9M'7/38B#.'$#3.
$%+*'20N:
O%+
8'J3*#$0
3)
$%+
/<#.#/'<
9'$'
'*+
)*38
P$-90
E>?QR?
>-*A'<-8'B?  I41
"%#/%
%'7
$%+
(*+'$+7$
.-8B+*
3)
+.*3<<+9
7-BJ+/$7:
O%#7
#7
'
=%'7+
 1
8-<$#/+.$+*
7$-90
#.
'9-<$
7-BJ+/$7
"#$%
'9A'./+9
73<#9
$-83*7
*+)*'/$3*0
$3
7$'.9'*9
$%+*'20
LR
S T47-BJ+/$7N:
='*$#'<
+))#/'/0
9'$'
'A'#<'B<+
)3*
E>?QR?>-*A'<-8'B?  I4
B'7+9
3.
U+723.7+
VA'<-'$#3.
E*#$+*#'
#.
P3<#9
O-83*7
LUVE;PON:
Q)
$%+
 FF
7-BJ+/$7
$*+'$+9
"#$%
9-*A'<-8'B
 I
8(WX(YHZ1
FF
%'A+
%'9
'$
<+'7$
3.+
237$?B'7+<#.+
9#7+'7+
'77+778+.$:
[3-*
7-BJ+/$7
LK:H5N
%'9
'B+7$*+723.7+
3)
=U:
;.
'99#$#3.1
M!
7-BJ+/$7
LG!:45N
%'9
7$'B<+
9#7+'7+:
Q)$%+ FF
7-BJ+/$7
$*+'$+9
"#$%
 I
8(WX(
YHZ1
 H 
7-BJ+/$7
LF :45N
%'9
'$
<+'7$
 
$*+'$8+.$?
+8+*(+.$DV
LO'B<+
K:M: :M? 
3)
;\
+9#$#3.
!:IN:
O%+
837$
)*+,-+.$<0
*+23*$+9
]^
 I5
3)
7-BJ+/$7NOVDV7
L'<<
(*'9+7N
"+*+
)'$#(-+1
9072.+'1
.'-7+'1
/3.7$#2'$#3.1
'.9
9+/*+'7+9
'22+$#$+:
O%+8'J3*#$0
3)
$%+7+
OVDV7
"+*+
_*'9+7
 
$3
H
#.
7+A+*#$0
'.9
8'.'(+'B<+
B0
$%+
(+.+*'<
$*+'$8+.$(-#9+<#.+7
'7
9+7/*#B+9
#.
$%+
/-**+.$
9-*A'<-8'B
7$-90
2*3$3/3<7:
_*'9+
M
3*
%#(%+*
OVDV7"+*+
.3$+9
#.
GGW FF
7-BJ+/$7
LHG:T5N:
O%+7+
+A+.$7
3//-**#.(
#.
83*+
$%'.
 
7-BJ+/$
#./<-9+99072.+'
LT
7-BJ+/$7N`
9+%09*'$#3.
LG
7-BJ+/$7N`
'B938#.'<
2'#.1
)'$#(-+1
7+27#71
#./*+'7+9'72'*$'$+
'8#.3$*'.7)+*'7+1
'.9
#./*+'7+9
('88'?(<-$'80<$*'.7)+*'7+
LM
7-BJ+/$7N`
'.9
%02+*B#<#*-B#.+8#'1
B'/X
2'#.1
2-<83.'*0
+8B3<#781
*+72#*'$3*0
)'#<-*+1
'.9
%023$+.7#3.
LH
7-BJ+/$7+'/%N:
O%+
(*'9+
M
3*
%#(%+*
OVDV7
$%'$
"+*+
/3.7#9+*+9
B0
$%+
#.A+7$#('$3*
$3
B+
*+<'$+9 $3
9-*A'<-8'B
"+*+
#./*+'7+9
'72'*$'$+
'8#.3$*'.7)+*'7+
LH
7-BJ+/$7N1
'.9
%023$%0*3#9#781
A38#$#.(1
)'$#(-+1
#.)-7#3.?*+<'$+9
*+'/$#3.1
$*323.#.1
9+%09*'$#3.1
'.9
'*$%*'<(#'L 
7-BJ+/$
+'/%N:
O*+'$8+.$?*+<'$+91
OVDV7
"+*+
*+23*$+9
)3*
KHW FF
7-BJ+/$7
LHT:G5N:
O%+837$)*+,-+.$<0
*+23*$+9
LH
3*
83*+
7-BJ+/$7N
$*+'$8+.$?*+<'$+9
OVDV7
L'<<
(*'9+7N
"+*+
)'$#(-+L  :M5N`
.'-7+'
LK:!5N`
9072.+'
LG:I5N`
9#'**%+'1
A38#$#.(1
'.9
20*+6#'
LM:G5
+'/%N`
80'<(#'LH:45N`
%023$%0*3#9#781
9+/*+'7+9
'22+$#$+1
9#aa#.+771
/3-(%1
2*-*#$-71
'.9
*'7%
LH:M5
+'/%N1'B938#.'<
2'#.1
#./*+'7+9
'72'*$'$+
'8#.3$*'.7)+*'7+1
'.9
'*$%*'<(#'
L :F5
+'/%N`
'.9
'7$%+.#'1#.)<-+.a'?<#X+
#<<.+771
+9+8'
2+*#2%+*'<1
#./*+'7+9
'<'.#.+
'8#.3$*'.7)+*'7+1
%+'9'/%+1
'.99*07X#.
L : 5
+'/%N:
R3
>@O7
%'A+
B++.
*+23*$+9:
O%+
PDV7
*+23*$+9
)3*
M
3*
83*+
7-BJ+/$7"+*+
9072.+'1
9+%09*'$#3.1
'B938#.'<
2'#.1
'.9
7+27#7:
O%*++
7-BJ+/$7
%'9
$*+'$8+.$?
*+<'$+9PDV7b
'*$%*'<(#'
L 
7-BJ+/$N`
2<+-*'<
+))-7#3.
'.9
2.+-83.#$#7
LB3$%
#.
$%+
7'8+
7-BJ+/$N`
'.98-7/-<'*
"+'X.+77
'.9
c*-<+
3-$
/3*9
/382*+77#3.d
LA+*B'$#8
$+*8N
LB3$%
#.
$%+
7'8+
7-BJ+/$N:[3*
$%+
+.$#*+
7$-90
232-<'$#3.1
.3.+
3)
$%+
9+'$%7
3*
OVDV7
*+7-<$#.(
#.
9#7/3.$#.-'$#3.
3)
9-*A'<-8'B
#.
$%#7
7$-90
"+*+
/3.7#9+*+9
*+<'$+9
$3
9-*A'<-8'B
$*+'$8+.$:
 :H:! D.$#?EO@DG
#.
/38B#.'$#3.
"#$%
'.$#?=> W=>?@ :
>-*A'<-8'B
'.9
$*+8+<#8-8'B
9'$'b
O%+*+
#7
'
73-.9
*'$#3.'<+
)3*
+A'<-'$#.(
$%+
/38B#.'$#3.
3)9-*A'<-8'B'.9$*+8+<#8-8'B)3*$%+$*+'$8+.$3)'9A'./+98'<#(.'./#+7:O%+8+/%'.#787
3)'/$#A'$#3.3)X.3".'/$#A#$07#$+7)3*EO@D?G'.9=>?@ '*+.3.?*+9-.9'.$17-((+7$#.($%'$
$'*(+$#.(B3$%2'$%"'078'0%'A+'99#$#A+3*70.+*(#7$#/'/$#A#$0eFf:











 !
"#$&'()*+,-*'+
-#$.,/0
123,4
-,.5$-*+5
'6
789: 
,+2
;":<9=>
#,?
)$$+
?#'@+
*+
/.$&4*+*&,4
?-32*$?@*-#
,
('3?$
('2$4
-'
&,3?$
-3('.
.$5.$??*'+
'6
&'4'.$&-,4
&,+&$.A
"'
2,-$B
C
&4*+*&,4
-.*,4?$(/4'0*+5
23.D,43(,)
,?
&'()*+,-*'+
-#$.,/0
@*-#
-.$($4*(3(,)
*+
,234-?
@*-#
,2D,+&$2
+'+9?(,44
&$44
43+5
&,+&$.
1EF;:;>
,+2
,2D,+&$2
?'4*2
-3('.?
@,?
*+*-*,-$2
@*-#
/.$4*(*+,.0
$66*&,&02,-,
6'.
&'()*+,-*'+
?-*44
/$+2*+5A
E*D'43(,)
/43?
*/*4*(3(,)
&4*+*&,4
2,-,G
H$?34-?
'6
E*D'43(,)
,2(*+*?-$.$2
*+
&'()*+,-*'+
@*-#
*/*4*(3(,)
6'.
?-,5$
III
'.
IJ
($,?3.,)4$B
3+.$?$&-,)4$
($4,+'(,
#,D$
.$&$+-40
)$$+
.$/'.-$2A
<-
-#$
(,K*(3(
-'4$.,-$2
&'()*+,-*'+
2'?$L (5MN5
,+-*978 
/43?
O
(5MN5
*/*4*(3(,)
$D$.0
-#.$$
@$$N?
,2(*+*?-$.$2
&'+&3..$+-40B
POQ '6/,-*$+-?
#,2
,+
')R$&-*D$
.$?/'+?$B
,44
@*-#
-3('.
.$23&-*'+
'6
STQ
'.
('.$A
<2D$.?$
$66$&-?'&&3..$2
*+
POQ
'6
/,-*$+-?
,+2
@$.$
?*(*4,.
*+
U3,4*-0
,+2
*+-$+?*-0
-'
-#'?$
')?$.D$2
@*-#*/*4*(3(,)
('+'-#$.,/0A
F$U3$+-*,4
,2(*+*?-.,-*'+
.$?34-$2
*+
,
4'@$.
.$?/'+?$
.,-$
,+2
4'@$.-'K*&*-0
.,-$A
V*-#
.$5,.2
-'
)*'(,.N$.?
/.$D*'3?40
,??'&*,-$2
@*-#
.$?/'+?$?
-'
,+-*9
;":<= '.
,+-*978 B
*+D$?-*5,-'.?
$D,43,-$2
789: 
$K/.$??*'+
*+
-3('.?
,+2
,)?'43-$
40(/#'&0-$
&'3+-?
,+2
4''N$2
6'.
.$4,-*'+?#*/?
@*-#
.$?/'+?$A
I+
/,-*$+-?
-.$,-$2
&'+&3..$+-40B
WM O/,-*$+-?
@*-#
789: X
-3('.?
.$?/'+2$2
@#$.$,?
YMCC
/,-*$+-?
@*-#
789: Z
-3('.?
.$?/'+2$2
17[TAYY
)0
\*?#$.]?
$K,&->A
I+-$.$?-*+540
#'@$D$.B
*+
-#$
?$U3$+-*,4
5.'3/B
=MS
/,-*$+-?
@#'?$-3('.?
@$.$
789: X
.$?/'+2$2
@#$.$,?
'+40
 M O
@#'
#,2
789: 9
-3('.?
.$?/'+2$2A
<)?'43-$40(/#'&0-$
&'3+-?
,-
@$$N?
P9!
@$.$
+'-
,??'&*,-$2
@*-#
.$?/'+?$
*+
-#*?
?-320A
 ACAWA ^/2,-$2
*+6'.(,-*'+
6'.
&'()*+,-*'+
'6
23.D,43(,)
,+2
-.$($4*(3(,)G
F-3208= YT;TTTTW
*?
,
/#,?$
I)
2'?$9$?&,4,-*'+
?-320
-'
$?-,)4*?#
?,6$-0B
7_M78KB
,+2
/.$4*(*+,.0
,+-*9-3('.
,&-*D*-0
'6
23.D,43(,)
X
-.$($4*(3(,)
&'()*+,-*'+
-#$.,/0
*+
/,-*$+-?
@*-#,2D,+&$2
EF;:;A
"#$
2'?*+5
?&#$234$
3-*4*`$2
*?
23.D,43(,)
$D$.0
C
@$$N?
1UC@>
'.
$D$.0=@$$N?
1U=@>
3/
-'
V$$N
PT
,+2
=S
1 C
('+-#?>B
&'()*+$2
@*-#
-.$($4*(3(,)
U=@
3/
-'V$$NC=
6'.
!
2'?$?
-#$+
$D$.0
 C
@$$N?
6'.
C
,22*-*'+,4
2'?$?
6'.
3/
-'
 C
('+-#?A
"#$
?-320*?'+5'*+5
,+2
&'+-*+3$?
-'
,&&.3$A
F-3208= YT;TTTTWG
<?
'6
CT\$)CT PB
23.D,43(,)
7_
1+
a
PP>
,+2
-.$($4*(3(,)
7_
1+
a
CW>2,-,@$.$
,D,*4,)4$
6.'(
 T
&'#'.-?
1 ,B
C,B
O,B
O)B
=B
=,B
PB
P,B
SB
,+2
Y>
6'44'@*+5
23.D,43(,)
$D$.0
=
@$$N?
1b=V>
'.
bCV
2'?*+5
*+
&'()*+,-*'+
@*-#
-.$($4*(3(,)
b=V
.$5*($+?A<+
,//.'K*(,-$40
2'?$9/.'/'.-*'+,4
*+&.$,?$
*+
7_
$K/'?3.$
1;(,K
,+2
,.$,
3+2$.
-#$&'+&$+-.,-*'+9-*($
&3.D$
6.'(
T
-'
CS
2,0?
c<^;T
CSd>
'6
)'-#
23.D,43(,)
,+2
-.$($4*(3(,)
@,?
')?$.D$2
'D$.
-#$
2'?$
.,+5$
'6
O
-'
 P
(5MN5
23.D,43(,)
b=V
,+2
 
-'
 T
(5MN5-.$($4*(3(,)
b=VA
eK/'?3.$?
6'44'@*+5
(34-*/4$
2'?$?
2$('+?-.,-$2
,&&3(34,-*'+
&'+?*?-$+-
@*-#
7_
/,.,($-$.?
$?-*(,-$2
6.'(
-#$
6*.?-
2'?$A
I-
*?
-'
)$
+'-$2
-#,-
?-$,20
?-,-$
7_
/,.,($-$.?
,.$
),?$2
'+
4*(*-$2
+3()$.?
'6
?3)R$&-?A
"#$
')?$.D$2
7_
$K/'?3.$?
'6
23.D,43(,)
,+2-.$($4*(3(,)
6'44'@*+5
&'()*+,-*'+
@$.$
&'+?*?-$+-
@*-#
.$?/$&-*D$
('+'-#$.,/0
2,-,B
*+2*&,-*+5+'
7_
*+-$.,&-*'+
)$-@$$+
-#$?$
C
,5$+-?A
<?'6\$).3,.0
CTB
CT PB
<8<
2,-,
@$.$
,D,*4,)4$
6.'(
WT
?3)R$&-?
6'.
23.D,43(,)
,+2
PO
?3)R$&-?6'.
-.$($4*(3(,)
*+
F-320
8= YT;TTTTWA
\'3.
'6
WT
?3)R$&-?
@$.$
<8<
/'?*-*D$
6'.
,+-*23.D,43(,)
,+-*)'2*$?
/'?-
-.$,-($+-A
f+$
'6
PO
?3)R$&-?
@$.$
<8<
/'?*-*D$
6'.
,+-*
-.$($4*(3(,)
,+-*)'2*$?
/'?-
-.$,-($+-A
"#$.$
@,?
+'
&4$,.
.$4,-*'+?#*/
)$-@$$+
<8<
,+2
-#$
2'?$'6$*-#$.
23.D,43(,)
'.
-.$($4*(3(,)B
,+2
+'
')D*'3?
,??'&*,-*'+
)$-@$$+
<8<
,+2
?,6$-0'.$66*&,&0A
"#$23.D,43(,)X-.$($4*(3(,)2'?$?,+2.$5*($+?$4$&-$26'.-#*??-320@$.$),?$2'+-#$
5',4'6?$4$&-*+5,+'/-*(,4&'()*+,-*'+2'?$'623.D,43(,),+2-.$($4*(3(,)-#,-@'342











 !
"#$%&()(*+#,$&
*+-.$*
()//-$((#0,
1(2345 67
&$80,(*-+*$
/-08#(#,.
$99#:+:"7
+,&
;+<$
+,
+::$/*+=%$
(+9$*"
/-09#%$>
?,0-&$-*0
-$&):$
*;$
&0(#,.
9-$@)$,:"
09
&)-<+%)8+=
*0
+%#.,
A#*;
*;$
@BA
&0(#,.
09
*-$8$%#8)8+=7
A;#%$
$,()-#,.
+,
+::$/*+=%$
2CD23E7
(+9$*"7
+,&
$99#:+:"
/-09#%$7
:0;0-*(
A$-$
,+--0A$& *0
 F
+,&
GH
8.DI.
&)-<+%)8+=
@BA>
2C
(#8)%+*#0,(
9-08
*;$
&)-<+%)8+=
80,0*;$-+/"
&+*+
#,&#:+*$&
*;+*
+
(#8#%+-
+-$+
),&$-
*;$
/%+(8+
&-).
:0,:$,*-+*#0,4*#8$
:)-<$
+*
(*$+&"(*+*$
1JKL((M
B
A$$I(6
A+(
$E/$:*$&
90%%0A#,.
=0*;
 H
8.DI.
@GA
+,&
GH
8.DI.
@BA
&)-<+%)8+=>
N;$
0=($-<$&
&)-<+%)8+=
2C
&+*+
9-08
*;$
3B OHLHHHHP
(*)&"
A$-$
A$%%
#,
%#,$
A#*;*;$/-$&#:*$&
80,0*;$-+/"
2C
&+*+
&$<$%0/$&
/-$:%#,#:+%%">
N;#(
&$80,(*-+*$(
(#8#%+-
$E/0()-$09
&)-<+%)8+=
GH
8.DI.
@BA
+,&
 H
8.DI.
@GA7
A#*;
,0
+%*$-+*#0,(
#,
2C
A;$,
&)-<+%)8+=
+,&
*-$8$%#8)8+=
1&0($(
-+,.#,.
9-08
 
*0
Q
8.DI.6
+-$
&0($&
*0.$*;$->
R;#%$
*;$
8$&#+,L8+E
+*
(*$+&"
(*+*$
1L8+E7((6
#(
$E/$:*$&
*0
=$
;#.;$-
A#*;
GH
8.DI.
@BA
1+//-0E#8+*$%"
 >F490%&6
+,&
8$&#+,
*-0).;
:0,:$,*-+*#0,
+*
(*$+&"
(*+*$
1L*-0).;7((6
#(
$E/$:*$&*0
=$
;#.;$-
A#*;
 H
8.DI.
@GA
1+//-0E#8+*$%"
 >GF490%&67
*;#(
#(
,0*
$E/$:*$&
*0
#8/+:**;$
0<$-+%%
(+9$*"
+,&
$99#:+:"
/-09#%$7
=+($&
0,
$E#(*#,.
/-$:%#,#:+%
+,&
:%#,#:+%
&+*+>
S0,0*0,#:
#,:-$+($(
#,
23E
+:*#<#*"
A$-$
0=($-<$&
A#*;
#,:-$+(#,.
&0($(
09
*-$8$%#8)8+=
-$%+*#<$*0
*;$
+:*#<#*"
0=($-<$&
#,
/+*#$,*(
*-$+*$&
A#*;
&)-<+%)8+=
80,0*;$-+/">
N;$-$
A+(
$<#&$,:$09
+).8$,*$&
23E
+:*#<#*"
-$%+*#<$
*0
&)-<+%)8+=
80,0*;$-+/"
A#*;
:08=#,+*#0,
&0($(:0,*+#,#,.
 
8.DI.
*-$8$%#8)8+=7
#,:%)(#<$
09
=0*;
*;$
 F
+,&
GH
8.DI.
&)-<+%)8+=
/%)(
 8.DI.*-$8$%#8)8+=
:08=#,+*#0,(>
2+*#$,*(*-$+*$&
A#*;
&0($(
09
*-$8$%#8)8+=
+=0<$
 
8.DI.
;+&
+
;#.;$-
-+*$
09
+&<$-($
$<$,*(
1JT(67#,:%)&#,.
&#(:0,*#,)+*#0,(
&)$
*0
JT(7
($-#0)(
JT(
1UJT(67
+,&
($<$-$
JT(>
V$*A$$,
*;$
 H8.DI.
&)-<+%)8+=
W
 
8.DI.
*-$8$%#8)8+=
+,&
 H
8.DI.
&)-<+%)8+=
W
Q
8.DI.
*-$8$%#8)8+=
:0;0-*(
*-$+*$&
+*
*;$
@GA
(:;$&)%$7
*;$
,)8=$-
09
/+*#$,*(
-$/0-*#,.
+,"
JT7
.-+&$QJT(7
UJT(7
+,&
*-$+*8$,*4-$%+*$&
JT(
A+(
;#.;$-
#,
*;$
 H
8.DI.
&)-<+%)8+=
W
Q
8.DI.*-$8$%#8)8+=
:0;0-*
*;+,
*;$
 H
8.DI.
&)-<+%)8+=
W
 
8.DI.
*-$8$%#8)8+=
:0;0-*>
J
(#8#%+-/+**$-,
A+(
,0*$&
#,
*;$
@BA
-$.#8$,(7
()..$(*#,.
*;+*7
+(
*;$
&0($
09
*-$8$%#8)8+=
#,:-$+($&+=0<$
 
8.DI.7
+
;#.;$-
-+*$
09
*-$+*8$,*4-$%+*$&
$<$,*(
8+"
=$
+,*#:#/+*$&>
X)-*;$-7
*;$UJT(9-$@)$,*%"
+**-#=)*$&
*0
#88),0*;$-+/"7
/,$)80,#*#(
+,&
:0%#*#(7
A$-$
80-$
:0880,%"
($$,#,:0;0-*(
)(#,.
$#*;$-
Q
0-
 H
8.DI.
09
*-$8$%#8)8+=
:08/+-$&
*0
*;$
 48.DI.
&0($
:0;0-*(>N0.$*;$-7
*;$($
&+*+
()..$(*
*;+*
+
:08=#,+*#0,
)(#,.
+
*-$8$%#8)8+=
&0($
09
 
8.DI.
+//$+-$&*0
8#,#8#Y$
*;$
-+*$
09
*0E#:#*"
A;$,
:08=#,$&
A#*;
&)-<+%)8+=>
J(
+
-$()%*7
+%%
:08=#,+*#0,
&0($(
)*#%#Y#,.
$#*;$-
*;$
Q
0-
 H
8.DI.
&0($(
09
*-$8$%#8)8+=
A$-$
$%#8#,+*$&
#,
*;$9#,+%&0($
($%$:*#0,>
?,:0,*-+(*7
:0;0-*(
+(($((#,.
;#.;$-
&0($(
09
&)-<+%)8+=
A#*;
+
:0,(*+,*
&0($
09
*-$8$%#8)8+=
&#&,0*(;0A
+,
#,:-$+($
#,
*;$
-+*$
09
JT(>
N;$
&+*+
()..$(*$&
*;+*
#,:-$+(#,.
&0($(
09
&)-<+%)8+=
8+"
,0*
#8/+:*
*;$
(+9$*"
09
*;$
:08=#,+*#0,
+(
8):;
+(
*;$
*-$8$%#8)8+=
&0($>
X)-*;$-7(+9$*"
&+*+
=$*A$$,
*;$
 H48.DI.
+,&
GH48.DI.
:0;0-*(
A$-$
(#8#%+-7
A#*;
,0
:;+,.$
#,
(+9$*"$<$,*(
A#*;
#,:-$+(#,.
&0($
09
&)-<+%)8+=>
?,U*)&"3B OHLHHHHP7
09
+%%
*-$+*8$,*
:0;0-*(7
*;$
:0;0-*
09
  
/+*#$,*(
*-$+*$&
#,
*;$
GH
8.DI.&)-<+%)8+=
W
 
8.DI.
*-$8$%#8)8+=
.-0)/
;+&
*;$
9$A$(*
JT(7
Z-+&$
[\
JT(7
UJT(7
+,&*-$+*8$,*&#(:0,*#,)+*#0,(&)$*0JT(7=)*(*#%%(;0A$&(*-0,.$<#&$,:$09:%#,#:+%+:*#<#*">
N;#(:0;0-*;+&+%0A$-,)8=$-09*-$+*8$,*4-$%+*$&Z-+&$[\JT(0-*-$+*8$,*-$%+*$&UJT(>
]0&0($4%#8#*#,.*0E#:#*#$(A$-$-$/0-*$&>











 !
"#$%&'&()#*
,%&(&,)%
),-&.&-*
/0
-1$
23#.)%3')4
)(2
-#$'$%&'3')4
,/'4&()-&/(
2&2
(/-
)55$)#
-/
,1)(6$7&-1
&(,#$)8&(6
2/8$8
/0
-#$'$%&'3')49
:1$
 ;<
)(2
=><'6?@6
23#.)%3')4
AB7
,/1/#-8
2$'/(8-#)-$2
/4C$,-&.$
#$85/(8$8
)-
)%%
2/8$8
/0
-#$'$%&'3')4
)(2
&(,#$)8&(6
2/8$8
/0
-#$'$%&'3')4
2&2
(/-
5#/.&2$
2$$5$#
/#
'/#$
#)5&2
#$85/(8$89
D00&,),*2)-)
8366$8-$2
-1)-
-1$
=>
'6?@6
23#.)%3')4
E
 
'6?@6
-#$'$%&'3')4
2/8$
,/1/#-
')*2$'/(8-#)-$
$A3&.)%$(-
,%&(&,)%
),-&.&-*
-/
/-1$#
2/8$
,/'4&()-&/(89
F
-/-)%
/0
;
/0
  
5)-&$(-8&(
-1$
=>
'6?@6
23#.)%3')4
E
 
'6?@6
-#$'$%&'3')4
,/1/#-
7$#$
$.)%3)4%$
0/#
$00&,),*7&-1
)-
%$)8-
G
7$$@8
/0
0/%%/7<359
H0
-1$8$I
-1$#$
7$#$
=
5)-&$(-8
JB>KL
7&-1
5)#-&)%
#$85/(8$J"MLI
 
5)-&$(-
J=>KL
7&-1
8-)4%$
2&8$)8$
JNOLI
)(2
 
5)-&$(-
J=>KL
7&-1
5#/6#$88&.$
2&8$)8$J"OL9
J:1$
0&0-1
5)-&$(-
1)2
/(%*
)
8&(6%$
8,)(I
71&,1
7)8
,/(23,-$2
/3-8&2$
-1$
7&(2/7
0/#-1$8$$.)%3)-&/(89L
F22&-&/()%%*I
/0
)%%
,/1/#-8I
-1$
=>
'6?@6
23#.)%3')4
E
 
'6?@6
-#$'$%&'3')4
2/8$
,/1/#-
1)2
-1$0$7$8-
FD8I
P#)2$
QR
FD8I
NFD8I
)(2
-#$)-'$(-
2&8,/(-&(3)-&/(8
23$
-/
FD8I
43-
8-&%%
81/7$28/'$
$.&2$(,$
/0
,%&(&,)%
),-&.&-*9
F%-/6$-1$#I
-1$
2)-)
8366$8-$2
-1)-
)
=>
'6?@6
23#.)%3')4
E
 
'6?@6
-#$'$%&'3')4
2/8$
,/'4&()-&/(
81/3%2
4$
8$%$,-$2
0/#
03#-1$#
2$.$%/5'$(-9
 9=9S M)-&/()%$
0/#
T&#)%
U$5)-&-&8
N-32&$8
)(2
N5$,&0&,)%%*
0/#
U$5)-&-&8
V
N3#0),$
F(-&6$(
)(2
U$5)-&-&8
V
W''3($
X/(&-/#&(6
F(-&<UYT
85$,&0&,
&''3($
#$85/(8$8
)8
7$%%
)8
)
#$23,-&/(
&(
U$5)-&-&8
Y
.&#)%
%/)2
1).$
4$$(
2$8,#&4$2&(
&(
5)-&$(-8
7&-1
,1#/(&,
UYT
&(0$,-&/(
)(2
UYY
-#$)-$2
7&-1
)(-&<Y:ZFB
-1$#)5*
J2$,%&($&(
8$#3'
UYT
.&#)%
%/)2
0#/'
'$2&)(
.)%3$8[
4)8)%
\9SG] >$;
,/5&$8?'%
-/
'$2&)(
.)%3$8/(2)*
 =>
/0
\9>=] >$B
,/5&$8?'%I
5^>9>=_
.89
2)*
= >
 9`!] >$\
,/5&$8?'%I
5^>9>BL_
&(
)22&-&/(-1#$$
5)-&$(-8
2$'/(8-#)-$2
)
,/'5%$-$
.&#)%
#$85/(8$
0/#
-1$
23#)-&/(
/0
-1$
0/%%/7<
35a=Sb9
:1$)(-&.&#)%
$00$,-
/0
Y:ZF<B
4%/,@)2$
&(
5)-&$(-8
7&-1
,1#/(&,
UVT
&(0$,-&/(
&8
3(@(/7(9
U$5)-&-&8$
)(-&6$(
JUV$F6L
&8
)
')#@$#
/0
.&#)%
#$5%&,)-&/(
)(2
&(0$,-&.&-*
-1)-
&8
383)%%*
)88/,&)-$2
7&-1
)(2
),-&.$
%&.$#
2&8$)8$9
U$5)-&-&8
V
83#0),$
)(-&6$(
JUV8F6L
&8
)
5#/-$&(
/(
-1$
83#0),$/0
-1$
1$5)-&-&8
V
.&#389
W-8
5#$8$(,$
&2$(-&0&$8
5)-&$(-8
7&-1
,1#/(&,
&(0$,-&/(9
Y:ZF<B
4%/,@)2$&(
,*(/'/%638
'),)A3$8
$(1)(,$2
)(-&4/2*
#$85/(8$
-/
1$5)-&-&8
V
83#0),$
)(-&6$(
JUV8F6La=Gb9
W(-$#$8-&(6%*I
5/%*'/#51&8'8
/0
Y:ZF<B
1).$
4$$(
)88/,&)-$2
7&-1
,1#/(&,
1$5)-&-&8V
)(2
Y
&(0$,-&/(a=!I
\>b9
:1$
'$,1)(&8'8
4$1&(2
-1$8$
$.$(-8
&'5%*
)(
$]&8-&(6
%&(@
4$-7$$(Y:ZF<B
),-&.&-*
)(2
1$5)-&,
.&#)%
5)-1/6$($8&8
-1)-
81/3%2
4$
$]5%/&-$2
&(
2$-)&%
0/#
-1$#)5$3-&,
4$($0&-9
:1$
5/53%)-&/(
/0
UYY
5)-&$(-8
7&-1
,1#/(&,
1$5)-&-&8
V
.&#38
JUVTL
&(0$,-&/(7&%%
5#/.&2$
)(
$],$5-&/()%
/,,)8&/(
-/
8&'3%-)($/38%*
-$8-
-1$
)(-&<-3'/#)%I
&''3($
)(2)(-&.&#)%
$00$,-
/0
-#$'$%&'3')49
 9=9G c38-&0&,)-&/(
0/#
:3'/#
V&/58&$8
d1&%8--1$
5#$,%&(&,)%
2)-)
8366$8-
&'5/#-)(-
&''3($<#$63%)-/#*
$00$,-8
/0
#)2&)-&/(
-#$)-'$(-
/(
-3'/#8I7&-1
5/-$(-&)%
0/#
)'5%&0&,)-&/(
7&-1
&''3($
,1$,@5/&(-
-1$#)5*I
-1$
$00$,-
/(
13')(8
&8#$)%%*3(@(/7(9
P&.$(
-1)-
-1&8
&8
$88$(-&)%%*
)
8')%%
5&%/-
8-32*
$.)%3)-&(6
0$)8&4&%&-*
)(2
8)0$-*71/8$
($]-
8-$5
&(
2$.$%/5'$(-
e
&0
8)0$
)(2
0$)8&4%$
)8
5$#
-1$
5#&')#*
$(25/&(-
e
7&%%
'/8-%&@$%*4$)%)#6$##)(2/'&f$28-32*I&-&88,&$(-&0&,)%%*&'5/#-)(--//4-)&()8'3,1
&(0/#')-&/()4/3--1$-#$)-'$(-$00$,-9:1&8')*%$)2-/)%-$#$2)(2&'5#/.$22$8&6(/0-1$($]-
8-32*9:1$4$8-8-#)-$6*0/#2/&(6-1&8&87&-1-3'/#4&/58&$8&(/#2$#-/$.)%3)-$2&''3($,$%%











 !
"#$"%&'(&")#
+,-./0
1234%%56
7-8,9:
;)<4=4'6
"$
(
>(&"4#&
?(5
&43?#"3(%%@
A")>5"(A%4
B"54(54
AC&
&?4"#&4'=4#&")#(%
'(B")%)D"5&
?(5
3)#34'#5
&?(&
>C'5C"#D
&?4
A")>5@
"#3'4(545
&?4
'"5E
&)
(A)=4
(=4'(D46)'
"$
>C'5C"#D
&?4
A")>5@
3'4(&45
(BB"&")#(%
%)D"5&"3(%
3)F>%"3(&")#5
+(=("%(A"%"&@6
>'42
(#45&?45"(
'4GC"'4F4#&5
4&3:9
<?"3?
3(C54
B4%(@5
)'
"#3)#=4#"4#34
&)
(#
C#'4(5)#(A%4
B4D'446
<4
<"%%$)'D)(&
"#=45&"D(&)'
B"53'4&")#:
H: :I J(&")#(%
$)'
F"3')
A")F4
(#(%@5"5
1?4'4%(&")#5?">
A4&<44#
&?4
DC&
$%)'(
(#B
&?4
"FFC#4
5@5&4F
"5
(
3)F>%4K
(#B
"#&'"DC"#D
)#4
&?(&#44B5
&)
A4
B"5543&4B
(#B
3?('(3&4'"L4B
"#
&?4
B"54(54
54&&"#D:
1?4
DC&
F"3')A")&(
"5
E#)<#
&)($$43&"FFC#4
'45>)#545
A@
"#$%C4#3"#D
"##(&4
(#B
(B(>&"=4
"FFC#"&@6
&"55C4
'4>("'6
4&3:
7C'"#45&CB"45
C5"#D
F"34
<"&?
54%43&"=4
"FFC#4
B4$"3"4#3"45
?(=4
$)C#B
&?(&
A)&?
"##(&4
(#B
(B(>&"=4"FFC#4
34%%5
(>>4('
&)
5?(>4
&?4
3)F>)5"&")#
)$
&?4
DC&
F"3')A")&(:
M%&4'(&")#5
"#
&?4
DC&F"3')A")&(
3)F>)5"&")#6
$'4GC4#&%@
'4$4''4B
&)
(5
B@5A")5"56
('4
(55)3"(&4B
<"&?
&?4
B4=4%)>F4#&
)$
(%%4'D"45
(#B
"#$%(FF(&)'@/(C&)"FFC#4
B"54(5456
"#3%CB"#D
"#$%(FF(&)'@
A)<4%
B"54(54+NO-96
'?4CF(&)"B
('&?'"&"5
+JM9
(#B
1H-6
"#
?CF(#5
+7"3')A")F4
(#B
M#&"3(#34'
NFFC#)5C'=4"%%(#34
PQHR:
H: :H!,C''4#&
5&(&C5
)$
HQ2,2!H !
(#B
'(&")#(%4
$)'
&?"5
#4<
>')&)3)%
+(5
)$
7('3?
HH6
 !HS9:
1?43C''4#&
5&(&C5
)$
T,N
HQ2,2!H !
"5
(5
$)%%)<5:
U4
A4D(#
4#')%%F4#&
)#
VC%@
 .&?6
 !HQ:
N#
&)&(%6TW.H
>(&"4#&5
?(=4
A44#
4#')%%4B
(3')55
.
3)?)'&5
(5
5?)<#
+TWQ 
<"&?
;,,X
TWI
<"&?
3?)%(#D")3('3"#)F(9:
Y$
&?4
TWQ 
>(&"4#&5
<"&?
;,,6
TW.
?(=4
A44#
C#4=(%C(A%46
?(="#D
3)F4
)$$5&CB@&'4(&F4#&
$)'
4"&?4'
&)K"3"&@
)'
B"54(54
>')D'455")#
<"&?"#
&?4
$"'5&
$4<
<44E5
)$
&'4(&F4#&:
1'4(&F4#&
)=4'(%%
?(5
A44#
<4%%
&)%4'(&4B:
T)
-Z1
<(5
4#3)C#&4'4B
(&
(#
"#"&"(%
F"#"
B)54453(%(&")#
)$
Q:[FD/ED
5)
<4
>')344B4B
&)
&?4
'43)FF4#B4B
&'4F4%"FCF(A
B)54
)$
H!FD/ED:7)5&
3)FF)#
&)K"3"&@
<(5
D'(B4
H/ 
>'C'"&C5:
Y#4
>(&"4#&
B4=4%)>4B
>C%F)#"&"5
(#B
<(5&(E4#
)$$
5&CB@
AC&
'4F("#4B
B"54(542$'44
(&
HSF:
N#
&)&(%
#WQ
>(&"4#&5
B"53)#&"#C4B
&?4'(>@
BC4&)"FFC#42'4%(&4B
(B=4'54
4=4#&5
+>#4CF)#"&"56
3)%"&"56
(B'4#(%
"#5C$$"3"4#3@9
<?"3?
"5
3)#5"5&4#&
<"&?
<?(&
<)C%B
A4
4K>43&4B
$')F
5"#D%42(D4#&
"FFC#4
3?43E>)"#&
4K>4'"4#34:
U4
?(=4(%5)544#
4="B4#34
)$
4$$"3(3@
<"&?
(
\J
'(&4
)$
 Q:[]
(#B
>')%)#D4B
5&(A"%"&@
+^S
F)#&?59
"#(#(BB"&")#(%
 Q:[]:
_"=4#
&?4
3)#&4K&
)$
;,,
`
D4#4'(%%@
(
>))'%@
'45>)#5"=4
&CF)'
&@>4
`
&?454'45C%&5
('4
4#3)C'(D"#D:
1?4$"4%B?(5
F)=4B
)#
(
%"&&%4
D"=4#
&?4
'434#&%@
>'454#&4B
B(&(
5?)<"#D
?"D?%@
4#3)C'(D"#D
(#B
B'(F(&"3'45C%&5
$)'
#"=)%CF(A
+(#&"2\-H
&?4'(>@9
"#
;,,:
O(54B
)#
&?"5
"&
"5
%"E4%@
&?(&
#"=)%CF(A
<"%%
3?(%%4#D4
&?4
5&(&C5
)$
5)'($4#"A
(5
&?4
$')#&2%"#4
+(#B
)#%@9
)>&")#
$)'
&?"5
B"54(54:J(#B)F"L4B
&'"(%5
('4
)#D)"#D:
a=4#
"$
&?"5
)33C'5
?)<4=4'6
(#B
<?"%4
3)F>%4&4
'45>)#545<4'4
544#
"#
&?4
#"=)%CF(A
5&CB@6
&?4
F(b)'"&@
)$
>(&"4#&5
B"B
#)&
544F
&)
B4'"=4
A4#4$"&:1?4
3C''4#&
'454('3?
$)3C5
)$
&?4
$"4%B
"5
)#
3)FA"#(&")#56
4"&?4'
)$
&<)
B"$$4'4#&
"FFC#)&?4'(>"45
)'
"FFC#)&?4'(>@
3)FA"#4B
<"&?
#)#2"FFC#)&?4'(>@:
Y#4
)$
&?4
5&'"E"#D
&?"#D5&?(&
<4
?(=4
544#
"#
)C'
)<#
5&CB@
5)
$('
"5
&?(&
(#&"2,1ZM.
&?4'(>@
+<"&?
&'4F4%"FCF(A9
"5
3(>(A%4
)$
B'"="#D
1234%%
"#$"%&'(&")#
"#&)
&?4
&CF)'PQ R:
N#
(3&C(%
$(3&6
A(54B
)#$C'&?4'
(#(%@5"5
&?(&
<4
?(=4
>4'$)'F4BPQQR
"&
(>>4('5
&?(&
&?"5
)33C''4#34
"5
(
>'4'4GC"5"&4
$)''45>)#54
&)
&'4F4%"FCF(A
"#
;,,:
;)<4=4'6
&?4
3)#34>&
)$
\-ZH2F4B"(&4B
c(B(>&"=4
'45"5&(#34d`
":4:
'45"5&(#34
4F4'D"#D
BC4
&)
\-ZH
C>'4DC%(&")#
543)#B('@
&)
"#&4'$4')#2D(FF(
`
F4(#5&?(&'45>)#545('4B45&"#4B&)A45?)'&2%"=4B:1?"5?(5A44#)C'4K>4'"4#346<"&?)#%@)#4
)$)C'[\J5%(5&"#D%)#D4'&?(#)#4@4(':,)#=4'54%@63)FA"#4B"FFC#43?43E>)"#&"#?"A"&")#6
<"&?&?4(BB"&")#)$(#&"2\-H/\-ZH&?4'(>@3(#)=4'3)F4&?"5(#B?(5B4F)#5&'(&4B"#3'4(54B











 !
"#$%$"&#()*+,%*)
(&-)*
$%
.)#&%,.&/
0)
1,2#3
-4)()5,()
#$6)
-,
,+)%
%)1
",4,(-*
14$"4
",.7$%)&%-$89:;!
-4)(&+<
=32(>&#2.&7?
1$-4
&%-$8@A;BC
=-().)#$.2.&7?/
A4)",.7$%&-$,%
,5
-().)#$.2.&7
&%3
32(>&#2.&7
4&*
7))%
-)*-)3
$%
&
3,*)8)*"&#&-$,%
*-23<
+)(5,(.)3
7<
B*-(&D)%)"&
).+#,<$%E
3,*)
(&%E)*
,5
!8!F.EG6E
HC1))6*
=-().)#$.2.&7?
&%3
!F8 F.EG6E
H 8C1))6*
=32(>&#2.&7?/
9&-$)%-*
-()&-)3
$%
-4)
 F
.EG6E
32(>&#2.&7
I
!
.EG6E
-().)#$.2.&7
E(,2+
4&3
-4)
5)1)*-
BJ*K
L(&3)
MN
BJ*K
OBJ*K
&%3
-()&-.)%-
3$*",%-$%2&-$,%*
32)-,BJ*K
72-
*-$##
*4,1)3
*-(,%E
)>$3)%")
,5
"#$%$"&#
&"-$>$-</
A4$*
",4,(-
4&3
&
#,1)(
%2.7)(
,5-()&-.)%-8()#&-)3
L(&3)
MN
BJ*
,(
-()&-.)%-
()#&-)3
OBJ*/
P,
3,*)8#$.$-$%E
-,Q$"$-$)*
1)()
()+,(-)3/A4$*
$*
-4)
3,*)
#)>)#
-4)
",.+&%<
$*
7($%E$%E
5,(1&(3/
B#*,K
,5
%,-)K
9R
&%&#<*$*
$%3$"&-)3,%#<
.$%,(
$.+&"-
,5
7,3<
1)$E4-
=0A?
,%
9R
,5
7,-4
&E)%-*
*,
-,
.$%$.$S)
)((,(*
&%35,()&*)
,5
2*)
-4)
",.+&%<
4&>)
.,>)3
-,
&
5$Q)383,*)
*"4)32#)
,5
!TFF
.E
UC0
32(>&#2.&7
=)H2$>&#)%-
-,
 F
.EG6E
UC0?
&%3
VT
.E
UC0
-().)#$.2.&7
=)H2$>&#)%-
-,
!
.EG6EUC0?/
!/ /!!W)E&(3$%E
()*)&("4
%&-2()
,5
-4)
XW
+(,")32()*
04$#)WYB
&%3
"(<,&7#&-$,%
&()
&++(,>)3K
*-&%3&(3
,5
"&()
+(,")32()*
5,(
-4)*)
"&%")(
-<+)*K
-4)$%-)%-
,5
-4)$(
2*)
$%
-4$*
+(,-,",#
$*
*-($"-#<
()*)&("4/
A4)
&7#&-$>)
+(,")32()
1$##
7)
+)(5,(.)3
$%
&
*27-,-&#
5&*4$,%
=+)(
(&3$,#,E$*-
Z23E).)%-?
$%
,(3)(
-,
*-$.2#&-)
&%
$..2%)
()*+,%*)K(&-4)(
-4&%
",.+#)-)
)(&3$"&-$,%
,5
-4)
#)*$,%
&*
+)(
*-&%3&(3
,5
"&()
$%3$"&-$,%/
A4)
AB@J4,1)>)(
1$##
7)
&*
+)(
*-&%3&(3
,5
"&()
=[@;@
[
+&-$)%-*?/
B##
+(,")32()*
1$##
,(
.&<
7)
+)(5,(.)3
2%3)(
@A
E2$3&%")/
\ ]^_`_a_^_bc
eff]ffg]hb
ehi
]hjk^^g]hb
\lm ]^_`_a_^_bc
nj_b]j_e
 /!/! X%"#2*$,%
@($-)($&
 /!/!/!9&-$)%-*
.2*-
4&>)
4$*-,+&-4,#,E$"&#
",%5$(.&-$,%
,5
4)+&-,")##2#&(
"&("$%,.&
=o@@?
,(
7$#$&(<
-(&"-
"&("$%,.&
=[A@?
7<
-4)
;&7,(&-,(<
,5
9&-4,#,E<
,5
-4)
P@X
+($,(
-,
)%-)($%E
-4$*
*-23<
pW
4$*-,+&-4,#,E$"&#
",%5$(.&-$,%
,5
"&("$%,.&
$%
-4)
*)--$%E
,5
"#$%$"&#
&%3
(&3$,#,E$"&#
"4&(&"-)($*-$"*
14$"4K
-,E)-4)(
1$-4
-4)
+&-4,#,E<K
&()
4$E4#<
*2EE)*-$>)
,5
&
3$&E%,*$*
,5
o@@
=,(
7$#$&(<
-(&"-
"&("$%,.&?/
Y$7(,#&.)##&(
>&($&%-
$*
&#*,
&##,1)3/
A4)
-)(.
[A@
$%"#23)*
$%-(&8
,(
)Q-(&4)+&-$"
"4,#&%E$,"&("$%,.&K
E&##7#&33)(
"&%")(
,(
&.+2##&(<
"&%")(/
 /!/!/ 9&-$)%-*
.2*-
4&>)
3$*)&*)
-4&-
$*
%,-
&.)%&7#)
-,
+,-)%-$&##<
"2(&-$>)
()*)"-$,%K
-(&%*+#&%-&-$,%
,(
&7#&-$,%/
o@@
+&-$)%-*
.2*-
4&>)
+(,E()**)3
,%K
7))%
$%-,#)(&%-
-,K
,(
()52*)3
+($,(
*,(&5)%$7
-4)(&+</
9&-$)%-*
1$-4
[A@
.2*-
4&>)
()")$>)3K
7))%
$%-,#)(&%-
,5
,(
()52*)3
&-
#)&*-
,%)
#$%)
,5
"4).,-4)(&+</
 /!/!/q9&-$)%-*
.2*-
4&>)
.2#-$+#)
-2.,(
#)*$,%*
=&-
#)&*-
 ?r
,%)
5,(
-4)
&7#&-$,%
+(,")32()
&%3
&%,-4)(
5,(
)>&#2&-$,%
#,"&-)3
,2-*$3)
-4)
+(,+,*&#
&7#&-$,%
S,%)/
 /!/!/C:$*)&*)
.2*-
7)
-)"4%$"&##<
&.)%&7#)
-,
-(&%*4)+&-$"
&(-)($&#
"4).,).7,#$S&-$,%
=AB@J?
=o@@
+&-$)%-*
,%#<?K
(&3$,5()H2)%"<
&7#&-$,%
=WYB?K
,(
"(<,&7#&-$,%/
J&"4
"&*)
1$##
7)
3$*"2**)3
&-
LX
-2.,(
7,&(3
1$-4
$%-)(>)%-$,%&#
(&3$,#,E</
9&-$)%-*
.2*-
4&>))>&#2&7#)3$*)&*)/
 /!/!/TJ@pL+)(5,(.&%")*-&-2*F8 =*))ess]hi_te?











  
 !"!"!#$%'()*+
,(++-./(/
(/
0+*/*123
042(*12
56/2
-4)*
4
7-('89:6;-
<=>?
,'4//(%(,42(.1
@/**
ABBCDEFG
IJ!
 !"!"!?<;*
K"L
M*4+/
 !"!"!L:42(*12/
56/2
-4)*
1.+54'
.+;41
418
54++.N
%61,2(.1
4/
8*%(1*8
O*'.NP
'*6Q.,M2*/
K
R3SSS=5,T
4O/.'62*
1*62+.0-('
,.612 K
"3SSS=5,T
0'42*'*2/
U
#S3SSS=5,T
2.24'
O('(+6O(1
$%
,(++-./(/
0+*/*12P
:4+2
.%
7-('8
:6;-
+*V6(+*5*12
$%
1.
,(++-./(/P
O('(+6O(1
/-.6'8
O*
W
 
X
YTZ
/*+65
4'O65(1
$%
,(++-./(/
0+*/*12P
:4+2
.%
7-('8
:6;-
+*V6(+*5*12
$%
1.
,(++-./(/P
4'O65(1
/-.6'8
O*
U
 ![;=8'
:42(*12/
4+*
*'(;(O'*
N(2-
<T\
.+
<]\
60
2.
[
X
YTZ!
,+*42(1(1*
^
"![X
(1/2(262(.1
600*+
'(5(2
.%
1.+54'
_`
,+*42(1(1*
,'*4+41,*
K
a[
5T=5(1="!?R
5 
%.+
042(*12/
N(2-
,+*42(1(1*
'*)*'/
4O.)*
(1/2(262(.14'
1.+54'
 !"!"!b:42(*12/
56/2
-4)*
+*,.)*+*8
%+.5
41M
4,62*
2.X(,(2M
+*'42*8
2.
0+(.+
2-*+40M3
(1,'68(1;
/6+;*+M!
\.X(,(2M
/-.6'8
O*
W
;+48*
"
.+
+*26+1*8
2.
O4/*'(1*!
 !"!"!"S:42(*12/
56/2
1.2
-4)*
.2-*+
(1)4/()*
54'(;141,(*/
N(2-(1
2-*
04/2
[
M*4+/
@N(2-
2-*
*X,*02(.1
.%
1.195*'41.54
/Q(1
,41,*+/3
1.19(1)4/()*
O'488*+
,41,*+
.+
'.,4'(c*8
0+./242*
,41,*+
%.+
N-.5
/M/2*5(,
2-*+40M
(/
1.2
+*V6(+*8J!
 !"!"!"":42(*12
56/2
O*
4O'*
2.
618*+/2418
418
N(''(1;
2.
/(;1
4
N+(22*1
(1%.+5*8
,.1/*12
8.,65*12!
 !"!"!" d)(8*1,*
.%
0./295*1.046/4'
/2426/
.+
1*;42()*
6+(14+M
.+
/*+65
0+*;141,M
2*/2
%.+
%*54'*
0+*95*1.046/4'
042(*12/!
e.5*1
N(''
O*
,.1/(8*+*8
0./295*1.046/4'
(%
2-*M
-4)*
O**1
45*1.++-*(,
%.+
" 
5.12-/
N(2-.62
41
4'2*+142()*
5*8(,4'
,46/*!
\-*
%.''.N(1;
4;*9/0*,(%(,
+*V6(+*5*12/
400'MP
fe.5*1
^[S
M*4+/
.%
4;*
N.6'8
O*
,.1/(8*+*8
0./295*1.046/4'
(%
2-*M
-4)*
O**1
45*1.++-*(,
%.+
" 
5.12-/
.+
5.+*
%.''.N(1;
,*//42(.1
.%
*X.;*1.6/
-.+5.14'
2+*425*12/
418
(%
2-*M
-4)*
'62*(1(c(1;
-.+5.1*
418
%.''(,'*9/2(56'42(1;
-.+5.1*
'*)*'/
(1
2-*
0./295*1.046/4'
+41;*
%.+
2-*
(1/2(262(.1
.+
618*+N*12
/6+;(,4'
/2*+('(c42(.1
@O('42*+4'
..0-.+*,2.5M
.+
-M/2*+*,2.5MJ!
fe.5*1
Ugh
M*4+/
.%
4;*
N.6'8
O*
,.1/(8*+*8
0./295*1.046/4'
(%
2-*M
-4)*
O**1
45*1.++-*(,
%.+
" 
5.12-/
.+
5.+*
%.''.N(1;
,*//42(.1
.%
4''
*X.;*1.6/
-.+5.14'
2+*425*12/3-48+48(42(.19(186,*85*1.046/*N(2-'4/25*1/*/K"M*4+4;.3-48
,-*5.2-*+40M9(186,*85*1.046/*N(2-'4/25*1/*/K"M*4+4;.3.+618*+N*12/6+;(,4'











 !
"#$%&'&()#&*+
-.&')#$%)'
**/0*%$1#*234
.&')#$%)'
")'/&+5$1#*23
*%
03"#$%$1#*236
78.9$1#
&"
:&''&+5
)+;
).'$
#*
1*2/'3
:&#0
#0$
/%*#*1*'
<*%
#0$
;8%)#&*+
*<
#0$
"#8;3
&+1'8;&+5
8+;$%5*&+5
#%$)#2$+#
)+;
"10$;8'$;
=&"&#"
)+;
$>)2&+)#&*+"
&+1'8;&+5
<*''*:
8/6
 6?6?6?!@*;3
:$&50#
A!BC5
 6?6 D>1'8"&*+
E%&#$%&)
 6?6 6?F)#&$+#"
:0*
0)=$
0);
"#)+;)%;
*<
1)%$
10$2*#0$%)/34
')%5$
<&$';
%);&*#0$%)/34
*%
2)9*%
"8%5$%3
28"#
:)&#
 
:$$C"
/%&*%
#*
$+#$%&+5
#0$
"#8;36
G*%
%$1$+#
$>/$%&2$+#)'
#0$%)/&$"4
)
 HI;)3
/$%&*;
*<
#&2$
28"#
$')/"$
.$<*%$
#%$)#2$+#6
 6?6 6 F)#&$+#"
:0*
0)=$
8+;$%5*+$
/%&*%
'&=$%
#%)+"/')+#)#&*+
)%$
&+$'&5&.'$6
 6?6 6!F)#&$+#"
:&#0
C+*:+
.%)&+
2$#)"#)"$"
:&''
.$
$>1'8;$;
<%*2
#0&"
1'&+&1)'
#%&)'
.$1)8"$
*<
#0$&%
/**%
/%*5+*"&"
)+;
.$1)8"$
#0$3
*<#$+
;$=$'*/
/%*5%$""&=$
+$8%*'*5&1
;3"<8+1#&*+
#0)#
:*8';
1*+<*8+;
#0$
$=)'8)#&*+
*<
+$8%*'*5&1
)+;
*#0$%
);=$%"$
$=$+#"6
 6?6 6JK+1*+#%*''$;
&+#$%18%%$+#
&''+$""
&+1'8;&+54
.8#
+*#
'&2&#$;
#*4
*+5*&+5
*%
)1#&=$
"3"#$2&1
&+<$1#&*+4
"32/#*2)#&1
1*+5$"#&=$
0$)%#
<)&'8%$4
8+"#).'$
)+5&+)
/$1#*%&"4
1)%;&)1
)%%03#02&)
-$>1'8;&+5
&+"&5+&<&1)+#
"&+8"
.%);31)%;&)
)+;
"&+8"
#)1031)%;&)L
*%
/"310&)#%&1
&''+$""M"*1&)'
"&#8)#&*+"
#0)#
:*8';
'&2&#
1*2/'&)+1$
:&#0
"#8;3
%$N8&%$2$+#"6
 6?6 6OP&"#*%3
*<
10%*+&1
)8#*&228+$
;&"$)"$
-$6564
Q;;&"*+R"
;&"$)"$4
28'#&/'$
"1'$%*"&"4
S%)=$"R
;&"$)"$4
P)"0&2*#*R"
#03%*&;&#&"4
%0$82)#*&;
)%#0%&#&"4
03/*/03"&#&"4
$#16L
:&#0
"32/#*2)#&1
;&"$)"$
:&#0&+
#0$
!
3$)%"
.$<*%$
%)+;*2&()#&*+6
T*#$U
Q1#&=$
=&#&'&5*
*%
)
0&"#*%3
*<
=&#&'&5*
:&''
+*#
.$
)
.)"&"
<*%
$>1'8"&*+6
 6?6 6VW$2$+#&)
*%
"&5+&<&1)+#'3
)'#$%$;
2$+#)'
"#)#8"
#0)#
:*8';
/%*0&.&#
#0$
8+;$%"#)+;&+5
*%
%$+;$%&+5
*<
X+<*%2)#&*+
)+;
E*+"$+#
)+;
1*2/'&)+1$
:&#0
#0$
%$N8&%$2$+#"
*<
#0$
/%*#*1*'6
 6?6 6YW&=$%#&18'&#&"
$&#0$%
)1#&=$
*%
0&"#*%3
*<
:&#0&+
#0$
/)"#
 
3$)%"6
T*#$
#0)#
;&=$%#&18'*"&"
&"
/$%2&##$;6
 6?6 6HQ1#&=$
*%
0&"#*%3
*<
&+<')22)#*%3
.*:$'
;&"$)"$
-1*'&#&"4
E%*0+R"L4
&%%&#).'$
.*:$'
;&"$)"$4
1$'&)1
;&"$)"$4
*%
*#0$%
"$%&*8"4
10%*+&14
5)"#%*&+#$"#&+)'
1*+;&#&*+"
)""*1&)#$;
:&#0
;&)%%0$)6
Q1#&=$
*%
0&"#*%3
*<
"3"#$2&1
'8/8"
$%3#0$2)#*"8"
*%
Z$5$+$%R"
5%)+8'*2)#*"&"6
 6?6 6[E8%%$+#'3
%$1$&=&+5
&228+*"8//%$""&=$
;*"$"
*<
"#$%*&;"
*%
*#0$%
&228+*"8//%$""&=$
2$;&1)#&*+"
-&+0)'$;
)+;
#*/&1)'
"#$%*&;"
)%$
/$%2&##$;L
 6?6 6?BP&"#*%3
*<
")%1*&;*"&"
"3+;%*2$
 6?6 6??F)#&$+#"
"0*8';
+*#
.$
=)11&+)#$;
:&#0
'&=$
)##$+8)#$;
=)11&+$"
:&#0&+
!B
;)3"
*<
"#)%#&+5
;8%=)'82).
*%
#%$2$'&282).
#%$)#2$+#6
 6?6 6? P)"
)
C+*:+
0&"#*%3
*<
P82)+
X228+*;$<&1&$+13
\&%8"
-PX\L6
PX\I/*"&#&=$
/)#&$+#"
%$1$&=&+5
)+#&I%$#%*=&%)'
#0$%)/3
)%$
$>1'8;$;
<%*2
#0&"
"#8;3
;8$
#*
#0$
/*""&.&'&#3
*<
/0)%2)1*C&+$#&1
&+#$%)1#&*+"
.$#:$$+
)+#&%$#%*=&%)'
2$;&1)#&*+"
)+;
#%$2$'&282).6
PX\
/*"&#&=$
/)#&$+#"
+*#
%$1$&=&+5
)+#&%$#%*=&%)'
#0$%)/3
)%$
$>1'8;$;
;8$
#*
#0$
/*""&.&'&#3
#0)#
#%$2$'&282).
2)3
:*%"$+
#0$&%
1*+;&#&*+
)+;
#0$
'&C$'&0**;
#0)#
#0$
8+;$%'3&+51*+;&#&*+2)3*."18%$#0$)##%&.8#&*+*<);=$%"$$=$+#"6
 6?6 6?!P&"#*%3*<03/$%"$+"&#&=&#3%$)1#&*+#*082)+*%2*8"$)+#&.*;3/%*;81#"6











 !
 "#" "#!$%&'()(*+
)(-
.%&)/0
1&&-2('
)%&
&3*45/26(
1)*06%/"
78&
&11&*0/
61
0%&9&42959).
6(
08&
-&:&46;2('
859)(
1&05/
)%&
5(<(6=("
>(%644&-
;)02&(0/
95/0
)'%&&
06
5/&
)-&?5)0&
*6(0%)*&;026(
@/&&
/&*026(
ABC
)(-
ABDE
;%26%
06
/05-+
&(0%+F
08&
-5%)026(
61
/05-+
;)%02*2;)026(
)(-
G
96(08/
)10&%
08&
&(-
61
08&
0%&)09&(0"
H8654-
)
=69)(
.&*69&
;%&'()(0
6%
/5/;&*0
/8&
2/
;%&'()(0
=824&
/8&
6%
8&%
;)%0(&%
2/
;)%02*2;)02('
2(
082/
/05-+F
/8&
/8654-
2(16%9
8&%
0%&)02('
;8+/2*2)(
299&-2)0&4+"
 "#" "#I$)02&(0/
=208
5(8&)4&-
/5%'2*)4
=65(-/
16%
96%&
08)(
JK
-)+/"
 "#"J L(*45/26(
61
M69&(
)(-
N2(6%202&/
N&()(-=69&(
61
)44
%)*&/
)(-
&08(2*
'%65;/
)%&
&42'2.4&
16%
082/
0%2)4"
 "#"! O&*%5209&(0
H0%)0&'2&/
78&/05-+=244
.&
;6/0&-
6(
08&
PPO
=&./20&
)(-
6(
*42(2*)40%2)4/"'6:"
DBD QRSTTUVUW
TYZ[\Z]V^U
 " "# H*%&&(2('
)*02:202&/
;&%16%9&-
;%26%
06
6.0)2(2('
2(16%9&-
*6(/&(0
N2(29)4%2/<
)*02:202&/
08)0
9)+
.&
;&%16%9&-
.&16%&
08&
/5._&*0
8)/
/2'(&-
)
*6(/&(0
2(*45-&
08&
16446=2('`
a >9)24F
=%200&(F
2(
;&%/6(
6%
0&4&;86(&
6%
:2-&6
*6995(2*)026(/
=208
;%6/;&*02:&
/5._&*0/
a O&:2&=
61
&32/02('
9&-2*)4
%&*6%-/
06
2(*45-&
bc$F
4).6%)06%+
/05-2&/F
&0*"
a O&:2&=
61
&32/02('
NOLF
3d%)+F
6%
P7
29)'&/
a O&:2&=
61
&32/02('
;8606'%);8/
6%
:2-&6/
a O&:2&=
61
&32/02('
;)08646'+
/;&*29&(/e%&;6%0/
1%69
)
/;&*29&(
6.0)2(&-
16%
-2)'(6/02*
;5%;6/&/"
 " " H*%&&(2('
)*02:202&/
;&%16%9&-
)10&%
)
*6(/&(0
16%
/*%&&(2('
8)/
.&&(
/2'(&-
78&16446=2('
)*02:202&/
=244
.&
;&%16%9&-
6(4+
)10&%
08&
/5._&*0
8)/
/2'(&-
08&
*6(/&(0
16%
/05-+
fK#dPdK# g
6(
=82*8
/*%&&(2('
)*02:202&/
=244
.&
;&%16%9&-"
h//&//9&(0/
;&%16%9&-
)0
650/2-&
1)*24202&/6%
6(
)(608&%
iLb
;%606*64
=2082(
08&
029&1%)9&/
.&46=
9)+
)4/6
.&
5/&-
06
-&0&%92(&
&42'2.2420+6(*&
)
;)02&(0
8)/
/2'(&-
08&
*6(/&(0"
H05-2&//8654-
.&
-6(&
=2082(
 j
-)+/
;%26%
06
&(%6449&(0
5(4&//
608&%=2/&
(60&-
.&46="
a P69;4&0&
82/06%+
@2(*45-2('
;%26%
86%96(&
5/&E
)(-
;8+/2*)4
&3)92()026(
@2(*45-2('
8&2'80F
=&2'80F
:20)4
/2'(/F
>klF
)(-
;&%16%9)(*&
/0)05/E"
a P7
/*)(
61
*8&/0F
).-69&(
)(-
;&4:2/
@6%
NOL
42:&%
@21
*42(2*)44+
2(-2*)0&-E
@9)+
.&
-6(&
)0)(
650/2-&
2(/0205026(E
a m).6%)06%+
>:)45)026(
n b&9)0646'2*)4
;%6124&`
PoP
=208
-211&%&(02)4
)(-
;4)0&4&0
*65(0
n $7F
LiOF
)$77F
12.%2(6'&(
n o26*8&92*)4;%6124&`&4&*0%64+0&/FopiF*%&)02(2(&FhH7Fhm7F060)4)(--2%&*0
.242%5.2(F*)4*259F;86/;86%5/F)4.592(F9)'(&/259











 !
" #$%&
(&%)
(*)
(+,-(./
" 0(++(
1-23(+,-3$(*.4/$(./
5%4
&-%*%&(--,
%*)%&(3/)67
" #$%*(-,.%.
" 8/$2+
9$
2$%*/
:$/1*(*&,
3/.3
49$
4/+(-/
:($3%&%:(*3.
94
&;%-)</($%*1
(1/
5%*
3;/
(<./*&/
94
:$%9$
;,.3/$/&39+,67
=/.3
39
</
:/$49$+/)
>%3;%*
? 
;92$.
:$%9$
39
/*$9--+/*37
@ A%.39-91%&
&9*4%$+(3%9*
5(3
(*,
3%+/
:9%*3
:$%9$
39
/*$9--+/*367
B
<-9&C
9$
2*.3(%*/)
.-%)/.
94
:$%+($,
9$
+/3(.3(3%&
32+9$
3%..2/
>%--
</
$/D2%$/)
4$9+
/(&;
:($3%&%:(*3
39
&9*4%$+
)%(1*9.%.
>%3;
(*(-,.%.
</%*1
:/$49$+/)
<,
3;/
E(<9$(39$,
94
F(3;9-91,G
HIA7
B.
.3(3/)
%*
3;/
%*&-2.%9*
&$%3/$%(
(<9J/G
;%.39:(3;9-91%&(-
&9*4%$+(3%9*
94
&($&%*9+(
+(,
</
.244%&%/*37
K%<$9-(+/--($
J($%(*3
%.
(-.9
(--9>/)7
LMN OPQRSTSOPUR
QWXSYRQPRSZU
PU[
YRPR\Y
\O[PRW
OQZTW[\QWY
]/1%.3$(3%9*
(*)
.3(32.
2:)(3/.
5/717G
>;/*
(
:($3%&%:(*3
%.
3(C/*
944
:$939&9-
3;/$(:,
(*)
>;/*
(
:($3%&%:(*3
%.
3(C/*
944^.32),6
>%--
3(C/
:-(&/
:/$
__]
8`F
Ba_]^ G
__]
F($3%&%:(*3
]/1%.3$(3%9*
b
83(32.
#:)(3/.
492*)
;/$/7
 7c7d =$/(3+/*3
B..%1*+/*3
F$9&/)2$/.
5K9$
$/1%.3$(3%9*
:2$:9./.
9*-,6e
Tfgfhij
Uklmnh
Uoln
[njphqriqfs
d
Bd
K%$.3
dt
82<u/&3.
>%3;
B)J(*&/)
A__G
v_E_
83(1/
_
 
B 
82<u/&3.
>%3;
B)J(*&/)
A__G
v_E_
83(1/
vw_
c
v
82<u/&3.
>%3;
I*3$(w/x3$(^;/:(3%&
&;9-(*1%9&($&%*9+(











 !
"#$%
&'$()#
&*$)
+)%,#-./-01
2
32
56789:6;9<
=
>7?;?:@;6;9<
 
3 
56789:6;9<
=
>7?;?:@;6;9<
=
>3AB
C
3C
56789:6;9<
=
>7?;?:@;6;9<
=
DE3
F
3F
56789:6;9<
=
>7?;?:@;6;9<
=
A7GH
I6<J?KLM@N
KHOH7L
32
P@::
<?
Q@7?KL:G
9MM@RN?Q
LH
97;
32S
I6<J?KLM@N
KHOH7L
3 
P@::
<?
Q@7?KL:G
9MM@RN?Q
LH
97;M
3 T
3C
H7
3F
U?7
KHNM6:L9L@HN
P@LO
LO?
@NL?78?NL@HN9:
79Q@H:HR@MLMS
>O?
7?9MHN
VH7
LO@M
@M
LO9L
LO?7?
97?
L?KON@K9:
KHNM@Q?79L@HNM
WM@X?
9NQ
:HK9L@HNHV
:?M@HNT
;9@N
UH7L9:
8?@N
HKK:6M@HN
?LKSY
PO@KO
PH6:Q
;9Z?
HN?
U7HK?Q67?
U7?V?79<:?
H8?7LO?HLO?7S
2[
?89:69<:?
M6<J?KLM
P@::
<?
9MM@RN?Q
LH
?9KO
@NL?78?NL@HNS
>O?V@7ML2[
M6<J?KLM
@N
KHOH7L
\
P@::
<?
Q@7?KL:G
9MM@RN?Q
LH
97;
32S
>O?7?;9@N@NR
M6<J?KLM
@N
AHOH7L
\
P@::
<?
Q@7?KL:G
9MM@RN?Q
LH
97;M
3C
H7
3F
U?7
KHNM6:L9L@HN
P@LOLO?@NL?78?NL@HN9:
79Q@H:HR@MLMS
>O?
7?9MHN
VH7
LO@M
@M
LO9L
LO?7?
97?
L?KON@K9:
KHNM@Q?79L@HNM
WM@X?9NQ:HK9L@HN
HV
:?M@HNT
;9@N
UH7L9:
8?@N
HKK:6M@HN
?LKSY
PO@KO
PH6:Q
;9Z?
HN?
U7HK?Q67?
U7?V?79<:?
H8?7
LO?
HLO?7S
2[
?89:69<:?
M6<J?KLM
P@::
<?
9MM@RN?Q
LH
?9KO
@NL?78?NL@HNS
]^_ `"abcd&b
bf"cg"hdi&
\9M?:@N??89:69L@HNM
QH
NHL
N??Q
LH
<?
7?U?9L?Q
@V
U?7VH7;?Q
Q67@NR
IK7??N@NR
P@LO@N
Q?M@RN9L?Q
L@;?jV79;?T
k@LO@N l
Q9GM
U7@H7
LH
V@7ML
QHM?T
6N:?MM
HLO?7P@M?
MU?K@V@?Qm
n A>
MK9N
HV
KO?MLT
9<QH;?N
9NQ
U?:8@M
WH7
oDp
HV
:@8?7
@V
K:@N@K9::G
@NQ@K9L?QY
n B:?KL7HK97Q@HR79;
n q9<H79LH7G
?89:69L@HN
r s?U9L@L@M
\
9NQtH7
A
8@79:
:H9Q
9NQ
M?7H:HRG
r sq3j3T
sq3j\T
sq3jA
9NQ
sq3j3u[ 
UO?NHLGU?
W;9G
<?
QHN?
9L
9NG
L@;?
U7@H7
LH
L7?9L;?NLY
r 3o3
v
q@8?7tZ@QN?G
;@K7HMH;9:
9NL@<HQG
r 3w3
r D?KL9:
MP9<
WHUL@HN9:Y
r I?76;
H7
67@N?
U7?RN9NKG
L?ML
VH7
V?;9:?
U97L@K@U9NLM
HV
KO@:Q<?97@NR
9R?
W@N
LO?
9<M?NK?HVU7@H7OGML?7?KLH;GTP@LO@Nx OH67MU7@H7LHV@7MLQHM?Y
n D?M?97KOL6;H7<@HUMGS











 !
" #$%&'
)*+,-*-.$/$)0.
"12 #$%&'
&-#)3.
45689:8:;6<
;=><?
@;
A
8@B:=
;=><?
C:DE@F@FG
=96D6B@D>DAE
AF<
<>9HAB>DAE
=96A=D6F=
@F
8A=@6F=;I@=5
A<HAFC6<
JKK
LK:5:9=;
MN
AF<
M O
6@=569
AB:F6
LM9D
MNO
:9
I@=5
C9?:AEBA=@:FP
4MKQ:9RSM
LM9D;
M P
MTP
MUO
AF<
8A=@6F=;
I@=5
A<HAFC6<
V4K
LK:5:9=
VO
6@=569
AB:F6
LM9DMNO:9
I@=5
C9?:AEBA=@:F
:9
RSM
LM9D;
MTP
MUOW
456<6C@;@:F
:F
I5@C5
@F=69H6F=@:FAB
9A<@:B:G@C
89:C6<>96
=:
A<D@F@;=69
L@W6W
RSM
H;W
4MKQ
H;W
C9?:AEBA=@:FO
I@BB
E6
DA<6
@F
C:F;>B=A=@:F
I@=5
=56
@F=69H6F=@:FAB
9A<@:B:G@;=;W
456
96A;:F
X:9
=5@;@;=5A=
=5696
A96
=6C5F@CAB
C:F;@<69A=@:F;
L;@Y6
AF<
B:CA=@:F
:X
B6;@:FP
DA@F
8:9=AB
H6@F
:CCB>;@:F6=CWO
I5@C5
I:>B<
DAZ6
:F6
89:C6<>96
896X69AEB6
:H69
=56
:=569W
[ 49AF;A9=69@AB
C56D:6DE:B@YA=@:F
@;
869C>=AF6:>;
89:C6<>96
869X:9D6<
>F<69
G6F69AB
AF6;=56;@A
:9
C:F;C@:>;
;6<A=@:FW
L\66
"1]12
X:9
<6=A@B;O
[ ^A=@6F=;
>F<69G:@FG
=9AF;_A9=69@AB
C56D:6DE:B@YA=@:FP
RSM
:9
C9?:AEBA=@:F
A96
896_
D6<@CA=6<
I@=5
AFABG6;@C;P
AF=@E@:=@C;
AF<
AF=@_6D6=@C;
869
CB@F@CAB
;=AF<A9<;W
S:9
<6=A@B;
96GA9<@FG
6AC5
89:C6<>96
8B6A;6
;66
"1]W
`abacd +aefghdiaj
)kkfjl
mdikfghdijn
ecaolpfcl
&aml
glqlg
+ghjjlp
.
MN
M<HAFC6<
JKKP
VKrK
\=AG6
K
s:
AEBA=@H6
89:C6<>96
496D6B@D>DAE
!tDG
XBA=
<:;6
u v
<A?;
X:9
U
<:;6;
w>9HAB>DAE
NtxxDG
XBA=
<:;6
u v
<A?;
>F=@B
Qy\zzz
2{
dadhg
M 
M<HAFC6<
JKKP
VKrK
\=AG6
V|K

K9?:AEBA=@:F|
RSM|4MKQ}
496D6B@D>DAE
!tDG
XBA=
<:;6
u v
<A?;
X:9
U
<:;6;
w>9HAB>DAE
NtxxDG
XBA=
<:;6
u v
<A?;
>F=@B
Qy\}}
"{
dadhg
Nx
=96D~
<>9
~
4MKQ
Nx
=96D
~
<>9
~
RSM
Nx
=96D
~
<>9
~
C9?:
V
F=9A|6=9A_
568A=@C
C5:BAFG@:CA9C@F
:DA
s
N;=
Nx
8=;
s:
AEBA=@H6
89:C6<>96
RSM|
C9?:AEBA=@:F
496D6B@D>DAE
!tDG
XBA=
<:;6
u v
<A?;
X:9
U
<:;6;
w>9HAB>DAE
NtxxDG
XBA=
<:;6
u v
<A?;
>F=@B
Qy\}}
"{
dadhg
Nx
=96D~
<>9
AB:F6
Nx
=96D
~
<>9
~
RSM
Nx
=96D
~
<>9
~
C9?:
}S:9VKrK
;=AG6
V
8A=@6F=;
4MKQ
DA?
E6
9686A=6<
A;
869
;=AF<A9<
:X
CA96
}}Qy\6F<
:X
;=><?
=96A=D6F=
A;
<6X@F6<
@F
;6C=@:F
"112W











 !
"#$ %&'()*+(
,- -. /01023
5.
6 577
.8
9:3;<=3>
?;31
@/A/
B3:C<
/
?;77
2<D<;E<
D0FG;=<H
;FFI=<
D1<DJ90;=3
;=1;G;3;0=
0=7K
;-<-
=0
;=3<2E<=3;0=:7
2:H;070C;D
920D<HI2<-
6 L:3;<=3>
?;77
2<D<;E<
.M88
FC
HI2E:7IF:G
E;:
NO
;=PI>;0=
QR?
P02
I9
30
R
H0><>SDKD7<>
:=H
TM
FC
32<F<7;FIF:G
E;:
NO
;=PI>;0=
QR?
P02
I9
30
R
H0><>SDKD7<>U
:=H
31<=
D0=3;=I<
.M88
FC
HI2E:7IF:G
QR?-
V2<F<7;FIF:G
?;77
G<
:HF;=;>3<2<H
P;2>3-
WI2E:7IF:G
;=PI>;0=
?;77
>3:23
:9920X;F:3<7K
.
10I2
:P3<2
31<
<=H
0P
32<F<7;FIF:G
;=PI>;0=-
V1<
HI2:3;0=
?;77
G<
:9920X;F:3<7K
.
10I2
P02
<:D1
;=PI>;0=-
5
.Y10I2
0G><2E:3;0=
9<2;0H
;>
2<QI;2<H
:P3<2
31<
P;2>3
;=PI>;0=
0P
HI2E:7IF:G
:=H
32<F<7;FIF:G-
NP
=0
D7;=;D:77K
>;C=;P;D:=3
;=PI>;0=
2<:D3;0=>
:2<
0G><2E<H
HI2;=C
02
:P3<2
31<
P;2>3
DKD7<U
>IG><QI<=3
;=PI>;0=
0G><2E:3;0=
9<2;0H>
D:=
G<
:3
31<
N=E<>3;C:302Z>
H;>D2<3;0=
[>ICC<>3<H
,8
F;=I3<>
:P3<2
<:D1
HI2E:7IF:G
:=H
32<F<7;FIF:G
;=PI>;0=\-
,- - /01023
5 
V1<>D1<F:
P02
/01023
5 
;>
>10?=
G<70?-
]02
/01023
5 
[@/A/
B3:C<
@S/
9:3;<=3>\
V5/^U
_]502D2K0:G7:3;0=
?;77
G<
9<2P02F<H
0=D<
0=7KU
0=
W:K
,`
[aSY
b`12>\-
6 @031
@/A/
>3:C<
@
:=H
/
:2<
<7;C;G7<
P02
D01023
5 -
6 L:3;<=3>
?;77
2<D<;E<
.M88
FC
HI2E:7IF:G
E;:
NO
;=PI>;0=
QR?
P02
I9
30
R
H0><>SDKD7<>
:=H
TM
FC
32<F<7;FIF:G
E;:
NO
;=PI>;0=
QR?
P02
I9
30
R
H0><>SDKD7<>U
:=H
31<=
D0=3;=I<
.M88
FC
HI2E:7IF:G
QR?-
V2<F<7;FIF:G
?;77
G<
:HF;=;>3<2<H
P;2>3-
WI2E:7IF:G
;=PI>;0=
?;77
>3:23
:9920X;F:3<7K
.
10I2
:P3<2
31<
<=H
0P
32<F<7;FIF:G
;=PI>;0=-
V1<
HI2:3;0=
?;77
G<
:9920X;F:3<7K
.
10I2
P02
<:D1
;=PI>;0=-
5
.Y10I2
0G><2E:3;0=
9<2;0H
;>
2<QI;2<H
:P3<2
31<
P;2>3
;=PI>;0=
0P
HI2E:7IF:G
:=H
32<F<7;FIF:G-
NP
=0
D7;=;D:77K
>;C=;P;D:=3
;=PI>;0=
2<:D3;0=>
:2<
0G><2E<H
HI2;=C
02
:P3<2
31<
P;2>3
DKD7<U
>IG><QI<=3
;=PI>;0=
0G><2E:3;0=
9<2;0H>
D:=
G<
:3
31<
N=E<>3;C:302Z>
H;>D2<3;0=
[>ICC<>3<H
,8
F;=I3<>
:P3<2
<:D1
HI2E:7IF:G
:=H
32<F<7;FIF:G
;=PI>;0=\-











 !
"#$%&'
)*
+,-'./
,0-0&1
23
45 54 67879:
<
=8>?@8>AB
C79
67879:
<
D?
?87EF
G>H7E5
I79
67879:
<
J<=6
KB:D>F:?L
?:B:M?
K7?:
K9D79
@8>A7:8>9BKN
ED:8
DF:9B8>KB:D@
OD?>B?>P
QIR
79
@9N7BGHB:D7F
EDHH
G>
K>9C79A>O
7F@>
7FHNL
7F
SBN4TJUVW
!T89?P5
=8>
CD9?:
XYZ[
KB:D>F:?
EDHH
F7:
MFO>9\7
BF
BGHB:D]>
K97@>OM9>
D5>5
:8>N
EDHH
9>@>D]>O9M\
7FHN5
^ =8>
CD9?:
XYZ[
KB:D>F:?
EDHH
9>@>D]>
@7AGDF>O
DAAMF>
@8>@_K7DF:
DF8DGD:D7F
7FHN
D5>5
F7
DF:>9]>F:D7FBH
9BOD7H7\D@
K97@>OM9>5
^ `B:D>F:?
EDHH
9>@>D]>
Za[[
A\
OM9]BHMABG
]DB
bc
DFCM?D7F
deE
C79
MK
:7
e
O7?>?V@N@H>?
BFO
fa
A\
:9>A>HDAMABG
]DB
bc
DFCM?D7F
deE
C79
MK
:7
e
O7?>?V@N@H>?L
BFO
:8>F
@7F:DFM>
Za[[
A\
OM9]BHMABG5
=9>A>HDAMABG
EDHH
G>
BOADFD?:>9>O
CD9?:5
SM9]BHMABG
DFCM?D7F
EDHH
?:B9:
BKK97gDAB:>HN
Z
87M9
BC:>9
:8>
>FO
7C
:9>A>HDAMABG
DFCM?D7F5
=8>
OM9B:D7F
EDHH
G>BKK97gDAB:>HN
Z
87M9
C79
>B@8
DFCM?D7F5
R
ZW87M9
7G?>9]B:D7F
K>9D7O
D?
9>dMD9>O
BC:>9
:8>
CD9?:
DFCM?D7F
7C
OM9]BHMABG
BFO
:9>A>HDAMABG5
bC
F7
@HDFD@BHHN
?D\FDCD@BF:
DFCM?D7F
9>B@:D7F?
B9>
7G?>9]>O
OM9DF\
79
BC:>9
:8>
CD9?:
@N@H>L
?MG?>dM>F:
DFCM?D7F
7G?>9]B:D7F
K>9D7O?
@BF
G>
B:
:8>
bF]>?:D\B:79h?
OD?@9>:D7F
J?M\\>?:>O
4[
ADFM:>?
BC:>9
>B@8
OM9]BHMABG
BFO
:9>A>HDAMABG
DFCM?D7FP5











 !
"#$%&'
)*
+,-'./
,0-0&1
2
343 5678
95:;<;+=69=;><
 ? ?@ ABCDCEFDGDHI
KBGL
MNDFOFPQBHQFRO
ASCTFBPQNHU
RT
NRPFOL
FP
VROPFNCBCN
KHU
@?
WHVS
NRPC
RT
FOXCPQFLHQFROHE
YBRNGVQ
PSRGEN
IC
HNDFOFPQCBCN
GPFOL
QSC
TREERZFOL
LGFNCEFOCP[
@\]OXCPQFLHQFROHE
YBRNGVQ
DGPQ
IC
HNDFOFPQCBCN
HQ
BRRD
QCDYCBHQGBC
^_`ab\
IU
VROQBREECN
FOTGPFRO
HQ
H
BHQC
RT
_`!
DcdSRGB
XFH
HO
FOTGPFRO
YGDY
FOQR
H
YCBFYSCBHE
XCFO?
eBFRB
QR
QSC
PQHBQ
RT
QSC
FOTGPFROf
COPGBC
QSHQ
QSC
IHL
VROQCOQP
HBC
HQ
BRRD
QCDYCBHQGBC
QR
HXRFN
HO
FOTGPFRO
BCHVQFRO
NGC
QR
QSC
HNDFOFPQBHQFRO
RT
QSC
PREGQFRO
HQ
ERZ
QCDYCBHQGBCP?
_\]OXCPQFLHQFROHE
YBRNGVQ
DGPQ
g01
IC
HNDFOFPQCBCN
XFH
]h
YGPS
RB
IREGP
IGQ
HP
H
PERZ
]h
FOTGPFRO?
ASC
COQFBC
VROQCOQP
RT
CHVS
]h
IHL
ZFEE
IC
FOTGPCN
GPFOL
HO
FOTGPFRO
YGDY?
 \ASC
FOTGPFRO
EFOCP
PSRGEN
IC
HQQHVSCN
ROEU
HQ
QFDC
RT
GPC?
cFOCP
GPCN
TRB
FOTGPFRO
NGBFOL
NRPC
HNDFOFPQBHQFRO
ZFEE
OCCN
QR
IC
CiGFYYCN
ZFQS
!?__
RB
!?_
jk
FOlEFOC
TFEQCBP?
m\ ]TQSCBC
HBC
OR
BCiGFBCDCOQP
QR
PERZf
FOQCBBGYQf
RB
YCBDHOCOQEU
PQRY
QSC
FOTGPFROf
QSC
HOQFVFYHQCN
FOTGPFRO
QFDC
QR
NCEFXCB
CHVS
NRPC
^_`!
Dc\
FP
HOQFVFYHQCN
QR
IC
HYYBRnFDHQCEU
o!
DFOGQCP?
ASCNGBHQFRO
RT
QSC
FOXCPQFLHQFROHE
YBRNGVQ
HNDFOFPQBHQFRO
ZFEE
IC
BCVRBNCN?
 ? ?_ KGBXHEGDHI
KBGL
MNDFOFPQBHQFRO
WHVSNRPCRTNGBXHEGDHIPSRGENICHNDFOFPQCBCNGPFOLQSCTREERZFOLLGFNCEFOCP[
@\KGBXHEGDHIZFEEICHNDFOFPQCBCNHPHO]hFOTGPFRORXCBHYYBRnFDHQCEUo!DFOGQCP?











 !
"#$%&'
)'
*+
,)-
./
0/&1
234
5%&
.'20/.3'6
5%&
*+
7.'&
8.77
,&
270/%&1
8.5%
)
9370:&
32
'34:)7
/)7.'&
&;0)7
53
5%&
<4.:.'-
9370:&
32
5%&
.'20/.3'
/&5
0/&1
)25&4
5%&
=3'5&'5/
32
5%&
*+
,)-
)4&
2077>
)1:.'./5&4&1
?0'7&//
<43%.,.5&1
,>
.'/5.505.3')7
<4)=5.=&#@
 #A.'=&
5%&
=3:<)5.,.7.5>
32
1049)70:),
8.5%
35%&4
*+
:&1.=)5.3'/
)'1
/3705.3'/6
35%&4
5%)'
'34:)7
/)7.'&
?B@CD
E8F9G
A31.0:
H%734.1&
234
*'I&=5.3'#6
./
'35
J'38'6
5%&
1049)70:),
/3705.3'
/%3071
'35
,&
.'20/&1
5%430-%
)'
*+
7.'&
.'
8%.=%
35%&4
/3705.3'/
34
:&1.=)5.3'/
)4&
,&.'-
)1:.'./5&4&1@
K#L%&
104)5.3'
32
5%&
.'9&/5.-)5.3')7
<4310=5
)1:.'./54)5.3'
8.77
,&
4&=341&1@
 @ @ M3'.534.'-
32
N3/&
O1:.'./54)5.3'
+.5)7/.-'/
8.77
,&
=377&=5&1
,&234&
.'9&/5.-)5.3')7
<4310=5
.'20/.3'
)'1
)5
5%&
=3:<7&5.3'
32
5%&
.'20/.3'@
*'5%&&9&'5
32
)
P
-4)1&
"
.'20/.3'Q4&7)5&1
4&)=5.3'6
5%&
.'20/.3'
4)5&
32
/501>
140-
:)>
,&
1&=4&)/&1,>
RBD
34
.'5&440<5&1
0'5.7
4&/3705.3'
32
5%&
&9&'5
)'1
4&Q.'.5.)5&1
)5
RBD
32
5%&
.'.5.)7
4)5&0'5.7=3:<7&5.3'
32
5%&
.'20/.3'@
S34
<)5.&'5/
8.5%
)
PTUVWX
"
.'20/.3'
4&7)5&1
4&)=5.3'6
/0,/&;0&'5
.'20/.3'/
:)>
,&
)1:.'./5&4&1
)5
RBD
32
5%&
.'.5.)7
4)5&@
O=&5):.'3<%&'
)'1F34
)'
)'5.%./5):.'&
?&@-@6
1.<%&'%>14):.'&#
34
&;0.9)7&'5
:&1.=)5.3'/
<&4
.'/5.505.3')7
/5)'1)41
:)>
,&)1:.'./5&4&1
)5
5%&
1./=4&5.3'
32
5%&
.'9&/5.-)534@
*2
5%&
.'20/.3'
4&7)5&1
4&)=5.3'
./
YTUVWX
 
34%.-%&4.'
/&9&4.5>6
/501>
140-
8.77
,&
1./=3'5.'0&1@
L%&
/5)'1)41
.'20/.3'
5.:&
./
3'&
%3046
%38&9&46.2
5%&4&
)4&
.'5&440<5.3'/
104.'-
.'20/.3'6
5%&
535)7
)7738&1
5.:&
243:
.'20/.3'
/5)45
53
=3:<7&5.3'
32
.'20/.3'
/%3071
'35
&Z=&&1
[
%304/
)5
433:
5&:<&4)504&
?35%&48./&
4&;0.4&/
'&8
.'20/.3'<4&<)4)5.3'#@
O/8.5%)'>
)'5.,31>6
)77&4-.=
4&)=5.3'/
53
13/&
)1:.'./54)5.3'
)4&
<3//.,7&@
L%&4&234&6
)<<43<4.)5&
140-/
)'1
:&1.=)7
&;0.<:&'5
53
54&)5
)=05&
)')<%>7)=5.=
4&)=5.3'/
:0/5
,&
.::&1.)5&7>
)9).7),7&6
)'1
/501>
<&4/3''&7
:0/5
,&
54).'&1
53
4&=3-'.\&
)'1
54&)5
)')<%>7)Z./6
)/<&473=)7
.'/5.505.3')7
-0.1&7.'&/@
]^_ `abcde
`ghijb
L%&237738.'-
,43)1
-0.1&7.'&/
234
13/&
1&7.9&4>
/=%&107&
1&7)>/
)'1
)75&4')5.3'/
)<<7>
53
,35%
<7)''&113/)-&/
32
54&:&7.:0:),
)'1
1049)70:),
)'1
)4&
1&<&'1&'5
3'
5%&
=7.'.=)7
)'1
7),34)534>
)//&//:&'5
3'
5%&
1)>
32
13/.'-@
L4&:&7.:0:),
)'1
1049)70:),
=)'
,&
1&7.9&4&1
8.5%.'k1)>/
32
<7)''&1
.'5&49)7
53
)==3::31)5&
/=%&107.'-
.//0&/F73-./5.=/@
 @K@! *::0'&Q:&1.)5&1
Ol/
?.:Ol/#
m)/&13'5%&
:&=%)'./:
32
)=5.3'
32
1049)70:),
)'1
54&:&7.:0:),
7&)1.'-
53
LQ=&77
)=5.9)5.3'
)'1<437.2&4)5.3'6
5%&4&
./
5%&
<3//.,.7.5>
32
3,/&49.'-
.::0'&Q:&1.)5&1
Ol/
?.:Ol/#
104.'-
5%&
=3'10=532
5%./
/501>@
n35&'5.)7
.:Ol/
:)>
,&
/.:.7)4
53
5%3/&
/&&'
8.5%
5%&
0/&
32
.<.7.:0:),6
mMAQC oRR[
?)'5.QnNQ!
:O,#6
)'1
mMAQC oRRC
?)'5.QnNQp!
:O,#
)'1
:)>
.'=701&
.::0'&Q
:&1.)5&1&'5&43=37.5./6
1&4:)5.5./6
%&<)5.5./
?%&<)5353Z.=.5>#6
)'1
&'13=4.'3<)5%.&/EK6
 K6
 RG@
L%&/&Ol/
)4&
.'27)::)534>
.'
')504&
)'1
=)'
)22&=5
)'>
34-)'@
A0,I&=5//%3071
,&
:3'.534&1
234
/.-'/
)'1
/>:<53:/
32
.:Ol/@
*'
5%&
),/&'=&
32
)'
)75&4')5&
&5.373->?&@-@6.'2&=5.3'34nN#6)'.::0'&Q:&1.)5&1&5.373->/%3071,&=3'/.1&4&1234/.-'/34
/>:<53:/32&'5&43=37.5./61&4:)5.5./6%&<)5.5./6)'1&'13=4.'3<)5%>@N3/.'-:31.2.=)5.3')'1
:)')-&:&'5-0.1&7.'&/234.:Ol//<&=.2.&1.'iqqrstuvw@











 !
 "#"! $%&'()'
+&',-)
./
01'2345
6,-'(')-
$,4%&'()'
'&',-
./
)1'2345
3,-'(')-
7$+068
3)
.,'
./
)23',-3/32
4,%
9'%3245
3,-'(')-
)1'23/32
-.
:,%'()-4,%3,;
./
-<'
3,&')-3;4-3.,45
1(.%:2-
4,%
94=
('>:3('
25.)'
9.,3-.(3,;
4,%
(413%
2.99:,324-3.,
?=
-<'
3,&')-3;4-.(
-.
-<'
)1.,).("
$,
$+06
94=
?'
)'(3.:)
.(
,.,@)'(3.:)"
A<'
(413%('1.(-3,;
./
$+06)
455.B)
.,;.3,;
):(&'3554,2'
./
-<')'
'&',-)
3,
.(%'(
-.
2<4(42-'(3C'
4,%
:,%'()-4,%
-<'9
3,
4)).234-3.,
B3-<
-<'
:)'
./
-<3)
3,&')-3;4-3.,45
1(.%:2-"
$+06)/.(
%:(&45:94?
4,%
-('9'539:94?
3,25:%'
?:-
4('
,.-
5393-'%
-.
'&',-)
B3-<
4
1.-',-345
3,/54994-.(=
.(
399:,'@9'%34-'%
9'2<4,3)9
4,%
B<32<
94=
('>:3('
9.('
/('>:',-
9.,3-.(3,;
4,%D.(3,-'(&',-3.,)
):2<
4)
)-'(.3%)E
399:,.):11('))4,-)
4,%D.(
<.(9.,'
('1542'9',-
-<'(41="
A<')'$+06)
4('
?'3,;
25.)'5=
9.,3-.('%
3,
253,3245
)-:%3')
B3-<
%:(&45:94?
9.,.-<'(41=
4,%
2.9?3,4-3.,
-<'(41="
$,
399:,'@9'%34-'%
4%&'()'
'&',-
739$+8
3)
%'/3,'%
4)
4,
4%&'()'
'&',-
-<4-3)4)).234-'%
B3-<
%(:;
'F1.):('
4,%
3)
2.,)3)-',-
B3-<
4,
399:,'@9'%34-'%
9'2<4,3)9
./
42-3.,4,%
B<'('
-<'('
3)
,.
25'4(
45-'(,4-'
'-3.5.;="
0'(.5.;32E
399:,.5.;32E
4,%
<3)-.5.;32
7?3.1)=8%4-4E
4)
411(.1(34-'E
)<.:5%
?'
:)'%
-.
):11.(-
4,
39$+
%34;,.)3)"
$11(.1(34-'
'//.(-)
)<.:5%?'94%'
-.
(:5'
.:-
,'.154)-32E
3,/'2-3.:)E
9'-4?.532E
-.F3,E
.(
.-<'(
'-3.5.;32
24:)')
./
-<'39$+"
$+06).?)'(&'%
B3-<
%:(&45:94?
4,%
-('9'539:94?
3,25:%'G
H I34((<'4
D
J.53-3)
4,%
3,-')-3,45
1'(/.(4-3.,
H K,':9.,3-3)
D
6LI
H M'14-3-3)
D
-(4,)493,4)'
3,2('4)')
H +,%.2(3,.14-<3')
73"'"
'&',-)
./
<=1.1<=)3-3)D<=1.13-:3-4(3)9E
4%(',45
3,)://323',2=E
<=1'(@
4,%
<=1.-<=(.3%3)9
4,%
-=1'
6
%34?'-')
9'553-:)
H N4)<
D
I'(94-3-3)
H O'1<(3-3)
D
P5..%
2('4-3,3,'
3,2('4)')
H K4,2('4-3-3)
D
)'(:9
5314)'
4,%
49=54)'
3,2('4)')

H Q=.24(%3-3)
H Q=.)3-3)
D
K.5=9=.)3-3)
H O':(.14-<=
D
,':(.9:)2:54(
-.F323-=
73"'"
R:35543,@P4(('E
4,%
9=4)-<',34
;(4&3)8
H S-<'(
3,/54994-.(=
(')1.,)')
-<4-
4('
(4('
D
5'))
/('>:',-
B3-<
4
1.-',-345
399:,'@
9'%34-'%
'-3.5.;=
3,25:%'E
?:-
4('
,.-
5393-'%
-.E
1'(324(%3-3)E
)4(2.3%.)3)E
:&'3-3)
4,%
.-<'(
'&',-)
3,&.5&3,;
-<'
'='E
)T3,E
<'94-.5.;3245
4,%
(<':94-.5.;3245
'&',-)E
&4)2:53-3)E
,.,@3,/'2-3.:)
9',3,;3-3)
4,%
,.,@3,/'2-3.:)
',2'1<453-3)"
U.(2:((',-
53)-
./
4%&'()'
%(:;
('42-3.,)
7$IN8)
/.(
%:(&45:94?E
15'4)'E
)''
VWWXYZ[\
^
U:(-<'(3,/.(94-3.,
.,
-<')'
(3)T)
7'";"
1(')',-3,;
)=91-.9)8
24,
?'
/.:,%
3,
-<'
2:((',-
&'()3.,
./ -<' %:(&45:94?
4,%
-('9'539:94?
6,&')-3;4-.(
P(.2<:('"
U.(
%:(&45:94?
4,%
-('9'539:94?E
$+06)
B355
2.91(3)'
-<'
/.55.B3,;G












  
 !"!#!$%&'()*&+,+-
./-*12&'()*&+,+-
34'
35-*
*1
+&,'4'-,
1*4
.-,436'&'738
3-
2&'()*&+,+-
93-
:''&
*:-'4;'<
=+,9
(-'*13&,+>%?>$
).:-
@:(,
&*,
=+,9
3&,+>%?>A$
).:-B!
C&+,+35
=*4D>(2
-9*(5<
+&75(<'
3
9+E9>
4'-*5(,+*&FG
-73&8
4(5+&E
*(,
+&1'7,+*&8
3&<
2(5-'
*H+)',4I!
%(5)*&34I
7*&-(5,3,+*&
+-
9+E95I
4'7*))'&<'<!
J(+<'5+&'-
1*4
,9'
)3&3E')'&,
*1
23,+'&,-
=+,9
+))(&'>)'<+3,'<
./-
@+)./-B
+&75(<+&E2&'()*&+,+-
34'
24*;+<'<
+&
KLLMNOPQ
S!
 !"!#!#C&1(-+*&
4'37,+*&-
./-*1+&1(-+*&
4'37,+*&-
@35-*
,'4)'<
+&1(-+*&>4'53,'<
4'37,+*&-B
34'
*1
-2'7+35
+&,'4'-,
,*
.-,436'&'73
3&<
34'
<'1+&'<8
1*4
,9'
2(42*-'
*1
,9+-
24*,*7*58
3-
355
./-
*77(44+&E
14*)
,9'
-,34,
*1C%+&1(-+*&
(2
,*
"T
9*(4-
31,'4
,9'
+&1(-+*&
-,34,
,+)'!
U*4
355
+&1(-+*&
4'37,+*&-8
V./-
-9*(5<
:'4'2*4,'<
,*
.-,436'&'73
%3,+'&,
-31',I
3-
<'-74+:'<
+&
V'7,+*&
WXY!
 !"!#! ZI2'4-'&-+,+;+,I
4'37,+*&-
ZI2'4-'&-+,+;+,I
4'37,+*&-
3-
='55
3-
+&1(-+*&>4'53,'<
4'37,+*&-
93;'
:''&
4'2*4,'<
=+,9
3&,+
%?>
A$3&<3&,+>%?>$
,9'432I[ "\!
.-
=+,9
,9'
3<)+&+-,43,+*&
*1
3&I
1*4'+E&
24*,'+&
3&<]*4
*,9'4
:+*5*E+73E'&,-8
4'37,+*&-
1*55*=+&E
,9'
+&1(-+*&
*1
).:-
73&
:'
73(-'<
:I
;34+*(-
)'793&+-)-8
+&75(<+&E37(,'
3&329I537,+7
@CE/>)'<+3,'<B
3&<
3&329I537,*+<
4'37,+*&-
3E3+&-,
,9'
).:-
3&<
-'4() -+7D&'--!
.7(,'
355'4E+7
4'37,+*&-
)3I
*77(48
)3I
:'
-';'4'8
3&<
)3I
4'-(5,
+&
<'3,9!
.7(,'355'4E+7
4'37,+*&-
)3I
+&75(<'
9I2*,'&-+*&8
<I-2&'38
7I3&*-+-8
4'-2+43,*4I
13+5(4'8
(4,+734+3824(4+,(-8
3&E+*'<')38
9I2*,*&+38
34,9435E+38
:4*&79*-23-)8
=9''^'8
7*(E98
<+^^+&'--8
13,+E('89'3<379'8
9I2'4,'&-+*&8
)I35E+38
;*)+,+&E8
3&<
(&4'-2*&-+;'&'--!
J(+<'5+&'-
1*4
,9'
)3&3E')'&,
*1
23,+'&,-
=+,9
9I2'4-'&-+,+;+,I
@+&75(<+&E
3&329I537,+7
4'37,+*&B
3&<
+&1(-+*&>
4'53,'<4'37,+*&-
34'
24*;+<'<
+&
KLLMNOPQ
S!

 !"!#!"Z'23,+7
1(&7,+*&
3:&*4)35+,+'-
@9'23,*,*H+7+,IB
Z'23,+71(&7,+*&
3:&*4)35+,I
+-
<'1+&'<
3-
3&I
+&74'3-'
+&
.AG
*4
.VG
,*
E4'3,'4
,93&
 
_
`Aa
3&<7*&7(44'&,
+&74'3-'
+&
,*,35
:+5+4(:+&
,*
:'
E4'3,'4
,93&
#
_
`Aa!
F*&7(44'&,
1+&<+&E-
34'
,9*-',93,<'4+;'
14*)
3
-+&E5'
:5**<
<43=
*4
14*)
-'2343,'
:5**<
<43=-
,3D'&
=+,9+&
T
<3I-
*1
'379 *,9'4!
U*55*=>(2
+&;'-,+E3,+*&-
3&<
+&b(+4+'-
=+55
:'
+&+,+3,'<
24*)2,5I
:I
,9'
+&;'-,+E3,+*&35
-+,'
,*
<','4)+&'
=9',9'4
,9'
1+&<+&E-
34'
4'24*<(7+:5'
3&<]*4
=9',9'4
,9'4'
+-
*:c'7,+;'';+<'&7'
,93,
75'345I
-(22*4,-
73(-3,+*&
:I
3
<+-'3-'
@'!E!8
79*5'5+,9+3-+-
3&<
:+5'
<(7,
*:-,4(7,+*&
=+,9
<+-,'&<'<
E355:53<<'4B
*4
3&
3E'&,
*,9'4
,93&
,9'
C%!
J(+<'5+&'-
1*4
)3&3E')'&,
*123,+'&,-
=+,9
9'23,+7
1(&7,+*&
3:&*4)35+,I
34'
24*;+<'<
+&
KLLMNOPQ
S!
?(',*,9'
137,
,93,
+&
ZFF
23,+'&,-
'5';3,'<
,43&-3)+&3-'
3&<]*4
:+5+4(:+&
5';'5-
34'
7*))*&
3&<15(7,(3&,
3-
3
4'-(5,
*1
(&<'45I+&E
5+;'4
<+-'3-'
@'!E!
;+435
9'23,+,+-B8
,9'
,*H+7+,I
74+,'4+3
*(,5+&'<+&
KLLMNOPQ
S
=+55
:'
+&,'424','<
=+,9
,9'
1*55*=+&E
73;'3,-d
$BU*4
23,+'&,-
=+,9
ZFF
=+,9
&*4)35
5+;'4
,43&-3)+&3-'-
3&<]*4
:+5+4(:+&
3,
:3-'5+&'8
,9'
74+,'4+33225I
3-
*(,5+&'<
+&
KLLMNOPQ
S!
@+!'!
+1
3
E43<'
#
';'&,
*77(4-
,4'3,)'&,
=+55
:'
9'5<
(&,+54'-*5(,+*&
,*
E43<'
$B
#BU*4
23,+'&,-
=+,9
ZFF
=9*
93;'
'5';3,'<
5+;'4
,43&-3)+&3-'-
3&<]*4
:+5+4(:+&
3,
:3-'5+&'@E43<'
$
*4
#
+!'!
-,+55
355*=+&E
1*4
-,(<I
'&,4IB8
-(:-'b('&,
*77(44'&7'-
*1
E43<'
#
'5';3,+*&-=+55&*,4'-(5,+&9*5<+&E*1,9'432I!
 BJ43<' ';'&,-=+55:',4'3,'<3-2'4KLLMNOPQS+44'-2'7,+;'*1:3-'5+&'5';'5-!











 !
 "!"#"$%&'()*+,(-'(+,&.
0+'*)0-)'
1+&))2-&34*.+(+'
+'
(2-
5*'(
4*55*,.6
*7'-)8-0
()-&(5-,(
-5-)9-,(
:;<
=2-,
()-5-.+5>5&7
+'
>'-0&'5*,*(2-)&?6"
@,
)&)-
4&'-'A
4*.*,
?-)B*)&(+*,
5&6
*44>)
(2&(
)-C>+)-'
'>)9-)6
D4*.-4(*56E
*)
4&,
.-&0
(*
&
B&(&.
*>(4*5-
+B
,*(
?)*?-).6
5&,&9-0"
%>+0-.+,-'
*,
5&,&9-5-,(
*B0+&))2-&
&,0
4*.+(+'
+,
?&(+-,('
)-4-+8+,9
()-5-.+5>5&7
&)-
?)*8+0-0
+,
FGGHIJKL
N"
 "!"#"O<,0*4)+,-
0+'*)0-)'
@55>,-P5-0+&(-0
-,0*4)+,*?&(2+-'
+,4.>0-
26?*?26'+(+'A
&0)-,&.
+,'>BB+4+-,46A
&,0
26?-)P
&,0
26?*(26)*+0+'5"
%>+0-.+,-'
B*)
(2-
5&,&9-5-,(
*B
?&(+-,('
=+(2
+55>,-P5-0+&(-0
-,0*4)+,-
-8-,('&)-
?)*8+0-0
+,
FGGHIJKL
N"
 "!"#"QR&,4)-&(+4
0+'*)0-)'
@55>,-P5-0+&(-0
?&,4)-&(+(+'
+,4.>0-'
&>(*+55>,-
?&,4)-&(+(+'A
&,0
.+?&'-
&,0
&56.&'-
-.-8&(+*,"%>+0-.+,-'
B*)
(2-
5&,&9-5-,(
*B
?&(+-,('
=+(2
+55>,-P5-0+&(-0
?&,4)-&(+4
0+'*)0-)'&)-
?)*8+0-0
+,
FGGHIJKL
N"
 "!"#"ST->)*(*U+4+(6
@55>,-P5-0+&(-0
,-)8*>'
'6'(-5
-8-,('
+,4.>0-
-,4-?2&.+(+'A
?-)+?2-)&.
5*(*)
&,0
'-,'*)6
,->)*?&(2+-'A
%>+..&+,PV&))-A
&,0
56&'(2-,+&
9)&8+'"
%>+0-.+,-'
B*)
(2-
5&,&9-5-,(
*B
?&(+-,('
=+(2+55>,-P5-0+&(-0
,->)*(*U+4
-8-,('
&)-
?)*8+0-0
+,
FGGHIJKL
N"
 "!"#"WT-?2)+(+'
X*,'>.(=+(2
T-?2)*.*9+'("
Y*,+(*)
B*)
'+9,'
&,0
'65?(*5'
(2&(
5&6
7-
)-.&(-0
(*
42&,9-'
+,
)-,&.B>,4(+*,
D-"9"
)*>(+,-
>)+,&.6'+'A
-.-8&(-0
'-)>5
VZT
&,0
4)-&(+,+,-A
0-4)-&'-0
4)-&(+,+,-
4.-&)&,4-A
-.-4()*.6(-
+57&.&,4-A
0-4)-&'-
+,
>)+,-
*>(?>(A
?)*(-+,>)+&A
-(4"E
R&(+-,(''2*>.0
7-
(2*)*>92.6
-8&.>&(-0
(*
)>.-
*>(
&,6
&.(-),&(+8-
-(+*.*96
D-"9"A
0+'-&'-
?)*9)-''+*,A
+,B-4(+*,'
-(4"E
:(-)*+0''2*>.0
7-
4*,'+0-)-0
+,
(2-
&7'-,4-
*B
4.-&)
&.(-),&(+8-
-(+*.*96
-8-,
B*)
.*=
9)&0-
-8-,('D%)&0-
#EA
+,
*)0-)
(*
?)-8-,(
?*(-,(+&.
?)*9)-''+*,
(*
2+92-)
9)&0-
-8-,("

%>+0-.+,-'
B*)
(2-5&,&9-5-,(
*B
?&(+-,('
=+(2
+55>,-P5-0+&(-0
,->)*(*U+4
-8-,('
&)-
?)*8+0-0
+,
FGGHIJKL
N"
 "!"#"[\ 
;>(*+55>,+(6
@B&'>7]-4(
-U?-)+-,4-
&,
;<
(2&(
+'
(2*>92(
(*
7-
?*''+7.6
*B
&>(*+55>,-
,&(>)-
D-"9"A
(26)*+0+(+'A
2-?&(+(+'A
?&,4)-&(+(+'A
(2)*57*46(*?-,+&A
26?*?26'+(+'A
0+&7-(-'
+,'+?+0>'EA
(2-
+,8-'(+9&(*)
'2*>.0
'-,0
&
7.**0
'&5?.-
B*)
&??)*?)+&(-
&>(*+55>,-
&,(+7*06
(-'(+,9
&,0
'2*>.0
+55-0+&(-.6
4*,'+0-)
-,0*4)+,*.*96
4*,'>.(&(+*,"
@B
'?-4+B+4
&>(*P&,(+7*0+-'
&)-
?)-'-,(A
(2-
7.**0'&5?.-
(&^-,
B*)
'(*)&9-
&(
7&'-.+,-
4&,
7-
(-'(-0
B*)
(2-
?)-'-,4-
*B
&>(*
&,(+7*0+-'"
X*,(+,>&(+*,
*B
+,8-'(+9&(+*,&.
?)*0>4(
+,
(2-
?)-'-,4-
*B
+55>,-P5-0+&(-0
-8-,('
'2*>.0
7-
0*,-76(2-
+,8-'(+9&(*)
=+(2
4*,'+0-)&(+*,
(*
)+'^P7-,-B+(
&,&.6'+'"
_`a bcdefNfe
cghedijgdb
Nhg
kFedl

gNF
Fmi
egnhFopFkfhm
 "$"[ q)&,'&)(-)+&.42-5*-57*.+r&(+*,
R-)4>(&,-*>'?)*4-0>)-+'?-)B*)5-0>,0-)9-,-)&.&,-'(2-'+&*)4*,'4+*>''-0&(+*,";44-''+'
*7(&+,-0 B)*5 (2-4*55*, B-5*)&.&)(-)6 &,0 '-.-4(+8-4&(2-(-)+r&(+*, *B(2-'>?-)+*)











 !
"#$#%&#'()
+%,
)#-(+)
+'&#'(#$
($
.#'/0'"#,
&0
,#/(%#
+%+&0"1
+%,
2#.+&()
+'&#'(+-
$3..-14
53.#'
$#-#)&(6#)+&2#&#'(7+&(0%
0/
2#.+&()
+'&#'1
8'+%)2#$
/##,(%9
&2#
&3"0'$
($
&2#%
.#'/0'"#,
/0--0:#,81
(%/3$(0%
0/
+
)2#"0&2#'+.#3&()
"(;&3'#4
<'+%$=+'&#'(+-
)2#"0#"80-(7+&(0%
:(--
8#
.#'/0'"#,
:(&2
,'39
#-3,(%9
8#+,$
>?@AB4
C%
&2($
)+$#DEFF"9
0/
,0;0'38()(%
+'#
-0+,#,
(%&0
EFF=G!F
"()'0%
8#+,$4
<2#
?@A
+'#
"(;#,
:(&2
)0%&'+$&+%,
(%/3$#,
(%&0
&2#
2#.+&()
+'&#'1
8'+%)2#$
$3..-1(%9
&2#
&3"0'4
H+&(#%&$
3%,#'90(%9
&'+%$=+'&#'(+-
)2#"0#"80-(7+&(0%
+'#
.'#="#,()+&#,
:(&2
+%+-9#$()$D
+%&(8(0&()$
+%,
+%&(=#"#&()$
.#')-(%()+-
$&+%,+',$4
 4!4G I+,(0/'#J3#%)1
+8-+&(0%
<2#'"+-+8-+&(0%
($
+
"(%("+--1
(%6+$(6#
("+9#
93(,#,
.'0)#,3'#
.#'/0'"#,
3%,#'
9#%#'+-
+%#$&2#$(+
0'
)0%$)(03$
$#,+&(0%4
I+,(0/'#J3#%)1
0'
"()'0:+6#
+8-+&(0%$
+'#
.#'/0'"#,K
&2#
+8-+&(0%70%#
(%)-3,#$
&2#
&3"0'
+%,
+
$+/#&1
"+'9(%
0/
$3''03%,(%9
&($$3#4
<2#'"+-
+8-+&(0%
&2#'+.1:(--
8#
+,"(%($&#'#,
+))0',(%9
&0
&2#
"+%3/+)&3'#'L$
(%$&'3)&(0%$
0/
&2#
,#6()#4
<2#
.'08#)20$#%
6+'(#$
,#.#%,(%9
0%
&2#
&1.#
0/
&2#'"+-
+8-+&(0%D
$(7#
0/
&2#
&3"0'4
<2#
+8-+&(0%
.'08#:(--
8#
(%$#'&#,
(%&0
&2#
-#$(0%D
3%,#'
("+9#
93(,+%)#4
M/&#'
)0%/('"+&(0%
0/
+..'0.'(+&#
.0$(&(0%(%9D
&2#
-#$(0%
:(--
8#
2#+&#,
&1.()+--1
/0'
EF=E!
"(%3&#$
/0'
INM
+%,
!=EF
"(%3&#$
/0'
"()'0:+6#D
+))0',(%9
&0
"+%3/+)&3'#'L$
93(,#-(%#$4
<2#
&("#
0/
+8-+&(0%
:(--
,#.#%,
0%
&2#'"+-
+8-+&(0%&#)2%(J3#
>IN
6$4
"()'0:+6#B
+$
:#--
+$
&2#
$(7#
0/
&2#
+8-+&(0%
70%#
,#$('#,4
<2#
+8-+&(0%&("#
"(92&
+-$0
6+'1
,#.#%,(%9
0%
.'0;("(&1
0/
)'(&()+-
$&'3)&3'#$D
.+&(#%&=$.#)(/()
+%+&0"10'
($$3#$4
?#.#%,(%9
0%
+8-+&(0%
70%#
$(7#D
$#6#'+-
.'08#$
"(92&
8#
'#J3('#,
:(&2
$#6#'+-2#+&(%9
&("#$
&0
+)2(#6#
)0".-#&#
)06#'+9#
0/
&2#
,#$('#,
+8-+&(0%
70%#4
A+--00%
)+&2#&#'
"+18#3$#,
(%
)+$#$
:2#'#
&2#
&3"0'
($
+,O+)#%&
&0
+
2#.+&()
6#(%
&0
+60(,
P2#+&
$1%)Q
:2#'#
&2#+8-+&(0%
70%#
($
)00-#,
81
&2#
8-00,
(%/-0:4
<2($
)+&2#&#'
($
&1.()+--1
(%$#'&#,
/'0"
&2#
%#)R
6#(%+%,($
&2#%
.-+)#,
(%&0
+
2#.+&()
6#(%4
S1,'0,($$#)&(0%
"+1
+-$0
8#
3$#,
(%
)+$#$
:2#'#
&2#
&3"0'($+,O+)#%&
&0
+
)'(&()+-
$&'3)&3'#
$3)2
+$
&2#
2#+'&
0'
)0-0%4
<2#$#
0'9+%$
)+%
$3$&+(%
,+"+9#/'0"
2#+&(%9D
&2#'#/0'#
+
)+&2#&#'
($
(%$#'&#,
(%&0
&2#
$.+)#
$#.+'+&(%9
&2#"
+%,
&2#
&3"0'+%,
/-3(,
>,#;&'0$#
!TB
($
+,"(%($&#'#,
,3'(%9
&2#
+8-+&(0%4
 4!4 U'10+8-+&(0%
<2#/'##7#
70%#
0/
)'10+8-+&(0%
#//#)&$
,#.#%,
3.0%
&2#
.'08#
$(7#
+%,
)0%/(93'+&(0%
+$
:#--
+$
&2#%+,('0/
&2#
/'##7#
)1)-#
>,#.#%,#%&
3.0%
&2#
$.#)(/()
)'109#%B4
<:0
)'10+8-+&(0%
$1$&#"$
+'#)0""#')(+--1
+6+(-+8-#
+%,
N?M
)-#+'#,
/0'
23"+%
3$#
>@%,0)+'#
V
S#+-&2&'0%()$
+%,
W+-(-B4
A0&23$#2#-(3"
+%,
+'90%
9+$#$
&0
(%,3)#
-#&2+-
&#".#'+&3'#$
-0)+--14
<2#$1$&#"$
'#J3('#
+'90%
+%,
2#-(3"
9+$#$
:2()2
.'0,3)#
-0:
&#".#'+&3'#$
3.0%
.2+$#
)2+%9#
/'0"9+$&0
-(J3(,4
<2#
)'10&2#'+.1
#J3(."#%&
:(--
8#
+%
+'90%=2#-(3"
9+$
$1$&#"
3$(%9
E4X""
0'G4Y""
)'10.'08#$
>@%,0)+'#D
C%)4D
C'6(%#D
UMB
0'
F4FYZ
(%)2#$
[
E\
9+39#
[
E4 
""
)'10.'08#$
>W+-(-B4
<2#
()#=8+--
,(+"#&#'$
/0'
&2#$#
.'08#$
"+1
6+'1
+))0',(%9
&0
&2#
&($$3#
+%,
8-00,$3..-1D
83&
&2#('
/'##7#
-#%9&2$
$203-,
8#
)0".+'+8-#
&0
&2#
INM
$1$&#"
>EF= F
""B4
C)#=
8+--,(+"#&#'$
'#/#'
&0
&2#
03&#'
F]U
"+'9(%D
83&
)1&0&0;()
&#".#'+&3'#$
>#494D
^
=GF
&0
=YF
]UB
+'#R%0:%
&0
0))3'
 =!
""
8#2(%,
6($3+-(7#,
()#
"+'9(%$4
M
EF=GF
"(%3&#$L
/'##7#D
/0--0:#,
81
+!=EF"(%3&#$L
&2+:D
+%,
+
EF=GF
"(%3&#
'#=/'##7#
.'0,3)#$
6($(8-#
()#
+%,
%#)'0$($
81
'+.(,
+%,$-0: "#)2+%($"$>,#21,'+&(0%+%,6+$)3-+'$&+$($B4<2#$.#)(/()&("#$,#.#%,3.0%&2#
&#".#'+&3'#$+%,.0&#%&(+--1&2#&#".#'+&3'#$0/+%1'#"0&#&2#'"0"#&'13$#,&0+$$#Y$$
&#".#'+&3'#+&&2#"+'9(%0/+/'##7#4I+.(,(%&'+)#--3-+'()#/0'"+&(0%)+3$#$(''#6#'$(8-#)#--











 !
"#$%&')#**
+#+,-$.#
"/012.3%45.
5332-0
,#*56
789
"#:-##0
);
*#$"4.:
%5
4.%-$3#**2*$-
43#
15-+$%45.;
"40-2<%4.:
5-:$.#**#0'
=2-4.:
%&$64.:;
50+5*$-
0&41%0
3$20#
3#**2*$-
06#**4.:
$."
-2<%2-#'><5<%5040
$."
?$032*$-
0%$040
+$/
$*05
<*$/
$
-5*#
4.
3#**
"#$%&
,/
1-##@4.:'
A&#<-5,#0
$-#
<*$3#"
4.%5
%&#
%2+5-B0C
,/
2*%-$052.";
)A
5-
DEF
:24"$.3#'
G<
%5
H
04+2*%$.#520
<-5,#0
+$/
,#
<*$3#"
0#I2#.%4$**/
15-
04+2*%$.#520
%-#$%+#.%
B"411#-#.%
1-5+
32--#.%+5.5<5*$-
EJ>C'
8
K
*4"53$4.#
40
$<<*4#"
%5
%&#
02,32%$.#520
%4002#0
"56.
%5
%&#
5-:$.
514.%#-#0%'
A&#
&#*42+
$."
$-:5.
:$0#0
$-#
&55L#"
2<
%5
%&#
0/0%#+;
$."
%&#
3-/5%&#-$</
+$3&4.#$."
051%6$-#
$-#
-#*$%4?#*/
$2%5+$%43
$%
%&40
<54.%
64%&
%&#
1-##@#;
%&$6;
-#1-##@#
3/3*#0
$0"#03-4,#"
$,5?#'
A&#
<-53#00
40
+5.4%5-#"
64%&
2*%-$052."
$."
)A
03$.0
$0
3*4.43$**/
-#I24-#"
15-0%$."$-"
5<#-$%4.:
<-53#"2-#0
"#03-4,#"
,/
%&#
+$.21$3%2-#-0'
 'M'N =#%#-+4.$%45.
51
%&#
$+52.%
51
02,%5%$*
$,*$%45.'
>%$**%4+#0;
%&#
?5*2+#
%5
,#
$,*$%#"
0&52*"
,#
64%&4.
%&$%
-#:$-"#"
$0
$33#<%$,*#
<#-
0%$."$-"
513$-#15-
$,*$%45.0
<#-15-+#"
15-
32-$%4?#
4.%#.%'
)#-%$4.*/;
%&40
652*"
,#
*#00
%&$.
N
3+
+$O
4.
3-50070#3%45.$*
4+$:4.:'
J5-
%&#
<2-<50#0
51
%&40
<-5%535*
02,%5%$*
$,*$%45.
-#1#-0
%5
%&#
35+<*#%#
%-#$%+#.%51
$
05*4%$-/
*#045.
4.
%&#
0#%%4.:
51
+2*%4153$*
"40#$0#;
*#$?4.:
5%&#-
*#045.0
B,5%&
4.%-$&#<$%43
$."
#O%-$&#<$%43C
4.%$3%
$."
2.%-#$%#"'
A&#
*#045.
02,P#3%#"
%5
$,*$%45.
40
%5
,#
3&50#.$%%&#
"403-#%45.
51
%&#
4.%#-?#.%45.$*
-$"45*5:40%
,$0#"
5.
%#3&.43$*
1$3%5-0;
023&
$0
#$0#
51$33#00;<-5O4+4%/
%5
?#00#*0
#%3'











 !
"#$ %&'()
+,-./(,0
123456725
1258
9:76
;
+;4<5
=
+;4<5
>
+;4<5
"
+;4<5
?
(=
3@
5A52;
97B95
C75D:
4;4<5
3
.E&F
-&
G'2
(H;
=
I
=J
>>
=
I
K6H;
"$L
=J
>>
=
I
=J
>>
=
K6H;
IJL
I
=J
>>
MNOPOQRPSPTU
T
W
W
W
W
XSNYTQSPTU
T
W
W
W
W
W
Z[\]M\^_]
^N`aTUQTbRac
U
W
dceaNPOfgachOcb
 W
XOPaiNTjkRgh
W
lOfRgTQkRhbaN`
W
\fYTcgO
XRNOgbRYOg
W
^acgaPRbTcb
POfh
W
W
W
W
W
\fYONhOOYOcb
OYTQSTbRac
W
W
W
W
W
W
mk`hRgTQOnTP
f
W
W
W
W
W
W
W
oRbTQhRich
W
W
O
W
O
W
O
W
O
W
O
W
pORikb
W
qORikb
W
W
W
W
W
W
mONeaNPTcgO
rbTbSh
W
W
W
W
W
W
W











 !
"#$%&'(#&
"#&)
*+('
,
-,%.&0
-,%.&1
-,%.&2
-,%.&3
40$5
&6&#,
*(7*&
8(&9+
%,%.&
$
:;<=
><
?@#
4A,
0
B
0C
11
0
BD'A,2EF
0C
11
0
B
0C
11
0D'A,BCF
B
0C
11
GHG
JKLMNNOPOQRMSTU
VTSROTORWN
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
VYUZ[\UVYYU
]M^PMQ_`OQN
X
X
X
X
X
X
X
YabP_MLVSQOT
cU
a
X
X
X
X
X
d[d
X
X
c
HM_eaOfMeST
gP_NMTONU
`
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
hPMeSeMLU
SfbTSWO

N
X
X
X
X
X
X
iSffS
`TjRSfbTRPSQWNOPS
WOM
X
X
X
kOPjfS]V_P
GS
lmnmc
X
X
X
X
X
oOgSRMRMWHSQL
G
NU
p
X
X
X
X
X
X
hPMQSTbWMWN
X
X
X
X
X
X
hPMQO_PWOPjf
gPO`QSQebROWR
X











 !
"#$%&'(#&
"#&)
*+('
,
-,%.&0
-,%.&1
-,%.&2
-,%.&3
40$5
&6&#,
*(7*&
8(&9+
%,%.&
$
:;<=
><
?@#
4A,
0
B
0C
11
0
BD'A,2EF
0C
11
0
B
0C
11
0D'A,BCF
B
0C
11
GHI
KLMNOPQRSNT
U
VWX
U
WONYSZ[\PSON
OY
]^_Q`WaHK
U
bMcP\TSNT
Z\]SOdOTSe
Vf\dg\PSONh
U
U
U
ig[OZ_SORcQ
d
U
U
U
a[[gNM
[ONSPOZSNT
j
U
U
U
N
U
U
Uc
KL\Z[\eOkSNMPSe
cPg]SMc[
U
U
N
U
N
U
U
U
a[[gNOTMNSeSPQ
P
U
U
U
U
Uc
U
IlIm
HSfMZnkS]NMQ
[SeZOcO[\d
\NPS_O]Q
j
U
U
ig[OZocRMeSYSe
pqrZMcRONcMcj
U
U
U
U
Uc
WstV
U
U
U
U
Uc











 !
"#$%&'(#&
"#&)
*+('
,
-,%.&0
-,%.&1
-,%.&2
-,%.&3
40$5
&6&#,
*(7*&
8(&9+
%,%.&
$
:;<=
><
?@#
4A,
0
B
0C
11
0
BD'A,2EF
0C
11
0
B
0C
11
0D'A,BCF
B
0C
11
GHIJKLMHNOKIP
R
SMJJTU
VWXYLZPSOKIPNJ
NTTN[U
\
\
\
\
\T
RSMJJ
NSOK]NOKIP^_Y`X
MaGHMTTKIP
bcdVYe

O
\
\
P
\
P
\
\
\
\T
cJNTfNghNTMi
NTTN[TLIH
SKHSZJNOKPj
HMSMGOIHT^JKjNPiT
MkjkcWlmO
\
\
\
P
\
\
P
\
\T
nMSONJToNh
bIGOKIPNJe
\
\
\
cpIPMSNJJIH
Mg
fNKJ
\
\
NkRHMfMJKfZfNhq

LJNO
iITM
IL
rs
fj
U ot
bu^g
r
iN[Te
LIH
 
iITMT
IPJ[k

WZH]NJZfNhq
LJNO
iITM
IL
ms!!
fj
U ot
bu^g
r
iN[Tek
hknvw^RwYx^SH[INhJNOKIP
IP
iN[
yz
u^g
{z
pHTk
SkvKJJKPjIZOILOpMwi]NPSMWKHMSOK]MvIHfoKJJhMILLMHMihZOIhONKPKPjILKOKTPIOHMUZKHMikRpKTTpIZJihMiIPMGHMLMHNhJ[NO
hNTMJKPMhZOSNPhMiIPMNONP[OKfMiZHKPjOpMTOZi[NTJIPjNTOpMSNGNSKO[OIiITIKTHMONKPMikvIHiMONKJTTMMXMSOKIP01|3k











 !
"#$%&&
()*+,-.&
/0.1,2.3,42
.3
+-5//2,267
3.56/3/"
()*+,-.&
/0.1,2.3,42
.3
43)/5
3,1/
(4,23+
/#8,3),2
9:
1,2%3/+
;/<45/
.2"
8,3),2
9:
1,2%3/+
.<3/5
,2<%+,42#
<# =<(5/>+3%"*
&.;45.345*
.++/++1/23+
.5/
(/5<451/"
8,3),2
9
".*+
(5,45
34
?.*
!
3)/*
"4
243
2//"
34
;/
5/(/.3/"
.3
?.*
!#
@/+%&3+
<45
+.</3*
;&44"+
1%+3
;/
.A.,&.;&/
.2"
5/A,/8/"
;/<45/
-411/2-,26
.2
,2<%+,42#
$45
.&&
&.;+B
.
CDE>
FG
)5H
8,2"48
.((&,/+B
8,3)
3)/
/0-/(3,42
4<
3)4+/
2//"/"
34
"/3/51,2/
(54-//",26
8,3)
35/.31/23#
I.;+
1.*
;/
(/5<451/"
4%3+,"/
4<
J=K#
6#L,4-)/1,-.&
(54<,&/M
/&/-354&*3/+B
LNJB
-5/.3,2,2/B
OPQB
OIQB
343.&
.2"
",5/-3
;,&,5%;,2B
-.&-,%1B
()4+()45%+B
.&;%1,2B
1.62/+,%1#
)#$5//
Q9
.2"
<5//
Q 
8,&&
42&*
;/
1/.+%5/"
,<
QPK
,+
.;2451.&#
Q)/*
+)4%&"
.&+4
;/
1/.+%5/"
,<
3)/5/
,+
-&,2,-.&
+%+(,-,42
4<
.2."A/5+/
/A/23
5/&.3/"
34
3)/
/2"4-5,2/
+*+3/1#
,# P-5//2,26B
?.*
!
.2"
"%5,26
3)/
+3%"*B
;%3
42&*
,<
-&,2,-.&&*
,2",-.3/"
R# $45
A,5.&
)/(.3,3,+
(.3,/23+M
$45
K/(.3,3,+
LM
KLS
A,5.&
&4."7
O23,>KL-
O23,;4"*B
O23,>KL/
O23,;4"*B
KL/O6
.2"
T%.23,3.3,A/
K/(L
O6B
KLS
+(/-,<,-
,11%2/
5/+(42+/#
$45
K/(.3,3,+
UM
KUS
A,5.&
&4."B
.23,>KUS
O23,;4"*
3,35/#
V#@/+3.6,26
UQ
4<
-)/+3B
.;"41/2
.2"
(/&A,+
W45
X@=
4<
&,A/5
,<
-&,2,-.&&*
,2",-.3/"Y
+-.2
/A/5*
Z
8//V+
34
/A.&%.3/
QQ[
,2
3.56/3
&/+,42#
[4+3
-*-&/
\
5/+3.6,26
8,&&
4--%5
/A/5*
!G
8//V+
%23,&
-42<,51/"
[?#
K48/A/5B
"/(/2",26
42
3)/
+3%"*
"/+,62
.2"E45
-41(.5.345
.51B
3)/
3,1,26
4<
+-.2+
1.*
-).26/
<541
/A/5*
Z
8//V+#
&# O&&
(.3,/23+
8,&&
5/-/,A/
.
;.+/&,2/
1.2".345*
;,4(+*#
](3,42.&
;,4(+,/+
8,&&
;/
5/T%/+3/"
42
?9\
.2"
?Z^#
Q)4+/
5/-/,A,26
.;&.3,A/
3)/5.(*
8,&&
).A/
.
;,4(+*
42
?9\
"%5,26
3)/
.;&.3,A/
3)/5.(*
(54-/"%5/#
1#[5/>,2<%+,42
.2"
8,3),2
.((540,1.3/&*
!^
1,2%3/+
(4+3
,2<%+,42#
2#$45
&4-.&
(.3,/23+
42&*#
4#[.3,/23+
8,&&
-423,2%/
!^::
16
"%5A.&%1.;
T 8
%23,&
/2"
4<
+3%"*
35/.31/23
.+
"/<,2/"
,2
+/-3,42
_`a`b#
(#Q)/
/2"
4<<>35/.31/23
A,+,3+
8,&&
4--%5
,<
(.3,/23
,+
.65//.;&/
34
-41,26
;.-V
.2"
()*+,-.&&*
.;&/
34
5/3%52
<45
3)/
A,+,3+#
Q)/+/
A,+,3+
8,&&
4--%5
.((540,1.3/&*
\:
.2"
c:
".*+
(4+3
3)/
&.+3
"4+/
4<
+3%"*
"5%6#
[.3,/23+
"/-&,2/"
34
-41/B
8,&&
;/
-423.-3/"
;*
()42/
45
/>1.,&
34
/A.&%.3/
3)/,5
+3.3%+#
T#CDE>
FG
)5H
8,2"48
.((&,/+#
5# I426
3,1/
<4&&48
%(#
O&&
+%;R/-3+
8,&&
;/
<4&&48/"
<45
+%5A,A.&
;*
()42/
-.&&
45
/>1.,&
/A/5*
\
1423)+
+# dA/5*
!G
8//V+
%23,&
[?
3# [5/>,2<%+,42











 !
"#$%&'(
*+,
%&-./+'*(0&+
12324 %5676
89:<=>?@=A
BCDD
E>FDAE
C@?GHF@I>
I=JKF@C>?
=H
KFHACICKF@A?
L=H
F@M
H>?>FHIE
=H
H>DFA><
IDC@CIFD
IFH>AEFAKFHACICKF@A?
H>I>CN>
FA
AE>
89:
ODC@CIFD
O>@A>H2

9L
?=J>
A>?A?
F@<
KH=I><GH>?
K>HL=HJ><
=GA?C<>AE>
89:
ODC@CIFD
O>@A>HP
KFHACICKF@A?
JFM
EFN>
A=
KFM
L=H
AE>?>
I=?A?
CL
AE>M
FH>
@=A
I=N>H><BM
C@?GHF@I>
I=JKF@M2

Q><CIC@>?
AEFA
FH>
@=A
KFHA
=L
AE>
?AG<M
AH>FAJ>@A
RCDD
@=A
B>
KH=NC<><=H
KFC<
L=H
BM
AE>
89:
ODC@CIFD
O>@A>H2



1232! %5STUV6W7X5V
YFHACICKF@A?
RCDD
@=A
B>
I=JK>@?FA><
=@
AEC?
?AG<MZ
12321 [UXS\]^6USUV7
_E>8O9RCDD
I=N>H
AE>
I=?A?
=L
?=J>
>`K>@?>?
F??=ICFA><
RCAE
KH=A=I=D
KFHACICKFAC=@2

a=J>
=L
AE>?> I=?A?
JFM
B>
KFC<
<CH>IADM
BM
AE>
89:
F@<
?=J>
JFM
B>
H>CJBGH?><
A=
AE>
KFHACICKF@AbcGFH<CF@
F?
FKKH=KHCFA>2

_E>
FJ=G@A
F@<
L=HJ
=L
AE>?>
KFMJ>@A?
FH>
<>A>HJC@><
BM
AE>8O9_HFN>D
F@<
d=<cC@c
e>CJBGH?>J>@A
Y=DCIM
"#f %[0(/[0*
g&[
[/-&h*i
g[&-
.[&(&%&i
(j/[*.k
*+,
&gg
'(l,k
%[0(/[0*
YHC=HA=H>J=NFD
LH=J
?AG<MP
>LL=HA
JG?A
B>
JF<>
A=
EFN>
FDD
?GBm>IA?
I=JKD>A>
F
?FL>AM
NC?CA?
FKKH=`CJFA>DM
no
F@<
po
<FM?
L=DD=RC@c
AE>
DF?A
<=?>
=L
?AG<M
AE>HFKM2
12q24 OHCA>HCF
L=H
e>J=NFD
LH=J
YH=A=I=D
_E>HFKM
r@C@<CNC<GFD
?GBm>IA
RCDD
@=A
H>I>CN>
F@M
LGHAE>H
C@N>?ACcFAC=@FD
KH=<GIA
CL
F@M
=L
AE>
L=DD=RC@c
=IIGHC@AE>
?GBm>IA
C@
sG>?AC=@t
u 
YH>c@F@IM
=H
C@A>@A
A=
B>I=J>
KH>c@F@A
u r@M
rv
AEFA
J>>A?
IHCA>HCF
L=H
<C?I=@AC@GFAC=@
F?
<>LC@><
C@
?>IAC=@
"#w2
u YFAC>@A
<>IC<>?
A=
RCAE<HFR
LH=J
AE>
?AG<M
u r<N>H?>
>N>@A
H>DFA><
A=
<GHNFDGJFB
=H
AH>J>DCJGJFBP
RCAE
AE>
>`I>KAC=@
=L
A=`CICAC>?
AEFA
<=
@=A
J>>A
AE>
IHCA>HCF
L=H
<C?I=@AC@GFAC=@
F?
<>LC@><
C@
?>IAC=@
"#w
CL
FKKDCIFBD>
u xHF<>
y
1
C@LG?C=@
H>FIAC=@
u 9@CACFAC=@
=L
FDA>H@FACN>
F@ACIF@I>H
AE>HFKM
C@IDG<C@c
F@=AE>H
C@N>?ACcFAC=@FD
Fc>@A
u O=@LCHJFAC=@
=L
Yz
F@<
C@N>?ACcFA=H
<>A>HJC@FAC=@
AEFA
AE>
?GBm>IA
C?
@=
D=@c>H
B>@>LCAC@c
LH=J
AH>FAJ>@A
RCAE
<GHNFDGJFB
{
AH>J>DCJGJFB
u 9@N>?ACcFA=H
<C?IH>AC=@
aGBm>IA?RE=
FH>
K>HJF@>@ADM
<C?I=@AC@G><
LH=J
LGHAE>H
H>I>CKA
=L
C@N>?ACcFAC=@FD
KH=<GIAP
H>cFH<D>??
=L
AE>
H>F?=@
|RCAE<HFRFD
=L
I=@?>@AP
<G>
A=
F@
rvP
=AE>H}P
RCDD
B>
C<>@ACLC><
F?
EFNC@c
K>HJF@>@ADM
<C?I=@AC@G><
AH>FAJ>@A2
aGBm>IA?RE=
FH>
K>HJF@>@ADM
<C?I=@AC@G><
LH=J
H>I>CNC@c
C@N>?ACcFAC=@FD
KH=<GIA
RCDD
B>
L=DD=R><L=H?FL>AMK>Ha>IAC=@$PC@IDG<C@cAE>I=DD>IAC=@=LF@MKH=A=I=D~?K>ICLC><BD==<
?K>ICJ>@?PG@D>??I=@?>@AC?RCAE<HFR@=HAE>?GBm>IAC?D=?AA=L=DD=R~GK=H>@H=DD><C@F@=AE>H
IDC@CIFD?AG<M2aGBm>IA?RE=<>IDC@>A=H>AGH@A=AE>?CA>L=H>NFDGFAC=@?RCDDB>=LL>H><L=DD=R~GK











 !
"#%&'())*)+#
!
,'(-&.
/.
/(
/0-)+(/-1*)2
300
.4"5)6-.
7100
")
8'00'7)9
8'+
.4+*1*/0
"#
%&'()
6/00'+):,/10
)*)+#
;
,'(-&.2
!2<2= >88:?-49#
@+1-)+1/
A B/+-161%/(-
+)C4).-.
-'
")
71-&9+/7(
8+',
.-49#
A D'.-
-'
8'00'7:4%
A ?4"5)6-
('(6',%01/(6)
-&/-E
1(
-&)
'%1(1'(
'8
-&)
1(*).-1F/-'+
'+
.%'(.'+E
7/++/(-.
71-&9+/7/0G
)2F2E
+)84./0
-'
/9&)+)
-'
.6&)940)9
*1.1-.
A H(*).-1F/-'+
91.6+)-1'(
A I)/-&
A BH9)61.1'(
-'
)(9
-&)
.-49#
!2<2! D'.-
-'
J'00'7:4%
3%/+-161%/(-
7100
")
6'(.19)+)9
0'.-
-'
8'00'7:4%
18
&)
'+
.&)
8/10.
-'
+)-4+(
8'+
!
.6&)940)9
*1.1-.
/(91.4(/"0)
-'
")
6'(-/6-)9
"#
-&)
.-49#
.1-)
.-/882
K&)8'00'71(F
/6-1'(.
,4.-
")
-/L)(
18
/
%/+-161%/(-
8/10.
-'
+)-4+(
-'
-&)
601(16
8'+
/
+)C41+)9
.-49#*1.1-M
A K&)
.1-)
7100
/--),%-
-'
6'(-/6-
-&)
%/+-161%/(-
/(9
+).6&)940)
-&)
,1..)9
*1.1-
71-&1(
N
,'(-&
/(9
6'4(.)0
-&)
%/+-161%/(-
'(
-&)
1,%'+-/(6)
'8
,/1(-/1(1(F
-&)
/..1F()9
*1.1-
.6&)940)
/(9
/.6)+-/1(
18
-&)
%/+-161%/(-
71.&).
-'
/(9O'+
.&'409
6'(-1(4)
1(
-&)
.-49#2
A P)8'+)
/
%/+-161%/(-
1.
9)),)9
0'.-
-'
8'00'7:4%E
-&)
1(*).-1F/-'+
'+
9).1F())
7100
,/L)
)*)+#
)88'+-
-'
+)F/1(
6'(-/6-
71-&
-&)
%/+-161%/(-
Q7&)+)
%'..1"0)E
!
-)0)%&'()
6/00.
/(9E
18()6)../+#E
/
6)+-181)9
0)--)+
-'
-&)
%/+-161%/(-R.
0/.-
L('7(
,/101(F
/99+)..
'+
0'6/0
)C41*/0)(-
,)-&'9.S2
K&).)
6'(-/6-
/--),%-.
.&'409
")
9'64,)(-)9
1(
-&)
%/+-161%/(-R.
,)916/0
+)6'+9
'+
.-49#
810)2
A ?&'409
-&)
%/+-161%/(-
6'(-1(4)
-'
")
4(+)/6&/"0)E
&)
'+
.&)
7100
")
6'(.19)+)9
-'
&/*)
71-&9+/7(
8+',
-&)
.-49#
71-&
/
%+1,/+#
+)/.'(
'8
0'.-
-'
8'00'7:4%2
T UVWUVXYZ[WZ
X]^YU[ZYVW_`X][_ab]_
300+'4-1()
/(9
/%%+'%+1/-)
.4%%'+-1*)
6/+)
Q1(60491(F
"0''9
%+'946-.S
7100
")
%+'*19)9
94+1(F
-&1..-49#E
/.
601(16/00#
1(916/-)9E
/(9
1(
/66'+9/(6)
71-&
-&)
.-/(9/+9
'8
6/+)
%+/6-16).2
@01(16/0
549F,)(-.&'409
")
4-101c)9
1(
-&)
-+)/-,)(-
'8
/(#
3d
)e%)+1)(6)9
"#
-&)
%/-1)(-2
H(8'+,/-1'(
'(
/00
6'(6',1-/(-
,)916/-1'(.E
/9,1(1.-)+)9
"0''9
%+'946-.E
/.
7)00
/.
1(-)+*)(-1'(.
'664++1(F
94+1(F
-&)
.-49#
,4.-
")
+)6'+9)9
'(
-&)
%/-1)(-R.
)@fJ2
K&)8'00'71(F
+).-+16-1'(.
/%%0#
7&10)
-&)
%/-1)(-
1.
+)6)1*1(F
.-49#
-+)/-,)(-
/(9
8'+
-&)
.%)6181)9-1,).
")8'+)
/(9
/8-)+M
Tgh i]X[j]
k[ZY]WZ
Vi
UlYj^m
n][bYWo
kVZ]WZY[j
J),/0).'86&109")/+1(F%'-)(-1/07&'/+).)e4/00#/6-1*)71-&/('(:.-)+101c)9,/0)%/+-()+
,4.-4.)/-0)/.-=&1F&0#)88)6-1*),)-&'9'86'(-+/6)%-1'(QZpqrstS8+',-&)-1,)'8.6+))(1(F
/(9,4.-/F+))-'6'(-1(4)4.1(F.46&%+)6/4-1'(.8'+N<u9/#./8-)+-&)0/.-9'.)'894+*/04,/"











  
!#$%&%'(&)&*+
,-&+(.*#(-.
#/%$*01
-$
23
4*15
*6#%$
#/%
'*5#
4-5%
-6
4)$7*')&*+
&-.-#/%$*018
9-.:5#%$('(;%4
&*'%
0*$#.%$5
-6
*
6%&*'%
0*#(%.#
&)5#
)5%
&*'%
,-.4-&
0')5
50%$&(,(4%
#/$-)</-)#
#/(5
0%$(-48
=%55*#(-.
-6
+($#/
,-.#$-'
*6#%$
#/(5
0-(.#
5/-)'4
+%
4(5,)55%4
>(#/
*
$%50-.5(+'%
0/15(,(*.8
9-#
%.<*<(.<
(.
5%?)*'
*,#(7(#1
6-$
#/%
#-#*'
4)$*#(-.
-6
#/%
4$)<
#$%*#&%.#
*.4#/%4$)<
>*5/-)#
0%$(-4
(5
*.
*,,%0#*+'%
0$*,#(,%@
/->%7%$A
0%$(-4(,
*+5#(.%.,%A
#/%
$/1#/&
&%#/-4A*.4
#/%
>(#/4$*>*'
&%#/-4
*$%
.-#
*,,%0#*+'%
&%#/-45
-6
+($#/
,-.#$-'8
B%&*'%
0*#(%.#5
5/-)'4*'5-
$%6$*(.
6$-&
+$%*5#6%%4(.<
#/$-)</-)#
#/(5
0%$(-48
C6*0*#(%.#
+%,-&%5
0$%<.*.#
4)$(.<
#/%
,-)$5%
-6
#/%
5#)41A
#/%
5#)41
4$)<5
5/-)'4
+%
4(5,-.#(.)%4
(&&%4(*#%'18
DEF GHIJ
LHMNJOMP
QNMR
H
SJGHIJ
LHTMOJT
US
VRNIWXJHTNOY
LUMJOMNHI
9-.:5#%$('(;%4
&*'%5
>/-
*$%
5%?)*''1
*,#(7%
>(#/
*
6%&*'%
0*$#.%$
-6
,/('4+%*$(.<
0-#%.#(*'
&)5#)5%*
&*'%
,-.4-&
0')5
50%$&(,(4%
6$-&
5,$%%.(.<
#/$-)</
Z[3
4*15
*6#%$
$%,%(0#
-6
#/%
6(.*'4-5%-6
4)$7*')&*+
!
#$%&%'(&)&*+
,-&+(.*#(-.
#/%$*01
-$
23
4*15
*6#%$
$%,%(0#
-6
#/%
6(.*'4-5%-6
4)$7*')&*+
&-.-#/%$*018
9-#
%.<*<(.<
(.
5%?)*'
*,#(7(#1
(5
*.
*,,%0#*+'%
0$*,#(,%@
/->%7%$A-,,*5(-.*'
*+5#(.%.,%A
#/%
$/1#/&
&%#/-4A
*.4
#/%
>(#/4$*>*'
&%#/-4
*$%
.-#
*,,%0#*+'%
&%#/-45
-6
,-.#$*,%0#(-.8
\*'%
0*#(%.#5
5/-)'4
$%6$*(.
6$-&
50%$&
4-.*#(-.
#/$-)</-)#
#/(5
0%$(-48
B%&*'%0*$#.%$5
]-6
,/('4+%*$(.<
0-#%.#(*'^
-6
&*'%
0*#(%.#5
&)5#
*'5-
)5%
*
/(</'1
%66%,#(7%
&%#/-4-6
,-.#$*,%0#(-.
#/$-)</-)#
#/(5
0%$(-4
]M_`ab
F^8
B%&*'%5
-6
,/('4+%*$(.<
0-#%.#(*'
*$%
4%6(.%4*5
#/-5%
>/-
*$%
.-#
5)$<(,*''1
5#%$('%
](8%8A
+('*#%$*'
#)+*'
'(<*#(-.A
+('*#%$*'
--0/-$%,#-&1A
-$
,-&0'%#%
/15#%$%,#-&1^
-$
0-5#:&%.-0*)5*'8
c-&%.>(''
+%
,-.5(4%$%4
0-5#:&%.-0*)5*'
(6
#/%1
/*7%
+%%.
*&%.-$$/%(,
6-$
Zd
&-.#/5
>(#/-)#*.
*'#%$.*#(7%
&%4(,*'
,*)5%8
e/%
6-''->(.<
*<%:50%,(6(,
$%f)($%&%.#5
*00'1g
c-&%.hi3
1%*$5
-6
*<%
>-)'4
+%
,-.5(4%$%4
0-5#:&%.-0*)5*'
(6
#/%1
/*7%
+%%.
*&%.-$$/%(,
6-$Zd&-.#/5
-$
&-$%
6-''->(.<
,%55*#(-.
-6
%?-<%.-)5
/-$&-.*'
#$%*#&%.#5
*.4
(6
#/%1
/*7%
')#%(.(;(.<
/-$&-.%
*.4
6-''(,'%:5#(&)'*#(.<
/-$&-.%
'%7%'5
(.
#/%
0-5#:&%.-0*)5*'
$*.<%
6-$
#/%
(.5#(#)#(-.
-$
).4%$>%.#
5)$<(,*'
5#%$('(;*#(-.
]+('*#%$*'
--0/-$%,#-&1
-$
/15#%$%,#-&1^8
c-&%.jkl
1%*$5
-6
*<%
>-)'4
+%
,-.5(4%$%4
0-5#:&%.-0*)5*'
(6
#/%1
/*7%
+%%.
*&%.-$$/%(,
6-$Zd&-.#/5
-$
&-$%
6-''->(.<
,%55*#(-.
-6
*''
%?-<%.-)5
/-$&-.*'
#$%*#&%.#5A
/*4
$*4(*#(-.:
(.4),%4&%.-0*)5%
>(#/
'*5#
&%.5%5
mZ
1%*$
*<-A
/*4
,/%&-#/%$*01:(.4),%4
&%.-0*)5%
>(#/
'*5#&%.5%5
mZ
1%*$
*<-A
-$
).4%$>%.#
5)$<(,*'
5#%$('(;*#(-.
]+('*#%$*'
--0/-$%,#-&1A
+('*#%$*'
5*'0(.<%,#-&1
-$
/15#%$%,#-&1^
n(</'1%66%,#(7%
&%#/-45
-6
,-.#$*,%0#(-.A
4%6(.%4
*5
-.%
#/*#
$%5)'#5
(.
*
'->
6*(')$%
$*#%
](8%8A
'%55#/*.Zo
0%$
1%*$^
>/%.
)5%4
,-.5(5#%.#'1
*.4
,-$$%,#'1
*$%
4%5,$(+%4
(.
M_`ab
F8
9-#%
#/*#
5-&%,-.#$*,%0#(-.
&%#/-45
*$%
.-#
,-.5(4%$%4
/(</'1
%66%,#(7%
]%8<8
&*'%
-$
6%&*'%
,-.4-&
>(#/-$>(#/-)#
50%$&(,(4%@
6%&*'%
,*0A
4(*0/$*<&A
-$
50-.<%
>(#/
-$
>(#/-)#
50%$&(,(4%@
.-.:
,-00%$,-.#*(.(.<
(.#$*)#%$(.%
4%7(,%@
0$-<%5#-<%.:-.'1
-$*'
/-$&-.*'
,-.#$*,%0#(7%
0(''5
>/%$%
(./(+(#(-.-6
-7)'*#(-.
(5
.-#
#/%
0$(&*$1
&-4%
-6
*,#(-.
p%?,')4(.<
=%$*;%##%q4%5-<%5#$%'
>/(,/
(5,-.5(4%$%4
/(</'1
%66%,#(7%r@
*.4
#$(0/*5(,
,-&+(.%4
-$*'
,-.#$*,%0#(7%
0(''5^8
M_`abF
Rstuav
Jwwbxyszb
Gbyu{|}
{w
V{~y_xbys{~


w_sab
_yb











 !
"#$$%&$'()*$#+*&$%)&
-&*./01
2/$3/)#4
-&*./01
5 67889:
<
=>?:@A?9:=>9
B9C=D9
5 E9C7>7:F9G?9:9HI:9H9@G=>F
=>?:@A?9:=>9
GJG?9K
L9MFMN
O=:9>@PQ@
5 R?7>7F9G?:9H
=K8H@>?GS
9MFM
TK8H@>7>
7:
U7:8H@>
5 T>?:@C@F=>@H
B9C=D9S
9MFM
9?V=>JH9G?:@B=7H
@>B
9?7>7F9G?:9H
5 O9B:7WJ8:7F9G?9:7>9
=>X9D?=7>S
9MFM
Y987I
Z:7C9:@
5 U7:K@H
@>B
H7[
B7G9
D7K\=>9B
7:@H
D7>?:@D98?=C9
8=HH
5 U7:9HF9G?:7K=>]9?V=>JH9G?:@B=7H
?:@>GB9:K@H
GJG?9K
5 69:@^9??9
LB9G7F9G?:9HQ
_`a "bccd
dcefg(ce
hA\X9D?GGV7AHB
>7?
B7>@?9
\H77B
[V=H9
8@:?=D=8@?=>F
=>
?V=G
G?ABJN
7:
i7:
@?
H9@G?
jk
B@JG
i7HH7[=>F?V9
H@G?
=>iAG=7>
7i
BA:C@HAK@\
7:
?:9K9H=KAK@\
7:
jk
B@JG
@i?9:
:9D9=8?
7i
?V9
i=>@H
B7G97iBA:C@HAK@\
@H7>9M
_`_ lcelc-(gfeg
gmnfg-nego
pq
<V9Z:=>D=8@H
T>C9G?=F@?7:
KAG?
\9
=>i7:K9B
@G
G77>
@G
87GG=\H9
@\7A?
@>J
K9B=D@?=7>
?@r9>
i:7K?V9?=K9
7i
GD:99>=>F
A>?=H
?V9
9>B
7i
?V9
DH=>=D@H
8V@G9
7i
?V9
G?ABJ
Li=>@H
G?ABJ
C=G=?QM
s>J
D7>D7K=?@>?
K9B=D@?=7>LGQN
=>DHAB=>F
V9:\@H
8:98@:@?=7>GN
?@r9>
BA:=>F
?V9
G?ABJ
[=HH
\9
:9D7:B9B=>
?V9
6tuM
t9G?:=D?9BN
8:7V=\=?9BN
@>B
89:K=??9B
D7>D7K=?@>?
K9B=D@?=7>G
@:9
B9GD:=\9B
=>
?V9
i7HH7[=>F
?@\H9GMt9i9:
?7
h9D?=7>
a`_
i7:
FA=B@>D9
7>
K@>@F9K9>?
7i
TZI:9H@?9B
?7W=D=?=9GM
_`v wnm-(ggnd
lcelc-(gfeg
-nd(lfg(cep
g#x4&ay
p+zz/$*%{&
-&0%|#*%/)1
p+zz/$*%{&
3&0%|#*%/)'|4#11
/}
0$+~
1#~&
67>D7K=?@>?
K9B=D@?=7>G
7:
?:9@?K9>?G
L9MFMN
@D9?@K=>78V9>
7:
B=8V9>VJB:@K=>9Q
B99K9B
>9D9GG@:J
?7
8:7C=B9
@B9A@?9
8:78VJH@D?=D
7:
GA887:?=C9
D@:9N
9WD98?
i7:
?V7G9
K9B=D@?=7>G
=B9>?=i=9B
@G
8:7V=\=?9BN
@G
H=G?9B
@\7C9
<7
\9
@BK=>=G?9:9B
@G
8:9GD:=\9B
\J
?V9
T>C9G?=F@?7:
9G?GA887:?=C9
D@:9
L=>DHAB=>F
@>?=\=7?=DGN
>A?:=?=7>@H
GA887:?N
D7::9D?=7>
7i
K9?@\7H=D
B=G7:B9:GN
78?=K@H
GJK8?7K
D7>?:7HN
@>B
8@=>
K@>@F9K9>?
=>DHAB=>F
8@HH=@?=C9
:@B=7?V9:@8J
?7
>7>I?@:F9?H9G=7>GN9?DMQ
hV7AHB
\9
AG9BN
[V9>
>9D9GG@:JN
i7:
@HH
8@?=9>?GM











 !
"#$$%&'()*,*-(./'(%01.2/33%4-&#5
63/5*
789:;<=9;>?
=<ABC>CD
CB:E
9C
;EFC>
<8
;E>
<8GHB>8I9
=9::<8>
J>AK<;;>?
LMN OPQR6SOS
QTUQTVWXYUX
VOSWQYXWTU"
X/Z2*L[
\&%](Z('*-
Q%0.%,('/0'
V*-(./'(%03
\&%](Z('*-
,*-(./'(%01.2/33
%4
-&#5
63/5*
^8_<8=>C;<`9;<F89H
98;<:98:>A
;E>A9a_
F;E>A
;E98
;EFC>B8?>A
<8=>C;<`9;<F8
<8
;E<C
C;B?_
bEFBH?
8F;
c>
`<=>8
:F8:FK<;98;H_
dE<HC;
;E>
a9;<>8;
<C
F8
C;B?_
;A>9;K>8;
K^cC9`9<8C;
efg^h D
JihjD
FA
Jihgj
F;E>A
;E98
;EFC>B8?>A
<8=>C;<`9;<F8
<8
;E<C
C;B?_
bEFBH?
8F;
c>
`<=>8
:F8:FK<;98;H_
dE<HC;
;E>
a9;<>8;
<C
F8
C;B?_
;A>9;K>8;
^8_:F8:BAA>8;
:E>KF;E>A9a_D
A9?<F;E>A9a_D
<KKB8F;E>A9a_D
FA
c<FHF`<:
FA
EFAKF89H
;E>A9a_
GFA:98:>A
;A>9;K>8;
F;E>A
;E98
;EFC>
B8?>A
<8=>C;<`9;<F8
<8
;E<C
C;B?_
bEFBH?
8F;
c>
`<=>8
:F8:FK<;98;H_
dE<HC;
;E>
a9;<>8;
<C
F8
C;B?_
;A>9;K>8;k
leF8:BAA>8;
BC>
FG
EFAKF8>C
GFA
8F8h:98:>AhA>H9;>?
:F8?<;<F8C
m>`D
<8CBH<8
GFA
?<9c>;>C
98?
EFAKF8>
A>aH9:>K>8;
;E>A9a_n
<C
9::>a;9cH>k
gF:9H
;A>9;K>8;
FG
<CFH9;>?
H>C<F8CD
>o:HB?<8`
;9A`>;
H>C<F8CD
GFA
a9HH<9;<=>
<8;>8;
<C
9::>a;9cH>
m>k`kD
c_
HF:9H
CBA`>A_
FA
A9?<F;E>A9a_np
7KKB8FCBaaA>CC<=>
K>?<:9;<F8C
<8:HB?<8`D
cB;
8F;
H<K<;>?;FD
C_C;>K<:
:FA;<:FC;>AF<?C
9;
?FC>C
>o:>>?<8`
qqjr
K`s?9_tt
FG
aA>?8<CF8>
FA
>uB<=9H>8;D
K>;EF;A>o9;>D
9I9;E<FaA<8>D
98?
;BKFA
8>:AFC<Cvwxyz{|}
cHF:~>AC
bEFBH?
8F;
c>
`<=>8
:F8:FK<;98;H_k
lC>
FG
<KKB8FCBaaA>CC<=>
K>?<:9;<F8C
GFA
;E>
K989`>K>8;
FG
7JhA>H9;>?
^CD
qqaA>K>?<:9;<F8
GFA
a9;<>8;C
A>:><=<8`
ttD
FA
<8
a9;<>8;C
d<;E
:F8;A9C;
9HH>A`<>C
<C
9::>a;9cH>pk
78
9??<;<F8D
BC>
FG
<8E9H>?D
;Fa<:9HD
98?
<8;A989C9H
:FA;<:FC;>AF<?C
<C
a>AK<;;>?k
iAB`Cd<;E
H9o9;<=>
aAFa>A;<>C
98?
E>Ac9H
FA
89;BA9H
A>K>?<>C
GFA
:F8C;<a9;<F8
bEFBH?
c>
BC>?
d<;E
:9B;<F8
;EAFB`E
;F
r
?9_C
9G;>A
;E>
H9C;
?FC>
FG
;A>K>H<KBK9c
?BA<8`
;E>
C;B?_
bB8<;<8<c
bEFBH?
8F;
c>
`<=>8
:F8:FK<;98;H_
FA
;EAFB`E
r
?9_C
9G;>A
;E>
H9C;
?FC>
FG
;A>K>H<KBK9c
l9:B;>
A>89H
G9<HBA>
E9C
c>>8
A>aFA;>?
d<;E
:FKc<89;<F8
;E>A9a_
FG
;A>K>H<KBK9c
98?
CB8<;<8<cp











 !
"#$%&'&()*,)*&-.(&$/0-1.22$3*#45
62.5)
789:<=>?
@ABCDE
FBG
HI
JKLIF
MBFMBNKGOFGDPQ
@ABCDE
HI
C?IE
RKGA
MOCGKBF
KF
GAI
ST
EOP?
UB?G
DO?G
EB?I
BV
ECWLODCNOHQ
>FMWIO?IE
KFMKEIFMI?
BV
UFICNBFKGK?
XRKGA
GAKWE
JIFIWOGKBF
789:
<=>?Y
OFE
KFMWIO?IE
KFMKEIFMI
BV
GWOF?ONKFO?I
KFMWIO?I?
XRKGA
Z?G
JIFIWOGKBF
789:
<=>?Y
AO?
HIIF
WIUBWGIE
RAIF
ECWLODCNOH
AO?
HIIF
JKLIF
MBFMBNKGOFGDPQ
@ABCDEHI
C?IE
RKGA
MOCGKBF
KF
GAI
ST
EOP?
UB?G
DO?G
EB?IBVECWLODCNOHQ
@ABCDE
FBG
HI
JKLIF
GAWBCJA
[T
EOP?
OVGIW
GAI
DO?G
EB?I
BV
>\
XKFMDCEKFJ
@B]Y
^ _`ab"cd`ecf
daggcdh`af
^ij dakkcglh`mc
bh6n`cb
oak
kcbclkdp0"plkeldaq`fch`d
bh6n`cb
<AIMBWWIDOGKLI
?GCEKI?
RAKMA
RI
RK?A
GB
UIWVBWN
OWI
BCGDKFIE
HIDBR
OFE
?CNNOWKrIE
KF
GAI
GOHDIQsEI?MWKUGKBF
BV
IOMA
GI?G
KFMDCEKFJ
O
HWKIV
?GOGINIFG
BV
WOGKBFODI
OFE
UWBMI??KFJ
KFVBWNOGKBF
K?
NOEI
HIDBRQ
h.'1)^t
b.,u1)
d$11)-(&$/
h.'1)
h)2(0.22.v
b.,u1)
2&w)
x.uu#$yiz
hvu)
$3
(4')
d$11)-(&$/
u$&/(
g$-.(&$/
$3
2u)-&,)/
./.1v2&2
Z{T
ND
XVBW
\|}]Y
7~<s
>NNCFI
NBFKGBWKFJ
ZT
ND
XVBW
?IWCNY
7~<s
@II
@GCEP
]ODIFEOW
i
9KJJ
OH
\=
[
ND
@@<
@II
@GCEP
]ODIFEOW
[Q
}IE>NNCFI

>NNCFBJIFKMKGP
 
ND
@@<
@II
@GCEP
]ODIFEOW
i
}IEKNNCFI

sFGKFCMDIOW
OFGKHBEPXssY
 
ND
@@<
@II
@GCEP
]ODIFEOW
i
]]
~IUOWGNIFG
BV
OHBWOGBWP
}IEKMKFI
X~}Y
sFGKNKGBMABFEWKOD
OFGKHBEPXs}sY
KLIWKEFIP
NKMWB?BNOD
OFGKHBEP
 
ND
@@<
@II
@GCEP
]ODIFEOW
i
]]
~}
RKDD
?IFE
GB
}OPB
OH?
<CNBW?UIMKVKM
WI?UBF?I?XIQJQ

{T
ND
7~<s
@II
@GCEP
]ODIFEOW
i
8WIGIF
OH
]9@7
ND
7~<s
@II@GCEP]ODIFEOWi
8WIGIFOH











 !
"#$%&'$$'(
)'*+,#
$./#
0'++12345
"(+#26
%78#
92,,#:%.2;+2.;%
<2:'%.2;26
$+#:.*#;
';',($.$
=>?@ABC>DEA?F
H
IC@@J
KLMNBOFIEA?FD@
DJJDP
QR
S@
TLHU
MCC
MEOVP
ND@CFVD>
W4X
Y>CECF
ZD[
\C=DEAEAJ]
^
N
_A>D@@?DV
!
S@
MMH
MCC
MEOVP
ND@CFVD>
W4X
NN
LC=D>ESCFE
?B
H>DFJBOJA?F
KCVAIAFC
H`IC@@
DIEA_DEA?FabNcM
Cd=>CJJA?F
ef]KNg
hR
S@
TLHU
MCC
MEOVP
ND@CFVD>
W4X
KCVASSOFC
i
f@DJSD`[DJCV
DJJDPJB?>
IA>IO@DEAFj
>CIC=E?>Ja@AjDFVJ
CkjkfLZh
l
S@
TLHU
MCC
MEOVP
ND@CFVD>
W4X
KCVASSOFCi
HOS?>[A?=JP
mU
maU
MCC
MEOVP
ND@CFVD>
W4X
ZD[?>DE?>P
?B
fDEn?@?jP
on?@CjCF?SC
Jn?EjOF
JCpOCFIAFj
?B
SAI>?[AD@LmU
qCIED@
MrD[
maU
MCC
MEOVP
ND@CFVD>
W4X
Y>CECF
@D[
iN?VCV@AFsCV
JDS=@CJ
rAEn?OE
sCP
rA@@
[C
JCFE
B?>
=C>B?>SAFj
?B
Cd=C>ASCFEJ
t4u v9w
9xyyz<{"w|z
)"}~wz)
kQkh bSSOFC
S?FAE?>AFj
eU@@
I?n?>EJg
oCrA@@DFD@PC
f]KN
B?>
pODFEAEDEA_C
DFV
BOFIEA?FD@
InDFjCJ
?B
CBBCIE?>
IC@@J
DJ
rC@@
DJ
DFD@PCJC>D
B?>
IPE?sAFCJ
DFV
InCS?sAFCJk
HnC
CBBCIE
?F
eAg
NL 
H
IC@@
FOS[C>
DFV
DIEA_AEP
eAAg
NL!HIC@@
FOS[C>
DFV
DIEA_AEP
eAAAg
m
IC@@
FOS[C>
DFV
DIEA_AEP
eA_g
H>Cj
FOS[C>
e_Ag
KLMNB>CpOCFIP

BOFIEA?FD@
DJJDP
e_AAg
JC@CIECV
IPE?sAFCJ
AF
JC>OS
DFV
e_AAAg
EnC
VCECIEA?F
?B\NN`DJJ?IADECV
DFEAjCFJ
OJAFj
TZbMfcH
DJJDPk
fDEACFEJrA@@
OFVC>j?
[@??V
JDS=@AFj
eIkhQRS@J
[@??Vg
?F
EnC
EASC
=?AFEJ
?OE@AFCV
AF
EnC
MEOVP
ND@CFVD>W4Xk
]@??V
rA@@
AFAEAD@@P
[C
JCFE
E?
EnC
Ajj
@D[?>DE?>P
B?>
[D>I?VAFj
DFV
=>?ICJJAFj
eMCIEA?Ft445k
cF
IC>EDAF
?IIDJA?FJ
EnC
[@??V
SDP
D@J?
[C
[>?OjnE
E?
EnC
Y>CECF
@D[
B?>
=>?ICJJAFj
DFV
DFD@PJAJk
f]KNrA@@
[C
AJ?@DECV
[P
AI?@@
VCFJAEP
ICFE>ABOjDEA?Fk
U@ApO?EJ
?B
h
d
hR
f]KNaEO[C
rA@@
[C
AFVA_AVOD@@PB>?CFDBEC>AFAEAD@nDFV@AFjDFV=>?ICJJAFjDEEnCAjj@D[?>DE?>Pk











 !
"#$#$ %&'()
+,-.+/-&0.12
3+/(4
5.)
+,-.&66,/(
7(3+-&-&8
9:;<=
:;< &8+>7)./&>
1&8.)1()
>7+)+>-()&?(1
02
3).@)(88&'(
7(3+-.>(44,4+)
4.88
+/1
>(44A6(1&+-(1
&66,/.4.@&>
+--+>B#
<&8-.4.@&>
&/54+66+-&./
&8
3)(8(/-
+/1
&8
,8,+442
+>>.63+/&(1
02
5&0).8&8C
D7&>7>+/
3).@)(88
-.
>&))7.8&8
+/1
4&'()
5+&4,)(#
:;<
+>>.,/-8
5.)
EEF
-.
$GF
.5
>7)./&>
4&'()
1&8(+8(&/H.)-7
:6()&>+
+/1
+0.,-
IF
.5
4&'()
-)+/834+/-8
&/
-7(
J/&-(1
K-+-(8#
L7(:;< M&+@/.8-&>
N+/(4
&/>4,1(8
-(8-8
5.)
+>-&/
986..-7
6,8>4(=
+/-&0.12C
+/-&/,>4(+)
+/-&0.1&(8
9:H:8=C
+/1
4&'()OB&1/(2
6&>).8.6(
+/-&0.12
9%PQAE=#
:H:8
+/1
+>-&/
+/-&0.12
+)(+88.>&+-(1
D&-7
-23(
E
:;<C
-7(
6.8-
>.66./
5.)6
&/
-7(
J/&-(1
K-+-(8C
D7&4(
%PQAE
+/-&0.12&8
+88.>&+-(1
D&-7
-23(
$
:;<C
6.)(
>.66./42
5.,/1
&/
R,).3(
+/1
&/
8.6(
K.,-7
:6()&>+/ >.,/-)&(8#
L7(
3+/(4
+48.
&/>4,1(8
6&-.>7./1)&+4
+/-&0.12C
D7&>7
>+/
7(43
1&55()(/-&+-(
:;<
5).6
NST#
V&'(/
-7+-
+,-.&66,/(
7(3+-&-&8
&8
+
3.-(/-&+4
>.634&>+-&./
.5
&66,/(>7(>B3.&/-
&/7&0&-&./
D(
D&44
3()5.)6
-7&8
3+/(4
.5
+,-.&66,/(
+/-&0.1&(8
-.
&/'(8-&@+-(
-7&8#
K+634(8
D&44
0(
>.44(>-(1
+-
0+8(4&/(
+/1
./
MW"
+33).X&6+-(42#
L7(8(
+/-&0.12
-&-()8+)((X34.)+-.)2
+/1
D&44
/.-
0(
,8(1
-.
@,&1(
-7()+32
&/
-7(
+08(/>(
.5
>4&/&>+4
>.))(4+-&./#
"#$#G <(3+-&-&8
8().4.@2
+/1
'&)+4
4.+1
:86(/-&./(1
&/
-7(
0+>B@).,/1
8(>-&./
-7(
37+8(
;;
8-,12
.5
-)(6(4&6,6+0
&/
<TT
87.D(1
8&@/&5&>+/-
+/-&A<TY
&66,/(
)(83./8(
D&-7
3).@)(88&'(
1(>4&/(
&/
8(),6
<TY
'&)+4
4.+1
96(1&+/'+4,(8[
0+8+4
G#\WXE]("
>.3&(8O64
'8#
1+2
E$]
G#]$XE]( 
>.3&(8O64C
3^]#]$_
'8#
1+2
$E]E#I!XE](G
>.3&(8O64C
3^]#] =#
L7()(5.)(C
5.)
+44
'&)+4
7(3+-&-&8
3+-&(/-8
D(
D&44
6(+8,)(
'&)+44.+1+/1
+/-&0.12
-&-()8
+-
0+8(4&/(
+/1
('()2
G]
1+28#
`.)
3+-&(/-8
D&-7
>7)./&>
<SY
&/5(>-&./C&/
+11&-&./
-.
-7(
8-,1&(8
+4)(+12
1(8>)&0(1C
D(
34+/
-.[
a 1(-()6&/(
<S8:@
>./>(/-)+-&./8
&/
8(),6
a 1(-()6&/(
<S(:@
9&/
<S(:@
3.8&-&'(
3+-&(/-8=
a 1(-()6&/(
<S8:@
5)+>-&./8
986+44C
6&114(C
4+)@(
<S8:@=
a 1(-()6&/(
<SY
83(>&5&>
L
>(44
)(83./8(8
L7(8(8-,1&(8
D&44
0(
3()5.)6(1
./
8+634(8
.0-+&/(1
+>>.)1&/@
-.
K-,12
T+4(/1+)
bcd#
K+634(8
D&-70(3).>(88(1
02
TT
M(3+)-6(/-
.5
%+0.)+-.)2
6(1&>&/(#
`.)
<S8:@
+/1
<(3+-&-&8
S
83(>&5&>&66,/(
)(83./8(C
8+634(8
D&44
0(
3).>(88(1
02
-7(
M(3+)-6(/-
.5
V+8-).(/-().4.@2C
<+//.'()Q(1&>+4
K>7..4C
V()6+/2#
L7(HT;L7.)+>&>
+/1
V;
e/>.4.@2
S)+/>7
D&44
)(4(+8(
>.1(1
8(),6
8+634(8
>.44(>-(1
&/
>./'(/-&./+4
fT)2.L,0(8g
&/
+88.>&+-&./
D&-7
-7&8
3).-.>.4
-.[
<(&/()
h(1(6(2()
M(3+)-6(/-
.5
V+8-).(/-().4.@2
<+//.'()
Q(1&>+4
K>7..4
T+)4
H(,0()@
K-)+88(
E
G]I$"
<+//.'()
V()6+/2
5.)<S8:@
+/1
<(3+-&-&8
S
83(>&5&>
&66,/(
)(83./8(C
+8
D&44
0(
83(>&5&(1
&/
HT;
Q+-()&+4
L)+/85():@)((6(/-iGWG\IAE #











 !
"#$%&'$()
+&,,
-$
,.-$,$/
+&01
01$
)02/3
&/$(0&4&$5
6(,3
.(/
+&,,
-$
)1&##$/
06
01$
.//5$))
.-67$8$&01$5
6(
/53
&%$
65
.0
.'-&$(0
0$'#$5.025$)
.)
5$92&5$/
-3
01$
03#$
64
).'#,$
06
-$
.(.,3:$/;
 ;<;= >2'65?)#$%&4&%
@AB
5$)#6()$)
C5$92$(%3
64
DCE?)#$%&4&%
FG=H
>
%$,,)
+&,,
-$
.(.,3:$/
2)&(I
01$
&(0$54$56(
JKCLM?NI.''.O
%306P&($)$%5$0&6(
.)).3
.)
#5$7&62),3
/$)%5&-$/NQRO;
K(
-5&$48
ESTF)
+&,,
-$
5$)2)#$(/$/
&(
'$/&2'%2,025$/
&(
/2#,&%.0$
+&01
01$
46,,6+&(I
#$#0&/$)U
DCEVQW?V= 
JEXCYZE[EZM8
DCE<=\?< ]
J^ZLC>[KY^XM8
.(/
DCEQR=?QWQ
JYXDZ"ZKX_ZM
65
.(
&55$,$7.(0
%6(056,
#$#0&/$
J"KKLC[^XM;
_$%6'-&(.(0
&(0$5,$2P&(?<
J< 
K`a'XM
+&,,
-$
.//$/
6(
/.3
<
64
%2,025$;
D40$5
W
/.3)8
ESTF)
+&,,-$5$?)0&'2,.0$/
+&01
01$
).'$
#$#0&/$
.(/
&(%2-.0$/
465
 
1625)
.0
QWbF
.(/
KCL?NI.''.O
)$%5$0&6(-3
FG=H
>
%$,,)
.(.,3:$/
-3
KCL?NI.''.O
%.#025$
.)).3;
X&7$
I.0&(I
6(
FG=H
>
%$,,)
+&,,-$#$5465'$/
2(0&,
2#
06
V!!8!!!
$7$(0)
+$5$
.%92&5$/;
c(,3
DCE
5$)#6()$)
d!;Ve
64
FG=H
>%$,,)+&,,
-$
%6()&/$5$/
#6)&0&7$;
 ;<; TG"F
42(%0&6(.,
.)).3
C5$)1,3&)6,.0$/
ESTF
+&,,
-$
,.-$,$/
+&01
F"C[
.(/
)0&'2,.0$/
+&01
FG<aFGQaFG<]
-$./)
&(
01$#5$)$(%$a.-)$(%$
64
X?LTTD
.(/
L65LcfD;
K(
%6(056,
$g#$5&'$(0)
FGV=
/$#,$0$/
ESTF+&,,
-$
)0&'2,.0$/
2(/$5
01$
).'$
%6(/&0&6();
E56,&4$5.0&7$
5$)#6()$
64
>
%$,,)
+&,,
-$
.))$))$/-3
CDF"
.(.,3)&);
 ;<;R _$%0.,
"+.-
F6,,$%0&6(8
"065.I$
.(/
D(.,3)&)
J6#0&6(.,M
_$%0.,)+.-)
'.3
-$
%6,,$%0$/
.0
01$
%,&(&%
.0
01$
&(/&%.0$/
0&'$
#6&(0)
+&01
)0.(/.5/
)0$5&,$
)+.-);_$%0.,
)+.-)
+62,/
-$
6-0.&($/
2)&(I
)0.(/.5/
%,&(&%.,
'$016/)
J&()$50$/
hV
&(%1
-$36(/
.(.,)#1&(%0$58
560.0$/
I$(0,38
.(/
5$'67$/M;
".'#,$)
+&,,
-$
)065$/
465
42025$
)02/&$)8
&(%,2/&(I
+16,$I$(6'$
)160I2(
)$92$(%&(I
64
'&%56-&.,
GLD;
".'#,$)+&,,
-$
/$,&7$5$/
06
G5;
C&IIi)
S,66/
E56%$))&(I
F65$
JSEFM8
"$%0&6(
jkklkm
opqpkprsp
tluksp
rlv
qlurwx
`#6(5$%$&7&(I
01$
).'#,$)8
01$3
+&,,
-$
P$#0
456:$(
2(0&,
.(.,3)&);
T&%56-&.,GLD
+&,,
-$
&)6,.0$/
.(/
GLD
)$92$(%&(I
64
01$
'&%56-&6'$
+&,,
-$
#$5465'$/;
".'#,$))$92$(%$/
06
)02/3
'&%56-&.,
%6''2(&0&$)
+&,,
%6(0.&(
12'.(
GLD
)$92$(%$);
f6+$7$58-&6&(465'.0&%)
.(.,3)$)
64
01$
)$92$(%$)
+&,,
5$'67$
)$92$(%$)
%6(0.&(&(I
)&I(&4&%.(0
.,&I('$(006
#2-,&%,3
.7.&,.-,$
12'.(
GLD
)$92$(%$);
>1$)$
/.0.
+&,,
-$
%6/$/
.(/
)065$/
.0
01$LKfK(05.'25.,
"$92$(%&(I
F$(0$5
JLK"FM
#$5
)0.(/.5/
#5606%6,)
465
&(05.'25.,
)$92$(%&(I;
>1$5$)2,0&(I
)$92$(%$)
+&,,
-$
.(.,3:$/;
E2-,&%,3
.7.&,.-,$
12'.(
GLD
)$92$(%$)
,&P$,3
/6
(60&(%,2/$
.,,
#6))&-,$
GLD
)$92$(%$)
.(/
%62,/
5$)2,0
&(
45.I'$(0)
64
12'.(
GLD
)$92$(%$)
-$&(I&(%65#65.0$/
&(06
01$
'&%56-&.,
GLD
.(.,3)&);
 ;<;W >2'65
S&6#)&$)
D02'65-&6#)3
+&,,
-$
#$5465'$/
.0
-.)$,&($
465
.(.,3)&)
64
&''2($
&(4&,05.0&6(
.(/
.0
.
)2-)$92$(0
0&'$#6&(0)
GQR
.(/
G] 
&4
01$
#.0&$(0
&)
+&,,&(I
.(/
01$
#56%$/25$
%.(
-$
#$5465'$/
).4$,3;>1$
-&6#)&$)
'.3
-$
#$5465'$/
2(/$5
2,05.
)62(/
65
F>
I2&/.(%$;
E.0&$(0)
5$%$&7&(I
.-,.0&7$01$5.#3+&,,1.7$.-&6#)36(GQR/25&(I01$.-,.0&7$01$5.#3#56%$/25$;>2'65>&))2$
+&,,-$#56%$))$/-301$G$#.50'$(064E.016,6I38LFK8LKfJG5;G.7&/^,$&($5M;>+6%65$
-&6#)&$)+&,,-$01$.00$'#0$/;C65$.%1)#$%&'$(6-0.&($/01$%65$+&,,-$/&7&/$/&(0+6#.50)











 !
"#$&'$()*+,
-+./#,#(0
+12
"$#341
5$464$7+.)#18
9"
"#$
6#:4
$4+6#1
#1,0
#14
*#$4
)6
+;,4
.#
;4
#;.+)142<./4
*#$4
=),,
;4
2)7)242<
=)./
/+,"
6';:)..42
.#
&'$()*+,
-+./#,#(0
+12
/+,"
'642
"#$
->6.'2)468
!?@#$:+,)1A")B428
)8
C/4
/+,"
")B42
)1
!DE
"#$:+,)1
=),,
;4
6';:)..42
.#
&'$()*+,
-+./#,#(0<
FFGHIF9
JK,2(8
!D<
LIL!L?8
))8
C/4
654*):416
=),,
/+74
$#'.)14
MNO
6.+)16
:+24
+6
=4,,
+6
 
+22).)#1+,
'16.+)142
64*.)#168
L?@$#341A5$464$7+.)#1
)8
C=#
!8 
:,
*$0#(41)*
7)+,6
J#;.+)142
"$#:
P$4.41
,+;?
=),,
;4
,+;4,42
=)./
./4
5+.)41.Q6
1+:4<
+**466)#1
1':;4$
JM-R?
+12
2+.4
'6)1(
+
=+.4$5$##"
6/+$5)48
))8
C/4
)6#./4$:
",+6S
JP$4.41
,+;?
=),,
;4
"),,42
=)./
,)T')2
1).$#(41
#1
./4
:#$1)1(
#"
./4
5$#*42'$4
+12
=),,
;4
+7+),+;,4
.#(4./4$
=)./
./4
*$0#(41)*
7)+,6
"#$
5)*S
'5
=/41
$+2)#,#(0
5+(46
./4
*#1.+*.
54$6#1
.#
*#,,4*.
./4
654*):4168
)))8
U1*4
./4
;)#560
)6
$4+20<
./4
/+,"A*#$4
.#
;4
*$0#5$464$742
=),,
;4
.$+16"4$$42
)1.#
+1
4:5.0
!8 A:V
*$0#(41)*
7)+,
=)./
./4
'64
#"
6.4$),4<
5$4A*/),,42
J)1
2$0
)*4?
2)65#6+;,4
.=4434$68
)78
C/4
7)+,
=)./
654*):41
=),,
;4
)::42)+.4,0
2$#5542
)1.#
,)T')2
1).$#(41
*#1.+)142
)1
+1
)6#./4$:
",+6S8
78
C/4
"$#341
/+,"
=),,
;4
.$+16"4$$42
)1
./4
)6#./4$:
",+6S
.#
./4
5$#.#*#,A654*)")42
,#*+.)#1
"#$
./+.
5+$.)*',+$
+1+,06)68
WXY Z[\]ZZ^_[
abc__[\
de^\][d
f,,6+:5,46
=),,
;4
5$#*46642
+12
*$0#5$464$742
)1
./4
@)((
,+;#$+.#$08
C$+16"4$
)1
;+.*/
.#
g42)::'14
"+*),).)46
"#$
"'$./4$
+1+,06)6
=),,
#**'$
+.
+
,+.4$
2+.48
-,4+64
+,6#
644
chhijklm
\8
 8n8! -/+$:+*#S)14.)*6
C/4.):45#)1.6
"#$
-o
6+:5,)1(
+$4
246*$);42
)1
./4
&.'20
F+,412+$
YXp8
f
7+,)2+.42
4130:4A
,)1S42)::'1#6#$;41.
+66+0
JOV9&f?
=),,
;4
'642
"#$
./4
T'+1.).+.)74
24.4$:)1+.)#1
#"
.$4:4,):':+;
)1
/':+1
64$':8
 8n8L 9::'1#(41)*).0
C/4.):45#)1.6
"#$
./4
+66466:41.
#"
+1.)A.$4:4,):':+;
+1.);#2)46
+$4
246*$);42
)1
./4
&.'20
F+,412+$YXp8
f
7+,)2+.42
4,4*.$#*/4:),':)146*41*4
+66+0
JOFVf?
'6)1(
+
g46#
&*+,4
>)6*#74$0
Jg&>?
5,+."#$:
=),,
;4
'642
"#$
./4
24.4*.)#1
#"
+1.)A2$'(
+1.);#2)46
+(+)16.
.$4:4,):':+;
)1
/':+1
64$':8
 8n8n CFOVV
f*.)7+.)#1H9FU&
4B5$466)#1
C/41':;4$
+12
6';64.6
#"
C
*4,,6
+6
=4,,
+6
#./4$
)::'14
*4,,6
=),,
;4
47+,'+.42
)1
-KgF
;0
",#=*0.#:4.$08C/4+*.)7+.)#16.+.'6#"C*4,,6=),,+,6#;4+6646642)1./46+:46.'208q/#,4
;,##26+:5,46=),,;4*#,,4*.42+6654*)")42)1&.'20F+,412+$YXp8&+:5,46=),,;45$#*46642.#
-KgF+126.#$42"$#341'1.),.):4#"+1+,06)68f22).)#1+,,0<+;6#,'.4,0:5/#*0.4*#'1.+.











 !
"#$%&'(%#(*
'(
+%$,-($%
.-
.+%/%&'/0/#"
.+%#./%(.
1'&&
"%
%2#&0#.%*
3-+
#(4
+%&#.'-($5',
1'.5
.+%#./%(.-0.6-/%7
 7879 :&#$/#;"#$%*
#$$#4$
3-+
6'+60&#.'(<
+%6%,.-+$=&'<#(*$
%7<7
:>?@
:&#$/#$#/,&%$
#+%
.-
"%
6-&&%6.%*
#.
.5%
.'/%
,-'(.$
&'$.%*
*'+%6.&4
'(
A.0*4
B#&%(*#+
DEF
'(.-
,&#$.'6G/&
&#2%(*%+
2#60.#'(%+
.0"%
1'.5
H>IJ
#$
#(.'6-#<0&#(.7
!;8
/&
-3
-".#'(%*
,&#$/#
#+%
.-"%#&'K0-.%*
L@
/&
%#65M
#(*
3+-N%(7
A#/,&%$
/#4
"%
#(#&4N%*
3-+
6'+60&#.'(<
&%2%&$
-3
$-&0"&%
3#6.-+$$065
#$
BO:P
64.-Q'(%$P
#(*
65%/-Q'(%$7
I5%4
/#4
'(6&0*%
"0.
#+%
(-.
&'/'.%*
.-
$-&0"&%
BI?J;9P$-&0"&%
:>;?@P
$-&0"&%
RS7@=RS7!P
$-&0"&%
T?;GOP
2#$60&#+
%(*-.5%&'#&
<+-1.5
3#6.-+P
3'"+-"&#$.<+-1.5
3#6.-+P
T?;@
T?;!P
T?;9P
T?;GP
T?;UP
T?;@VP
6#(6%+
"'-/#+Q%+$
L#&,5#
3%.-,+-.%'(P
6#+6'(-%/"+4-('6
#(.'<%(P
6#(6%+
#(.'<%(
@! P
,+-$.#.%
$,%6'3'6
#(.'<%(P
$-&0"&%
/%$-.5%&'(;
+%&#.%*,+-.%'(
WAXO:YMP
<+#(N4/%
RP
TZ[P
B;\;B
/-.'3
65%/-Q'(%
@V
LB\B?@VMP
$0,,+%$$-+
-364.-Q'(%
$'<(#&'(<
8
LA]BA8MP
#
,+-&'3%+#.'-(
'(*06'(<
&'<#(*P
R;6%&&
#6.'2#.'(<
3#6.-+P
'($0&'(;&'Q%
<+-1.5
3#6.-+
LT^ZM;@P
T^Z;!P
#(*
#0.-#(.'"-*'%$
.-
5-$.
#(*
.0/-+
#(.'<%($
#(*
%_,&-+%.5%'+
#$$-6'#.'-(
1'.5
.+%/%&'/0/#"
.+%#./%(.
#(*
6&'('6#&
-0.6-/%7
`Ea bcdefg
bhijckgl

hjcmnopk
cpq
qobeibohoip
A#/,&%$1'&&
"%
-+*%+%*
'(
BOTA
#(*
.+#6Q%*
.5+-0<5
B&'('6#&
I+'#&
>#.#
X#(#<%/%(.
$4$.%/7
A5-0&*#BOTA
$6+%%(
(-.
"%
#2#'&#"&%P
.5%
BOTA
*-1(.'/%
,+-6%*0+%$
1'&&
"%
3-&&-1%*7
J&&
$#/,&%$1'&&
"%
$%(.
.-
>+7
Z'<<r$
&#"
3-+
,+-6%$$'(<
#(*
$.-+#<%
0(.'&
.5%4
#+%
*'$.+'"0.%*
.-
>+7
^+%.%(r$&#"P
>+7
J&.#(;R-((%.r$
&#"
-+
X%*T//0(%
3-+
$#/,&%
#(#&4$'$
#$
*%$6+'"%*
'(
.5%
,+-.-6-&7A#/,&%$
1'&&
(-.
"%
$%(.
-0.$'*%
[Ts
1'.5-0.
#,,+-,+'#.%
#,,+-2#&$
#(*=-+
#<+%%/%(.$P
'3+%K0'+%*7
J&&$#/,&%$
1'&&
"%
"#+6-*%*P
1'.5
*#.#
%(.%+%*
#(*
$.-+%*
'(
.5%
$%60+%
*#.#"#$%
?#"/#.+'_7
I5%$%*#.#"#$%$
6+%#.%
#
0('K0%
"#+6-*%
T>
3-+
%2%+4
$#/,&%
#(*
$#/,&%
"-_P
15'65
6#((-.
"%
.+#6%*"#6Q
.-
,#.'%(.$
1'.5-0.
*#.#"#$%
#66%$$7
I5%
*#.#
+%6-+*%*
3-+
%#65
$#/,&%
'(6&0*%$
.5%
,#.'%(.T>P
(#/%P
.+'#&
(#/%=,+-.-6-&
(0/"%+P
.'/%
*+#1(P
646&%
.'/%
,-'(.P
*-$%P
/#.%+'#&
.4,%P
#$1%&&#$
"-_
#(*
3+%%N%+
&-6#.'-(7
:#.'%(.
*%/-<+#,5'6$
#$$-6'#.%*
1'.5
.5%
6&'('6#&
6%(.%+
,#.'%(.(0/"%+
#+%
,+-2'*%*
'(
.5%
$4$.%/7
Z-+
%#65
$#/,&%P
.5%+%
#+%
(-.%$
#$$-6'#.%*
1'.5
.5%
,+-6%$$'(<
/%.5-*
L*%&#4
'(
$#/,&%
,+-6%$$'(<P
$.-+#<%
6-(*'.'-($
-(
.5%
1#+*P
%.67M7
R#+6-*%*$#/,&%$
#+%
$.-+%*
'(
"#+6-*%*
"-_%$
'(
#
&-6Q%*
3+%%N%+
#.
%'.5%+
;!V
-+
;UVVB
#66-+*'(<.-
$.#"'&'.4
+%K0'+%/%(.$7
J66%$$.-
$.-+%*
6&'('6#&
$#/,&%$
'$
+%$.+'6.%*7
A#/,&%$
1'&&
"%
$.-+%*
0(.'&
+%K0%$.%*
"4
#
+%$%#+65%+
(#/%*
-(
.5%
,+-.-6-&7
J&&
+%K0%$.$
#+%
/-('.-+%*
#(*
.+#6Q%*
'(
*#.#"#$%7
J&&
+%$%#+65%+$
#+%
+%K0'+%*
.-
$'<(
#
3-+/
$.#.'(<
.5#.
.5%
$#/,&%$
#+%
-(&4
.-
"%
0$%*
3-+
+%$%#+65
,0+,-$%$#$$-6'#.%*
1'.5
.5'$
.+'#&
L#$
,%+
.5%
TOR
#,,+-2%*
,+-.-6-&M
#(*
.5#.
#(4
0(0$%*
$#/,&%$/0$.
"%
+%.0+(%*7
T.
'$
.5%
+%$,-($'"'&'.4
-3
.5%
[BT
:+'(6',#&
T(2%$.'<#.-+
.-
%($0+%
.5#.
.5%$#/,&%$
+%K0%$.%*
#+%
"%'(<
0$%*
'(
#
/#((%+
6-($'$.%(.
1'.5
TOR
#,,+-2#&7
 797@ A#/,&%$
X#(#<%*
"4
>+7
Z'<<r$
R&--*
:+-6%$$'(<
B-+%
LR:BM
:&%#$%%;/#'&
[BTR&--*6-+%t/#'&7('57<-2
#.
&%#$.
!9
5-0+$
"%3-+%
.+#($,-+.'(<
$#/,&%$
L.5%
Z+'*#4"%3-+%
'$
,+%3%++%*M7
Z-+$#/,&%,'6Q0,P,#<%@V!;@@uG97











 !
"#$&''()&*+(
,(-./
0*--
123456346783
9'*&:
;-##)
.$#0(<<&:=
0#$(
:>';($?
#$/
&@
:#
*:<A($/
1234563467B3
9'*&:
0-&:&0*-
.,*$'*0#-#=C
-*;
:>';($?
#$
.*=($
:>';($D
77B62E
"#$F>(<+&#:<
$(=*$)&:=
<*'.-(
.$#0(<<&:=/
0#:+*0+
GHIJ-##)0#$(K'*&-E:&,E=#LE
 E2E1 M$
N$(+(:
O*;
H#:+*0+
&:@#$'*+&#:
H#:+*0+&:@#$'*+&#:P
Q#.,&(R*:=
J>&-)&:=73
S'
!J22
T,#:(P12348 84!178
U4'*&-P<#.,&(EA*:=K:&,E=#L
 E2E! T$#+#0#-
H#'.-(+&#:VQ*'.-(
M(<+$>0+&#:
W--<.(0&'(:<
#;+*&:()
&:
+,(
.$#+#0#-
*$(
><()
*<
)(@&:()
&:
+,(
.$#+#0#-E
W:C
<.(0&'(:<
+,*+
*$($('*&:&:=
*+
+,(
0#'.-(+&#:
#@
+,(
.$#+#0#-
A&--
;(
<+#$()
&:
+,(
0#:)&+&#:<
)(<0$&;()
&:
<(0+&#:<*;#L(E
X,(
<+>)C
A&--
$('*&:
#.(:
<#
-#:=
*<
<*'.-(
#$
)*+*
*:*-C<&<
0#:+&:>(<E
Q*'.-(<@$#'
0#:<(:+&:=
<>;Y(0+<
A&--
;(
<+#$()
>:+&-
+,(C
*$(
:#
-#:=($
#@
<0&(:+&@&0
L*->(
#$
&@
*
<>;Y(0+A&+,)$*A<
0#:<(:+
@#$
+,(&$
0#:+&:>()
><(/
*+
A,&0,
+&'(
+,(C
A&--
;(
)(<+$#C()E
I@+,(.*+&(:+
A&+,)$*A<
0#:<(:+
+,(
.*$+&0&.*:+Z<
)*+*
A&--
;(
([0->)()
@$#'
@>+>$(
)&<+$&;>+&#:</
;>+)*+*+,*+
,*L(
*-$(*)C
;((:
)&<+$&;>+()
@#$
*..$#L()
$(<(*$0,
><(
A&--
:#+
;(
*;-(
+#
;(
$(+$&(L()E
X,(TIA&--
$(0#$)
*:C
-#<<
#$
>:*:+&0&.*+()
)(<+$>0+&#:
#@
<*'.-(<
*<
*
)(L&*+&#:E
S(.#$+<
A&--
;()#:(.($
+,(
$(F>&$('(:+<
#@
<(0+&#:
\]^E
_ `aba
deffgdbhei
ai`
gjafkabhei
_]l `aba
deffgdbhei
X,(TIA&--
;(
$(<.#:<&;-(
@#$
#L($<((&:=
(:+$C
#@
)*+*
&:+#
*:
&:4,#><(
.*<<A#$)
.$#+(0+()
(-(0+$#:&0<C<+('
9H!M?
*:)
O*;'*+$&[
(:<>$&:=
)*+*
*00>$*0C/
0#:<&<+(:0C
*:)
+&'(-&:(<<E
X,(
.$&:0&.*-&:L(<+&=*+#$/
*<<#0&*+(
&:L(<+&=*+#$<V$(<(*$0,
:>$<(<
*:)V#$
*
0#:+$*0+()
)*+*
'*:*=($
A&--*<<&<+
A&+,
+,(
)*+*
'*:*=('(:+
(@@#$+<E
T$&'*$C
*:)
@&:*-
*:*-Cm()
)*+*
A&--
,*L(
&)(:+&@&($<
<#
+,*+
$(<(*$0,
)*+*
0*:
;(
*++$&;>+()
+#
*:
&:)&L&)>*-
,>'*:
<>;Y(0+
.*$+&0&.*:+E
W--*)L($<(
(L(:+</
&:0->)&:=
0-&:&0*--C
<&=:&@&0*:+
*;:#$'*-
@&:)&:=<
#:
-*;#$*+#$C
(L*->*+&#:</
$(=*$)-(<<
#@
<(L($&+C/
A&--
;(
@#--#A()
>:+&-
$(+>$:
+#
;*<(-&:(
#$
<+*;&-&m*+&#:
#@
(L(:+E
M#0>'(:+
WU<
@$#'
+,(
@&$<+
<+>)C
&:+($L(:+&#:/
Q+>)C
M*C
7
#@
HC0-(
7
+,$#>=,
B3
)*C<
*@+($
+,(<>;Y(0+
$(0(&L()
+,(
-*<+
<+>)C
)$>=
*)'&:&<+$*+&#:E
J(C#:)
B3
)*C<
*@+($
+,(
-*<+
&:+($L(:+&#:/
#:-C
*)L($<(
(L(:+<
A,&0,
*$(
<($&#><
*:)
$(-*+()
+#
+,(
<+>)C
&:+($L(:+&#:
:(()
+#
;($(0#$)()E
W:*;:#$'*-
-*;#$*+#$C
L*->(
A&--
;(
$(0#$)()
&:
+,(
)*+*;*<(
*<
*:
WU
nopq
&@
+,(
-*;#$*+#$C
*;:#$'*-&+C
&<
0,*$*0+($&m()
;C
*:C
#@
+,(
@#--#A&:=P
r S(<>-+<&:)&<0#:+&:>*+&#:@$#'+,(<+>)C
r I<*<<#0&*+()A&+,0-&:&0*-<&=:<#$<C'.+#'<











 !
" #$%&'($)
+($,+-$.+
/(
,.0
/+1$(
+1$(,2$&+'3
'.+$(4$.+'/.
" 5),))/3',+$6
7'+1
6$,+1
/(
,./+1$(
)$('/&)
,64$()$
$4$.+8
'.39&6'.:
1/)2'+,9';,+'/.<
" 5)=&6:$6
>0
+1$
5.4$)+':,+/(
+/
>$
/?
)':.'?'3,.+
39'.'3,9
'-2,3+
" 5?,.0
,>./(-,9
9,>/(,+/(0
($)&9+
')
3/.)'6$($6
39'.'3,990
)':.'?'3,.+8
+1$
'.4$)+':,+/(
7'99
2(/4'6$
6$+,'9)
,>/&+
+1$
,3+'/.
+,@$.
7'+1
($)2$3+
+/
+1$
+$)+
6(&:
,.6
,>/&+
+1$
2,+'$.+A)
/&+3/-$<
B,+,3/99$3+'/.
($%&'($6
>0
C$65--&.$
6$)3('>$6
'.
DEEFGHIJ
L
LGHMNOPQHR
ESMTFHQSFOU
B,+,
7'99
>$
)+/($6
,33/(6'.:
+/
VVW8
XBY8
,.6
Z5V
5.+(,-&(,9
#$3/(6)#$+$.+'/.
W31$6&9$
($:&9,+'/.)
,)
,229'3,>9$<
[MOOMSHFOPSQTPIMG
MN
H\P\U
W1/&96
7$
>$3/-$
,7,($
+1,+
,
-,=/(
>($,31
'.
/&(
29,.
+/
2(/+$3+
)&>=$3+3/.?'6$.+',9'+0
,.6
+(',9
6,+,
1,)
/33&(($68
+1')
7'99
>$
($2/(+$6
$]2$6'+'/&)90
2$(
($%&'($-$.+)
'.
)$3+'/.
^_`_a<
b_` cDdD
efDghij
k[Die
l<m<n V&-,.
B,+,
W1,('.:
o9,.
57'99)1,($
3/6$68
9'.@$6
1&-,.
6,+,
:$.$(,+$6
'.
+1')
($)$,(31
?/(
?&+&($
($)$,(31
'.
,
Z5Vp
?&.6$6/(
,22(/4$6
2&>9'3
($2/)'+/(0
q39'.'3,9+(',9)<:/48
6>r,os8
'.
tu#5W8
7'+1
,22(/4$6
/&+)'6$3/99,>/(,+/()
&.6$(
,22(/2(',+$
,:($$-$.+)8
'.
2&>9'3,+'/.
,.6v/(
2&>9'3
2($)$.+,+'/.)
,+
+1$+'-$/?
2&>9'3,+'/.
/(
)1/(+90
+1$($,?+$(<
l<m<m r$./-'3
B,+,
W1,('.:
o9,.
w.9'.@$6:$./-'3
6,+,
7'99
>$
6$2/)'+$6
'.
2&>9'3
:$./-'3
6,+,>,)$)
)&31
,)
6>r,o
'.
3/-29',.3$
7'+1
+1$
Z5V
r$./-'3
B,+,
W1,('.:
o/9'30
b_x gLekyieL
zghdLghD
X/(+1$2&(2/)$)
/?
+1')
)+&608
2,+'$.+)
)1/&96
>$
($p$4,9&,+$6
?/(
($)2/.)$
$4$(0
{
7$$@)<
5.
,66'+'/.+/
,
>,)$9'.$
)3,.8
3/.?'(-,+/(0
)3,.)
)1/&96
,9)/
>$
/>+,'.$6
!p{
7$$@)
?/99/7'.:
'.'+',96/3&-$.+,+'/.
/?
/>=$3+'4$
($)2/.)$<
#$)2/.)$,.6
2(/:($))'/.
7'99
>$
$4,9&,+$6
'.
+1')
)+&60
&)'.:
+1$
.$7
'.+$(.,+'/.,9
3('+$(',
2(/2/)$6>0
+1$
($4')$6
#$)2/.)$
|4,9&,+'/.
}('+$(',
'.
W/9'6
u&-/()
q#|}5Wus
:&'6$9'.$
q4$()'/.n<ns~<
}1,.:$)
'.
+1$
9,(:$)+
6',-$+$(
q&.'6'-$.)'/.,9
-$,)&($-$.+s
/?
+1$
+&-/(
9$)'/.),.6
+1$
)1/(+$)+
6',-$+$(
'.
+1$
3,)$
/?
-,9':.,.+
90-21
./6$)
,($
&)$6
'.
+1$
#|}5Wu
3('+$(',<
l<<n B$?'.'+'/.)
|4,9&,>9$?/(
+/]'3'+0
Y99
2,+'$.+)
7'99
>$
$4,9&,>9$
?/(
+/]'3'+0
?(/-
+1$
+'-$
/?
+1$'(
?'()+
+($,+-$.+7'+1
+($-$9'-&-,>
,.6
6&(4,9&-,><
|4,9&,>9$?/(
/>=$3+'4$
($)2/.)$
.90
+1/)$
2,+'$.+)
71/
1,4$
-$,)&(,>9$
6')$,)$
2($)$.+
,+
>,)$9'.$81,4$
($3$'4$6
,+
9$,)+
/.$
3039$
/?
+1$(,208
,.6
1,4$
1,6
+1$'(
6')$,)$
($p$4,9&,+$6
7'99
>$3/.)'6$($6$4,9&,>9$?/(($)2/.)$<u1$)$2,+'$.+)7'991,4$+1$'(($)2/.)$39,))'?'$6
,33/(6'.:+/+1$6$?'.'+'/.))+,+$6>$9/7<qZ/+$o,+'$.+)71/$]1'>'+/>=$3+'4$6')$,)$
2(/:($))'/.2('/(+/+1$$.6/?3039$n7'99,9)/>$3/.)'6$($6$4,9&,>9$<s











  
!"#$%#&$')*+,-#./'0
123'#3'
4'35*+3'6
7#02'+03
89*
9#"'
$'32*+3
5.'3'+0
#0
&#3'$2+'
09#0
#.'
'"#$%#&$'&%0
:*
+*0
;''0
09'
:'<2+202*+3
*<
;'#3%.#&$'
:23'#3'=
9#"'
.'>'2"':
#0
$'#30
*+'
>?>$'
*<09'.#5?=
#+:
9#"'
9#:
09'2.
:23'#3'
.','"#$%#0':
82$$
&'
>*+32:'.':
'"#$%#&$'
<*.
+*+,0#./'0
:23'#3'@-9'
.'35*+3'
#33'33;'+0
23
&#3':
*+
09'
5.'3'+>'=
#&3'+>'=
*.
%+'A%2"*>#$
5.*/.'332*+
*<09'$'32*+3@
B@C@D 123'#3'
7#.#;'0'.3
E'#3%.#&$'
:23'#3'6
E'#3%.#&$'
$'32*+3
#.'
:'<2+':
#3
09*3'
09#0
>#+
&'
#>>%.#0'$?
;'#3%.':
2+
#0$'#30*+'
:2;'+32*+
F$*+/'30
:2#;'0'.
0*
&'
.'>*.:':G
#3
HDI
;;
&?
>9'30
J,.#?=
#3
HKI
;;
8209L-3>#+=
*.
HKI
;;
8209
>#$25'.3
&?
>$2+2>#$
'J#;@
M$$
0%;*.
;'#3%.';'+03
;%30
&'
.'>*.:':2+
;2$$2;'0'.3
F*.
:'>2;#$
<.#>02*+3
*<
>'+02;'0'.3G@
E#$2/+#+0
$?;59
+*:'3@
-*
&'
>*+32:'.':
5#09*$*/2>#$$?
'+$#./':
#+:
;'#3%.#&$'=
#
$?;59
+*:'
;%30&'HK 
;;
2+
39*.0
#J23
89'+
#33'33':
&?
L-
3>#+
FL-
3>#+
3$2>'
092>N+'33
.'>*;;'+:':
0*&'+*/.'#0'.
09#+
 
;;G@
M0
&#3'$2+'
#+:
2+
<*$$*8,%5=
*+$?
09'
39*.0
#J23
82$$
&'
;'#3%.':
#+:<*$$*8':@
)*+,;'#3%.#&$'
:23'#3'@
M$$
*09'.
$'32*+3
F*.
320'3
*<
:23'#3'G=
2+>$%:2+/
3;#$$
$'32*+3
F$*+/'30
:2#;'0'.OKI
;;
*.
5#09*$*/2>#$
$?;59
+*:'3
8209
PQR
0*
OK 
;;
39*.0
#J23G=
#.'
>*+32:'.':
+*+,;'#3%.#&$'
:23'#3'@
S*+'
$'32*+3=
$'50*;'+2+/'#$
:23'#3'=
#3>20'3=
5$'%.#$T5'.2>#.:2#$
'<<%32*+3=$?;59#+/2023
>%023T5%$;*+2023=
2+<$#;;#0*.?
&.'#30
:23'#3'=
#+:
#&:*;2+#$
;#33'3
F+*0<*$$*8':
&?
L-
*.
E4UG=
#.'
>*+32:'.':
#3
+*+,;'#3%.#&$'@
)*0'6L?302>
$'32*+3
09#0
;''0
09'
>.20'.2#
<*.
.#:2*/.#592>#$$?
:'<2+':
32;5$'
>?303
39*%$:
+*0
&'
>*+32:'.':
#3
;#$2/+#+0
$'32*+3
F+'209'.
;'#3%.#&$'
+*.
+*+,;'#3%.#&$'G
32+>'
09'?
#.'=
&?
:'<2+202*+=
32;5$'
>?303@
VL?302>$'32*+3W
09*%/90
0*
.'5.'3'+0
>?302>
;'0#30#3'3
>#+
&'
>*+32:'.':
#3
;'#3%.#&$'
$'32*+3=
2<09'?;''0
09'
:'<2+202*+
*<
;'#3%.#&2$20?
:'3>.2&':
#&*"'@
X*8'"'.=
2<
+*+,>?302>
$'32*+3
#.'
5.'3'+02+09'
3#;'
5#02'+0=
09'3'
#.'
5.'<'..':
<*.
3'$'>02*+
#3
0#./'0
$'32*+3@
-#./'0$'32*+3@
M$$
;'#3%.#&$'
$'32*+3
%5
0*
#
;#J2;%;
*<
D
$'32*+3
5'.
*./#+
#+:
 
$'32*+3
2+
0*0#$=.'5.'3'+0#02"'
*<
#$$
2+"*$"':
*./#+3=
39*%$:
&'
2:'+02<2':
#3
YZ[\]Y
_]`abc`
#+:
.'>*.:':
#+:;'#3%.':
#0
&#3'$2+'@
-#./'0
$'32*+3
39*%$:
&'
3'$'>0':
*+
09'
&#323
*<
09'2.
32d'
F$'32*+3
820909'$*+/'30
:2#;'0'.G=
&'
.'5.'3'+0#02"'
*<
#$$
2+"*$"':
*./#+3=
&%0
2+
#::202*+
39*%$:
&'
09*3'09#0$'+:
09';3'$"'3
0*
.'5.*:%>2&$'
.'5'#0':
;'#3%.';'+03@
U0
;#?
&'
09'
>#3'
09#0=
*+
*>>#32*+=09'
$#./'30
$'32*+
:*'3
+*0
$'+:
203'$<
0*
.'5.*:%>2&$'
;'#3%.';'+0
2+
892>9
>2.>%;30#+>'
09'
+'J0
$#./'30
$'32*+
892>9
>#+
&'
;'#3%.':
.'5.*:%>2&$?
39*%$:
&'
3'$'>0':@
M
3%;*<09'
:2#;'0'.3
F$*+/'30
<*.
+*+,+*:#$
$'32*+3=
39*.0
#J23
<*.
+*:#$
$'32*+3G
<*.
#$$
0#./'0
$'32*+382$$
&'
>#$>%$#0':
#+:
.'5*.0':
#3
09'
&#3'$2+'
3%;
:2#;'0'.3@
U<
$?;59
+*:'3
#.'
0*
&'
2+>$%:':2+
09'
3%;=
09'+
*+$?
09'
39*.0
#J23
23
#::':
2+0*
09'
3%;@
-9'
&#3'$2+'
3%;
:2#;'0'.3
82$$&'%3':
#3
.'<'.'+>'
0*
<%.09'.
>9#.#>0'.2d'
#+?
*&e'>02"'
0%;*.
.'/.'332*+
2+
09'
;'#3%.#&$'
:2;'+32*+
*<
09'
:23'#3'@
)*+,0#./'0
$'32*+3@
M$$
*09'.
$'32*+3
F*.
320'3
*<
:23'#3'G
2+>$%:2+/
#+?
;'#3%.#&$'
$'32*+3
*"'.
#+:#&*"'
09'
 
0#./'0
$'32*+3
39*%$:
&'
2:'+02<2':
#3
cbcfYZ[\]Y
_]`abc`
#+:
39*%$:
#$3*
&'
.'>*.:':#0
&#3'$2+'@
E'#3%.';'+03
*<
09'3'
$'32*+3
#.'
+*0
.'A%2.':=
&%0
09'
5.'3'+>'=
#&3'+>'=
*.2+.#.'>#3'3%+'A%2"*>#$5.*/.'332*+*<'#>939*%$:&'+*0':09.*%/9*%0<*$$*8,%5@











 !
!"#"# $%&'()*
,(-
./0120&3(4
(,
$%0*2-051%
63*%0*%
7118%0*2-%8%4&*
*'(21)
5%
&09%4
04)
-%:(-)%)
34
8%&-3:
4(&0&3(4
2*34;
0
-21%-
(-
:013<%-*"
711
50*%134%%/0120&3(4*
*'(21)
5%
<%-,(-8%)
0*
:1(*%1=
0*
<(**351%
&(
&'%
5%;34434;
(,
&-%0&8%4&
04)
4%/%-8(-%
&'04
>
?%%9*
5%,(-%
&'%
5%;34434;
(,
&'%
&-%0&8%4&"
@'%*08%
8%&'()
(,
0**%**8%4&
04)
&'%
*08%
&%:'43A2%
*'(21)
5%
2*%)
&(
:'0-0:&%-3B%
%0:'
3)%4&3,3%)04)
-%<(-&%)
1%*3(4
0&
50*%134%
04)
)2-34;
,(11(?C2<"
D80;34;C50*%)
%/0120&3(4
3*
<-%,%--%)&(
%/0120&3(4
5=
:1343:01
%E08340&3(4
241%**
&'%
1%*3(4F*G
5%34;
,(11(?%)
:044(&
5%
380;%)52&
0-%
0**%**051%
5=
:1343:01
%E08"
H1343:011%*3(4*I
H1343:01
1%*3(4*
?311
(41=
5%
:(4*3)%-%)
8%0*2-051%
?'%4
&'%=
0-%
*2<%-,3:301
F%";"K*934
4()21%*
04)
<01<051%
1=8<'
4()%*G
04)
LMN
88
)308%&%-
0*
0**%**%)
2*34;
:013<%-*
F%";"K*9344()21%*G"
D4
&'%
:0*%
(,
*934
1%*3(4*K
)(:28%4&0&3(4
5=
:(1(-
<'(&(;-0<'=K
34:12)34;
0
-21%-&(%*&380&%
&'%
*3B%
(,
&'%
1%*3(4K
3*
-%:(88%4)%)"
H'%*&EC-0=I
O%*3(4*
(4
:'%*&
EC-0=
0-%
0::%<&051%
0*
8%0*2-051%
1%*3(4*
?'%4
&'%=
0-%
:1%0-1=
)%,34%)04)
*2--(24)%)
5=
0%-0&%)
124;"
P(?%/%-K
H@
3*
<-%,%-051%"
H(4/%4&3(401
H@
04)
$QDI
@'3*
;23)%134%
'0*
)%,34%)
8%0*2-05313&=
(,
1%*3(4*
(4
H@
*:04
50*%)
(4&'%0**28<&3(4
&'0&
H@
*13:%
&'3:94%**
3*
 
88
(-
1%**"
D,
H@
*:04*
'0/%
*13:%
&'3:94%**
;-%0&%-&'04
 
88K
&'%
8343828
*3B%
,(-
0
8%0*2-051%
1%*3(4
*'(21)
5%
&?3:%
&'%
*13:%
&'3:94%**"
$QD3*01*(
0::%<&051%
34
:%-&034
*3&20&3(4*
F%";"
,(-
5()=
*:04*G"
R*%(,$QD
-%8034*
0
:(8<1%E
3**2%"
$QD
'0*
%E:%11%4&
:(4&-0*&K
*<0&301K
04)
&%8<(-01
-%*(12&3(4S
'(?%/%-K
&'%-%
0-%
804=
380;%
0:A23*3&3(4
/0-3051%*
34/(1/%)
34
$QDK
?'3:'
;-%0&1=
38<0:&380;%
A2013&=K
1%*3(4
:(4*<3:23&=K
04)
8%0*2-%8%4&"
T2-&'%-8(-%K
&'%
0/03105313&=
(,
$QD
3*/0-3051%
;1(5011="
7*
?3&'
H@K
3,
04
$QD
3*
<%-,(-8%)K
&'%
&%:'43:01
*<%:3,3:0&3(4*
(,
&'%
*:04434;*%A2%4:%*
2*%)
*'(21)
5%
(<&383B%)
,(-
&'%
%/0120&3(4
(,
&'%
&=<%
04)
*3&%
(,
)3*%0*%"
T2-&'%-8(-%K
0*
?3&'
H@K
&'%
8()013&=
2*%)
0&
,(11(?C2<
*'(21)
5%
&'%
*08%
0*
?0*
2*%)
0&
50*%134%04)
&'%
1%*3(4*
*'(21)
5%
8%0*2-%)U0**%**%)
(4
&'%
*08%
<21*%
*%A2%4:%"
D&
3*
5%=(4)
&'%*:(<%(,
&'%
Q.HDV@
;23)%134%*
&(
<-%*:-35%
*<%:3,3:
$QD
<21*%
*%A2%4:%
<0-08%&%-*
,(-
011
*:044%-*K5()=
<0-&*K
04)
)3*%0*%*"
D)%011=K
&'%
*08%
&=<%
(,
*:044%-
*'(21)
5%
2*%)
04)
&'%
380;%0:A23*3&3(4
<-(&(:(1
*'(21)
5%
,(11(?%)
0*
:1(*%1=
0*
<(**351%
&(
<-3(-
*:04*"
W()=
*:04*
*'(21)5%<%-,(-8%)
?3&'
5-%0&'C'(1)
*:04434;
&%:'43A2%*K
3,
<(**351%"
X.@CH@I7&
<-%*%4&K
&'%
1(?
)(*%
(-
0&&%420&3(4
:(--%:&3(4
H@
<(-&3(4
(,
0
:(8534%)
X.@CH@
3*
4(&01?0=*
(,
(<&3801
)30;4(*&3:
H@
A2013&=
,(-
2*%
?3&'
Q.HDV@
8%0*2-%8%4&*"
P(?%/%-K
3,
&'%*3&%:04
)(:28%4&
&'0&
&'%
H@
<%-,(-8%)
0*
<0-&
(,
0
X.@CH@
3*
(,
3)%4&3:01
)30;4(*&3:
A2013&=&(0
)30;4(*&3:
H@
F?3&'
DY
04)
(-01
:(4&-0*&GK
&'%4
&'%
H@
<(-&3(4
(,
&'%
X.@CH@
:04
5%
2*%),(-Q.HDV@
8%0*2-%8%4&*
04)
:04
5%
2*%)
34&%-:'04;%051=
?3&'
:(4/%4&3(401
H@
34
0::2-0&%1=
8%0*2-34;
:04:%-
1%*3(4*
(/%-
&38%"
Z(&%K
'(?%/%-K
&'0&
&'%
X.@
<(-&3(4
(,
&'%
H@
34&-()2:%*
0))3&3(401
)0&0
?'3:'
80=
530*
04
34/%*&3;0&(-
3,
3&
3*
4(&
-(2&34%1=
(-
*%-3011=
<%-,(-8%)"
R1&-0*(24)I
R1&-0*(24)
3*
4(&
2*%,21
34
0**%**8%4&
(,
1%*3(4
*3B%
04)
*'(21)
4(&
5%
2*%)
0*
0
8%&'()(,
8%0*2-%8%4&"
R1&-0*(24)
%E08340&3(4*
:044(&
5%
-%<-()2:%)
34
&'%3-
%4&3-%&=
,(-
34)%<%4)%4&
-%/3%?
0&
0
10&%-
)0&%
04)K
5%:02*%
&'%=
0-%
(<%-0&(-
)%<%4)%4&K
3&
:044(&
5%
;20-04&%%)&'0&&'%*08%&%:'43A2%04)8%0*2-%8%4&*?3115%&09%4,-(8(4%0**%**8%4&&(&'%
4%E&"D,4%?1%*3(4*0-%3)%4&3,3%)5=21&-0*(24)34&'%:(2-*%(,&'%*&2)=K:(4,3-80&3(45=H@(-











 !
"#$&'()*&'+),
$-
./+0+
&'
1231+03
(425.
0()&(.&23
+672'50+
(.
89:
"#$
;(<
4+
5'+)
&3'.+()
2-
89&3'+=+1.+)
&3'.(31+',
>3)2'127<:
?(7(02'127<@
9/+
5.&=&A(.&23
2-
./+'+
.+1/3&B5+'
-20
24C+1.&*+
.5;20
+*(=5(.&23
&'
32.()*&'+),
D2E+*+0:
'51/
.+1/3&B5+'
;(<
4+
5'+-5=
.2
123-&0;
12;7=+.+
7(./2=2F&1(=
0+'723'+
E/+34&27'&+'
(0+
24.(&3+)
20
.2
)+.+0;&3+
0+=(7'+
&3
.0&(='
E/+0+
0+1500+31+
-2==2E&3F
12;7=+.+
0+'723'+G8#H
20
'50F&1(=
0+'+1.&23
&'
(3
+3)72&3.,
95;20;(0I+0'@
95;20
;(0I+0'
(=23+
1(332.
4+
5'+)
.2
(''+''
0+'723'+,
$-
;(0I+0'
(0+
&3&.&(==<
(42*+./+577+0
320;(=
=&;&.:
./+<
;5'.
320;(=&A+
-20
(
7(.&+3.
.2
4+
123'&)+0+)
&3
12;7=+.+
1=&3&1(=0+'723'+,
J7+1&-&1
F5&)+=&3+'
-20
42./
8KLMN 
0+'723'+
G&3
0+1500+3.
2*(0&(3
1(31+0H
(3)
OJK0+'723'+
G&3
0+1500+3.
702'.(.+
1(31+0H
/(*+
4++3
754=&'/+)PQRS
PQTS
PUVS,
$3
())&.&23:
./+
W<3+12=2F&1
8(31+0
$3.+0F0257
/('
)+*+=27+)
8KLMN 
702F0+''&23
10&.+0&(
E/&1/
(0+
.2
4+
&3.+F0(.+)E&./
24C+1.&*+
.5;20
(''+'';+3.
-20
5'+
&3
-&0'.L=&3+
.0&(='
&3
2*(0&(3
1(31+0PUMS,
8<.2=2F<:D&'.2=2F<@
9/+'+
.+1/3&B5+'
1(3
4+
5'+)
.2
)&--+0+3.&(.+
4+.E++3
7(0.&(=
0+'723'+'
GO#H(3)12;7=+.+
0+'723'+'
G8#H
&3
0(0+
1('+'
G+,F,:
0+'&)5(=
=+'&23'
&3
.5;20
.<7+':
'51/
('
F+0;1+==.5;20':
E/+0+
I32E3
0+'&)5(=
4+3&F3
.5;20'
1(3
0+;(&3H,
9/+1<.2=2F&1(=
123-&0;(.&23
2-
./+
3+27=('.&1
20&F&3
2-
(3<
+--5'&23
./(.
(77+(0'
20
E20'+3'
)50&3F.0+(.;+3.
E/+3
./+
;+('50(4=+
.5;20
/('
;+.
10&.+0&(
-20
0+'723'+
20
'.(4=+
)&'+('+
&'
;(3)(.20<
.2
)&--+0+3.&(.+
4+.E++3
0+'723'+
20
'.(4=+
)&'+('+
G(3
+--5'&23
;(<
4+
(
'&)+
+--+1.
2-
./+.0+(.;+3.H
(3)
702F0+''&*+
)&'+('+,
XYWLO>9@
Z/&=+
XYWLO>9
0+'723'+
(''+'';+3.'
3++)
())&.&23(=
'.5)<:
&.
&'
'2;+.&;+'
0+('23(4=+
.2
&3120720(.+
./+
5'+
2-
XYWLO>9
'1(33&3F
.2
12;7=+;+3.
89
'1(33&3F
&3
(''+'';+3.
2-
702F0+''&23
G7(0.&15=(0=<
72''&4=+
[
3+E[

)&'+('+H,
\+E
=+'&23'
23
./+
4('&'
2-
XYWL
O>9&;(F&3F
1(3
4+
&)+3.&-&+)
(1120)&3F
.2
./+
-2==2E&3F
(=F20&./;@
(,\+F(.&*+
XYWLO>9
(.
4('+=&3+:
E&./
(
72'&.&*+
XYWLO>9
(.
-2==2EL57
&'
(
'&F3
2-
OY
4('+)
23
(
3+E
=+'&23,
4,\2
XYWLO>9
(.
4('+=&3+
(3)
(
72'&.&*+
XYWLO>9
(.
-2==2EL57@
$-
./+
72'&.&*+
XYWLO>9
(.-2==2EL57
1200+'723)'
.2
(
3+E
'&.+
2-
)&'+('+
123-&0;+)
4<
89:
./&'
&'
OY,
$-
./+
72'&.&*+
XYWLO>9
(.
-2==2EL57
&'
32.
123-&0;+)
('
(
3+E
'&.+
2-
)&'+('+
23
89:
())&.&23(=
-2==2EL57
89
'1(3'
(0+
3++)+)
.2
)+.+0;&3+
&-
./+0+
&'
.05=<
702F0+''&23
211500&3F
(.
./(.
'&.+
G&-
'2:
./+
)(.+
2-
OY
E&==
4+
./+
)(.+
2-
./+
&3&.&(=
(4320;(=
XYWL
O>9
'1(3H,
$-
./+
72'&.&*+
XYWLO>9
(.
-2==2EL57
1200+'723)'
.2
(
70+L+6&'.&3F
'&.+
2-
)&'+('+
23
89
./(.
&'
32.
702F0+''&3F
23
./+
4('&'
2-
./+
(3(.2;&1
&;(F+':
./&'
&'
32.
OY,
1,XYWLO>9
;(<
4+
5'+)
.2
57F0()+
(
0+'723'+
.2
(
8#
&3
(
;(33+0
'&;&=(0
.2
(
4&27'<
&3
1('+'
E/+0+
(
0+'&)5(=
0()&2F0(7/&1
(4320;(=&.<
&'
./25F/.
.2
0+70+'+3.
-&402'&'
20
'1(00&3F,
9/+
5'+
2-
XYWLO>9
&3
./&'
1&015;'.(31+
'/25=)
4+
702'7+1.&*+=<
)+'10&4+)
&3
./+
702.212=
(3)
'57720.+)
4<
)&'+('+L'7+1&-&1
;+)&1(=
=&.+0(.50+
-20
./+
&3)&1(.&23,
D2E+*+0:
&.
;5'.
4+
(1I32E=+)F+)
./(.
42./
(7702(1/+'
;(<
=+()
.2
-(='+
72'&.&*+
8#
)5+
.2
=&;&.(.&23'
2-
XYWLO>9
(3)
4&27'<
0+'2=5.&23]'+3'&.&*&.<,
\2.+@K^72'&.&*+_
XYWLO>9
'1(3
=+'&23
;+(3'
23+
E/&1/
&'
XYW
(*&)
E&./
(3
57.(I+
F0+(.+0
./(3.E&1+./(.2-./+'500253)&3F.&''5+23./+(..+35(.&231200+1.+)&;(F+,











 !
"#$#% &'()*+('
-./0'./1
"#$#%#23415610/*+
*7
81.9'0
:'(/*+(
-*;)5'0'&'()*+('
<-&=>
?/(1))'1.1+@'
*7
155
01.9'0
5'(/*+(#
A+B
)10C*5*9/@15
5B;)C
+*D'(
<EC'0C'.01.9'0
*.
+*+F01.9'0=
;6(0
C14'
.'D6@0/*+
/+
(C*.0
1G/(
0*
H2I
;;#
J1.0/15&'()*+('
<J&=>
A0
5'1(0
1
$IK
D'@.'1('
/+
0C'
(6;
*7
0C'
D/1;'0'.(
*7
01.9'0
5'(/*+(L
01M/+91(.'7'.'+@'
0C'
N1('5/+'
(6;
*7
D/1;'0'.(#
J.*9.'((/4'
?/('1('
<J?=>
A0
5'1(0
1
OIK
/+@.'1('
/+
0C'
(6;
*7
0C'
D/1;'0'.(
*7
01.9'0
5'(/*+(L
01M/+91(.'7'.'+@'
0C'
(;155'(0
(6;
*+
(06DB
<0C/(
/+@56D'(
0C'
N1('5/+'
(6;
/7
0C10
/(
0C'
(;155'(0*+
(06DB=#
P+
1DD/0/*+
0*
0C'
.'510/4'
/+@.'1('
*7
OIKL
0C'
(6;
;6(0
15(*
D';*+(0.10'
1+
1N(*560'/+@.'1('
*7
10
5'1(0
 
;;#
<Q*0'>
0C'
1))'1.1+@'
*7
*+'
*.
;*.'
+'E
5'(/*+(
/(
15(*
@*+(/D'.'D
).*9.'((/*+(=#
R01N5'?/('1('
<R?=>Q'/0C'.
(677/@/'+0
(C./+M19'
0*
S615/7B
7*.
J&
+*.
(677/@/'+0
/+@.'1('
0*
S615/7B7*.
J?L
01M/+9
1(
.'7'.'+@'
0C'
(;155'(0
(6;
*7
D/1;'0'.(
EC/5'
*+
(06DB#
"#$#%#O3415610/*+
*7
Q*+F81.9'0
:'(/*+(
-*;)5'0'&'()*+('
<-&=>
?/(1))'1.1+@'
*7
155
+*+F01.9'0
5'(/*+(
1+D
+*.;15/T10/*+
*7
06;*.
;1.M'.5'4'5#
A55
5B;)C
+*D'(
;6(0
N'
+*+F)10C*5*9/@15
/+
(/T'
<H2I
;;
(C*.0
1G/(=#
Q*0'>P706;*.
;1.M'.(
1.'
/+/0/155B
1N*4'
0C'
6))'.
+*.;15
5/;/0L
0C'B
;6(0
+*.;15/T'
7*.
1
)10/'+00*N'
@*+(/D'.'D
/+
@*;)5'0'
@5/+/@15
.'()*+('#
Q*+F-&UQ*+FJ?>
J'.(/(0'+@'
*7
*+'
*.
;*.'
+*+F01.9'0
5'(/*+<(=
1+DU*.
;1/+0'+1+@'
*7
06;*.
;1.M'.5'4'5
1N*4'
0C'
+*.;15
5/;/0(#
J.*9.'((/4'
?/('1('
<J?=>
A))'1.1+@'
*7
*+'
*.
;*.'
+'E
5'(/*+(
1+DU*.
VWXYVZ[\]^_
ab\cbXddZ\W
*7
'G/(0/+9
+*+F01.9'0
5'(/*+(#
eWXYVZ[\]^_
ab\cbXddZ\W
(C*65D
+*0
+*.;155B
0.6;)
01.9'05'(/*+
(0106(#
P0
;6(0
N'
.').'('+010/4'
*7
*4'.155
D/('1('
(0106(
@C1+9'L
+*0
1
(/+95'
5'(/*+
/+@.'1('#
A50C*69C1
@5'1.
).*9.'((/*+
*7
f+*+F01.9'0g
5'(/*+(
*+5B
/(
'G@')0/*+15L
0C'
*)/+/*+
*7
0C'
0.'10/+9)CB(/@/1+
(C*65D
).'41/5
/+
(6@C
@/.@6;(01+@'(L
1+D
0C'
).*9.'((/*+
(0106(
(C*65D
N'
@*+7/.;'D
10
1
510'.
0/;'
NB
0C'
.'4/'E
)1+'5
<*.
J./+@/)15
P+4'(0/910*.=#
"#$#%#$3415610/*+
*7
h'(0
i4'.155
&'()*+('
8C'N'(0*4'.155
.'()*+('
/(
0C'
N'(0
.'()*+('
.'@*.D'D
7.*;
0C'
(01.0
*7
0C'
0.'10;'+0
6+0/5
D/('1(' ).*9.'((/*+U.'@6..'+@'
<01M/+9
1(
.'7'.'+@'
7*.
).*9.'((/4'
D/('1('
0C'
(;155'(0
;'1(6.';'+0(
.'@*.D'D
(/+@'
0C'
0.'10;'+0
(01.0'D=#
8C'
)10/'+0j
(
N'(0
.'()*+('
1((/9+;'+0
E/55
D')'+D*+
0C'
1@C/'4';'+0
*7
N*0C
;'1(6.';'+0
1+D
@*+7/.;10/*+
@./0'./1#
klmopqrstqu
vrqw
xspuympz{s
|ruspus
}r~s~
pmsq
|ruspus
pmsq
surltu
ltpmsq
surltu
sv
surltu
smp{{
sultus
suq
smp{{
sultus
vwst
ltrmpqrlt
ru
syrms
-&
-&
Q*
-&
%EM(#-*+7/.;10/*+











 !
"#$%&'
)&*+,-*
.,-/"#$%&'
)&*+,-*
.&0
)&*+,-*
12&$#33
4&*5,-*&
6&*'12&$#334&*5,-*&07&-
8,-9+$:#'+,-+*4&;<+$&=>
?@
ABCD
?@EABCDFG
AB
F@
?@
ABH
JKLMNLHJO
AB
F@
F@
ABCD
?@EABCD
FGECBH
JKLMNLHJO
AB
F@
PQ
RSTU
?BCVWXYLHWBCZZ
[G
ABCD
?@EABCD
FGECBH
JKLMNLHJO
AB
[G
GB\NYJCHJO
LH
MJLTH
BC\J
PQ
RSTU
VXBY
]LTJMWCJZZ
FG
^C_
`JT
BX
AB
FG
^C_
FGZZZ
`JT
BX
AB
FG
^C_
^C_
`JT
FG
CB
aXWBX
[Gb
F@
BX
?@
Z
[JJ
@c?d[e
fUf
YLCNT\XWaH
VBX
VNXHgJX
OJHLWMT
BC
RgLH
WT
JKWOJC\J
BV
L
CJR
MJTWBCU
ZZ
hCM_
VBX
CBCDXLCOBYWiJO
HXWLMT
RWHg
XJTaBCTJ
LT
aXWYLX_
JCOaBWCHU
ZZZ
dC
Jj\JaHWBCLM
\WX\NYTHLC\JTb
NCJkNWKB\LM
aXBlXJTTWBC
WC
CBCDHLXlJH
MJTWBCT
YL_
]J
L\\JaHJO
LT
OWTJLTJ
aXBlXJTTWBCU
ABHJm
FLHWJCHT
RWHg
L
lMB]LM
OJHJXWBXLHWBC
BV
gJLMHg
THLHNT
XJkNWXWCl
OWT\BCHWCNLHWBC
BV
HXJLHYJCH
RWHgBNH
B]nJ\HWKJ
JKWOJC\J
BV
OWTJLTJ
aXBlXJTTWBC
LH
HgLH
HWYJ
TgBNMO
]J
XJaBXHJO
LT
opqrsturvtwx
z{t{|wu|vtwu}~
cKJX_
JVVBXH
TgBNMO
]J
YLOJ
HB
OB\NYJCH
HgJ
B]nJ\HWKJ
aXBlXJTTWBC
JKJC
LVHJX
OWT\BCHWCNLHWBC
BV
HXJLHYJCHU
,$#'+&-'*
0+'7
.,-/&#*<$#3&
+*&#*&
+&
.,-/"#$%&'
+*&#*&
.,-/"#$%&'
)&*+,-*
.&0
)&*+,-*
12&$#33
4&*5,-*&
?@
AB
?@
ABCD?@ECBCDFG
AB
ABCD?@ECBCDFGZ











 !
 "#"$ %&'()*+,
+.
/012+,10
 "#"$"3%&'()*+,
+.
+40'(55
'012+,10
6708&'()*+,
+.
+40'(55
'012+,10
*1
90(1&'08
.'+9
)70
)*90
90(1&'090,)
:'*)0'*(
('0
90)
.+'
;/
+'</=>7*:7040'
*1
.*'1)
'0:+'808?
&,)*5
)70
.*'1)
8()0
)7()
'0:&''0,)
+'
2'+@'011*40
8*10(10
*1
+AB0:)*405C
8+:&90,)08
=)(D*,@
(1
'0.0'0,:0
.+'
2'+@'011*40
8*10(10
)70
19(5501)
90(1&'090,)1
'0:+'8081*,:0
)70
)'0()90,)
1)(')08?"
6708&'()*+,
+.
+40'(55
;/
*1
90(1&'08
.'+9
)70
)*90
90(1&'090,)
:'*)0'*(
('0
.*'1)
90)
.+'
;/
&,)*5)70.*'1)
8()0
)7()
2'+@'011*40
8*10(10
*1
+AB0:)*405C
8+:&90,)08"
 "#"$"E%&'()*+,
+.
1)(A50
8*10(10
F)(A508*10(10
*1
90(1&'08
.'+9
)70
1)(')
+.
)70
)'0()90,)
&,)*5
)70
:'*)0'*(
.+'
2'+@'011*+,
('0
90)G)(D*,@
(1
'0.0'0,:0
)70
19(5501)
90(1&'090,)1
'0:+'808
1*,:0
)70
)'0()90,)
1)(')08G
*,:5&8*,@)70
A(105*,0
90(1&'090,)1"
HIJ KLMNONPM
NKKRSPT
UPVWXPM
UPYZLSYP
[UNXPUNW
\
NUU[]
^+8*.*08*99&,0_'05()08
'012+,10
:'*)0'*(
=*'/;?
>*55
(51+
A0
0925+C08
*,
)7*1
1)&8C"
67*1
,0>
:5(11*.*:()*+,
*1
A(108
+,
)70
'0:0,)
50(',*,@
.'+9
:5*,*:(5
1)&8*01
>*)7
:(,:0'
*99&,+)70'(2*01
)7()040,*.
1+90
,0>
501*+,1
(220('
()
)70
A0@*,,*,@
+.
(
)'0()90,)
+'
*.
)70
)+)(5
)&9+'
A&'80,
8+01,+)*,:'0(10
1&A1)(,)*(55CG
)&9+'
'0@'011*+,1
+'
1)(A*5*`()*+,1
9*@7)
1)*55
+::&'
5()0'"
670
*'/;>0'0
:'0()08
&1*,@
A*_8*90,1*+,(5
90(1&'090,)1
=(1
2'04*+&15C
>*805C
&108
*,
)70
a+'58
b0(5)7c'@(,*`()*+,
:'*)0'*(?"
d+'
)7*1
)'*(5G
)70
:+,:02)1
+.
)70
*'/;
('0
:+9A*,08
>*)7
/e;fF6
3"3)+:+90
&2
>*)7
)70
9+8*.*08
*'/;"
<50(10
'0.0'
)+
Wgghijkl
[
.+'
.&')70'
80)(*51"
HIm XLnN[NXo
[UNXPUNW
670.+55+>*,@
(840'10
040,)
9(,(@090,)
@&*805*,01
('0
*,)0,808
)+
0,1&'0
)70
1(.0)C
+.
0(:7
2()*0,)>7*50
+,
)70
1)&8C"
670
801:'*2)*+,1
(,8
@'(8*,@
1:(501
.+&,8
*,
)70
'04*108
p;f
;+99+,60'9*,+5+@C
;'*)0'*(
.+'
q840'10
e40,)1
=;6;qe?
40'1*+,
r"!
>*55
A0
&)*5*`08
.+'
qe
'02+')*,@"q55
(22'+2'*()0
)'0()90,)
('0(1
17+&58
7(40
(::011
)+
(
:+2C
+.
)70
;6;qe
40'1*+,
r"!"q :+2C
+.
)70
;6;qe
40'1*+,
r"!
:(,
A0
8+>,5+(808
.'+9
)70
;6e<
>0A
1*)0
=7))2stt:)02":(,:0'"@+4t2'+)+:+5%0405+290,)t050:)'+,*:u(225*:()*+,1t:):"7)9v:):ur!?"
p+)
(55
04(5&()08
p+
,+)
04(5&()08
w,0x&*4+:(5
<%
y01
+'
p+
<%
q,C
y01
<%
z{p+,_;/t,+,_<%|
*1
2'0.0''08
+40'
{1)(A50
8*10(10|
.+'
,+,_)('@0)
8*10(10
1*,:0
F%
*1
*,:'0(1*,@5C
&108
(1
(,
0,82+*,)
.+'
(1101190,)
+.
0..*:(:C
*,
1+90
)'*(51
1+
)+
(11*@,
)7*1
:()0@+'C
>70,
,+
501*+,1
:(,
A0
90(1&'08
*1
,+)
(84*108











 !
" #$%'()*'+$#,
'(-.$'(/(#+0123+3
3#2
034(+5
/*#$+*'$#,
)63#
"78 2(4$#$+$*#0
9:;<=;?;@;?
AB
C;@DEDADBE=
F?BGDC;C
DE
9B:DHI
JK!L
M;FB?ADEN
M;=;<?HO
PG;EA=
@BQEC
O;?;R
"7S *%0')
*44$T(
*4
T*/)6$3#T(
3#2
+'3$#$#,
1

$'U
'()*'+$#,
VRWR! PXF;CDA;C
M;FB?ADEN
9:;<=;?;@;?
AB
AO;
?;FB?ADEN
?;YQD?;Z;EA=
DE
9B:DHI
JK!L
M;FB?ADEN
M;=;<?HO
PG;EA=
<EC
9B:DHI
JKW[BE\]BZF:D<EH;
^QZ<E
_Q`a;HA=
M;=;<?HO
@BQEC
O;?;R
[BA;L
bE:I
c[d
_<@;AI
M;FB?A=
AO<A
Z;;AAO;C;@DEDADBE
B@
<E
QE<EADHDF<A;C
F?B`:;Z
eD::
E;;C
AB
`;
?;FB?A;C
F;?
AO;=;
FB:DHD;=R
VRWRW cMf
M;YQD?;Z;EA=
@B?
9c
M;FB?ADEN
<A
]BEADEQDEN
M;GD;e
9:;<=;?;@;?
AB
AO;
?;FB?ADEN
?;YQD?;Z;EA=
DE
9B:DHI
JK!L
M;FB?ADEN
M;=;<?HO
PG;EA=
@BQEC
O;?;R
"7g #T$
T6$#$T36
2$'(T+*'
'()*'+$#,
9?B`:;Z=;XF;CDADBQ=:I
?;FB?A;C
AB
AO;
b^_M9
DE
DMc_
eD::
<:=B
`;
?;FB?A;C
AB
AO;
[]c
]:DEDH<:
dD?;HAB?Rh
=;F<?<A;
=Q`ZD==DBE
D=
EBA
E;H;==<?I
<=
?;FB?A=
DE
DMc_
eD::
`;
<G<D:<`:;
AB
AO;
]:DEDH<:dD?;HAB?R
cE<CCDADBE
AB
AOB=;
?;FB?A=i
<::
C;<AO=
AO<A
BHHQ?
eDAODE
jK
C<I=
<@A;?
?;H;DGDEN
<
?;=;<?HO
DEA;?G;EADBE
kOBQ:C
`;
?;FB?A;C
GD<
;Z<D:
AB
AO;
]:DEDH<:
dD?;HAB?
QE:;==
AO;I
<?;
CQ;
AB
F?BN?;==DG;
CD=;<=;R

lB?;FB?AAO;=;
C;<AO=i
F:;<=;
=;EC
<E
;Z<D:
C;=H?D`DEN
AO;
HD?HQZ=A<EH;=
B@
AO;
C;<AO
AB
d?R
d<OQA<A[]c]]MmhnZ<D:REDORNBG
eDAODE
BE;
`Q=DE;==
C<I
B@
:;<?EDEN
B@
AO;
C;<AOR
"7o #$%
'(-.$'(2
23+3
3#2
034(+5
/*#$+*'$#,
)63#
VRpR! 9?DEHDF<:
cEG;=ADN<AB?qM;=;<?HO
l;<Z
lO;H:DEDH<:
?;=;<?HO
A;<Z
eD::
Z;;A
BE
<
e;;r:I
`<=D=
eO;E
F<AD;EA=
<?;
`;DEN
<HADG;:I
A?;<A;C
BEAO;A?D<:
AB
CD=HQ==
;<HO
F<AD;EAR
d;HD=DBE=
<`BQA
CB=;
:;G;:
;E?B::Z;EA
<EC
CB=;
;=H<:<ADBE
D@
<FF:DH<`:;
eD::
`;
Z<C;
`<=;C
BE
AO;
ABXDHDAI
C<A<
@?BZ
F?DB?
F<AD;EA=R
h::C<A<eD::
`;
HB::;HA;C
DE
<
ADZ;:I
Z<EE;?
<EC
?;GD;e;C
`I
AO;
F?DEHDF<:
DEG;=ADN<AB?
B?
<
:;<C
<==BHD<A;DEG;=ADN<AB?R
PG;EA=
Z;;ADEN
?;YQD?;Z;EA=
@B?
;XF;CDA;C
?;FB?ADEN
<=
C;=H?D`;C
DE
=;HADBE"7S78
eD::
`;
=Q`ZDAA;C
eDAODE
AO;
<FF?BF?D<A;
ADZ;:DE;=R
lO;F?DEHDF<:
DEG;=ADN<AB?
eD::
?;GD;e
<CG;?=;
;G;EA
<EC
?;=FBE=;
C<A<
BE
;<HO
F<AD;EA
AB
;E=Q?;
=<@;AI<EC
C<A<
<HHQ?<HIR
lO;
F?DEHDF<:
DEG;=ADN<AB?
eD::
F;?=BE<::I
HBECQHA
B?
=QF;?GD=;
AO;
DEG;=ADN<ADBE
<EC
F?BGDC;
<FF?BF?D<A;
C;:;N<ADBE
B@
?;=FBE=D`D:DAD;=
AB
BAO;?
Z;Z`;?=
B@
AO;
?;=;<?HO=A<@@R
s 0)*#0*'
)'*+*T*61034(+5
'()*'+$#,
s78 2(4$#$+$*#0
JR!R! hCG;?=;
PG;EA
hEIQEABe<?CZ;CDH<:BHHQ??;EH;DE<F<AD;EAB?H:DEDH<:DEG;=ADN<ADBE=Q`a;HA<CZDED=A;?;C<
FO<?Z<H;QADH<:F?BCQHA<ECeODHOCB;=EBAE;H;==<?D:IO<G;<H<Q=<:?;:<ADBE=ODFeDAOAOD=











 !
"#$%"&$'"(
*'
%+,$#-$
$,$'"
.*/0
1%'
"2$#$34#$
5$
%'6
7'3%,4#%58$
%'+
7'9'"$'+$+
-9:'
.9'187+9':
%'
%5'4#&%8
8%54#%"4#6
39'+9':0;
-6&<"4&;
4#
+9-$%-$
"$&<4#%886
%--419%"$+
=9"2
"2$
7-$ 43%
&$+919'%8
.9',$-"9:%"94'%80
<#4+71";
=2$"2$#
4#
'4"
#$8%"$+
"4
"2$
&$+919'%8
.9',$-"9:%"94'%80
<#4+71"
.>?@
/ 
.A!00
B(C(! D$#947-
*+,$#-$
/,$'"
.D*/0
*'%+,$#-$
$,$'"
4#
-7-<$1"$+
%+,$#-$
#$%1"94'
9-
14'-9+$#$+
-$#947-
93
9'
"2$
,9$=
43
"2$
9',$-"9:%"4#
4#
"2$
-<4'-4#;
9"
#$-78"-
9'
%'6
43
"2$
34884=9':E
F G$%"2;
F *893$H"2#$%"$'9':
%+,$#-$
$,$'"
.-$$
-$1"94'
IJKJL0
F >'<%"9$'"
24-<9"%89M%"94'
4#
<#484':%"94'
43
$N9-"9':
24-<9"%89M%"94'
O *
24-<9"%89M%"94'P%+&9--94'
"2%"
9-
<#$H<8%''$+
.9($(;
$8$1"9,$
4#
-12$+78$+
-7#:$#6
%##%':$+
<#94#
"4
"2$
-"%#"
43
"2$
-"7+60;
%
<8%''$+
24-<9"%89M%"94'
34#
<#$H$N9-"9':
14'+9"94';
4#
%
<#41$+7#$
#$Q79#$+
56
"2$
<#4"4148;
=9"247"
%
-$#947-
+$"$#94#%"94'
9'
2$%8"2;
9-
'4"
14'-9+$#$+
%
-$#947-
%+,$#-$
$,$'"(
O *
24-<9"%89M%"94'P%+&9--94'
"2%"
9-
-48$86
+#9,$'
56
'4'H&$+91%8
#$%-4'-
.$(:(;
24-<9"%89M%"94'
34#
<%"9$'"
4#
-75R$1"
14',$'9$'1$0
9-
'4"
14'-9+$#$+
%
-$#947-
%+,$#-$
$,$'"(
O /&$#:$'16
#44&
,9-9"-
4#
-"%6-
9'
45-$#,%"94'
7'9"-
"2%"
+4
'4"
#$-78"
9'
%+&9--94'
"4
"2$
24-<9"%8
=478+
'4"
5$
14'-9+$#$+
%
-$#947-
%+,$#-$
$,$'"(
S2$
#$%-4'
34#
-$$T9':
&$+91%8
1%#$
-2478+
5$
$,%87%"$+
34#
&$$"9':
4'$
43
"2$
4"2$#
-$#947-
1#9"$#9%
F U$#-9-"$'"
4#
-9:'9391%'"
9'1%<%19"6
4#
-75-"%'"9%8
+9-#7<"94'
43
"2$
%5989"6
"4
14'+71"
'4#&%8
893$
37'1"94'-
F *14':$'9"%8
%'4&%86P59#"2
+$3$1"(
F >&<4#"%'"
&$+91%8
$,$'"-
"2%"
&%6
'4"
#$-78"
9'
+$%"2;
5$
893$H"2#$%"$'9':;
4#
#$Q79#$
24-<9"%89M%"94'
&%6
5$
14'-9+$#$+
%
-$#947-
%+,$#-$
+#7:
$N<$#9$'1$
=2$';
5%-$+
7<4'
%<<#4<#9%"$
&$+91%8
R7+:&$'";
"2$6
&%6
R$4<%#+9M$
"2$
<%"9$'"
4#
-75R$1"
%'+
&%6
#$Q79#$
&$+91%8
4#
-7#:91%8
9'"$#,$'"94'
"4
<#$,$'"
4'$
43
"2$
47"14&$-
89-"$+
9'
"29-
+$39'9"94'(
B(C(V W93$H"2#$%"$'9':
*'%+,$#-$
$,$'"
4#
-7-<$1"$+
%+,$#-$
#$%1"94'
9-
14'-9+$#$+
X893$H"2#$%"$'9':X
93;
9'
"2$
,9$=
43
$9"2$#"2$9',$-"9:%"4#
4#
-<4'-4#;
9"-
4117##$'1$
<8%1$-
"2$
<%"9$'"
4#
-75R$1"
%"
9&&$+9%"$
#9-T
43
+$%"2(>"+4$-
'4"
9'187+$
%'
%+,$#-$
$,$'"
4#
-7-<$1"$+
%+,$#-$
#$%1"94'
"2%";
2%+
9"
4117##$+
9'
%
&4#$-$,$#$
34#&;
&9:2"
2%,$
1%7-$+
+$%"2(
.!C?YAVC!(V!0
B(C(Z D$,$#9"6
S2$-$,$#9"6
43
$%12
*+,$#-$
/,$'"
=988
5$
%--$--$+
7"989M9':
"2$
?S?*/
,$#-94'
Z([(
B(C(\ A$8%"94'-29<
"4
D"7+6
U#4+71"
*88*/-=988
2%,$
"2$9#
#$8%"94'-29<
"4
-"7+6
<#4+71"
%--$--$+
7-9':
"2$
"$#&-E

#$8%"$+
4#
'4"
#$8%"$+(











 !
" #$%&'$(
*
+,$-$
./
&
-$&/01&2%$
30//.2.%.'4
',&'
',$
/'5(4
3-0(56'
6&5/$(
',$
&(7$-/$
$7$1'8
#$&/01&2%$
30//.2.%.'4
9$&1/
',&'
',$-$
./
$7.($16$
'0
/5::$/'
&
6&5/&%
-$%&'.01/,.3
2$';$$1
',$
/'5(4
3-0(56'
&1(
',$
&(7$-/$
$7$1'8
" <0'
#$%&'$(
*
+,$-$
./
10'
&
-$&/01&2%$
30//.2.%.'4
',&'
',$
&(9.1./'-&'.01
0>
',$
/'5(4
3-0(56'
6&5/$(
',$
$7$1'8
?8@8 A(7$-/$
B7$1'/
0>
C3$6.&%
D1'$-$/'
EABCDF
C$$C$6'.01
GHIHJH
KHJ LMMNMMONPQ
RS
MLSNQT
NUNPQM
AB.1>0-9&'.01
60%%$6'$(
;.%%
.16%5($
$7$1'
($/6-.3'.01V
(&'$
0>
01/$'V
&//$//9$1'
0>
/$7$-.'4
&1(-$%&'.01/,.3
'0
/'5(4
3-0(56'
&1(
&%'$-1&'$
$'.0%0:4
E.>
10'
-$%&'$(
'0
/'5(4
3-0(56'FV
(&'$
0>
-$/0%5'.010>
',$
$7$1'V
/$-.05/1$//
&1(
05'609$8
+,$
&//$//9$1'
0>
/$7$-.'4
&1(
-$%&'.01/,.3
'0
',$/'5(43-0(56'
;.%%
2$
(01$
01%4
24
',0/$
;.',
',$
'-&.1.1:
&1(
&5',0-.'4
'0
9&W$
&
(.&:10/./
&1(%./'$(
01
',$
X0-9
XYA
@Z[\
&/
',$
/.'$
3-.16.3&%
.17$/'.:&'0-
0-
/52].17$/'.:&'0-8

AB/
0665--.1:(5-.1:
',$
60%%$6'.01
&1(
-$30-'.1:
3$-.0(
;.%%
2$
(0659$1'$(
&33-03-.&'$%4
-$:&-(%$//
0>-$%&'.01/,.38

AB/
;.%%
2$
>0%%0;$(
',-05:,
-$/0%5'.018
CAB/;.%%
2$^
" A//$//$(
>0-
/$7$-.'4
&1(
-$%&'.01/,.3
'0
/'5(4
3-0(56'
&1(
&%'$-1&'$
$'.0%0:4
E.>
10'
-$%&'$(
'0
/'5(4
3-0(56'F
24
&
%.6$1/$(
/'5(4
3,4/.6.&1
%./'$(
01
',$
X0-9
XYA
@Z[\
&/
',$
/.'$
3-.16.3&%
.17$/'.:&'0-
0-
/52].17$/'.:&'0-8
" #$60-($(
01
',$
&33-03-.&'$
CAB
-$30-'
>0-9V
',$
9$(.6&%
-$60-(
&1(
6&3'5-$(
.1
',$
6%.1.6&%
(&'&2&/$8
" X0%%0;$(
',-05:,
-$/0%5'.01
24
&
%.6$1/$(
/'5(4
3,4/.6.&1
%./'$(
01
',$
X0-9
XYA
@Z[\
&/',$
/.'$
3-.16.3&%
.17$/'.:&'0-
0-
/52].17$/'.:&'0-8
X0-'.9$>-&9$
0>
-$60-(.1:
&(7$-/$
$7$1'/V
3%$&/$
-$>$-
'0
/$6'.01
_H`8
A%%
/$-.05/
&(7$-/$
$7$1'/
-$60-($(>-09
',$
'.9$
0>
>.-/'
.17$/'.:&'.01&%
3-0(56'
&(9.1./'-&'.01
95/'
2$
-$30-'$(
'0
',$
/301/0-;.',
',$
$a6$3'.01
0>
&14
%./'$(
.1
/$6'.01
KHI8
KHG bNcRbQdPe
RS
MNbdRfM
LgUNbMN
NUNPQM
A14AB',&'
9$$'/
3-0'060%]($>.1$(
/$-.05/
6-.'$-.&
0-
9$$'/
',$
($>.1.'.01
0>
A(7$-/$
B7$1'
0>
C3$6.&%D1'$-$/'
',&'
-$h5.-$
$a3$(.'$(
-$30-'.1:
95/'
2$
/529.''$(
.99$(.&'$%4
E;.',.1
\i
,05-/
0>&;&-$1$//F
'0
jC#j
C&>$'4
5/.1:
',$
kk#
CAB
-$30-'
>0-98
A%%CAB-$30-'.1:
95/'
.16%5($
',$
$%$9$1'/
($/6-.2$(
.1
/$6'.01
KHJ8
CAB -$30-'/
;.%%
2$
/529.''$(
'0
',$
k$1'$-
>0-
k&16$-
#$/$&-6,
Ekk#F
&'^
jC#jC&>$'4l9&.%81.,8:07
&1(
'0
',$
kk#
mD
&1(
/'5(4
600-(.1&'0-8

kk#
CAB
-$30-'
>0-9
&1(
.1/'-56'.01/
6&1
2$
>051(
&'^

,''3/^nn66-0(86&16$-8:07n601>%5$16$n(./3%&4nkk#k#jnX0-9/o&1(oD1/'-56'.01/
X0%%0;.1:
',$
&//$//9$1'
0>
',$
CAB
24
jC#jV
0',$-
/5330-'.1:
(0659$1'&'.01
0>
',$
$7$1'
9&42$-$h5$/'$(
24
',$
jC#j
C&>$'4
&1(
/,05%(
2$
3-07.($(
&/
/001
&/
30//.2%$8











 !
"#$ %&'()*
,-
)./)0'1)0
*)/,*1'23
1,
44*
5689:;<8=9
;>
8?69:69
@A>BA966?>C
?6
@:A;
>D
;<9
6;=8E
>FG9H;?I96
JKLM
:C8
H:@;=A98
:6
:C
9C8@>?C;?C
;<?6
6;=8EN
89:;<
8=9
;>
8?69:69
@A>BA966?>C
O?PP
C>;
F9
A9@>A;98
?C
9Q@98?;98
R:CC9A
;>;<9L@>C6>AS
T>O9I9AN
?D
;<9A9
?6
9I?89CH9
6=BB96;?CB
:
H:=6:P
A9P:;?>C6<?@
F9;O99C
;<9
6;=8E
8A=B:C8;<9
9I9C;N
A9@>A;
;<9
9I9C;
?C
:C
9Q@98?;98
R:CC9A
:HH>A8?CB
;>
69H;?>C
"#U#
T>6@?;:P?V:;?>C
;<:;
?6
899R98
;>
F9
8=9
;>
8?69:69
@A>BA966?>CN
:C8
C>;
:;;A?F=;:FP9
;>
;<9
?C;9AI9C;?>C
O?PP
C>;
F9
A9@>A;98
:6
:C
L5WS
X<9
9I9C;N
:C8
;<9
:66966R9C;
;<:;
?;
O:6
H:=698
FE
8?69:69@A>BA966?>C
O?PP
F9
8>H=R9C;98
?C
;<9
R98?H:P
A9H>A86S
X<9
H:=6:P?;E
:66966R9C;
>D
<>6@?;:P?V:;?>C
O?PP
F9
A9Y9I:P=:;98
:CE
;?R9
O<9C
C9O
?CD>AR:;?>C
?6
A9H9?I98S
ZD
;<9
H:=6:P?;E
:66966R9C;
H<:CB96
DA>R
8?69:69
@A>BA966?>C
;>
A9P:;98
;>
;<9
6;=8E
?C;9AI9C;?>CN
L5W
A9@>A;
O?PP
F969C;;>
;<9
L@>C6>A
?C
:C
9Q@98?;98
R:CC9A
:HH>A8?CB
;>
69H;?>C
"#US
ZD
;<9A9
?6
:CE
=CH9A;:?C;E
O<9;<9A
;<9
?C;9AI9C;?>C
?6
:
H>C;A?F=;?CB
D:H;>A
;>
;<9
9I9C;N
;<9
9I9C;
6<>=P8
F9
A9@>A;98:6
5W
>A
L5W
:6
:@@A>@A?:;9S
"#[ *)/,*1'23
4*'1)*'&
1,
1\)
/\&*]&4)^1'4&_
4,__&`,*&1,*a
5PP9I9C;6
P?6;98
F9P>O
R=6;
F9
A9@>A;98
?C
;<9
89D?C98
;?R9P?C96
;>
KLbK6:D9;EcR:?PSC?<SB>IS
X<9ddbKDD?H9
>D
b9B=P:;>AE
5DD:?A6
O?PP
69C8
:PP
A9@>A;6
;>
;<9
R:C=D:H;=A9A
:6
896HA?F98
F9P>OS
eSfSg WQ@98?;98
58I9A69
WI9C;
b9@>A;?CB
dA?;9A?:
;>
;<9
Zhi
j:C=D:H;=A9A
5PP6:D9;E
A9@>A;6
:C8
:CC=:P
A9@>A;6
;<:;
:A9
6=FR?;;98
;>
;<9
ki5
O?PP
F9
6=FR?;;98
;>
56;A:l9C9H:S
5H>@E>D;<9
j98m:;H<
A9@>A;
>A
9n=?I:P9C;
D>AR
R=6;
F9
D:Q98
;>
56;A:l9C9H:
:;
;<9
;?R9
;<9
9I9C;?6A9@>A;98
;>
;<9
ki5S
5H>I9A@:B9
6<>=P8
:HH>R@:CE
;<9
j98m:;H<
D>AR
>A
9n=?I:P9C;
D>AR
?C8?H:;?CB
;<9
D>PP>O?CBo
p qh>;?D?H:;?>C
DA>R
:C
ZCI96;?B:;>A
L@>C6>A98
L;=8Er
p X<9
?CI96;?B:;>A
Zhi
C=RF9A
:66?BC98
FE
;<9
ki5
p X<9
?CI96;?B:;>As6
C:R9
:C8
:88A966
p X<9
;A?:P
C:R9t;?;P9
:C8
56;A:l9C9H:
ZLL
A9D9A9CH9
C=RF9A
JWLbug uggvwxM
yL@>C6>A
R=6;
:P6>
?C8?H:;9N
9?;<9A
?C
;<9
L5W
A9@>A;
>A
;<9
H>I9A
@:B9N
;<9
H:=6:P?;E
>D
9I9C;6
?CA9P:;?>C
;>
:PP
6;=8E
R98?H:;?>C6
:C8
?D
;<9
L5W
?6
A9P:;98
;>
8?69:69
@A>BA966?>CN
:6
89;9AR?C98
FE
;<9
@A?CH?@:P
?CI96;?B:;>AS
yL9C8L5W
A9@>A;
:C8
:HH>R@:CE?CB
H>I9A
@:B9
FE
O:E
>D
9R:?P
;>
56;A:l9C9H:s6
896?BC:;98
R:?PF>Qo5Wj:?PF>QdP?C?H:PXA?:PXdLc:6;A:V9C9H:SH>R
5PPL5W6
O?PP
F9
A9@>A;98N
O<9;<9A
>A
C>;
H>C6?89A98
H:=6:PPE
A9P:;98
;>
;<9
?CI96;?B:;?>C:P
@A>8=H;N>A
;>
;<9
6;=8E
@A>H98=A9J6MS
X<9
A9@>A;?CB
@9A?>8
D>A
L5W6
?6
;<9
@9A?>8
?RR98?:;9PE
D>PP>O?CB;<9
;?R9
;<:;
OA?;;9C
?CD>AR98
H>C69C;
?6
>F;:?C98
;<A>=B<
vz
8:E6
:D;9A
;<9
P:6;
8>69
>D8=AI:P=R:F{;A9R9P?R=R:F>A=C;?P;<9?C?;?:;?>C>D:P;9AC:;?I9:C;?H:CH9A;<9A:@ESX<9
?CI96;?B:;>A:C8t>AL@>C6>A:A9A96@>C6?FP9D>A?CD>AR?CB;<9W;<?H6d>RR?;;99:C8t>A;<9
b9B=P:;>AE5=;<>A?;E>D;<9L5W:6@9AP>H:PA9n=?A9R9C;6S











 !
"#%&'&()*+,'-)
./
0*1'2*)
)*+,'-)3
45,)
%&6
'45*+
+*7*8%&4
#'77'9(-:
,&#'+2%4,'&
2-)4
%7)'
0*
:+'8,6*64'
.)4+%;*&*1%<
=*+,'-)%68*+)*
*8*&4)
45%4
6'
&'4
+*>-,+*
*?:*6,4*6
+*:'+4,&@
4'
45*
AB.
)4,77
&**6
4'
0*
+*:'+4*64'
.)4+%;*&*1%
:+*#*+%07C
-),&@
45*
D*6BE.
1'6,&@
7%&@-%@*
#'+
)*+,'-)
%68*+)*
*8*&4)<F5,)
,&#'+2%4,'&
)5'-76
0*
+*:'+4*6
'&
%
2'&457C
0%),)
%&6
-&6*+
&'
1,+1-2)4%&1*
7*))
#+*>-*&47C
45%&
>-%+4*+7C<
F5*):'&)'+
2-)4
,&#'+2
45*
AB.3
8,%
%
D*6G%415
#'+2
'+
*>-,8%7*&4
#'+23
'#
%&C
)*+,'-)
'+
-&*?:*14*6
%68*+)*
*8*&4)
45%4
'11-+
,&
%11'+6%&1*
9,45
45*
+*:'+4,&@
'07,@%4,'&)
'#
HI
JAE
KIH<KH3%&6
9,77
1'&1-++*&47C
#'+9%+6
%77
)-15
+*:'+4)
4'
.)4+%;*&*1%<
.
1':C
'#
45*
D*6G%415L.6//E)
+*:'+4
'+
*>-,8%7*&4
#'+2
2-)4
0*
#%?*6
4'
.)4+%;*&*1%
%4
45*
4,2*
45*
*8*&4,)+*:'+4*6
4'
45*
AB.<
"4
,)
45*
+*):'&),0,7,4C
'#
45*
):'&)'+
4'
1'2:,7*
%77
&*1*))%+C
,&#'+2%4,'&
%&6
*&)-+*
45%4
45*
AB.
+*1*,8*)
%
+*:'+4
%11'+6,&@
4'
45*
AB.
+*:'+4,&@
+*>-,+*2*&4
4,2*7,&*)
%&6
4'
*&)-+*
45%4
45*)*
+*:'+4)
%+*
%7)'
)-02,44*6
4'
.)4+%;*&*1%
%4
45*
)%2*4,2*<
M<!<H N45*+
*8*&4)
+*>-,+,&@
+*:'+4,&@
M<!<H<IN8*+6')*
.&C'8*+6')*
'#
%
)4-6C
)-0O*14
9,45
6-+8%7-2%0
P
4+*2*7,2-2%03
9,45
'+
9,45'-4
%))'1,%4*6
./)L=./)3
,)
+*>-,+*6
4'
0*
+*:'+4*6
9,45,&
HQ
5'-+)
'#
R&'97*6@*
'#
45*
*8*&4
4'
45*
):'&)'+
%&6.)4+%;*&*1%LD*6"22-&*
S%4,*&4
=%#*4C
'+
6*),@&**
-),&@
45*
6*),@&%4*6
=%#*4C
*(2%,70'?
T)**=*14,'&
UVWVX
#'+
1'&4%14
,&#'+2%4,'&Y<
"#
45*
'8*+6')*
+*)-74)
,&
%&
./3
45*
./
2-)4
%7)'
0*
+*1'+6*6%)
%&
./
T)**
=*14,'&
XZVWY<
N8*+6')*
6'*)
&'4
%-4'2%4,1%77C
2%R*
%&
./
)*+,'-)3
0-4
,#45*1'&)*>-*&1*)
'#
45*
'8*+6')*
%+*
)*+,'-)3
#'+
*?%2:7*
6*%45
'+
5'):,4%7,[%4,'&3
45*
*8*&4
,)
)*+,'-)%&6
2-)4
0*
+*1'+6*6
%&6
+*:'+4*6
%)
%&
=./
T)**
=*14,'&
XZVWY<
F5*+*
,)
1-++*&47C
&'
):*1,#,14+*%42*&4
,&
45*
*8*&4
'#
%&
'8*+6')*
'#
6-+8%7-2%0
'+
4+*2*7,2-2%0<
M<!<H<H\*:%4,1
#-&14,'&
%0&'+2%7,4C
\*:%4,1#-&14,'&
%0&'+2%7,4C
T%)
6*#,&*6
,&
=*14,'&
]V^V_<Y
,&
%
)4-6C
)-0O*143
9,45
'+
9,45'-4
%))'1,%4*6
17,&,1%7
2%&,#*)4%4,'&)3
,)
+*>-,+*6
4'
0*
+*:'+4*6
%)
`5*:%4,1
#-&14,'&
%0&'+2%7a
b
c
bd
c


4'
45*
):'&)'+
%&6
.)4+%;*&*1%LD*6"22-&*
S%4,*&4
=%#*4C-),&@
45*
6*),@&%4*6
=%#*4C
*(2%,70'?
T)**
=*14,'&
eV^
#'+
1'&4%14
,&#'+2%4,'&Y3
-&7*))
%
6*#,&,4,8*-&6*+7C,&@
6,%@&'),)
#'+
45*
%0&'+2%7,4C
T*<@<3
15'7*7,45,%),)
'+
0,7*
6-14
'0)4+-14,'&Y
45%4,)-&+*7%4*6
4'
,&8*)4,@%4,'&%7
:+'6-14
5%)
0**&
1'&#,+2*6<
f "#45*
6*#,&,4,8*
-&6*+7C,&@
6,%@&'),)
#'+
45*
%0&'+2%7,4C
5%)
0**&
*)4%07,)5*6
%&6
,)
-&+*7%4*6
4'
,&8*)4,@%4,'&%7
:+'6-143
45*
6*1,),'&
4'
1'&4,&-*
6'),&@
'#
45*
)4-6C
)-0O*14
9,77
0*
0%)*6
'&
45*
17,&,1%7
O-6@2*&4
'#
45*
,&8*)4,@%4'+<
f "#&'
6*#,&,4,8*
-&6*+7C,&@
6,%@&'),)
#'+
45*
%0&'+2%7,4C
,)
*)4%07,)5*63
6'),&@
'#
45*
)4-6C
)-0O*14
2-)4
0*
,&4*++-:4*6
,22*6,%4*7C<
A'77'9(-:
,&8*)4,@%4,'&)
%&6
,&>-,+,*)
2-)4
0*
,&,4,%4*6
0C
45*
,&8*)4,@%4,'&%7
),4*
9,45'-4
6*7%C<
/%15+*:'+4*6
*8*&4
'#
5*:%4,1
#-&14,'&
%0&'+2%7,4C
9,77
0*
#'77'9*6
0C
45*
,&8*)4,@%4'+
%&6
*8%7-%4*60C
45*
):'&)'+
%&6
.)4+%;*&*1%LD*6"22-&*<











  
!"# $%&'$()*+
&$%+*-*./
01134567348
934:;<;=>
349?3@ABC?11?DE69
@?
FGHF
D711
I4
A6IJ7@@48
@?K
FGHFG<C4@>LJ<71M;7NM:?O
<;8
@?
@N4
PPH
QR
<;8
A@68>
=??387;<@?3M

S?3JA
<;8
7;A@36=@7?;A
=<;I4C?6;8
N434K
N@@9AKBB==3?8M=<;=43M:?OB=?;C164;=4B87A91<>BPPHPHFBS?3JAT<;8TR;A@36=@7?;A
UM MV W<@43;<1
4X9?A634
RC<9<@74;@
I4=?J4A
934:;<;@
8637;:
@N4
=?63A4
?C
@N4
A@68>Y
@N4
A@68>
@34<@J4;@
AN?618
I4
87A=?;@7;648
7JJ487<@41>Y
<;8
@N4
934:;<;=>
349?3@48
@?
@N4
G9?;A?3
;?
1<@43
@N<;
Z[
N?63A
?C
DN4;@N4R;O4A@7:<@?3
I4=?J4A
<D<34
?C
7@M
\N4
R;O4A@7:<@?3
AN?618
;?@7C>
@N4
G9?;A?3
;?
1<@43
@N<;Z[N?63A
?C
DN4;
@N4
?6@=?J4
?C
@N4
Q34:;<;=>
I4=?J4
];?D;Y
Q34:;<;=>
7@A41C
7A
;?@
34:<3848
<A
<;
G0^M
_?D4O43Y
=?;:4;7@<1
<I;?3J<17@74A
?3
I73@N
84C4=@A
<;8A9?;@<;4?6A
J7A=<337<:4A
@N<@
J44@
A437?6A
=37@437<
`A44
A4=@7?;
!"a"bc
AN?618
I4
349?3@48
<A
G0^AM
\N4?6@=?J4
?C
<11
934:;<;=74A
`A9?;@<;4?6A
J7A=<337<:4Y
414=@7O4
@43J7;<@7?;Y
4=@?97=
934:;<;=>Y
;?3J<1
I73@NY
?3
=?;:4;7@<1
<I;?3J<17@>d
AN?618
I4
C?11?D48
69
<;8
8?=6J4;@48M
UM MZ Q<@43;<1
4X9?A634
W<149<@74;@A
AN?618
34C3<7;
C3?J
C<@N437;:
<
=N718
?3
8?;<@7;:
A943J
8637;:
@N4
A@68>
<;8
C?3
VUe8<>A<C@43
@N4
1<A@
8?A4
?C
863O<16J<IT
@34J417J6J<I
=?JI7;48
@N43<9>
?3
fe
8<>A
<C@43
@N41<A@8?A4
?C
863O<16J<I
J?;?@N43<9>Y
DN7=N4O43
7A
@N4
1?;:43
@7J4
9437?8M
Q34:;<;=>
?C
@N4
9<@74;@gA
9<3@;43
7A
;?@
=?;A784348
@?
I4
<;
0^M
_?D4O43Y
@N4
?6@=?J4
?C
<11
934:;<;=74A
`A9?;@<;4?6A
J7A=<337<:4Y
414=@7O4
@43J7;<@7?;Y
4=@?97=
934:;<;=>Y
;?3J<1
I73@NY
?3
=?;:4;7@<1
<I;?3J<17@>d
?==6337;:
C3?J
@N4
8<@4
?C
@N4
C73A@
8?A4
6;@71
VUe
8<>A
<C@43
@N4
1<A@
8?A4
?C863O<16J<IT
@34J417J6J<I
=?JI7;48
@N43<9>
?3
fe
8<>A
<C@43
@N4
1<A@
8?A4
?C
863O<16J<I
J?;?@N43<9>Y
DN7=N4O43
7A
@N4
1?;:43
@7J4
9437?8
<C@43
@N4
1<A@
8?A4
AN?618Y
7C
9?AA7I14Y
I4
C?11?D4869
<;8
8?=6J4;@48M
!"h $%+ij-('$/
$%&'$()*+
k'$
l(im)%l
.'*mi.(%m
i*m%$
..$nl&'*l'$%m
)*m
S?11?D7;:
;?@7C7=<@7?;
C3?J
@N4
7;O4A@7:<@?3Y
PPHY
@N4
Rop
A9?;A?3Y
D711
349?3@
<;>
A6A94=@48
<8O43A434<=@7?;
@N<@
7A
I?@N
A437?6A
<;8
6;4X94=@48M

PPH
D711
349?3@
<;
0^
<A
<
A6A94=@48
<8O43A434<=@7?;
?;1>
7C
@N434
7A
4O784;=4
@?
A6::4A@
<
=<6A<1
341<@7?;AN79
I4@D44;
@N4
A@68>
93?86=@<;8
@N4
<8O43A4
4O4;@M

PPH
D711
;?@7C>
Sp0
<;8
<11
9<3@7=79<@7;:
7;O4A@7:<@?3A
`7M4MY
<11
7;O4A@7:<@?3A
@?
DN?J
@N4
A9?;A?3
7A
93?O787;:
836:
6;843
7@A
RopA
?3
6;843
<;>
7;O4A@7:<@?3gA
Ropd7;<;
Rop
A<C4@>
349?3@
?C
9?@4;@7<1
A437?6A
37A]A
C3?J
=17;7=<1
@37<1A
?3
<;>
?@N43
A?63=4Y
<A
A??;<A9?AA7I14Y
7;
<==?38<;=4
@?
ZV
PSH
Q<3@
qVZMqZM
011A437?6A
4O4;@A
D711
I4
349?3@48
@?
@N4
Sp0
<@
14<A@
<;;6<11>
7;
<
A6JJ<3>
C?3J<@M
r .j)*).-j
s'*)('$)*+
0A<A9?;A?3
C?3
=17;7=<1
@37<1AY
Sp0
34:61<@7?;A
3456734
@N4
PPH
@?
J<7;@<7;
<
J?;7@?37;:
93?:3<JM\N4PPHgA93?:3<J<11?DAC?3=?;C73J<@7?;?CKA@68>8<@<YA94=7C7=<11>8<@<@N<@=?618
<CC4=@@N47;@43934@<@7?;?C937J<3><;8A4=?;8<3>A@68>4;89?7;@At<8N434;=4@?@N493?@?=?1Y











 !
"#$%&'()*+,-
/01
2 -
'+3
456,7
'+3
8%9'+
,%:;#<(,
="*(#<()*+>
?8),
),
3*+#
(8"*%$8
)+3#=#+3#+(
@#")A)<'()*+
*A
,(%3B
3'('
C)(8
,*%"<#
3*<%9#+('()*+
A*<%,)+$
*+D
E /+A*"9#3
<*+,#+(
="*<#,,
E 2&)$):)&)(B
<*+A)"9'()*+
E F"%$
'39)+),("'()*+
'+3
'<<*%+(':)&)(B
E G3@#",#
#@#+(,
9*+)(*")+$
E H#,=*+,#
',,#,,9#+(>
?8#9*+)(*")+$
="*$"'9
'&,*
#I(#+3,
(*
9%&()J,)(#
"#,#'"<8
C8#+
(8#
00H
),
(8#
<**"3)+'()+$
<#+(#">
?8),(")'&C)&&
:#
9*+)(*"#3
:B
=#",*++#&
#9=&*B#3
:B
'
00H
<*+("'<(*">
K*+)(*",
'"#
L%'&)A)#3
:B("')+)+$
'+3
#I=#")#+<#
(*
9*+)(*"
(8#
="*$"#,,
*A
<&)+)<'&
(")'&,>
6#",*++#&
9*+)(*")+$
(8),
,(%3BC)&&+*(
:#
'AA)&)'(#3
)+
'+B
C'B
C)(8
(8#
(")'&
<*+3%<(>
MN OPQPROPRSQT
SVWORXYZQPRVWO
?8#=")9'"B
*:;#<()@#
*A
(8),
=)&*(
(")'&
),
(*
="#&)9)+'")&B
#@'&%'(#
(8#
#AA)<'<B
*A
<*9:)+)+$
("#9#&)9%9':
'+3
3%"@'&%9':
)+
='()#+(,
C)(8
'3@'+<#3
100-
#)(8#"
'&*+#
*"
C)(8
<"B*':&'()*+-
?G02-
*"
H[G-
'+3
)+
='()#+(,
C)(8
'3@'+<#3
:)&)'"B
("'<(
<'"<)+*9'
\]?0^-
#)(8#"
'&*+#*"C)(8
<"B*':&'()*+-
*"
H[G>
0*8*"(,G_
'+3
G`
C)&&
#+"*&&
='()#+(,
C)(8
'3@'+<#3
100-
]0a0
,('$#
]b0
'+3
<*8*"(
]
C)&&
#+"*&&='()#+(,
C)(8
)+("'b#I("'J8#='()<
<8*&'+$)*<'"<)+*9'>
0*8*"(
G_
C)&&
8'@#
_
("#'(9#+(
G"9_\*+#
C)(8*%(
'+B
':&'()@#
="*<#3%"#^
'+3
0*8*"(
G`
C)&&
8'@#
c
,#='"'(#
("#'(9#+(
'"9,
*A_d='()#+(,
'=)#<#
\*+#
'
=)#<#
C)(8
?G02-
H[G-
*"
<"B*':&'()*+^>
0*8*"(
]
C)&&
8'@#
c
,#='"'(#("#'(9#+(
'"9,
*A
_d
='()#+(,
'=)#<#
\*+#
C)(8*%(
'+B
':&'()@#
="*<#3%"#-
*+#
C)(8
H[G-'+3*+#
C)(8
<"B*':&'()*+^>
?8#
)+)()'&
_d
='()#+(,
)+
<*8*"(,
G_
'+3
]-
(8#
("#'(9#+(
'"9,
C)(8*%(':&'()@#
="*<#3%"#-
9%,(
8'@#
,'(),A'<(*"B
,'A#(B
'+3
A#',):)&)(B
*%(<*9#,
)+
*"3#"
(*
=#"9)((8#
("#'(9#+(
'"9,
C)(8
':&'()*+
(*
*=#+>
?8),
C)&&
&)e#&B
9#'+
(8'(
!
*"
9*"#
*A
_d
'"#
':&#(*"#,%&(
)+
<*9=&#(#
("#'(9#+(
A*"
(8#
='()#+(,>
[*"
(8),
=)&*(-
(8#
',,)$+9#+(
(*
,=#<)A)<
9#(8*3*A
':&'()*+
C)&&
:#
3*+#
:B
(8#
9%&()3),<)=&)+'"B
(%9*"
:*'"3
'+3
(8%,
C)&&
+*(
:#
3*+#
"'+3*9&B>
G,
,%<8-
(8#
"#,%&(,
9%,(
:#
("#'(#3
',
="#&)9)+'"B
'+3
#I=&*"'(*"B-
"#L%)")+$
)+3#=#+3#+(
<*+A)"9'()*+
*A
'+B
=*(#+()'&&B
=*,)()@#
A)+3)+$,>
G,#'<8*A
(8#,#
!
("#'(9#+(
'"9,
*A
_d
='()#+(,
C)&&
:#
<*+,)3#"#3
'
,9'&&
=)&*(-
#'<8
C)&&
8'@#
,'9#,('(),()<'&
*:;#<()@#-
'+3
#'<8
*A
(8#,#
'"9,
C)&&
:#
#@'&%'(#3
A*"
#AA)<'<B
',
A*&&*C,>
[*"
:*(8100
'+3
]?0
(8#"#
),
+*
,('+3'"3
,#<*+3J&)+#
(8#"'=B
)+
(8#
'3@'+<#3
,#(()+$>
]',#3
*+
8),(*")<'&3'('
*A
)+@#,()$'()*+'&
'$#+(,
A*"
:*(8
(8#,#
3),#',#,
'+3
,('$#
\)>#>
=*,(J,*"'A#+):
100'+3=*,(J$#9b<),
]?0^
(8#
 J9*+(8
6[4
C*%&3
:#
+*(
$"#'(#"
(8'+
_dJ_fghi`-
icj>
/+
#'<8("#'(9#+(
'"9
*A
_d
='()#+(,
)+
<*8*"(,
G_-
G`
'+3
]-
(8#
(")'&
C)&&
8'@#
k`g
=*C#"
(*
"%&#
*%(_fg',
(8#
="*=*"()*+
,(':&#
'(
 
9*+(8
)+
A'@*"
*A
fdg
:#)+$
,(':&#
'(
 
9*+(8,-
C)(8
#'<8
#@'&%'()*+
',,%9)+$
(8'(
'
*+#J,)3#3
d>_d
,)$+)A)<'+<#
&#@#&
#I'<(
:)+*9)'&
(#,(
C*%&3
:#
=#"A*"9#3>
/A
(8#"#
'"#
c
='()#+(,
)+
_d
C8*
'"#
':&#
(*
8'@#
,(':&#
3),#',#
'(
'
 
9*+(8
#@'&%'()*+-(8#+(8#&*C#"*+#J,)3#3ldg <*+A)3#+<#:*%+3A*"cb_d),__> g \(8#(C*,)3#3
kdg <*+A)3#+<#)+(#"@'&#I(#+3,A"*9 __> g (*ff>`g^>4)9)&'"&B-C)(8i)+_dC)(8,(':&#
3),#',#'( 9*+(8,-(8#&*C#"*+#J,)3#3ldg<*+A)3#+<#:*%+3A*"ib_d),_k>kg\(8#(C*,)3#3











 !
!"# %&'()*+'%+
)',+-./0
+1,+'*2
(-&3
4!5!#
,&
 65 #75
89:2;
)'
<&9&-,2
=4;
=>
&-
?;
@
&-
6
A/,)+',2&:,
&(
4"
/,,/)')'B
2,/C0+
*)2+/2+
/,
 
3&',92
)'
/'D
&(
,9+
E
,-+/,3+',
/-32
F&:0*
,+',/,).+0D
-:0+
&:,
4"G4H#
/2
,9+
(-/%,)&'
F9&
F&:0*
*&
2&;
F),9
I"#
&'+
2)*+*
%&'()*+'%+5
89+-+2:0,2
(-&3
,9+
/C0/,)&'
,-+/,3+',
/-32
&(
%&9&-,
=>
J:2)'B
8=<K;
LM=;
&-
%-D&/C0/,)&'7
3/D/02&9/.+
,9+)-
-+2:0,2
%&3C)'+*
)'
/'
+1A0&-/,&-D
(/29)&'
,&
-+A&-,
,9+)-
&.+-/00
+(()%/%D5

N)3)0/-0D;,9+
-+2:0,2
(-&3
,9+
/C0/,)&'
,-+/,3+',
/-32
&(
%&9&-,
?
J:2)'B
LM=
&-
%-D&/C0/,)&'7
3/D/02&9/.+
,9+)-
-+2:0,2
%&3C)'+*
)'
/'
+1A0&-/,&-D
(/29)&'
,&
-+A&-,
,9+)-
&.+-/00
+(()%/%D5
N9&:0*A&2),).+
()'*)'B2
C+
)*+',)()+*
)'
/'D
&(
,9+
,-+/,3+',
/-3
&(
%&9&-,2
=4;
=>
&-
%&9&-,
?;
,9+'/(,+-,9)2
A)0&,
A9/2+
9/2
C++'
%&'%0:*+*;
2:C2+O:+',;
3&-+
*+()'),).+
+./0:/,)&'
3/D
C+
%&'*:%,+*
)'
,9+
/AA-&A-)/,+
2:CG%&9&-,2
:2)'B
0/-B+-
':3C+-2
&(
A/,)+',2;
/2
*+()'+*
CD
/3+'*3+',2
J&-
2+A/-/,+
A-&,&%&02
)(
F/--/',+*7
:2+*
,&
*+2%-)C+
,9+
+1A/'2)&'
%&9&-,25
P,)2+1A+%,+*
,9/,
:A
,&
>
A/,)+',2
A+-
3&',9
3/D
C+
/C0+
,&
+'-&00
&',&
,9)2
,-)/05
<&9&-,
=4
F)00
-+O:)-+4"
+./0:/C0+
A/,)+',2;
<&9&-,
=>
3/D
-+O:)-+
:A
,&
@"
+./0:/C0+
A/,)+',2
/'*
%&9&-,
?
3/D-+O:)-+
:A
,&
@"
+./0:/C0+
A/,)+',25
89+
/%%-:/0
%+)0)'B
(&-
,9+
A-&,&%&0
F)00
C+
2+,
/,
I"
A/,)+',2,&
/00&F
(&-
/
23/00
':3C+-
&(
)'+./0:/C0+
A/,)+',2
,&
C+
+'-&00+*5
89:2;
),
)2
+1A+%,+*
,9/,>6G@ 
3&',92
3/D
C+
'++*+*
,&
/%%-:+
/00
A/,)+',2
&',&
,9)2
,-)/05
8&/**-+22
2/(+,D
/'*
(+/2)C)0),D
&(
%&3C)')'B
,-+3+0)3:3/C
/'*
*:-./0:3/C
)'
J<&9&-,2
=4
/'*=>7A/,)+',2
F),9
/*./'%+*
Q<<
J+),9+-
/0&'+
&-
F),9
%-D&/C0/,)&';
8=<K
&-
LM=7
/'*
J<&9&-,?7
)'
A/,)+',2
F),9
/*./'%+*
C)0)/-D
,-/%,
%/-%)'&3/
J?8<7
J+),9+-
/0&'+
&-
F),9
%-D&/C0/,)&'
&-
LM=7;
/*.+-2+
+.+',2
F)00
C+
,/C:0/,+*
CD
B-/*+
A+-
<8<=K
6
/'*
/'/0DR+*
/'*
-+A&-,+**+2%-)A,).+0D5
SS TUVVWXUYWZ[\]
W_Y]]`]aZb
SScS TUUd]YWZ[\]
Y]b]WYTe
Waf
f]\]VUd`]aZ
W_Y]]`]aZ
gTYWfWh
=<L=i=
)2
)'
A0/%+
F),9
j+*P33:'+;
P'%5
J">!H@7
(&-
2:AA0D
&(
,9+
)'.+2,)B/,)&'/0
/B+',25
SScl `WZ]Y[WV
ZYWabm]Y
W_Y]]`]aZb
g`ZWh
j8= n@!@E G46
F),9
Q/''&.+-
j+*)%/0
N%9&&0
)2
)'
A0/%+
(&-
,9+
,-/'2(+-
&(
2/3A0+2
,&
%&00/C&-/,&-2
/2
*+2%-)C+*
)'
2+%,)&'
oclcp5
Sl eq`Wa
bqXr]TZb
dYUZ]TZ[Uab
SlcS ]Ze[TWV
TUafqTZ
Um
Ze]
bZqfs
89+2,:*D
F)00
C+
A+-(&-3+*
)'
/%%&-*/'%+
F),9
+,9)%/0
A-)'%)A0+2
,9/,
9/.+
,9+)-
&-)B)'
)'
,9+
i+%0/-/,)&'
&(
Q+02)'t)
/'*
/-+
%&'2)2,+',
F),9
P<Quv&&*
<0)')%/0
w-/%,)%+;
/'*
/AA0)%/C0+
-+B:0/,&-D
-+O:)-+3+',2
N:Cx+%,
*/,/
A-&,+%,)&'
Slcl YWZ[UaWV]
mUY
bqXr]TZ
b]V]TZ[Ua
N:Cx+%,2,-+/,+*
&'
,9)2
2,:*D;
F)00
C+
)'*).)*:/02
F),9
/*./'%+*
9+A/,&%+00:0/-
%/-%)'&3/
JQ<<7&-C)0)/-D
,-/%,
%/-%)'&3/;
F9)%9
9/2
-+%:--+*
J&-
A+-2)2,+*7
/(,+-
/AA-&A-)/,+
2,/'*/-*
,-+/,3+',5
P'*).)*:/02
&(
/'D
-/%+
&-
+,9')%
B-&:A
F)00
C+
+0)B)C0+
(&-
,9)2
2,:*D5
K0)B)C)0),D
/22+223+',
F)00
C+
C/2+*
2&0+0D
&'
,9+
A/,)+',y2
3+*)%/0
2,/,:25
L+%-:),3+',
&(
A/,)+',2
&',&
,9)2
2,:*DF)00C+,9-&:B92,/'*/-*<<L 3+%9/')2325z&2A+%)/0-+%-:),3+',+((&-,2F)00C+
%&'*:%,+*5











 !
"#$% &'()*+*&')*,-
,/
+0*12(3-
45678769:;<
956>?
@A>
:B>
CD
EF
G7;;
5C@
H>
>;7B7H;>
@C
I:?@7J7I:@>
75
@A7<
<@96K
H>J:9<>
@A>K
:?>
95;7L>;K@C
A:8>
A>I:@CJ>;;9;:?
C?
H7;7:?K
@?:J@
J:?J75CM:N
:56
H>J:9<>
CD
95L5CG5
@CO7J7@7><
75
I>67:@?7JI:@7>5@<P
"#$Q &'()*+*&')*,-
,/
RSTU3+)R
S-'T13
),
V*W3
+,-R3-)
X69;@<95:H;>
@C
B78>
JC5<>5@
:?>
>OJ;96>6
D?CM
>5?C;;75B
75
@A>
I?C@CJC;P
YCG>8>?
?>ZJC5<>5@
M:KH>5>J><<:?K
:56
@A>?>
7<
:
IC<<7H7;7@KN
@AC9BA
95;7L>;KN
@A:@
<9H[>J@<
JC9;6
H>JCM>
6>J7<7C5:;;K
7MI:7?>6P
\C?
@A7<
?>:<C5
:56
H>J:9<>
@A>?>
7<
:
I?C<I>J@
CD
67?>J@
H>5>D7@
D?CM
?><>:?JAI:?@7J7I:@7C5
]<>J@7C5
"#$^$%_N
:;;
<9H[>J@<
G7;;
H>
CDD>?>6
@A>
CIIC?@957@K
@C
D7;;
75
@A>7?
G7<A><DC?
?><>:?JA
:56
J:?>N
:56
:<<7B5
:
<9H<@7@9@>
6>J7<7C5
M:L>?
C5
@A>
`a4Y
X68:5J>
b7?>J@78>DC?
Y>:;@A
c:?>
:56
d>67J:;
e><>:?JA
f:?@7J7I:@7C5g
DC?M
<C
@A:@
:5C@A>?
I>?<C5
J:5
M:L>6>J7<7C5<
:HC9@
@A>7?
M>67J:;
J:?>
75
@A>
>8>5@
@A:@
@A>K
H>JCM>
75J:I:J7@:@>6
C?
JCB57@78>;K
7MI:7?>6
69?75B
@A>
JC9?<>
CD
@A>
<@96KP
aC@>h
iA>
f4
C?
X4
G7;;
JC5@:J@
@A>
a4Y
XH7;7@K@CcC5<>5@
X<<><<M>5@
i>:M
]XcXi_
DC?
>8:;9:@7C5
@C
:<<><<
C5BC75B
J:I:J7@K
CD
@A>
<9H[>J@<:56
@C
76>5@7DK
:
jXeN
:<
5>>6>6P
f;>:<><>>
<>J@7C5
"#$k$"
DC?
JC5<>5@
I?CJ>69?>P
"#$^ 3W'1S')*,-
,/
T3-3/*)R
'-2
(*RlRm2*R+,n/,()R
/,(
'11
&'()*+*&'-)R
EoPpPEq5CG5
IC@>5@7:;
?7<L<
iA>I?7M:?K
?7<L
@C
I:@7>5@<
I:?@7J7I:@75B
75
@A7<
?><>:?JA
<@96K
7<
D?CM
@A>
@CO7J7@K
CD
69?8:;9M:H
:56
@?>M>;7M9M:HP
EoPpPEPEb9?8:;9M:Hh
dC?>@A:5
Ers
I:?@7J7I:5@<
M:K
A:8>h
t b7:??A>:N
t e:<Au6?K
7@JAK
<L75N
t j78>?
I?CH;>M<h
45J?>:<><
75
;78>?
>5vKM><N
75D;:MM:@7C5
CD
@A>
;78>?
]A>I:@7@7<_w
ACG>8>?N
@A7<
7<
95JCMMC5P
t \:@7B9>
t a:9<>:
t xCM7@75B
t XH6CM75:;
I:75
t XJJ9M9;:@7C5
CD
D;976
J:9<75B
<G>;;75B
t yII>?
?><I7?:@C?K
@?:J@
75D>J@7C5<
t b>J?>:<>6
:II>@7@>
t zAC?@5><<CDH?>:@A
t cC9BA











 !
" #$%$&
#&'(*+'*!,
-.&+/0/-.1+2
(.3
4.%$5
" 6178.((.+/'1
/1
+4$
891:2
;-1$9('1/+/2<=
>&$8/(/1.&3
?.+.
29::$2+$?
+4.+
+4$&$
(.3
@$
+4$
+$1?$103
'7
4/:4$&
7&$A9$103
.1?
2$%$&/+3
/1
B.-.1$2$
-.+/$1+2
0'(-.&$?
C/+4
1'1D
B.-.1$2$
-.+/$1+2=
" E'C
+43&'/?
;F3-'+43&'/?/2(<=
G4$
0'1?/+/'1
0.1
@$
+&$.+$?
C/+4
&$-8.0$($1+
+43&'/?
4'&('1$=
" F/:4
+43&'/?
;F3-$&+43&'/?/2(<=
H$-$1?/1:
'1
+4$
2$%$&/+3
'7
+4$
23(-+'(2I
+&$.+($1+
(.3
/1089?$
J92+
('1/+'&/1:
+4$
23(-+'(2I
+&$.+/1:
+4$
23(-+'(2
+4$(2$8%$2
.1?K'&
:/%/1:
($?/0/1$
+'
@8'0L
+4$
+43&'/?
4'&('1$=
" M/?1$3
-&'@8$(25
.1
/10&$.2$
'7
0&$.+/1/1$
8$%$82
/1
.
@8''?
+$2+=
N10'(('183
.
-.+/$1+
(.3
$O-$&/$10$
1$-4&/+/2
C4/04
/2
.1
/178.((.+/'1
'7
+4$
L/?1$32
+4.+
2+'-2
+4$
L/?1$32
7&'(
C'&L/1:
-&'-$&83=
" P$&%'92
232+$(
-&'@8$(25
23(-+'(2
0.1
/1089?$
91929.8
C$.L1$22
'7
8$:2I
.&(2I
'&
7.0$I
19(@1$22
'&
+/1:8/1:
/1
4.1?2
'&
7$$+=
61
&.&$
2/+9.+/'12
+4$&$
/2
+4$
-'+$1+/.8
7'&
+4$
/178.((.+/'1
'7
+4$
1$&%'92
232+$(
+'
@$
2$%$&$
.1?
0.92$
?.(.:$
+'
+4$
1$&%$
0$882
'&
@&$.L?'C1
/1
+4$
0'((91/0.+/'1
@$+C$$1
1$&%$2
.1?
(9208$2=
" 61792/'1
Q$8.+$?
Q$.0+/'12=
" 6178.((.+/'1
'7
+4$
/1+$2+/1$
;0'8/+/2<=
" R4'.&2$
%'/0$
" >./1798
9&/1.+/'1
" P/:4+
2C$.+2
" >1$9('1/.
" S&.8
+4&924
" H$1+.8
.1?
'&.8
2'7+
+/229$
/17$0+/'1
" >./1
/1
(9208$2
.1?
J'/1+2
" 61789$1T.=
E$22+4.1*,
-$'-8$
(.3
4.%$5
" 6178.((.+/'1
'7
+4$
-.10&$.2
;-.10&$.+/+/2<=
" R88$&:/0
&$.0+/'12=
" >&'@8$(2
C/+4
.?&$1.8
:8.1?2
;R?&$1.8
612977/0/$103<=
G4$2$
0'(-8/0.+/'12
(.3
@$
-$&(.1$1+
.1?
(.3
&$A9/&$
4'&('1$
&$-8.0$($1+=
" >&'@8$(2
C/+4
+4$
-/+9/+.&3
:8.1?
;43-'-/+9/+.&/2(<=
G4$2$
0'(-8/0.+/'12
(.3
@$
-$&(.1$1+.1?(.3&$A9/&$4'&('1$&$-8.0$($1+=
" 6178.((.+/'1'7+4$(9208$2'&.22'0/.+$?+/229$2I2904.2@8''?%$22$82+4.+29--83+4$











 !
"#$%&'$
)*+,$-.-$/0,&+"+,$-.-$12
3 4+0'
!
5-67'.'$
"'&&-.#$2
4+0'
!
8-67'.'$
9-&&
:';#-:'
:'0&6%'"'<.
,=
-<$#&-<
.>:,#?>
-<@'%.-,<2
3 A:,7&'"$
9-.>
.>'
0-.#-.6:+
?&6<8
)>+0,0-.#-.6:-$"12
4>'$'
%,"0&-%6.-,<$
"6+
7'
0':"6<'<.
6<8
"6+
:';#-:'
>,:",<'
:'0&6%'"'<.2
3 B<=&6""6.-,<
,=
.>'
>'6:.
"#$%&'
)"+,%6:8-.-$12
3 B<=&6""6.-,<
,=
.>'
"'"7:6<'
$#::,#<8-<?
.>'
>'6:.2
3 C:,9.>$
,=
.-<+
%,&&'%.-,<$
,=
-<=&6""6.,:+
%'&&$
-<
8-==':'<.
06:.$
,=
.>'
7,8+2
3 B<=&6""6.-,<
,=
.>'
"-88&'
&6+':
,=
.>'
'+'
6<8
,.>':
'D'<.$
-<D,&D-<?
.>'
'+'
)'2?2
-<=&6""6.-,<
,=
.>'
%,:<'6
6<8
,0.-%
<':D'$12
3 B<=&6""6.-,<
,=
.>'
7:6-<
,:
.>'
"'"7:6<'$
.>6.
%,D':
.>'
7:6-<
6<8
$0-<6&
%,:82
3 E6:8'<-<?
6<8
.-?>.'<-<?
,=
.>'
$F-<
6<8
%,<<'%.-D'
.-$$#'$
6<8
&,$$
,=
$F-<
%,&,:2
3 A'"0>-?,-8
6<8
>'"6.,&,?-%6&
'D'<.$
)'2?2G
67<,:"6&
7:'6F8,9<
,=
.>'
:'8
7&,,8
%'&&$
6<8
&,9
&'D'&$
,=
0&6.'&'.$12
3 B<=&6""6.-,<
,=
.>'
7&,,8
D'$$'&$
6<8
:>'#"6.,&,?-%6&
'D'<.$
)-<=&6""6.,:+
8-$,:8':
%6#$-<?
"#$%&'
06-<
6<8
$.-==<'$$
6<8
6#.,-""#<'
6:.>:-.-$12
!H2I2!2H4:'"'&-"#"67
4>'=,&&,9-<?
6:'
$-8'
'=='%.$
.>6.
>6D'
7''<
6$$,%-6.'8
9-.>
4:'"'&-"#"67J
3 5-6::>'6
3 K6$>
3 A:#:-.#$
)-.%>-<?1
3 L6.-?#'
3 M6#$'6
3 N,"-.-<?
3 O<,:'P-6
3 E'686%>'
3 O78,"-<6&
A6-<
3 *#$%&'
06-<
3 O#.,Q-""#<'
%>6<?'$
.,
.>'
0-.#-.6:+
?&6<8
&'68-<?
.,
>,:",<6&
%>6<?'$2
3 B<=&6""6.-,<
,=
.>'
06:.
,=
.>'
-<.'$.-<'
)%,&-.-$12
3 B<=&6""6.-,<
-<
.>'
&#<?$
)0<'#",<-.-$12
3 R-8<'+0:,7&'"$J6<-<%:'6$',=%:'6.-<-<'&'D'&$-<67&,,8.'$.2











 !
" #$%&'((')*+$
+%
)-.
/'$01.'2
3/'$01.')*)*245
" #$%&'((')*+$
+%
)-.
&*6.1
3-./')*)*245
#$
.7)1.(.
0'2.2
)-*2
('8
1.29&)
*$
&*6.1
%'*&91.
'$:
:.')-5
" ;2<*$
1'2-
1.&').:
)+
)-.
)1.')(.$)
'$:
)-*2
0'$
'&2+
1.29&)
*$
2.6.1.
'$:
&*%.=)-1.').$*$>
28(/)+(25
" ?1+@&.(2
1.&').:
)+
)1.(.&*(9('@
*$%92*+$
" ;2.1*+92
'&&.1>*0
1.'0)*+$
3'$'/-8&'7*24
A-.1.*2'
1.(+).
0-'$0.
)-')
/'1)*0*/'$)2
('8
:.6.&+/
$.B
'&&.1>*.2
)+
/1.6*+92&8
.7/+2.:
29@2)'$0.2C
+)-.1
)-'$
:916'&9('@
+1
)1.(.&*(9('@5
D+1
.7'(/&.C
*)
*2
/+22*@&.
)-')
/.+/&.
0+9&::.6.&+/
'$
'&&.1>8
)+
2-.&&%*2-
+1
#E
0+$)1'2)
B-*&.
)'<*$>
:916'&9('@
+1
)1.(.&*(9('@5
A-.2.'&&.1>*.2
('8
@.
2.6.1.
'$:
&*%.
)-1.').$*$>5
;&&0'1.B*&&
@.
)'<.$
)+
(*$*(*F.
2)9:8
)1.')(.$)
2*:.
.%%.0)2C
@9)
)-.8
0'$
@.
9$/1.:*0)'@&.
*$
$')91.'$:
2.6.1*)85
?')*.$)2
B*&&
@.
.7'(*$.:
'$:
.6'&9').:
/1*+1
)+
.$1+&&(.$)5
;&&
.6'&9')*+$2
)+(+$*)+1
)-.
)1.')(.$)
+%
/')*.$)2
B*&&
@.
1.0+1:.:
*$
)-.
/')*.$)
0-'1)5
G!5H5G5IJ*2<2
+%
JD;
K9@L.0)2*$
;1(
I
'::*)*+$'&&8
B*&&
-'6.
+$.
/1+)+0+&
1.M9*1.:
JD;
/1+0.:91.5
A-.
1*2<2
%1+(
JD;*$0&9:.
@&..:*$>C
*$L918
)+
)-.
$+1('&
&*6.1
)*229.C
1.=>1+B)-
+%
)-.
)9(+1
'$:
*$%.0)*+$5
G!5H5G5NJ*2<2
+%
018+'@&')*+$
K9@L.0)2*$
;1(
N
'::*)*+$'&&8
B*&&
-'6.
+$.
/1+)+0+&
1.M9*1.:
O18+
/1+0.:91.5
A-.
1*2<2
%1+(
018+'@&')*+$
/1+0.:91.
*$0&9:.
@&..:*$>C
*$L918
)+
)-.
$+1('&
&*6.1
)*229.C
1.=>1+B)-
+%
)-.
)9(+1
'$:$.16.:'('>.5
G!5H5G5HJ*2<
+%
+/)*+$'&
@*+/28
;&&0'1.B*&&
@.
)'<.$
)+
(*$*(*F.
1*2<2
)-')
('8
@.
*$0911.:
@8
)9(+1
2'(/&*$>5
P+B.6.1C
)-.1.
'1./1+0.:91.=1.&').:
1*2<2
3290-
'2
@&..:*$>C
*$%.0)*+$
'$:
6*20.1'&
*$L9184
)-')
B*&&
@.
.7/&'*$.:
%9&&8:91*$>
*$%+1(.:
0+$2.$)5
G!5H5G5QJ*2<2
+%
2.:')*+$
?+).$)*'&2*:.
.%%.0)2
+%
2.:')*+$
*$0&9:.
-.':'0-.C
$'92.'
'$:
:1+B2*$.225
A-.2.
2*:.
.%%.0)2
929'&&8>+
'B'8
M9*0<&85
G!5H5G5 J*2<2
+%
>.$.1'&
'$.2)-.2*'
J*2<2+%>.$.1'&
'$.2)-.2*'
*$0&9:.
).(/+1'18
0+$%92*+$
'$:
(.(+18
&+22C
'&)-+9>-
)-*2
*2
(+1.
0+((+$*$
)-.
.&:.1&8C
:*FF*$.22C
:*%%*09&)8
/'22*$>
91*$.C
@19*2*$>
+1
2+1.$.22
%1+(
)-.
#E
:1*/C
$'92.''$:
6+(*)*$>C
2-*6.1*$>
'$:
%..&*$>
0+&:C
2+1.
)-1+')
:9.
)+
)-.
@1.')-*$>
)9@.
G!5H5G5RJ*2<2
+%
.7/+291.
)+
*+$*F*$>
1':*')*+$
A-.2)9:8B*&&
*$6+&6.
1':*')*+$
%1+(
)-.
%+&&+B*$>
2+910.2S
" T/
)+
Q
OA
20'$2
/.1
8.'1
%+1
:*2.'2.
'22.22(.$)
3'&&
29@L.0)24
" T/)+IOA20'$2%+1)-.0+&&.0)*+$+%+$.('$:')+18'$:!+/)*+$'&@*+/2*.23;1(;G
+$&84











 !
" #$%
'()*
+,-.%/0,%
1(,2
(3
-$456
" 7+
8-
9
)'
:.;$
8-
<0=/%
>?(
" 7+
8-
9
)'
:.;$
8-
<0=/%
.,5-
@0AB%.8:=$
(,2
9
2;5
C;D%
0+
8-
E
)'
:.;$:
;$/
!
)'
<0=/%/
A=-+:=%:
;$/
A%
%F+-:%/
8-
;++,-F=2;8%45
G
,%2
+%,
5%;,H
'C=:
;2-0$8
=:
2-,%
8C;$
I-04/
A%
%F+%.8%/
J,-2
%D%,5/;5
A;.K<,-0$/
,;/=;8=-$H
L%=$<
%F+-:%/
8-
%F.%::
,;/=;8=-$
.;$
=$.,%;:%
8C%
,=:K
-J
.;$.%,H
'C%
,=:K
-J<%88=$<.;$.%,
J,-2
8C%
,;/=;8=-$
%F+-:0,%
=$
8C=:
:80/5
=:
MHG
-08
-J
9MM
1MHGN6
;$/
-J
<%88=$<
;J;8;4.;$.%,
=:
MHO
-08
-J
9MM
1MHON6H
@0AB%.8:=$
(,2
3
2;5
C;D%
0+
8-
E
)'
:.;$:P
3
)'
<0=/%/
A=-+:=%:
;$/
-$%
+,-8-.-4
,%Q0=,%/
'()*+,-.%/0,%H
'C%
;.80;4
/-:%
-J
;
'()*
=:
C=<C45
D;,=;A4%P
/%+%$/=$<
-$
8C%
+;8=%$8H
L;:%/
-$4=8%,;80,%
,%D=%I:
-$%
;D%,;<%
'()*
=:
;A-08
R
,%2H
@-P
:0AB%.8:
=$
(,2
3
2;5
A%
%F+-:%/
8-
8-8;4;2-0$8
-J
,;/=;8=-$
9EH3
,%2H
'C=:
;2-0$8
=:
2-,%
8C;$
I-04/
A%
%F+%.8%/
J,-2
%D%,5/;5
A;.K<,-0$/
,;/=;8=-$H
L%=$<
%F+-:%/
8-
%F.%::
,;/=;8=-$
.;$
=$.,%;:%
8C%
,=:K
-J
.;$.%,H
'C%
,=:K
-J<%88=$<.;$.%,
J,-2
8C%
,;/=;8=-$
%F+-:0,%
=$
8C=:
:80/5
J-,
+;,8=.=+;$8:
=$
(,2
3
=:
9HE
-08
-J
9MM19HEN6
;$/
-J
<%88=$<
;
J;8;4
.;$.%,
=:
MHR
-08
-J
9MM
1MHRN6H
@0AB%.8:=$
(,2
!
;$/
S
2;5
C;D%
0+
8-
E
)'
:.;$:P
3
)'
<0=/%/
A=-+:=%:P
9
)'
<0=/%/
>?(
-,
.,5-;$/A%
%F+-:%/
8-
;++,-F=2;8%45
G
,%2
+%,
5%;,H
'C=:
;2-0$8
=:
2-,%
8C;$
I-04/
A%
%F+%.8%/J,-2
%D%,5/;5
A;.K<,-0$/
,;/=;8=-$H
L%=$<
%F+-:%/
8-
%F.%::
,;/=;8=-$
.;$
=$.,%;:%
8C%,=:K-J
.;$.%,H
'C%
,=:K
-J
<%88=$<
.;$.%,
J,-2
8C%
,;/=;8=-$
%F+-:0,%
=$
8C=:
:80/5
=:
MHG
-08
-J9MM1MHGN6
;$/
-J
<%88=$<
;
J;8;4
.;$.%,
=:
MHO
-08
-J
9MM
1MHON6H
93HOH9HG>=:K:
-J
)'
@.;$:
T$;//=8=-$
8-
8C%
,;/=;8=-$
,=:K:
/=:.0::%/
;A-D%P
)'
:.;$:
2;5
=$.40/%
8C%
,=:K:
-J
;$
;44%,<=.
,%;.8=-$8-
8C%
.-$8,;:8H
U;,8=.=+;$8:
2=<C8
%F+%,=%$.%
C=D%:P
=8.C=$<P
C%;/;.C%P
/=JJ=.0485
A,%;8C=$<P
=$.,%;:%/
C%;,8,;8%
;$/
:I%44=$<H
93HOH9H9M
>=:K
-J
4-:=$<
/;8;
'C=:=$.40/%:
8C%
,=:K
8C;8
/;8;
-A8;=$%/
/0,=$<
8C=:
:80/5
.;$
A%
,%4%;:%/
8-
2%2A%,:
-J
8C%
+0A4=.P=$:0,%,:P
%2+4-5%,:P
-,
4;I
%$J-,.%2%$8
;<%$.=%:H
(48C-0<C
8C%,%
;,%
$-
+4;$:
8-
,%4%;:%
,%:048:8-8C%
+;8=%$8:P
J;2=45
2%2A%,:
-,
C%;48C
.;,%
+,-D=/%,:P
8C=:
,=:K
I=44
A%
=$.40/%/
=$
8C%
=$J-,2%/.-$:%$8
/-.02%$8H
93HOH9H99
L4--/
)-44%.8=-$
>=:K:
>=:K:-JA4--/
/,;I:
=$.40/%
+;=$
;$/
A,0=:=$<
=$
8C%
;,%;
IC%,%
8C%
$%%/4%
=:
+4;.%/P
4=<C8C%;/%/$%::P
;$/
,;,%45P
J;=$8=$<H
VC%$
4;,<%
;2-0$8:
-J
A4--/
;,%
.-44%.8%/P
4-I
,%/
A4--/
.%44.-0$81;$%2=;6
.;$
/%D%4-+H
93HOH9H93
>=:K:
-J
*WX
>=:K:=$.40/%
:-2%
2=$-,
:K=$
=,,=8;8=-$
J,-2
8C%
%4%.8,-/%:
93HOH9H9!
7,=$;45:=:
'C%,%;,%$-
+C5:=.;4
,=:K:
-J
0,=$;45:=:











 !
"#$%$#&'()'
+(,-',./0
1-'-2.,3
45-+(,-',./0
1-'-2.,
,(
/
+/,.-',
,5/,
6(-3
(',(
3,789
.3
/
:-87;,.('
.'
,5-
170<
(2
,5-.:
,7=(:
)5.;5=/9
(:
=/9
'(,
5/>-
2/>(:/10-
.=+/;,
('
39=+,(=3
/'8?(:
37:>.>/0$$
"#$%$@A.3<3?B-'-2.,3
C'/093.3
D(:+/,.-',3
).,5
5-+/,(;-0070/:
;/:;.'(=/
/'8
1.0./:9
;/';-:E
=-8./'
37:>.>/0
.3
.'
,5-
:/'6-
(2
F=(',53$
G,
.3
+(33.10-
,5/,
,:-/,=-',
('
,5.3
+:(,(;(0
=/9
:-87;-
,7=(:
17:8-'
(:
0-33-'
39=+,(=3
;/73-8
19
,5-
;/';-:$
H5.0-
,:-/,=-',
('
,5.3
+:(,(;(0
=/9
'(,
.'8.>.87/009
1-'-2.,
371I-;,3E,5-
<'()0-86-
6/.'-8
2:(=
,5.3
3,789
=/9
5-0+
(,5-:3
.'
,5-
27,7:-
)5(
5/>-
5-+/,(;-0070/:
;/:;.'(=/$

J(,-',./0
:.3<3
.';078-
,5-
+(33.10-
(;;7::-';-
(2
/'9
(2
/
:/'6-
(2
3.8--22-;,3
0.3,-8$
G2
+/,.-',3
3722-:
/'9
+593.;/0
.'I7:9
/3
/
:-370,
(2
,5-
1.(+3.-3E
.==-8./,-
=-8.;/0,:-/,=-',
.3
/>/.0/10-
/,
,5-
KGLM3
N0.'.;/0
N-',-:
.'
B-,5-38/E
O/:90/'8$
C0,5(765
'(
;(=+-'3/,.('
.3
/>/.0/10-E
/'9
.'I7:9
).00
1-
27009
->/07/,-8
/'8
,:-/,-8
.'
<--+.'6
).,5
,5-
1-'-2.,3(:
;/:-
,(
)5.;5
+/,.-',3
/:-
-',.,0-8
7'8-:
/++0.;/10-
:-670/,.('3$
45-:.3<3/'8
1-'-2.,3
(2
+/:,.;.+/,.('
2(:
/870,3
)5(
1-;(=-
7'/10-
,(
;('3-',E
/:-
'(
8.22-:-',
,5/',5(3-
8-3;:.1-8
2(:
+/,.-',3
)5(
/:-
0-33
>70'-:/10-$
PQRS TUVWXVY
[\UTXWW
]V^
^UT_`XVY]YaUV
45-.'2(:=-8
;('3-',
8(;7=-',
).00
1-
+:(>.8-8
,(
,5-
+/:,.;.+/',
(:
;('3-',
8-3.6'--b3c
b-$6$E
0-6/009/7,5(:.d-8
:-+:-3-',/,.>-
efCAg
2(:
:-;('3-',
+7:+(3-3
.2
+/:,.;.+/',
.3
/'
/870,
7'/10-
,(
;('3-',c2(:
:->.-)
+:.(:
,(
;('3-',.'6$
C
8-3.6'/,-8
3,789
.'>-3,.6/,(:
).00
;/:-27009
-h+0/.'
,5-
+:(;-87:-3
/'8
,-3,3
.'>(0>-8
.'
,5.3
3,789E
/'8
,5-
/33(;./,-8
:.3<3E
8.3;(=2(:,3
/'8
1-'-2.,3$
G'
(:8-:,(=.'.=.d-
+(,-',./0
;(-:;.('E
/3
=7;5
,.=-
/3
.3
'--8-8
,(
:->.-)
,5-
8(;7=-',
).00
1-
6.>-'E.';078.'6
/'
(++(:,7'.,9
,(
8.3;733
.,
).,5
2:.-'83E
2/=.09
=-=1-:3
/'8?(:
(,5-:
/8>.3(:3E
/'8,(/3<
i7-3,.('3
(2
/'9
8-3.6'/,-8
3,789
.'>-3,.6/,(:$
C
3.6'-8
.'2(:=-8
;('3-',
8(;7=-',
).001-(1,/.'-8
+:.(:
,(
-',:9
(',(
,5-
3,789$
45-.'.,./0
;('3-',
+:(;-33
/3
)-00
/3
:-j;('3-',E
)5-'
:-i7.:-8E
=/9
,/<-
+0/;-
.'
+-:3('
(:
:-=(,-09b-$6$E
>./
,-0-+5('-
(:
(,5-:
KGL
/++:(>-8
:-=(,-
+0/,2(:=3
73-8
.'
;(=+0./';-
).,5
0(;/0+(0.;9E
.';078.'6
O#kj"c
+-:
8.3;:-,.('
(2
,5-
8-3.6'/,-8
3,789
.'>-3,.6/,(:
/'8
).,5
,5-
/6:--=-',
(2
,5-
+/:,.;.+/',?;('3-',
8-3.6'--b3c$
H5-,5-:
.'
+-:3('
(:
:-=(,-E
,5-
+:.>/;9
(2
,5-
371I-;,).00
1-
=/.',/.'-8$
N('3-',.'6
.'>-3,.6/,(:3
b/'8
+/:,.;.+/',?;('3-',
8-3.6'--b3cE
)5-'
.'+-:3('c
).00
1-
0(;/,-8
.'
/
+:.>/,-
/:-/
b-$6$E
;0.'.;
;('370,
:((=c$
H5-'
;('3-',
.3
;('87;,-8
:-=(,-09E,5-
+/:,.;.+/',
).00
1-
.'2(:=-8
(2
,5-
+:.>/,-
'/,7:-
(2
,5-
8.3;733.('
/'8
).00
1-
-';(7:/6-8
,(
:-0(;/,-
,(
/
=(:-
+:.>/,-
3-,,.'6
.2
'--8-8$
D(:(+,.('/0
1.(+3.-3
2(:
:-3-/:;5
.'
,5-
+:(,(;(0E
,5-
+/,.-',
).00
;('3-',
/,
,5-
,.=-
(2
,5-
+:(;-87:-$
G2
,5-
+/,.-',
:-273-3
,5-
(+,.('/0
1.(+39
/,
,5/,
,.=-E
,5-
:-273/0
).00
1-
8(;7=-',-8
.',5-=-8.;/0
:-;(:8
/'8
.'
,5-
:-3-/:;5
:-;(:8$
"#$F$"N('3-',
J:(;-33
2(:
C870,3
H5(
f/;<
N/+/;.,9
,(
N('3-',
,(
A-3-/:;5
J/:,.;.+/,.('
D(:+/:,.;.+/',3
/88:-33-8
.'
3-;,.('
PQRlE
/'
fCA
).00
1-
.8-',.2.-8
;('3.3,-',
).,5
J(0.;9
!k@
/'8.'2(:=-8
;('3-',
(1,/.'-8
2:(=
,5-
fCAE
/3
8-3;:.1-8
.'
m-;,.('
PQRS$











 !
"# $%&'()*+$,
)./
+0%$)*1+.)(
2+.31/%$)*1+.3
"#4" 3*'/,
/132+.*1.')*1+.
)./
2(+3'$%
56788:;<=
>?=
@A
:A>BCD?D7E=
8;8BAF<A<
CD
BDA>?:;DAE=
:AD>7F?:A<
7G
:6ADA
78
8;GG7H7AF:
DA?8CF?@EA
H?;8AI
JD7::AF
FC:7G7H?:7CFK
<CH;>AF:7FL
:6A
DA?8CF
GCD
8:;<=
8;8BAF87CF
CD
:AD>7F?:7CFK
M7EE
@A
BDCN7<A<
@=
:6A
8;8BAF<7FL
CD
:AD>7F?:7FL
B?D:=
:C
8:;<=
B?D:7H7B?F:8K
?88CH7?:A7FNA8:7L?:CD8K
:6A
OFNA8:7L?:7CF?E
PAM
QD;L
ROPQS
8BCF8CD
?F<
DAL;E?:CD=
?;:6CD7:7A8I
OG:6A8:;<=
78
BDA>?:;DAE=
:AD>7F?:A<
CD
8;8BAF<A<K
:6A
TD7FH7B?E
OFNA8:7L?:CD
RTOS
M7EE
BDC>B:E=
7FGCD>8:;<=
B?D:7H7B?F:8K
:6A
OF8:7:;:7CF?E
UAN7AM
VC?D<
ROUVSK
?F<
8BCF8CD
?F<
M7EE
BDCN7<A
:6ADA?8CFR8S
GCD
:6A
:AD>7F?:7CF
CD
8;8BAF87CFI
W:;<=
B?D:7H7B?F:8
M7EE
@A
HCF:?H:A<K
?8
?BBE7H?@EAK
?F<
@A
7FGCD>A<
CG
H6?FLA8
:C
8:;<=
N787:
8H6A<;EAI
X7DH;>8:?FHA8
:6?:
>?=
M?DD?F:
:AD>7F?:7CF
CD
8;8BAF87CF
7FHE;<AK
@;:
?DA
FC:
E7>7:A<
:CY
Z QA:AD>7F?:7CF
CG
;FA[BAH:A<K
87LF7G7H?F:K
CD
;F?HHAB:?@EA
D78\
:C
B?D:7H7B?F:8
Z QA>CF8:D?:7CF
CG
AGG7H?H=
:6?:
MC;E<
M?DD?F:
8:CBB7FL
Z OF8;GG7H7AF:
HC>BE7?FHA
:C
BDC:CHCE
DA];7DA>AF:8
Z Q?:?
:6?:
?DA
FC:
8;GG7H7AF:E=
HC>BEA:A
?F<^CD
AN?E;?@EA
Z QA:AD>7F?:7CF
:6?:
:6A
BD7>?D=
AF<BC7F:
6?8
@AAF
>A:
Z QA:AD>7F?:7CF
CG
G;:7E7:=
W:;<=>?=
DA8;>A
CFHA
HCFHADF8
?@C;:
8?GA:=K
BDC:CHCE
HC>BE7?FHAK
?F<
<?:?
];?E7:=
?DA
?<<DA88A<K
?F<
8?:78G=
:6A
8BCF8CDK
OUV
?F<
?8
?BBE7H?@EAK
_CC<
?F<
QD;L
`<>7F78:D?:7CF
R_Q`SI
"#4a b')(1*,
)33'$).2%
)./
b')(1*,
2+.*$+(
56AHE7F7H?E
87:A
M7EE
BADGCD>
7F:ADF?E
];?E7:=
>?F?LA>AF:
CG
8:;<=
HCF<;H:K
<?:?
?F<
@7CECL7H?E
8BAH7>AFHCEEAH:7CFK
<CH;>AF:?:7CF
?F<
HC>BEA:7CFI
`F
7F<7N7<;?E7cA<
];?E7:=
>?F?LA>AF:
BE?F
M7EE@A<ANAECBA<
:C
<A8HD7@A
?
87:Ad8
];?E7:=
>?F?LA>AF:I
e;?E7:=HCF:DCE
ReXS
BDCHA<;DA8
M7EE
@A
7>BEA>AF:A<
@AL7FF7FL
M7:6
:6A
<?:?
AF:D=
8=8:A>
?F<
<?:?eXH6AH\8
:6?:
M7EE
@A
D;F
CF
:6A
<?:?@?8A
M7EE
@A
LAFAD?:A<I
`F=
>7887FL
<?:?
CD
<?:?
?FC>?E7A8
M7EE
@A
HC>>;F7H?:A<
:C
:6A
87:AR8S
GCD
HE?D7G7H?:7CF^DA8CE;:7CFI
_CEECM7FL
MD7::AF
W:?F<?D<
fBAD?:7FL
TDCHA<;DA8
RWfT8SK
:6A
>CF7:CD8
M7EE
NAD7G=
:6?:
:6A
HE7F7H?E:D7?E
78
HCF<;H:A<
?F<
<?:?
?DA
LAFAD?:A<
?F<
@7CECL7H?E
8BAH7>AF8
?DA
HCEEAH:A<K
<CH;>AF:A<
RDAHCD<A<SK
?F<
DABCD:A<
7F
HC>BE7?FHA
M7:6
:6A
BDC:CHCEK
OF:ADF?:7CF?E
XCFGADAFHA
CFg?D>CF78?:7CF
hCC<
XE7F7H?E
TD?H:7HA
ROXg
hXTSK
?F<
?BBE7H?@EA
DAL;E?:CD=
DA];7DA>AF:8
RAILIKhCC<
i?@CD?:CD=
TD?H:7HA8
RhiTSK
hCC<
j?F;G?H:;D7FL
TD?H:7HA8
RhjTSSI
56A7FNA8:7L?:7CF?E
87:A
M7EE
BDCN7<A
<7DAH:
?HHA88
:C
?EE
:D7?E
DAE?:A<
87:A8K
8C;DHA
<?:?^<CH;>AF:8K
?F<DABCD:8
GCD
:6A
B;DBC8A
CG
>CF7:CD7FL
?F<
?;<7:7FL
@=
:6A
8BCF8CDK
?F<
7F8BAH:7CF
@=
ECH?E
?F<DAL;E?:CD=
?;:6CD7:7A8I
"#4# 2+.k(12*
+k
1.*%$%3*
0+(12,
56A7F<ABAF<AFHACG:6788:;<=GDC> ?F=?H:;?ECDBADHA7NA<7FGE;AFHAK8;H6?8@=:6A
B6?D>?HA;:7H?E7F<;8:D=K78HD7:7H?EI56ADAGCDAK?F=?H:;?EHCFGE7H:CG7F:ADA8:CGBAD8CF8M6C6?NA











 !
"$%&'()*+'
,'-(.)/
0%),10*/
")"&2-(-/
314&(0"*(%)/
%$
")2
"-3'0*
%5
*+(-
*$("&
6(&&
4'
,(-0&%-',
"),7")".',8
91$*+'$7%$'/
3'$-%)-
6+%
+":'
"
3'$0'(:',
0%)5&(0*
%5
()*'$'-*
6(&&
4'
$';1($',
*%
+":'-10+
0%)5&(0*-
7")".',
()
"
6"2
*+"*
(-
"33$%3$("*'
*%
*+'($
3"$*(0(3"*(%)
()
*+'
,'-(.)
"),
0%),10*%5
*+(-
*$("&8
<+'
-*1,2
&'",'$-+(3
()
0%)=1)0*(%)
6(*+
*+'
>?@
+"-
'-*"4&(-+',
3%&(0('-
"),3$%0',1$'-
5%$
"&&
-*1,2
.$%13
7'74'$-
*%
,(-0&%-'
"&&
0%)5&(0*-
%5
()*'$'-*
"),
6(&&
'-*"4&(-+
"7'0+")(-7
5%$
*+'
7")".'7')*
%5
"&&
$'3%$*',
,1"&(*('-
%5
()*'$'-*8
ABCD EFGHIJKGLIMNILO
MGJ
QRISMEO
T"$*(0(3")*
0%)5(,')*("&(*2
"),
3$(:"02
(-
-*$(0*&2
+'&,
()
*$1-*
42
*+'
3"$*(0(3"*().
():'-*(."*%$-/
*+'($-*"55/
"),
*+'
-3%)-%$8
<+(-
0%)5(,')*("&(*2
(-
'U*'),',
*%
0%:'$
*'-*().
%5
4(%&%.(0"&
-"73&'-
"),.')'*(0
*'-*-
()
",,(*(%)
*%
*+'
0&()(0"&
()5%$7"*(%)
$'&"*().
*%
3"$*(0(3")*-8
<+'$'5%$'/
*+'
-*1,23$%*%0%&/
,%017')*"*(%)/
,"*"/
"),
"&&
%*+'$
()5%$7"*(%)
.')'$"*',
6(&&
4'
+'&,
()
-*$(0*
0%)5(,')0'8
>%
()5%$7"*(%)
0%)0'$)().
*+'
-*1,2
%$
*+'
,"*"
6(&&
4'
$'&'"-',
*%
")2
1)"1*+%$(V',
*+($,3"$*2
6(*+%1*
3$(%$
6$(**')
"33$%:"&
%5
*+'
-3%)-%$8
W&&$'-'"$0+
"0*(:(*('-
6(&&
4'
0%),10*',
()
"-
3$(:"*'
"
-'**().
"-
3%--(4&'8
<+'-*1,2
7%)(*%$/
%*+'$
"1*+%$(V',
$'3$'-')*"*(:'-
%5
*+'
-3%)-%$/
$'3$'-')*"*(:'-
%5
*+'
@)-*(*1*(%)"&
X':('6
Y%"$,
Z@XY[/
"),\%$
$'.1&"*%$2
".')0('-
7"2
()-3'0*
"&&
,%017')*-
"),
$'0%$,-$';1($',
*%
4'
7"()*"()',
42
*+'
():'-*(."*%$/
()0&1,().
41*
)%*
&(7(*',
*%/
7',(0"&
$'0%$,-Z%55(0'/
0&()(0/
%$
+%-3(*"&[
"),
3+"$7"02
$'0%$,-
5%$
*+'
3"$*(0(3")*-
()
*+(-
-*1,28
<+'
0&()(0"&-*1,2
-(*'
6(&&
3'$7(*
"00'--
*%
-10+
$'0%$,-8
<+'-*1,2
3"$*(0(3")*]-
0%)*"0*
()5%$7"*(%)
6(&&
4'
-'01$'&2
-*%$',
"*
'"0+
0&()(0"&
-(*'
5%$
()*'$)"&1-'
,1$().
*+'
-*1,28
W*
*+'
'),
%5
*+'
-*1,2/
"&&
$'0%$,-
6(&&
0%)*()1'
*%
4'
^'3*
()
"
-'01$'&%0"*(%)
5%$
"-
&%).
"
3'$(%,
"-
,(0*"*',
42
*+'
$':('6().
@XY/
@)-*(*1*(%)"&
3%&(0('-/
%$
-3%)-%$$';1($'7')*-8
_*1,2 3"$*(0(3")*
$'-'"$0+
,"*"
6(&&
)%*
()0&1,'
*+'
3"$*(0(3")*]-
0%)*"0*
%$
(,')*(52().
()5%$7"*(%)8
X"*+'$/
(),(:(,1"&
3"$*(0(3")*-
"),
*+'($
$'-'"$0+
,"*"
6(&&
4'
(,')*(5(',
42
"
1)(;1'
-*1,2(,')*(5(0"*(%)
)174'$8
<+'
-*1,2
,"*"
')*$2
"),
-*1,2
7")".'7')*
-2-*'7-
1-',
42
0&()(0"&-(*'-
6(&&
4'
-'01$',
"),
3"--6%$,
3$%*'0*',8
W*
*+'
'),
%5
*+'
-*1,2/
"&&
-*1,2
,"*"4"-'-
6(&&4'"$0+(:',
"*
*+'
>@`
?&()(0"&
?')*'$8
<%51$*+'$
3$%*'0*
*+'
3$(:"02
%5
-*1,2
3"$*(0(3")*-/
"
?'$*(5(0"*'
%5
?%)5(,')*("&(*2
+"-
4'')
(--1',42*+'
>"*(%)"&
@)-*(*1*'-
%5
`'"&*+
Z>@`[8

<+(-
0'$*(5(0"*'
3$%*'0*-
(,')*(5("4&'
$'-'"$0+
()5%$7"*(%)
5$%7
5%$0',
,(-0&%-1$'8
@*
"&&%6-
*+'
():'-*(."*%$
"),
%*+'$-
6+%
+":'
"00'--
*%
$'-'"$0+$'0%$,-
*%
$'51-'
*%
,(-0&%-'
(,')*(52().
()5%$7"*(%)
%)
$'-'"$0+
3"$*(0(3"*(%)
()
")2
0(:(&/0$(7()"&/
",7()(-*$"*(:'/
&'.(-&"*(:'/
%$
%*+'$
3$%0'',()./
6+'*+'$
"*
*+'
5','$"&/
-*"*'/
%$
&%0"&&':'&8
Y2
3$%*'0*().
$'-'"$0+'$-
"),
()-*(*1*(%)-
5$%7
4'().
0%73'&&',
*%
,(-0&%-'
()5%$7"*(%)
*+"*
6%1&,
(,')*(52
$'-'"$0+
3"$*(0(3")*-/
?'$*(5(0"*'-
%5
?%)5(,')*("&(*2
+'&3
"0+(':'
*+'$'-'"$0+
%4='0*(:'-
"),
3$%7%*'
3"$*(0(3"*(%)
()
-*1,('-
42
+'&3().
"--1$'
0%)5(,')*("&(*2
"),
3$(:"02*%
3"$*(0(3")*-8











  
!" #$%&'%()*+,(%-
,/01&'%+,1/
!"2! +&)')-,'*'%3
456464789:;<
=:<><?@>9>AB
D@??
B<
E9FF?@<G
BH
IEJ:AK<L<;AMN<GO>>9L<P
OL;6
45646QR8:>9?AJ@8L
ALG
S:<FA:AJ@8L
=:<><?@>9>AB
@E
A
T9>AL
OUVQ
ALJ@WX=YIW5
>IB
JTAJ
@E
B<@LU
G<Z<?8F<G
AE
AL
@>>9L8JT<:AF<9J@;
AU<LJ
[8:
ZA:@89E
;AL;<:E6

,]^_`abcdabe]df
#gehija
'd]ikdjaig_g
(e]j_]agdabe]
d]h
0eglifdabe]
d`
minnfb_h
=:<><?@>9>AB
N<GO>>9L<
=:<><?@>9>AB
D@??
B<
E9FF?@<G
BH
IEJ:AK<L<;A
<@JT<:
AE
A
5ooW>U
8:
A
QpW>U
Z@A?
E8?9J@8L
[8:
@L[9E@8L
A[J<:
G@?9J@8L6

=T<
E8?9J@8L
;8LJA@LE
Qo
>UM>Y
J:<><?@>9>ABP
Qo
>N
T@EJ@G@L<MT@EJ@G@L<
THG:8;T?8:@G<P
QQQ
>N
J:<TA?8E<
G@THG:AJ<P
o6Q 
>N
G@E8G@9>
<G<JAJ<
G@THG:AJ<P
ALG
o6oQq
D<@UTJMZ8?9><
rDMZs
F8?HE8:BAJ<
tou
@J
TAE
A
Fv
8[
p6p
ALG
G<LE@JH
8[
46ow5
UM>Y6

=T<
L8>@LA?
[@??
Z8?9><
@E
Qo6o
>Y
[8:
JT<
5ooW>U
Z@A?
ALG
46Qp
>Y
[8:
JT<
QpW>U
Z@A?6
OLZ<EJ@UAJ@8LA?
F:8G9;J
Z@A?E
A:<
EJ8:<G
AJ
QxX
J8
txX
rwyxR
J8
5yxRs
ALG
>9EJ
L8J
B<
[:8z<L6
{:9U
F:8G9;J
ET89?G
B<
|<FJ
@L
8:@U@LA?
;8LJA@L<:
9LJ@?
9E<
J8
F:<Z<LJ
F:8?8LU<G
?@UTJ
<}F8E9:<6
=T<Qo>UM>Y
E8?9J@8L
D@??
B<
G@?9J<G
@LJ8
A
EA?@L<
BAU
[8:
O~
@L[9E@8L6
~@A?E
;8LJA@L@LU
J:<><?@>9>AB
>AH
B<
U<LJ?H
@LZ<:J<G
[8:
>@}@LU
B9J
ET89?G
L8J
B<
ETA|<L6
R8:G8E<F:<FA:AJ@8L
EJ<FEP
JT<
[8??8D@LU
AL;@??A:H
@J<>E
A:<
:<9@:<G
 O~
@L[9E@8L
BAUE
8[
o6q
E8G@9>
;T?8:@G<
@L<;J@8L
rQpo
>Y
E@z<s6
7A?@L<
BAUE
>9EJ
B<
?AJ<}W[:<<
ALG
;AL
B<
>AG<
8[
F8?HZ@LH?
;T?8:@G<
rS~Xs
8:
F8?H8?<[@LE
r<6U6P
F8?H<JTH?<L<sP
>AL9[A;J9:<G
D@JT
B@E
rQW<JTH?T<}H?s
FTJTA?AJ<
r{vSs
8:
{vSW[:<<6
 O~
@L[9E@8L
?@L<E
>AG<
8[
S~XM{vS
8:
S~XMJ:@
8;JH?
J:@><??@JAJ<
r==Ns
8:
F8?H<JTH?<L<
8:
F8?H9:<JTAL<6
I??
{vSW;8LJA@L@LU
8:
{vSW[:<<
?@L<E
A:<
A;;<FJAB?<6
Y@L<E
ET89?G
;8LJA@L
A
o6QQ
8:
o6Q

@LW?@L<
[@?J<:6
=T<
@LW?@L<
[@?J<:
;AL
B<
>AG<
8[
F8?H<JT<:E9?[8L<
rS7s
8:
F8?HZ@LH?@G@L<
[?98:@G<
{R
rS~{Rs6
Y@L<E
;8LJA@L@LU
;<??9?8E<WBAE<G
[@?J<:E
ET89?G
L8J
B<
9E<G
D@JT
J:<><?@>9>AB6
 XAJT<J<:EM@L[9E@8L
E<JE
>AG<
8[
F8?H9:<JTAL<
8:
[?98:8F8?H><:
D@JT
E@?@;8L<
ALG
EJA@L?<EE
EJ<<?ALGM8:S~X;8>F8L<LJE6











 !
" #$%&'()*
,-.)
/0
1/2$1%/1$2)')
-'.
2-3)450%))6
7/2$8-%9/'-3)
*$%&'()*
*:/;2.
'/3
9)
;*).
<&3:
3%),)2&,;,-96
" =)).2)*
,-.)
/0
*3-&'2)**
*3))26
>?6>6@A.,&'&*3%-3&/'
7%/8).;%)*
B%),)2&,;,-9
&*
3/
9)
-.,&'&*3)%).
-*
-'
CD
*/2;3&/'
/0
>E
,(FG(
-3
-
%-3)
/0
HIE
,JF:%K
0/22/<).9$
/9*)%L-3&/'
0/%
ME
,&';3)*6
>?6>6?N/*)
O-28;2-3&/'
PQRSTB:)
./*&'(
0/%
3%),)2&,;,-9
<&22
9)
-
02-3
./*&'(
/0
 I
,(6
B:)8/%%)*1/'.&'(
L/2;,)
/0
&'L)*3&(-3&/'-2
1%/.;83
*:/;2.
9)
%/;'.).
3/
3:)
')-%)*3
3)'3:
/0
-
,JVE6>,JW6
X-8:
L&-2
8/'3-&'*
-
*,-22
-,/;'3
/0
/L)%-()
-'.
3:)
/L)%-()
*:/;2.
9)
;3&2&Y).
-*
,;8:-*1/**&92)
9)0/%)
;*&'(
-'/3:)%
L&-26
B:)';,9)%
/0
L&-2*
%)Z;&%).
0/%
./*)
1%)1-%-3&/'
&*
3:)
')43
(%)-3)*3
<:/2)
';,9)%
/0
L&-2*
0%/,3:)0/22/<&'(
0/%,;2-[
=;,9)%
/0
L&-2*
\
N/*)
V,JW
]
HE
V,JFL&-2W
>?6>6IC'L)*3&(-3&/'-2
7%/.;83
C'*1)83&/'
X-8:L&-2*)2)83).
0/%
./*)
1%)1-%-3&/'
*:/;2.
9)
&'*1)83).6
C03:)%)-%)
-'$
.)0)83*
'/3).
<&3:
3:)
&'L)*3&(-3&/'-2
1%/.;83K
3:)
&'L)*3&(-3/%
-'.
*&3)
,/'&3/%
*:/;2.9)'/3&0&).
&,,).&-3)2$6
^)0)%
3/
3:)
7%/.;83
O/,12-&'3
*)83&/'
V_`a_abW
0/%
0;%3:)%
&'*3%;83&/'*6
N;%&'(3:)
&'*1)83&/'
&0
3:)
*/2;3&/'
&*
'/3
82)-%
/%
-'$
3;%9&.&3$K
.&*8/2/%-3&/'
/%
1-%3&8;2-3)*
-%)
/9*)%L).K'/3&0$
$/;%
*&3)
,/'&3/%
-'.
*3/%)
3:)
L&-2V*W
&'
cdA^A=BC=X
-3
%)0%&()%-3).
VH5!eOW
3),1)%-3;%)
0/%
.%;(
-88/;'3-9&2&3$
-'.
1/3)'3&-2
0;3;%)
&'*1)83&/'6
=/3&0$3:)
Cf^#
3:-3
3:)
;';*-92)
L&-2*
-%)
.-,-().6
B:)
Cf^#
<&22
&'.&8-3)
3:)
%)12-8),)'3
L&-2*6#)2)83
-11%/1%&-3)
%)12-8),)'3
L&-2*
0/%
3:)
1%)1-%-3&/'
/0
3:)
*;9g)83h*
./*)
-'.
1)%0/%,
3:)*-,)&'*1)83&/'
/'
3:)
')<2$
*)2)83).
L&-2*6
i/%
-88/;'3-9&2&3$K
%)8/%.
3:)
3/3-2
';,9)%
/0
L&-2*%),/L).
0%/,
*&3)
&'L)'3/%$6
d*).
L&-2*
*:/;2.
9)
:)2.
0/%
-88/;'3-9&2&3$
1;%1/*)*
-3
-,9&)'3*3/%-()
3),1)%-3;%)6
>?6>6MN/*)
7%)1-%-3&/'
#3)1*
B%),)2&,;,-9
./)*
'/3
8/'3-&'
1%)*)%L-3&L)*
-'.
-'$
;';*).
1/%3&/'
,;*3
9)
.&*8-%.).6
7%)1-%-3&/'
/0
3%),)2&,;,-9
-'.
1%)1-%-3&/'
/0
3:)
CD
9-(
-%)
3/
9)
1)%0/%,).
-*)13&8-22$6
B/3-2&'5;*)
*3/%-()
3&,)
0/%
3:)
1%)1-%).
0&'-2
CD
9-(
*:/;2.
'/3
)48)).
H?
:/;%*
-3
H5!jO
/%
?
:/;%*-3%//,
3),1)%-3;%)
VHIjOW6
k/<)L)%K
&3
&*
%)8/,,)'.).
3:-3
3:)
1%)1-%).
0&'-2
CD
9-(
9)
*3/%).&'3:)
.-%G
-3
H5!jO
;'3&2
')).).6
B:)
%)0%&()%-3).
&'0;*&/'
*/2;3&/'*
&'
3:)
1%)1-%).
0&'-2
CD9-(*:/;2.
9)
)Z;&2&9%-3).
-3
%//,
3),1)%-3;%)
0/%
-9/;3
H
:/;%*
1%&/%
3/
-.,&'&*3%-3&/'6
C0
*3/%-()3&,)
)48)).*
3:)*)
2&,&3*K
-
')<
./*)
,;*3
9)
1%)1-%).
0%/,
')<
L&-2*6
B:)&'L)*3&(-3&/'-2
1%/.;83
,-'-()%
/%
Z;-2&0&).
1)%*/'')2
<&22
9)
%)*1/'*&92)
0/%
1%)1-%&'(
3:)
CD./*)*;*&'(
3:)
0/22/<&'(
*3)1*[
>W#)2)833:)Cf^#5-**&(').';,9)%/0L&-2*/0&'L)*3&(-3&/'-21%/.;83%)Z;&%).3/1%)1-%)3:)
*;9g)83h*./*)6











 !
"#%&&'()*+,'-.,'/(.&
01/234,
)'.&+
+5/3&2
6*
*73'&'61.,*2
,/
1//8
,*80*1.,31*
9/1
:;
8'(3,*+
01'/1,/2/+*
01*0.1.,'/(<
:#=/01*0.1*
,5*
>?
6.-@
9'1+,@
4.&43&.,*
,5*
2/+*
)/&38*
/9
'()*+,'-.,'/(.&
01/234,
1*73'1*2<
A*4/(2@1*8/)*
,5*
)/&38*
/9
;<!B
+/2'38
45&/1'2*
>?
+/&3,'/(
*73').&*(,
,/
,5*
4.&43&.,*2
2/+*)/&38*
/9
'()*+,'-.,'/(.&
01/234,
91/8
,5*
>?
6.-<
C.+,&D@
.22
,5*
4.&43&.,*2
2/+*
)/&38*
/9'()*+,'-.,'/(.&
01/234,
,/
,5*
>?
6.-<
E*(,&D
8'F
,5*
+/&3,'/(
'(
,5*
6.-
6D
'()*1,'(-
30
.(2
2/G(<%)/'2
+5.H'(-
,5*
>?
6.-
,/
01*)*(,
9/.8'(-<
C.6*&+G'&&
6*
01*0.1*2
'(
.44/12.(4*
G',5
E//2
I.(39.4,31'(-
J1.4,'4*
KEIJ#<
LM<L< >()*+,'-.,'/(.&
J1/234,
%44/3(,.6'&',D
=5*'()*+,'-.,/1N+
/1
+',*N+
2*+'-(.,*2
'()*+,'-.,'/(.&
01/234,
8.(.-*1
'+
1*73'1*2
,/
8.'(,.'(
.4431.,*'()*+,'-.,'/(.&
01/234,
.44/3(,.6'&',D
1*4/12+<
O0/(
4/80&*,'/(
/9
,5*
+,32D@
4/0'*+
/9
'()*+,'-.,'/(.&
01/234,
.44/3(,.6'&',D
1*4/12+
G'&&
6*
1*,31(*2
,/
I*2>883(*<
%&&
3(3+*2
'()*+,'-.,'/(.&
01/234,
G'&&
6*
1*,31(*2
,/
.
I*2>883(*P.3,5/1'Q*2
2*0/,
/1
2'+0/+*2
/9
30/(
.3,5/1'Q.,'/(
6D
I*2>883(*<
LM<L<RS*0/1,'(-
J1/234,
T/80&.'(,+
%(D2*9*4,+
G',5
,5*
'()*+,'-.,'/(.&
01/234,
83+,
6*
1*0/1,*2
UVVWXUYZW[\
,/
,5*
I*2>883(*
J1/234,T/80&.'(,
^*0.1,8*(,
6D
,5*
+',*
G',5
931,5*1
(/,'9'4.,'/(
,/
,5*
+',*
8/(',/1<
%&&
2*9*4,+G'&&
6*
4/883('4.,*2
,/
I*2>883(*
.(2
'()*+,'-.,*2
931,5*1
G',5
,5*
J1/234,
T/80&.'(,
^*0.1,8*(,<
^31'(-
,5*
'()*+,'-.,'/(
/9
,5*
01/234,
4/80&.'(,@
.&&
'()*+,'-.,'/(.&
01/234,+83+,
6*
+,/1*2
.,
&.6*&*2
4/(2','/(+
3(&*++
/,5*1G'+*
'(+,134,*2<
J1/234,2*9*4,+
8.D
6*
1*&.,*2
,/
4/80/(*(,@
01/234,@
/1
0.4H.-'(-
.(2
&.6*&'(-
'++3*+<
=5*
&'+,
6*&/G'(4&32*+@
63,
'+
(/,
&'8',*2
,/@
2*+41'0,'/(+
/9
01/234,
4/80&.'(,+
,5.,
+5/3&2
6*
1*0/1,*2<
_`ab`cdce
ghhidj
^*9*4,
'(
4/(,.'(*1
/1
2/+'(-
8*45.('+8
/9
,5*
'()*+,'-.,'/(.&
01/234,<
=5*
4/80/(*(,
2*9*4,
8.D
6*
2.8.-*2@
8'++'(-@
/1
61/H*(<
T/80/(*(,
*F.80&*+
'(4&32*
)'.&+@
+,/00*1+@4.0+@
+01.D
6.11*&+@
+01.D
(/QQ&*+@
/1
0&3(-*1+<
kl`mineghhidj
^*9*4,
'(
,5*
01/234,
',+*&9<
=5*
01/234,
.00*.1.(4*
5.+
)'+3.&
'80*19*4,'/(+
+345.+9/1*'-(
0.1,'4&*+@
41D+,.&&'Q.,'/(@
2'+4/&/1.,'/(@
,316'2',D@
'(+399'4'*(,
)/&38*@
/1
.(D,5'(-
,5.,2/*+(/,
.00&D
,/
,5*
01/234,
2*+41'0,'/(<
konpoqrcqstoudvrcq
ghhidj
^*9*4,
'(
,5*
0.4H.-'(-
/1
&.6*&'(-
/9
,5*
01/234,<
=5*
0.4H.-'(-
/1
&.6*&'(-2*9*4,+
8.D
6*
2.8.-*2
/1
3(1*.2.6&*@
/1
,5*
&.6*&
8.D
6*
8'++'(-<
w5*(1*0/1,'(-
.
01/234,
4/80&.'(,@
+',*
+,.99
83+,
6*
01*0.1*2
,/
01/)'2*
,5*
9/&&/G'(-
'(9/18.,'/(x
L#T3+,/8*1
'(9/18.,'/(x
1*0/1,*1
(.8*@
.221*++@
4/(,.4,
(386*1@
.(2
2.,*
/9
4/80&.'(,
"#J1/234,
'(9/18.,'/(x
01/234,
(.8*@
0.4H.-'(-
H',
(386*1
/1
&/,
(386*1@
*F0'1D
2.,*@
.(2
4&'('4.&01/,/4/&
(386*1
:#T/80&.'(,
'(9/18.,'/(x
4/80&.'(,
'++3*
4.,*-/1D
.(2
2*+41'0,'/(
I*2>883(*4/(,.4,'(9/18.,'/(9/11*0/1,'(-01/234,4/80&.'(,+x
y8.'&x01/234,4/80&.'(,+z8*2'883(*<4/8











 !
"#$%&'
)*+,!*+,- +.*!/
)*+ 00+1234+5**
6)*+ 00+7,,+55**8
9:;'
)*+,!*+,- +  !!
1:<='1&>4??@%&A
BBC
DEE%'
"F$>@GE
C$?H=:<%E
3&H:FE?&%E
I%&
1&>4??@%&
J:KA
L:<E#&FMN@FOA
13
PQD
.! 0 
RSTU VWXYZ[W\Z]
*5^.^*Q$@FG&
3@F_:=@?:N
`<==
N&
M@HH=<&>
NK
DMEF:a&%&G:b1&>4??@%&
4%G^
*5^.^.9$F?@=:E<$%
:%>
"F&H:F:E<$%
3@F_:=@?:N
<M
:
#@?:%
?$%$G=$%:=
:%E<N$>K
$c
E#&
<??@%$O=$N@=<%
L*
d:HH:
efghijk
M@NG=:MM^
lmnopqrstqrumtv
xyuz{|q
\tm{}t|q{yoy
~um|omqytqrum
tmz
uy{vtqrum
tp
{vroz
3@F_:=@?:N
1&><??@%&
3@F_:=@?:N
`<==
N&
M@HH=<&>
:M
:
/!!
?O
_<:=
M$=@E<$%
c$F
<%c@M<$%
:cE&F
><=@E<$%^
#&
M$=@E<$%
G$%E:<%M
/!
?Ob?B
>@F_:=@?:NA
.7
?1
#<ME<><%&b#<ME<><%&
#K>F$G#=$F<>&A
.0/
?1
EF&#:=$M&
><#K>F:E&A
:%>
!^!.
6`&<O#Eb_$=@?&8
H$=KM$FN:E&
 !
<E
#:M
:
H
$c
7^!^
#&
%$?<%:=
c<==
_$=@?&
<M
*!
?B^
4%_&ME<O:E<$%:=
HF$>@GE
_<:=M
:F&
ME$F&>
:E
.C
E$
 C
6,79
E$
5798
:%>
?@ME
%$E
N&
cF$&%^
3@F_:=@?:N
?@ME
N&
@M&>
`<E#<%
E#&
<%><_<>@:==K
:MM<O%&>
&;H<FK
>:E&
$%
E#&
=:N&=^
*5^.^,QE:N<=<EK
#&>$M&$c
>@F_:=@?:N
c$F
:>?<%<MEF:E<$%
?@ME
N&
HF&H:F&>
NK
E#&
4%_&ME<O:E$FM
$F
M<E&M
>&M<O%:E&>
4"
?:%:O&F
@M<%O
:M&HE<G
E&G#%<@&^
$E:=
E<?&
cF$?
%&&>=&
H@%GE@F&
$c
E#&
>@F_:=@?:N
_<:=
E$
E#&
ME:FE
$c
:>?<%<MEF:E<$%
M#$@=>
%$E
&;G&&>'
 .5
#$@FM
:E
.C
E$
 C
6,79
E$
5798
 5#$@FM
:E
F$$?
E&?H&F:E@F&











 !
"#%&'()*)+,-./*
+%0*
*12**3)
+4*)*
5%0%+)6
.
&*7
3,)*
0()+
8*
9-*9.-*3
#-,0
&*7
:%.5);
"&#()%,&
),5(+%,&)0()+
8*
.55,7*3
+,
*<(%5%8-.+*
+,
-,,0
+*09*-.+(-*
9-%,-
+,
2,00*&2*0*&+
,#
.30%&%)+-.+%,&;
=,%&2,09.+%8%5%+%*)
8*+7**&
3(-:.5(0.8
.&3
9,5>:%&>5245,-%3*
,-
9,5>,5*#%&
"?
8./)
4.:*
8**&
,8)*-:*3;@,)*
,#
!ABB0/
3(-:.5(0.8
#,-
9.+%*&+)
CDB
E/
7%55
8*
.30%&%)+*-*3
()%&/
.&
"?
8./
2,&+.%&%&/
B;FG
H7I:J
).5%&*6
7%+4
.
#%&.5
3(-:.5(0.8
2,&2*&+-.+%,&
-.&/%&/
#-,0
!
+,
KB
0/I0L6.&3
3*5%:*-*3
+4-,(/4
.&
"?
.30%&%)+-.+%,&
)*+
7%+4
.
B;K'
,-
MNOOPQR
%&'5%&*
#%5+*-;
S*0,:*DB;B
0L
,#
"?
),5(+%,&
#-,0
+4*
"?
8./
9-%,-
+,
.33%+%,&
,#
3(-:.5(0.8;
=*1+6
DB;B
0L
,#3(-:.5(0.8
H%;*;6
!ABB
0/
,#
3(-:.5(0.8J
%)
.33*3
+,
+4*
"?
8./
)(24
+4.+
#%&.5
2,&2*&+-.+%,&
%)7%+4%&!
+,
KB
0/I0L
H"?
8./
:,5(0*)
!BB
+,
!BBB
0LJ;
T%1
+4*
8./
8>
/*&+5>
%&:*-+%&/
+,
*&)(-*4,0,/*&*%+>
,#
+4*
3,)*
%&
+4*
8./;
U,-9.+%*&+)
VDBE/6
W.52(5.+*
+4*
3,)*
:,5(0*
,#
3(-:.5(0.8
.&3
+-*0*5%0(0.8
.&3
&(08*-
,#
:%.5)&**3*3
#,-
+4*
)(8X*2+
+,
.24%*:*
+4*
.22(-.+*
3,)*;
@(-:.5(0.8
7%55
8*
.30%&%)+*-*3
.+
-,,0
+*09*-.+(-*
H.99-,1%0.+*5>
KAYWJ
8>
2,&+-,55*3
%&#()%,&:%.
.&
%&#()%,&
9(09
%&+,
.
9*-%94*-.5
,-
2*&+-.5
:*%&;
U,55,7%&/
9-*9.-.+%,&
,#
3(-:.5(0.86
+4*
*&+%-*
2,&+*&+)
,#
+4*
"?
8./
)4,(53
8*
.30%&%)+*-*3
.)
.&
"?
%&#()%,&
,:*-
.99-,1%0.+*5>
ZB
0%&(+*)
H[A
0%&(+*)J6
()%&/
.
B;K6
,-
MNOOPQR
%&'5%&*
#%5+*-;
L*))
+4.&
AA
0%&(+*)%)
2,&)%3*-*3
.
3*:%.+%,&;
\4*"?5%&*
7%55
8*
#5()4*3
7%+4
.
:,5(0*
,#
"?
),5(+%,&
HB;FG
]7I:^
).5%&*
*<(.5
+,
+4*
9-%0%&/
:,5(0*,#
+4*
%&#()%,&
)*+
()*3
.#+*-
+4*
2,&+*&+)
,#
+4*
"?
8./
.-*
#(55>
.30%&%)+*-*36
,-
2,095*+*+4*
%&#()%,&
.22,-3%&/
+,
%&)+%+(+%,&.5
9,5%2>
+,
*&)(-*
+4*
#(55
3,)*
%)
.30%&%)+*-*3
.&3
3,2(0*&+%#
+4*
5%&*
7.)
&,+
#5()4*3;
_+.&3.-3%&#()%,&
+%0*
%)
!
4,(-;
`,7*:*-6
%#
+4*-*
.-*
%&+*--(9+%,&)
3(-%&/
%&#()%,&6
+4*
+,+.5
.55,7*3+%0*
)4,(53
&,+
*12**3
 
4,(-)
.+
-,,0
+*09*-.+(-*;
\4*
+.85*
8*5,7
)(00.-%a*)
+%0*
.55,7.&2*)
.&3
+*09*-.+(-*);
b-,+*2+#-,0
5%/4+;
!c;K;c@,)*
W.52(5.+%,&
=,+*d\4*
3,)%&/
#,-
3(-:.5(0.8
7%55
8*
.
#5.+
3,)%&/
,#
!ABB0/;
\4*2,--*)9,&3%&/
:,5(0*
,#
%&:*)+%/.+%,&.5
9-,3(2+
)4,(53
8*
-,(&3*3
+,
+4*
&*.-*)+
+*&+4
,#
.
0LHB;!0LJ;
e.24
:%.5
2,&+.%&)
.
)0.55
.0,(&+
,#
,:*-./*
.&3
+4*
,:*-./*
)4,(53
8*
(+%5%a*3
.)
0(24.)9,))%85*
8*#,-*
()%&/
.&,+4*-
:%.5;
\4*&(08*-
,#
:%.5)
-*<(%-*3
#,-
3,)*
9-*9.-.+%,&
%)
+4*
&*1+
/-*.+*)+
74,5*
&(08*-
,#
:%.5)
#-,0+4*#,55,7%&/
#,-0(5.d
=(08*-
,#
:%.5)
f
@,)*
H0LJ
g
KB
H0LI:%.5J
!c;K;A"&:*)+%/.+%,&.5
b-,3(2+
b-*9.-.+%,&
_+*9)
\4*%&:*)+%/.+%,&.5
9-,3(2+
0.&./*-
,-
<(.5%#%*3
9*-),&&*5
7%55
8*
-*)9,&)%85*
#,-
9-*9.-%&/
+4*
"?3,)*)()%&/
+4*
#,55,7%&/
)+*9)d
!J_*5*2+
+4*
"hS_'.))%/&*3
&(08*-
,#
:%.5)
,#
%&:*)+%/.+%,&.5
9-,3(2+
-*<(%-*3
+,
9-*9.-*
+4*
)(8X*2+i)
3,)*;
KJ j55%&:*)+%/.+%,&.59-,3(2+:%.5))4,(538**<(%5%8-.+*3+,-,,0+*09*-.+(-*#,-DB
0%&(+*)9-%,-+,3,)*9-*9.-.+%,&;











 !
"#$%
'()'*()
+,)
-.
/*01
23(4+1
5*6576*+)
+,)
8%4)
9%67:)
%2
3;9)4+30*+3%;*6
'(%875+
()<73()8=
>)5%;81
():%9)
+,)
9%67:)
%2
?=@A
4%837:
5,6%(38)
-.
4%67+3%;
)<739*6);+
+%
+,)
5*6576*+)8
8%4)
9%67:)
%2
3;9)4+30*+3%;*6
'(%875+
2(%:
+,)
-.
/*0=
B# C*4+6D1
*88
+,)
5*6576*+)8
8%4)
9%67:)
%2
3;9)4+30*+3%;*6
'(%875+
+%
+,)
-.
/*0=
E);+6D
:3F
+,)
4%67+3%;
3;
+,)
/*0
/D
3;9)(+3;0
7'
*;8
8%G;=
H9%38
4,*I3;0
+,)
-.
/*0
+%
'()9);+
2%*:3;0=
J#C*/)64
G366
/)
'()'*()8
3;
*55%(8*;5)
G3+,
E%%8
K*;72*5+7(3;0
L(*5+35)
MEKL#=
NB=!=O-;9)4+30*+3%;*6
L(%875+
-;4')5+3%;
P*5,93*64)6)5+)8
2%(
8%4)
'()'*(*+3%;
4,%768
/)
3;4')5+)8=
-2+,)()*()
*;D
8)2)5+4
;%+)8
G3+,
+,)
3;9)4+30*+3%;*6
'(%875+1
+,)
3;9)4+30*+%(
*;8
43+)
:%;3+%(
4,%768/);%+323)8
3::)83*+)6D=
Q)2)(
+%
+,)
L(%875+
R%:'6*3;+
4)5+3%;
MSTUVUW#
2%(
27(+,)(
3;4+(75+3%;4=
X7(3;0+,)
3;4')5+3%;
32
+,)
4%67+3%;
34
;%+
56)*(
%(
*;D
+7(/383+D1
8345%6%(*+3%;
%(
'*(+3576*+)4
*()
%/4)(9)81;%+32D
D%7(
43+)
:%;3+%(
*;8
4+%()
+,)
93*6M4#
3;
YZHQH[$-[P
*+
()2(30)(*+)8
M!\ ]R#
+):')(*+7()
2%(
8(70
*55%7;+*/363+D
*;8
'%+);+3*6
27+7()
3;4')5+3%;=
[%+32D+,)
-^Q>
+,*+
+,)
7;74*/6)
93*64
*()
8*:*0)8=
$,)
-^Q>
G366
3;835*+)
+,)
()'6*5):);+
93*64=>)6)5+
*''(%'(3*+)
()'6*5):);+
93*64
2%(
+,)
'()'*(*+3%;
%2
+,)
47/_)5+`4
8%4)1
*;8
')(2%(:
+,)4*:)3;4')5+3%;
%;
+,)
;)G6D
4)6)5+)8
93*64=
a%(
*55%7;+*/363+D1
()5%(8
+,)
+%+*6
;7:/)(
%2
93*64():%9)8
2(%:
43+)
3;9);+%(D=
Z4)8
93*64
4,%768
/)
,)68
2%(
*55%7;+*/363+D
'7('%4)4
*+
*:/3);+4+%(*0)
+):')(*+7()=
NB=!=b-;9)4+30*+3%;*6
L(%875+
H55%7;+*/363+D
$,)3;9)4+30*+%(`4
%(
43+)`4
8)430;*+)8
3;9)4+30*+3%;*6
'(%875+
:*;*0)(
34
()<73()8
+%
:*3;+*3;
*557(*+)3;9)4+30*+3%;*6
'(%875+
*55%7;+*/363+D
()5%(84=
Z'%;
5%:'6)+3%;
%2
+,)
4+78D1
5%'3)4
%2
3;9)4+30*+3%;*6
'(%875+
*55%7;+*/363+D
()5%(84
G366
/)
()+7(;)8
+%
K)8-::7;)=
H66
7;74)8
3;9)4+30*+3%;*6
'(%875+
G366
/)
()+7(;)8
+%
*
K)8-::7;)\*7+,%(3c)8
8)'%+
%(
834'%4)8
%2
7'%;
*7+,%(3c*+3%;
/D
K)8-::7;)=
NB=!= Q)'%(+3;0
L(%875+
R%:'6*3;+4
H;D8)2)5+4
G3+,
+,)
3;9)4+30*+3%;*6
'(%875+
:74+
/)
()'%(+)8
deefgdhifjk
+%
+,)
K)8-::7;)
L(%875+R%:'6*3;+
X)'*(+:);+
/D
+,)
43+)
G3+,
27(+,)(
;%+3235*+3%;
+%
+,)
43+)
:%;3+%(=
H66
8)2)5+4G366
/)
5%::7;35*+)8
+%
K)8-::7;)
*;8
3;9)4+30*+)8
27(+,)(
G3+,
+,)
L(%875+
R%:'6*3;+
X)'*(+:);+=
X7(3;0
+,)
3;9)4+30*+3%;
%2
+,)
'(%875+
5%:'6*3;+1
*66
3;9)4+30*+3%;*6
'(%875+4:74+
/)
4+%()8
*+
6*/)6)8
5%;83+3%;4
7;6)44
%+,)(G34)
3;4+(75+)8=
L(%875+8)2)5+4
:*D
/)
()6*+)8
+%
5%:'%;);+1
'(%875+1
%(
'*5I*03;0
*;8
6*/)63;0
3447)4=
$,)
634+
/)6%G3;5678)41
/7+
34
;%+
63:3+)8
+%1
8)45(3'+3%;4
%2
'(%875+
5%:'6*3;+4
+,*+
4,%768
/)
()'%(+)8=
mnopnqrqs
uvvwrx
X)2)5+
3;
5%;+*3;)(
%(
8%43;0
:)5,*;34:
%2
+,)
3;9)4+30*+3%;*6
'(%875+=
$,)
5%:'%;);+
8)2)5+
:*D
/)
8*:*0)81
:3443;01
%(
/(%I);=
R%:'%;);+
)F*:'6)4
3;5678)
93*641
4+%'')(415*'41
4'(*D
/*(()641
4'(*D
;%cc6)41
%(
'67;0)(4=
yzn{w|suvvwrx
X)2)5+
3;
+,)
'(%875+
3+4)62=
$,)
'(%875+
*'')*(*;5)
,*4
9347*6
3:')(2)5+3%;4
475,*42%()30;'*(+356)415(D4+*663c*+3%;18345%6%(*+3%;1+7(/383+D13;4722353);+9%67:)1%(*;D+,3;0
+,*+8%)4;%+*''6D+%+,)'(%875+8)45(3'+3%;=











 !
"#$%#&'(&)*#+,-'(&
/001,2
345467
9:
7;4
<=6>=?9:?
@A
B=C4B9:?
@5
7;4
<A@DE67F
G;4
<=6>=?9:?
@A
B=C4B9:?D45467H
I=J
C4
D=I=?4D
@A
E:A4=D=CB4K
@A
7;4
B=C4B
I=J
C4
I9HH9:?F
L;4:A4<@A79:?
=
<A@DE67
6@I<B=9:7K
H974
H7=55
IEH7
C4
<A4<=A4D
7@
<A@M9D4
7;4
5@BB@N9:?
9:5@AI=79@:O
PQREH7@I4A
9:5@AI=79@:O
A4<@A74A
:=I4K
=DDA4HHK
6@:7=67
:EIC4AK
=:D
D=74
@5
6@I<B=9:7
SQTA@DE67
9:5@AI=79@:O
<A@DE67
:=I4K
<=6>=?9:?
>97
:EIC4A
@A
B@7
:EIC4AK
4U<9AJ
D=74K
=:D
6B9:96=B<A@7@6@B
:EIC4A
!QR@I<B=9:7
9:5@AI=79@:O
6@I<B=9:7
9HHE4
6=74?@AJ
=:D
D4H6A9<79@:
V4DWIIE:4
6@:7=67
9:5@AI=79@:
5@A
A4<@A79:?
<A@DE67
6@I<B=9:7HO
XI=9BO
<A@DE676@I<B=9:7HYI4D9IIE:4F6@I
T;@:4O
ZP[!\P[!] [SP\^
ZP[ __[VX3W[`PP
aZP[ __[b!![``PPQ
c=UO
ZP[!\P[!] [  \\
V=9BOV4DWIIE:4K
ddR
e77:O
TA@DE67
R@I<B=9:7
34<=A7I4:7
f:4
V4DWIIE:4
L=JK
g=97;4AHCEA?K
V3
hie
S\ _ 











 !
"# $%&%$%'(%)
*+
,-./012
4+5+2
67
-8+2
9:;<=>;<?@
;BC
DEFGH
I>?ICF
JKFHC?L
MGEJEI>?
NOOOP
Q17
R
S-1T6.2
UVV*+
WXYUZ[
\+
*]^_`+
U+
a8bc672
R+5+2
67
-8+2
dC:<@?
>?H
C?HeE<?;:
Ef
IG<?<I>G
;F<>G:
<?
BCe>;EICGGKG>F
I>FI<?E=>P
R
g-78
S-1T6.
Q1h72
UVV +
"iiY*VZ[
\+
`j _k**+
^+
l-17bmm2
,+n+2
67
-8+2
o<eKGCKICGpq
<==K?E;BCF>er
fEF
I>:;F>;<E?pFC:<:;>?;
eFE:;>;C
I>?ICFP
g
s1t8
R
56u2
UV*V+
vwvY]Z[
\+
!**_UU+
!+
xbu02
y+z+2
67
-8+2
{=eFE|CH
:KF|<|>G
D<;B
<e<G<=K=>J
<?
e>;<C?;:
D<;B
=C;>:;>;<I
=CG>?E=>P
g
s1t8
R
56u2
UV*V+
vwvY Z[
\+
k**_U^+
]+
}b~6.72
S+2
67
-8+2
{e<G<=K=>J
eGK:
H>I>FJ><?C
fEF
eFC|<EK:Gr
K?;FC>;CH
=C;>:;>;<I
=CG>?E=>P
g
s1t8
R
56u2
UV**+
vwXYU`Z[
\+
U]*k_U`+
`+
x-1--12
4+
-1u
}++
n601~6.t2
>GG=>F:
Ef
I>?ICFL
;BC
?C;
@C?CF>;<E?P
S6882
UV**+
"XXY]Z[
\+
`!`_k!+
k+
,-.ub882
4+5+2
qBC
JGEI>HC
Ef
<==K?C
IBCIeE<?;:
<?
I>?ICF
<==K?E;BCF>erP
g-7
}6c
S-1T6.2
UV*U+
"Y!Z[
\+
U]U_`!+
 +
,bh7b2
5++2
67
-8+2
{==K?EGE@<I
IEFFCG>;C:
Ef
;BC
>J:IEe>G
CffCI;
<?
>
e>;<C?;
D<;B
=CG>?E=>P
g
s1t8
R
56u+
vwwY*VZ[
\+
jU]_^*+
j+
u61
.b/2
5+x+2
67
-8+2
9ff<I<C?;
GE>H<?@
Ef
HC?HF<;<I
ICGG:
fEGGED<?@
IFrE
>?H
F>H<EfFCKC?Ir
>JG>;<E?
<?
IE=J<?>;<E?
D<;B
<==K?C
=EHKG>;<E?
<?HKIC:
>?;<p;K=EKF
<==K?<;rP
.
R
S-1T6.2
UVV`+
W#YkZ[
\+
 j`_jV]+
*V+
6.~0102
+2
67
-8+2
>H<EfFCKC?Ir
;BCF=>G
>JG>;<E?
Ef
BCe>;EICGGKG>F
I>FI<?E=>
G<|CF
?EHKGC:
I>?
>I;<|>;C
>?H
C?B>?IC
;K=EFp:eCI<f<I
qpICGG
FC:eE?:C:P
S-1T6.
}6h2
UVV`+
wwYUZ[
\+
**^j_!`+
**+
6.~0102
+2
67
-8+2
{?IFC>:CH
<==K?E:;<=KG>;EFr
>I;<|<;r
IE?fCFFCH
;E
>?;<@C?peFC:C?;<?@
ICGG:
Jr
CeE:KFC
;E
>?;<@C?
C;F>I;
fFE=
BCe>;EICGGKG>F
I>FI<?E=>
>f;CF
F>H<EfFCKC?Ir
;BCF=>G
>JG>;<E?P
R
Q1b76.2
UVV +
v"Y^Z[
\+
Uk*_ U+
*U+
x-1h86.2
R+2
67
-8+2
I;<|>;<E?
>?H
HF>=>;<I>GGr
<?IFC>:CH
Ir;EGr;<I
>I;<|<;r
Ef
;K=EF
:eCI<f<I
q
Gr=eBEIr;C:
>f;CF
F>H<EpfFCKC?Ir
>JG>;<E?
<?
e>;<C?;:
D<;B
BCe>;EICGGKG>F
I>FI<?E=>
>?H
IEGEFCI;>G
G<|CF
=C;>:;>:C:P
nb.8u
R
-h7.b6176.b82
UVV`+
"YU^Z[
\+
^k*`_
U*+
*^+
x0.b0h02
l+2
67
-8+2
o;FE?@
d
qpICGG
FC:eE?:C:
>@><?:;
;K=EFp>::EI<>;CH
>?;<@C?:
eFEGE?@
;BC
FCIKFFC?ICpfFCC
<?;CF|>G
>f;CF
;K=EF
;FC>;=C?;
<?
e>;<C?;:
D<;B
BCe>;EICGGKG>F
I>FI<?E=>P
R
-h7.b6176.b82
UV*V+
X#Y!Z[
\+
!]*_ +
*!+
Rb1hb12
s+s+2
67
-8+2
>H<EfFCKC?Ir
>JG>;<E?
IE=J<?CH
D<;B
op{N
<==K?EIr;E<?C
9d
NO
FC:KG;:
<?
>?
C?B>?ICH
>?;<;K=EF
CffCI;
>@><?:;
=KF<?C
IEGE?
>HC?EI>FI<?E=>P
S801
S-1T6.
}6h2
UVVj+
"#Y*]Z[
\+
! k]_ !+











 !
"!#
$%&'()*+
-#.#+
/0
(1#+
23456789:;9<=>
3@A3B56<
67
=6A689=B3A
A5C98
D9B3EB3E9E
5<4;=9E
3<
5<7A3DD3B68>
89EF6<E9
5<
45EB3<B
G9F3B5=
D9B3EB3E9E
@;B
<6B
5<
A6=3A
3==9A983B94
6;BH86IBGJ
K
LMNO
PQRS1+
TU"U#
VWVXYZ[
*#
!!"\]#
"]#
^_(NM+
`#+
/0
(1#+
a<D3Eb5<H
67
3AFG3c79B6F86B95<cEF9=575=
defghi
j
=9AA
89EF6<E9E
5<
G9F3B6=9AA;A38
=38=5<6D3
F3B59<BE
;<498H65<H
9D@6A5k3B56<J
K
l))MQS1+
TUUY#
VmnXoZ[
*#
"p"q\TT#
"Y#
-%rM'Sst%+
u#+
/0
(1#+
d6DF383B5C9
3<3A>E5E
67
C3856;E
B;D68c3EE6=53B94
3<B5H9<cEF9=575=
Bc=9AA
89EF6<E9E
5<
F3B59<BE
I5BG
G9F3B6=9AA;A38
=38=5<6D3J
v/*(0S1SO_+
TU""#
wxXqZ[
*#
"TU]\"]#
" #
yNS)%+
L#^#+
/0
(1#+
23456789:;9<=>
3@A3B56<
5<4;=9E
3<B5H9<cF89E9<B5<H
=9AA
5<75AB83B56<
3<4
3DFA575=3B56<
67
I93b
B;D68c5<4;=94
5DD;<5B>J
z({%S1SO_+
TUUp#
|wVX"Z[
*#
! \]]#
"p#
LS(Q/s+
.#^#+
z#K#
^}1%Q+
(Q{
-#K#
~SQ{/N+
29D5EE56<
67
D9B3EB3B5=
A9E56<E
76AA6I5<H
=8>6E;8H98>
5<
F86EB3B5=
=3<=98
5DD;<6A6H5=
=6<E54983B56<EJ
K
NS1+
"pYU#
VWX"Z[
*#
"!q\p#
TU#
LS(Q/s+
.#^#+
-#K#
~SQ{/N+
(Q{
z#K#
^}1%Q+

F6EE5@A9
5DD;<6c=8>6BG98D5=
89EF6<E9
5<
F86EB3B5=
=3<=98J
1%Q
z({%S1+
"pYU#
|VXoZ[
*#
T!o\!#
T"#
L(QRt/r\PN0%r+
z##+
/0
(1#+
F6<B3<96;E
89H89EE56<
67
F;AD6<38>
D9B3EB3E9E
786D
89<3A
=9AA
=38=5<6D3
37B98
83456
789:;9<=>
3@A3B56<
67
F85D38>
B;D68
3<
5<
E5B;
B;D68
C3==5<9
K
NS1+
TUUo#
VmWX"Z[
*#
"Y \p#
TT#
.(%0r+
z#+
/0
(1#+
6B9<B
5<4;=B56<
67
B;D68
5DD;<5B>
@>
=6D@5<5<H
B;D68
=8>63@A3B56<
I5BG
3<B5cdjcf
BG983F>J
(QR/N
z/s+
TU"T#
m|XTZ[
*#
qoU\p#
To#
{/Q
NS'+
-#v#+
/0
(1#+
><98H>
@9BI99<
5<
E5B;
=8>63@A3B56<
3<4
j2
EB5D;A3B56<
89E;ABE
5<3
G5HGA>
9779=B5C9
5<
C5C6
49<485B5=
=9AA
C3==5<9J
(QR/N
z/s+
TUU]#
X"qZ[
*#
YT !\pT#
Tq#
-R$//1+
y#~#+
/0
(1#+
G3E9

B853A
67
B89D9A5D;D3@
5<
=6D@5<3B56<
I5BG
EG68BcB98D
3<486H9<
49F85C3B56<
5<
F3B59<BE
I5BG
c89=;889<B
F86EB3B9
=3<=98J
(QR/N
l))MQS1
l))MQS0t/N+
TU"T#
VXYZ[
*#
""oY\qY#
T!#
(Nt%Q%+
^#^#+
/0
(1#+
379B>
3<4
9775=3=>
67
=6D@5<3B56<
5DD;<6BG983F>
I5BG
5<B987986<
3A73c@
3<4
B89D9A5D;D3@
5<
F3B59<BE
I5BG
EB3H9

D9A3<6D3J
K
1%Q
PQRS1+
TU"T#
xWXoZ[
*#
oTT\ #
T]#
PO(Q/s_(Q+
#+
/0
(1#+
B8;=B;83A
=G383=B985k3B56<
67
3
G;D3<
=
783HD9<B
9<H5<99894
768
A3=b
67
9779=B68
7;<=B56<EJ
^R0(
N_s0(11SON(*t%R(
L/R0%SQ
y\%S1SO%R(1
N_s0(11SON(*t_+
TUU #
[
*#
YUU\YUq#
TY#
L(QONS+
#+
/0
(1#+

=A5<5=3A
B853A
67
djcf
@A6=b349
I5BG
B89D9A5D;D3@
5<
F3B59<BE
I5BG
G9F3B6=9AA;A38
=38=5<6D3
3<4
=G86<5=
G9F3B5B5E
dJ
K
v/*(0S1+
TU"o#
wX"Z[
*#
 "\ #
T #
/1/N+
#+
/0
(1#+
=B5C5B>
3<4
E379B>
67
djcf
@A6=b349
=6D@5<94
I5BG
C3==5<9E
5<
=><6D6AH;E
D3=3:;9EJ
K
l))MQS1+
TUUo#
VmVX""Z[
*#
]T!"\p#
Tp#
y(Q%1S%R+
y#`#+
/0
(1#+
d6889A3B56<E
67
djcf
H9<9
F6A>D68FG5EDE
3<4
G9F3B5B5E
d
=G86<5=5<79=B56<J`%/NlQ0+TU"T#x|X!Z[*# Uo\ #











 !
"#$
%&'(
*$(
+,
&-$(
.//01234205/
7849885
1:4040;21
<
=:>?@01:48A3//012348B
3542C85AD
?0=:>0E?@2/>/
35B
/8EF>
4F>0E
581E0/2/
G3140EA3=?@3
35B
2548EG8E05AC3>>3
=8H8=/
25
?342854/
924@
1@E0521
@8?34242/
I
H2EF/
25G814205J
K'L-&MM
N+O(
P#QQ$
RSTQQUV
W$
Q#XQY $
"Q$
Z[,\]^+-(
_$(
+,
&-$(
`21E0720>8
35B
.54213518E
a>>F50/FEH82==3518J
b+--(
P#Q!$
cRdTPUV
W$PX!YP X$
"P$
efO,['
g$
hfLLi(
j$k$l$YN$(
m[n
o
p+qr&q(
h&\[n
s
p-+['+q(
mft&''+
u[]q&\&',[(
l+-[OO&
v&-r+q(
m,+Ww&'[+
b&q+i(
v[--[&M
h]f^-&O
u[^^(
m+,w
l$
m,+['x+q^(
k[y,]q[&
e'n+qO]'(
z&n['+
ex[Y{&]fn+w(
s--[],
_+\[(
|q&nL]qn
{$
v]]n(
}[M
u$
gq+,+'(
.
?2=04
/4FB:
0G
4E8>8=2>F>37
~
3
>0501=053=
354270B:
3C325/4
<.AD
~
25
10>72534205
924@
824@8E
4E35/
134@848E
3E48E23=
1@8>08>70=234205
<.
0E
E3B20GE8F851:
37=34205
.
25
?342854/
924@
@8?34018==F=3E
13E1250>3
J
{
b-['
j'y]-
P#Q$
$
""$
hfLLi(
e$g$(
+,
&-$(
<E8>8=2>F>37
25
10>72534205
924@
37=34205
25
?342854/
924@
3BH3518B
@8?34018==F=3E
13E1250>3J
{]fq'&-
]L
%+W&,]-]^i(
P#QX$
RRT"UV
W$
YQ$
"$
|q&wM+q(
{$N$(
+,
&-$(
3G84:
35B
3142H24:
0G
3542AA
354270B:
25
?342854/
924@
3BH3518B
13518EJ
z
s'^-
{
l+n(
P#QP$
RRTP!UV
W$
PY!$
"$
}]W&-[&'(
m$_$(
+,
&-$(
3G84:
3142H24:
35B
2>>F58
10EE8=348/
0G
3542AA
354270B:
25
13518EJ
z
s'^-
{
l+n(
P#QP$
RRTP!UV
W$
P"Y$
"!$
p]q&'^i(
u$(
+,
&-$(
?0543580F/
4F>0EA/?812G21
@F>0E3=
35B
18==F=3E
2>>F58
E8/?05/8/
40AA
25
@8?34018==F=3E
13E1250>3J
b-['
b&'y+q
N+O(
P##$
cSTQ"UV
W$
""PYQ$
"X$
s[O+'w&f+q(
s$e$(
+,
&-$(
89
E8/?05/8
8H3=F34205
1E248E23
25
/0=2B
4F>0FE/
8H2/8B
a<
CF2B8=258
H8E/205
JJ
sfq]W+&'
{]fq'&-
]L
b&'y+q(
P##$
dTPUV
W$
PP YPX$
" $
NfO,['(
g${$m$(
+,
&-$(
8
89
CF2B8=258/
40
8H3=F348
4@8
E8/?05/8
40
4E834>854
25
/0=2B
4F>0E/
0H3E235
13518EJ
{]fq'&-
]L
,w+
z&,[]'&-
b&'y+q
K'O,[,f,+(
P##$
RT!UV
W$
 XY
  $
"$
|fx-+i(
g${$(
+,
&-$(
=2C272=24:
35B
E8/?05/8
CF2B8=258/
G0E
?@3/8
aa
1=25213=
4E23=/
25
35BE0C85A25B8?85B854
?E0/4348
13518E
810>>85B34205/
GE0>
4@8
?E0/4348A/?812G21
3542C85
90E25C
CE0F?J
{]fq'&-
]L
b-['[y&-
j'y]-]^i(
Q$
cTQQUV
W$
"!QY"!X$
#$
myw+q(
%$K$(
+,
&-$(
8/2C5
35B
85B
?0254/
0G
1=25213=
4E23=/
G0E
?342854/
924@
?E0CE8//2H8
?E0/4348
13518E
35B
13/4E348
=8H8=/
0G
48/40/48E058
810>>85B34205/
0G
4@8
?E0/4348
13518E
1=25213=
4E23=/
90E25C
CE0F?J
{]fq'&-
]L
b-['[y&-
j'y]-]^i(
P## $
RTXUV
W$
QQ Y
QQ$
Q$
k+q^],+(
K$(
+,
&-$(
8
89
CF2B8=258/
40
8H3=F348
4@8
E8/?05/8
40
4E834>854
25
/0=2B
4F>0E/
0H3E235
13518EJ
{]fq'&-
]L
,w+
z&,[]'&-
b&'y+q
K'O,[,f,+(
P###$
TQ UV
W$
Q"Y
Q"$
P$
hfLLi(
e$g$(
+,
&-$(
.
?@3/8
aa
/4FB:
0G
<
25
?342854/
924@
@8?34018==F=3E
13E1250>3
9@0
@3H8
?E0CE8//8B
05
/0E3G8527J
'[,+n
sfq]W+&'
g&O,q]+',+q]-
{(
P#Q$
TUV
W$
"Y
!Q$
"$
-&w&''&'(
m$k$(
+,
&-$(
aB8542G2134205
0G
3142H8
1@8>04@8E3?:
E8C2>85/
25
3BH3518B
72=23E:4E31413E1250>33E8H2890G1@8>04@8E3?:4E23=/254@8?3/4490B813B8/J%+W&,
j'y]-(P#Q$TQUVW$"Y#$











 !
"# $%%&'()*&+
"#,"-../0123
-
6%&7897:$'*&
+;$;<+
*7);&7)$
&*9=
%>?@A?BCDE>
+FCFGH
+ECI>
JKL1/
M/NOK2.P2Q0N
R
SQKTLU
LOP2V2PWX
YZUUW
LOP2V/[
L\U/
PQ
OLKKW
Q0
LUU
.K/]12N/LN/
./K^QKTL0O/
_2P`QZP
K/NPK2OP2Q0X
a
bWT.PQTN[
\ZP
LT\ZULPQKWX
c/NPK2OP/1
20
.`WN2OLUUW
NPK/0ZQZN
LOP2V2PW[
\ZP
LT\ZULPQKW
L01
L\U/
PQ
OLKKW
QZP
_QKd
Q^
L
U2e`P
QK
N/1/0PLKW
0LPZK/
f/XeX[
U2e`P
`QZN/_QKd[
Q^^2O/
_QKdgX
h
i0
\/1
jkRl
Q^
P`/
P2T/X
-T\ZULPQKW
L01
OL.L\U/
Q^
LUU
N/U^]OLK/[
\ZP
Z0L\U/
PQ
OLKKW
QZP
L0W
_QKd
LOP2V2P2/NX
m.
L01
L\QZP
TQK/
P`L0
kRl
Q^
_Ld20e
`QZKNX
n
i0
\/1
okRl
Q^
P`/
P2T/X
pL.L\U/
Q^
Q0UW
U2T2P/1
N/U^]OLK/[
OQ0^20/1
PQ
\/1
QK
O`L2K
TQK/
P`L0
kRl
Q^
_Ld20e
`QZKNX
q
aRRl
\/1K211/0X
pQT.U/P/UW
12NL\U/1X
pL00QP
OLKKW
Q0
L0W
N/U^]OLK/X
rQPLUUW
OQ0^20/1
PQ
\/1
QK
O`L2KX
k
M/L1X
"#,s 
$%%&'()t
u
6

*v)w(6%<=v
*w$++)8)*$;)9'
+x+;&:











  











 !
"#$% 
'(()*+,-
./

01+,2,)+
,003*)45)6'7)+
5)8(1*8)
.5,7)5,'
9
,55.:
;<=>@ABCDE>>=F=CEG=H@
=>
IE>AJ
H@
G<A
KACA@G
DAEK@=@L
FKHM
CD=@=CED
>GNJ=A>
B=G<
CE@CAK
=MMN@HG<AKEO=A>
G<EG
APA@
=F
>HMA
@AB
DA>=H@>
EOOAEK
EG
G<A
IAL=@@=@L
HF
E
GKAEGMA@G
HK
=F
G<A
GHGEDGNMHK
INKJA@
JHA>
@HG
=@CKAE>A
>NI>GE@G=EDDQR
GNMHK
KALKA>>=H@>
HK
>GEI=D=SEG=H@>
M=L<G
>G=DD
HCCNKDEGAKT
;<A
=KUV
BAKA
CKAEGAJ
N>=@L
I=WJ=MA@>=H@ED
MAE>NKAMA@G>
XE>
OKAP=HN>DQ
B=JADQ
N>AJ=@G<A
YHKDJ
ZAEDG<
[KLE@=SEG=H@
CK=GAK=E\T
]HK
G<=>
GK=EDR
G<A
CH@CAOG>
HF
G<A
=KUV
EKA
CHMI=@AJB=G<
U^V_`;
aTa
GH
CHMA
NO
B=G<
G<A
MHJ=F=AJ
=KUVT
]HKMHJ=F=AJ
=KUVR
H@DQ
GEKLAG
E@J
MAE>NKEIDA
DA>=H@>
EKA
GEbA@
=@GH
ECCHN@GT
_@
CH@GKE>G
GH
G<A
U^V_`;aTa
CK=GAK=ER
G<A
MHJ=F=AJ
=KUV
CK=GAK=E
XE\
KAcN=KA
CH@F=KMEG=H@
HF
IHG<
OKHLKA>>=H@
E@J
KA>OH@>AIQ
=MEL=@L
EG
d
BAAb>
EFGAK
=@=G=ED
=MEL=@L
E@J
XI\
JH
@HG
@ACA>>EK=DQ
>CHKA
G<A
EOOAEKE@CA
HF
@AB
DA>=H@>
E>
OKHLKA>>=PA
J=>AE>A
=F
G<A
>NM
HF
DA>=H@
J=EMAGAK>
HF
GEKLAG
DA>=H@>
XM=@=MNM
HF
ae
MM
OAK
DA>=H@R
MEf=MNM
HF
g
GEKLAG
DA>=H@>R
MEf=MNM
HF
h
OAK
HKLE@\
E@J
MAE>NKEIDA
@AB
DA>=H@>
JHA>
@HG
=@CKAE>A
IQ
i
hejT
;<A>EMAMAG<HJ
HF
E>>A>>MA@G
E@J
G<A
>EMA
GAC<@=cNA
><HNDJ
IA
N>AJ
GH
C<EKECGAK=SA
AEC<
=JA@G=F=AJE@J
KAOHKGAJ
GEKLAG
DA>=H@X>\
EG
IE>AD=@AR
JNK=@L
G<A
GK=EDR
E@J
EG
G<A
A@J
HF
GK=ED
P=>=GT
kDDMAE>NKAMA@G>
><HNDJ
IA
KACHKJAJ
=@
MAGK=C
@HGEG=H@T
;<A
MHJ=F=AJ
=KUV
IE>AJ
H@
U^V_`;
aTaEKAJ=>ODEQAJ
IADHBT











 !
"#$%&'')$*+,-*$*
.$%/#$0
1%,2
34&-5$*
/-
6-0$78
9,-:6-0$78
&-0
9$;
<$*/,-*











 !
"#$% 
'(()*+,-
+
.

/)+,//0*)
1'/(2)
(3)('3'4,5*
(356)+03)1
789:;<77>
>:?8
!@A9BC;BDE;:;
FGH:;8
GI
?HGGJ
EKLG
MGHJ
LGN
77>
L:?8
OPQ@
R8SG9J
LE;8
GI
SGHH8SLEGK@
T@U8KLHV
EKF89L
W
LE;8P@
X@YHHGC
LZ8
?HGGJ
LG
SHGL
IG9
X[
;EK:L8P
BL
9GG;
L8;N89BL:98@
\@]8KL9EI:M8
CELZEK
T
ZG:9P
GI
SGHH8SLEGK
BL
!![[
<!X[[
M
IG9
!W
;EK:L8P@
W@>9BKPI89
P89:;
EKLG
HB?8H8J
S9VGFEBHP@
^@_;;8JEBL8HV
I988`8
LZ8
S9VGFEBHP
:N9EMZL
BL
<T[a]
G9
SGHJ89@
b@7LG98BL
<T[a]
G9
SGHJ89
:KLEH
PZEN;8KL
GK
J9V
ES8@
cHBP;B<dT
eA>Y
>:?8
!@ A9BC;BDE;:;
FGH:;8
GI
?HGGJ
EKLG
HBF8KJ89
LGN
dT
eA>Y
L:?8OPQ@
R8SG9J
LE;8
GI
SGHH8SLEGK
T@U8KLHV
EKF89L
f
LG
![
LE;8P@
X@]8KL9EI:M8
CELZEK
T
ZG:9P
GI
SGHH8SLEGK
BL
!![[
<!X[[
M
IG9
![
;EK:L8P@
\@>9BKPI89
NHBP;B
EKLG
HB?8H8J
S9VGFEBHP@
W@_;;8JEBL8HV
I988`8
LZ8
S9VGFEBHP
:N9EMZL
BL
<T[a]
G9
SGHJ89@
^@7LG98BL
<T[a]
G9
SGHJ89
:KLEH
PZEN;8KL
GK
J9V
ES8@
>:?8gB?8H
PZG:HJ
EKSH:J8h
!@cBLE8KL_J8KLEIE89
T@7B;NH8
_A
O789:;
!i
]VSH8
!i
ABV
!8LS@Q
X@7B;NH8
LVN8
ONHBP;Bi
P89:;Q
\@7B;NH8
FGH:;8
W@]GHH8SLEGK
LE;8
^@jB9SGJ8OEILZEPPVPL8;EPBFBEHB?H8Q











 !
"#$% &''()*+,
(
.

*&/&
0122(0/+1)
(2(3()/4
5(67+5(*
89
3&)7:&0/75(5
;<=>?@>>=>BC@
DEFF
G>
?>HI?<><
J@EBK
L
?>HIKBEM><
N><EHLF
C>?N
I?
<ELKBI@E@
COLC
LHHJ?LC>FP
?>QF>HC@CO>
>=>BCR
;<=>?@>
>=>BC@
DEFF
G>
L@@>@@><
GP
CO>
EB=>@CEKLCI?
QI?
@>=>?ECPS
?>FLCEIB@OET
CI
CO>EB=>@CEKLCEIBLF
T?I<JHCS
TI@@EGF>
>CEIFIKE>@S
LB<
DO>CO>?
CO>
>=>BC
N>>C@
H?EC>?EL
IQ
LB
U;V
LB<CO>?>QI?>
?>WJE?>@
ENN><ELC>
BICEQEHLCEIB
CI
;@C?LX>B>HLYZ><[NNJB>
\LCE>BC
ULQ>CPR
/]^_`aa`bcde
fghcgia^j
bcaa
i^
k`aa^kl^m
_`h
^gk]
&(n
o ;V
pqrq;V
=>?@EIB
sRtu
o rO>
<LC>
LB<
CEN>
DO>B
CO>
;V
@CL?C><
LB<
@CITT><
o qOLBK>@
EB
vq[
qrq;V
K?L<>
LB<
CO>
NLwENJN
qrq
K?L<>
LCCLEB><
o xO>CO>?
CO>
;V
E@
@>?EIJ@
I?
BIC
o [B=>@CEKLCI?
HLJ@LFECP
?LCEBK
LKLEB@C
<J?=LFJNLG
I?
C?>N>FENJNLG
pP>@
I?
BIu
o ;HCEIB
CLy>B
DECO
?>KL?<
CI
<J?=LFJNLG
z
C?>N>FENJNLGY
HINGEBLCEIB
LK>BC
o {JCHIN>
+dgmmclc`d|
l]^
_`aa`bcde
fghcgia^j
bcaa
i^
k`aa^kl^m
_`h
4&(j
gj
g}}ackgia^n
o ~LC>
;V
N>C
H?EC>?EL
QI?
@>?EIJ@
;V
o ~LC>
[B=>@CEKLCI?
G>HLN>
LDL?>
IQ
@>?EIJ@
;V
o ;V
E@
@>?EIJ@
<J>
CI
T?ICIHIF
CO>?LTPR
o ~LC>
IQ
OI@TECLFEMLCEIB
o ~LC>
IQ
<E@HOL?K>
o \?IGLGF>
HLJ@>
IQ
<>LCO
o ~LC>
IQ
<>LCO
o ;JCIT@P
T>?QI?N><
o ~>@H?ETCEIB
IQ
;V
o qLJ@LFECP
L@@>@@N>BC
EB
?>FLCEIB
CI
UCJ<P
T?IH><J?>p@u
V=>BC@SDOEHO
L?>
JB>WJE=IHLFFP
<J>
CI
<E@>L@>
T?IK?>@@EIBS
@OIJF<
BIC
G>
?>TI?C><
L@
LB
;V
<J?EBKCO>
@CJ<PR
4lmh^k`hmcde
}^hc`m
gdm
_`aa`b.}
_`h
gmf^hj^
^f^dlj
gdm
j^hc`j
gmf^hj^
^f^dlj
;<=>?@>>=>BC@
LB<
@>?EIJ@
L<=>?@>
>=>BC@
DEFF
G>
?>HI?<><
Q?IN
CEN>
IQ
@EKBLCJ?>
IQ
EBQI?N><
HIB@>BCSCO?IJKOIJC
CO>
C?>LCN>BC
T>?EI<
LB<
EBHFJ<EBK
CO>
QIFFIDJT
T>?EI<
p t
<LP@
LQC>?
CO>
FL@C<I@>IQ
<J?=LFJNLG
z
C?>N>FENJNLGuR
~J?EBKCO>
HIJ?@>
IQ
CO>
@CJ<P
LFF
;V@
LB<
U;V@
@OIJF<
G>
T?ILHCE=>FP
QIFFID><
JT
QI?
>LHO
@JG>HCRV=>?P>QQI?C@OIJF<G>NL<>CIIGCLEBL?>@IFJCEIBQI?LFF>=>BC@S>=>BEQCO>>=>BC@
HIBCEBJ>LQC>?<E@HIBCEBJLCEIBY@CJ<PHINTF>CEIBR











 !
"#%&'()*+,
-.&+/0,.0'*&
#1/2
,1*%,2*0,
#/1
1*%&/0&
/,3*1
,3%0
-.&*%&*
41/51*&&./06
%0-
,3*1*#/1*
+/0,.0'*&,/
3%7*
,'2/1
%&&*&&2*0,&6
-1'5
/1
41/+*-'1*81*9%,*-
:;<&
2'&,
(*
+%4,'1*-
'0,.9
,3*
4%,.*0,.&+/0&.-*1*-
,/
3%7*
+/0#.12*-
=>
%0-
?.99
3%7*
0/
#'1,3*1
,'2/1
%&&*&&2*0,&@
A3*.07*&,.5%,/1
.&
1*&4/0&.(9*
#/1
#/99/?.05
%99
:;<&
'0,.9
1*&/9',./06
'0,.9
,3*
&'()*+,
1*,'10&
,/
(%&*9.0*&,%,'&6
/1
'0,.9
,3*
+/0-.,./0
3%&
&,%(.9.B*-
?.,3
,3*
*C4*+,%,./0
,3%,
.,
?.99
1*2%.0
+31/0.+6*7*0
.#
,3.&
*C,*0-&
(*D/0-
&,'-D
4%1,.+.4%,./0@











 !
"#$#%&&'()*+
-.

)/0*(1
2/)*-*3%4*/(
%()
4/+*3*45
2%(%1'2'(4
16*)'7*('0
84219

-/:
*226(';
2')*%4')<

*(-60*/(;:'7%4')<

%()
(/(;*226('=2')*%4')
:'%34*/(0
8)6:>%762%?
2/(/4@':%&5
/:
*(
3/2?*(%4*/(
A*4@
/4@':
&:/)63409

"B
/34/?':
CDCD











 !
"#$#%&'
)*$+,-#%&.,*$+
%#/&%-,$/
0112$#34#-,&.#-
5#&6.,*$+
7*+#
4*-,8,6&.,*$+
9*:,6,.;
4&$&/#1#$.
<=>?
ABCDEDFG=AGDHE
CHBDIDJAGDHEF
HI
FG>BK
B=>?LFG>BK
=M?DCME
NDOO
PM
CABM
GH
CAEA?M
QHGMEGDAO
DCC>EMR=MOAGMB
STF
PAFMB
HE
FMUM=DGK
HI
G=MAGCMEGRMCM=?MEG
GHVDJDGDMF
?=ABMB
QM=
WXY
XZXST
U![\[
YEABBDGDHE
GH
G]M
J=DGM=DA
IH=
QM=CAEMEG
BDFJHEGDE>AGDHE
HI
FG>BK
B=>?LFG>BK
=M?DCME
PAFMB
HE
XZX
?=ABMLFMUM=DGK
^GAPOM
PMOHN_`
QM=CAEMEGOK
BDFJHEGDE>M
FG>BK
B=>?LFG>BK
=M?DCME
IH=
G]M
IHOOHNDE?
JHEBDGDHEFa
b
YEAPDODGK
GH
=MB>JM
JH=GDJHFGM=HDB
GH
A
BHFM
HI
cde
C?
HI
Q=MBEDFHEM
QM=
BAK
^H=
Mf>DUAOMEG_
g,.h,$
ij
g##k+
HI
G]M
FGA=G
HI
G]M
DCC>EMRCMBDAGMB
ABUM=FM
MUMEG
^DCST_
b
l=ABM
m
=MJ>==MEJM
HI
A
Q=MUDH>FOK
MVQM=DMEJMB
G=MAGCMEGR=MOAGMB
DCST
IHOOHNDE?
=MF>CQGDHE
HI
BHFDE?
"%&-#
i
WH
BHFM
CHBDIDJAGDHE
"%&-#
j
nHOB
FG>BK
B=>?LFG>BK
=M?DCME
BHFM
>EGDO
l=ABM
o
=MFHO>GDHE
GHl=ABM
cdp
YI
GHVDJDGK
NH=FMEF`
G]ME
G=MAG
AF
l=ABM
m
H=
l=ABM
q[
rG>BK
B=>?LFG>BK
=M?DCME
JAE
PM
=MF>CMB
HEJM
MUMEG
FGAPDODsMF
GH
l=ABM
cd
AIGM=
JHCQOMGDHE
HI
FGM=HDB
GAQM=[
tAGDMEGF
NDG]
MEBHJ=DEHQAG]DMF
N]H
CAK
=Mf>D=M
Q=HOHE?MB
H=
JHEGDE>MB
FGM=HDB
=MQOAJMCMEG
JAE
PM
=MG=MAGMB
NDG]
FG>BK
B=>?LFG>BK
=M?DCME
HE
G]M
IHOOHNDE?
JHEBDGDHEFa
u[ Z]M
MUMEG
FGAPDODsMF
AEB
DF
JHEG=HOOMB[
o[ Z]M
QAGDMEG
DF
JODEDJAOOK
FGAPOM
AF
QM=
YEUMFGD?AGH=
H=
G=MAGDE?
Q]KFDJDAEvF
JODEDJAO
w>B?MCMEG[
m[ <HFMF
HI
Q=MBEDFHEM
A=M
AG
cde
C?LBAK
H=
Mf>DUAOMEG[
YG
DF
=MJHCCMEBMB
G]AG
CAEA?MCMEG
HI
DCC>EMRCMBDAGMB
ABUM=FM
MUMEGF
^DCSTF_
IHOOHNF
G]M
?>DBMODEMF
Q=MFMEGMB
DE
G]DF
GAPOMa
x
YG
DF
QHFFDPOM
G]AG
MUMEGF
NDG]
AE
DEIOACCAGH=K
H=
DCC>EM
CMBDAGMB
CMJ]AEDFC
JH>OB
HJJ>=
DE
EMA=OK
AOO
H=?AEF`
FHCM
HI
G]MC
EHG
EHGMB
FQMJDIDJAOOK
DE
G]MFM
?>DBMODEMF[
x
y]MG]M=
FQMJDIDJ
DCC>EMRCMBDAGMB
MUMEGF
^AEBLH=
OAPH=AGH=K
DEBDJAGH=F
HI
F>J]
MUMEGF_
A=M
EHGMB
DE
G]MFM
?>DBMODEMF
H=
EHG`
QAGDMEGF
F]H>OB
PM
G]H=H>?]OK
MUAO>AGMB
GH
=>OM
H>G
AEK
AOGM=EAGDUM
MGDHOH?K
^M[?[`
BDFMAFM
Q=H?=MFFDHE`
JHEJHCDGAEG
CMBDJAGDHEF`
AEB
DEIMJGDHEF_
GH
A
QHFFDPOM
DCC>EMR
CMBDAGMB
MUMEG[
YE
G]M
APFMEJM
HI
A
JOMA=
AOGM=EAGDUM
MGDHOH?K`
AOO
F>J]
MUMEGF
F]H>OB
PM
CAEA?MB
AF
DI
G]MK
NM=M
DCC>EM
=MOAGMB[
lMEM=AO
=MJHCCMEBAGDHEF
IHOOHN[
x
rKCQGHCAGDJ
AEB
GHQDJAO
G]M=AQK
F]H>OB
PM
JHEFDBM=MB
IH=
OHNR?=ABM
^l=ABM
u
H=
o`
>EOMFF
HG]M=NDFM
FQMJDIDMB_
MUMEGF[
x
zH=
QM=FDFGMEG
^{m
GH
!
BAKF_
OHNR?=ABM
^l=ABM
o_
H=
FMUM=M
^l=ABM
|}~
MUMEGF`
Q=HCQGOK
FGA=G
Q=MBEDFHEM
u
GH
o
C?L?LBAK
t
H=
Y
Mf>DUAOMEG[
x
rHCM
MUMEGF
NDG]
]D?]
ODMOD]HHB
IH=
CH=PDBDGK
AEBLH=
CH=GAODGK

M[?[`
CKHJA=BDGDF`
H=
HG]M=
FDCDOA=
MUMEGF
MUME
DI
G]MK
A=M
EHG
J>==MEGOK
EHGMB
DE
G]M
?>DBMODEMF

F]H>OB
Q=H?=MFF
=AQDBOK
GH
]D?]
BHFM
Y
JH=GDJHFGM=HDBF
^CMG]KOQ=MBEDFHOHEM
AG
o
GH
q
C?L?LBAK_
MUME
DI
G]M
MUMEG
DF
l=ABM
o`
AEB
DI
JODEDJAO
F>FQDJDHE
DF
]D?]
AEBLH=
G]M=M
]AF
PMME
JODEDJAO
JHEID=CAGDHE[
XHEFDBM=`
AF
EMJMFFA=K`
BDFJ>FFDE?
NDG]
G]M
FG>BK
Q]KFDJDAE`
AEB
Q=HCQGOK
Q>=F>M
FQMJDAODFG
JHEF>OGAGDHE[
x
YI
FKCQGHCF
=MJ>=
H=
NH=FME
B>=DE?
JH=GDJHFGM=HDB
GAQM=DE?
^o
BAKF
HI
GAQM=_`
DEJ=MAFM
G]M
JH=GDJHFGM=HDB
BHFM
^Q=MBEDFHEM
BHFM
M[?[`
>Q
GH
o
GH
q
C?L?LBAK
t
H=
Y
Mf>DUAOMEG_
>EGDO
FGAPDODsAGDHE
H=
DCQ=HUMCMEG
HI
FKCQGHCF`G]ME=MF>CMJH=GDJHFGM=HDBGAQM=DE?AGAFOHNM==AGM^{oBAKFHI











 !
"#"%&'()'
'&'*+,
-.-
-/00/*
./1232+4
-(2+'(25,
-.-"#
-/00/*
.'(02*/6/74
-(2+'(25
8/(
"%&'()'
#&'*+),
20"#
2009*':0'%25+'%
5%&'()'
'&'*+,
;<
2*+(5&'*/9),
=-;
=5+2/*56
-5*3'(
;*)+2+9+',
>?
@4
0/9+AB
CDEFG
I
J'K'*%2*7
/*
+A'
2*%2&2%956
+/1232+4L
)+9%4
%(97M)+9%4
('720'*
054
N'
K'(05*'*+64
%2)3/*+2*9'%B
>6'5)'
('8'(
+/
792%'62*')
N'6/OB
CDEFG
P
>'(05*'*+64
%2)3/*+2*9'
)+9%4
%(97M)+9%4
('720'*B
=/+'Q
R/(
5)40K+/05+23
50465)'
/(
62K5)'
6'&'6)
/8
STU
VW=L
A/6%
)+9%4
%(97M)+9%4
('720'*L
5*%
28
3/0K6'+'
O/(X
9K
)A/O)
*/
'&2%'*3'
/8
K5*3('5+2+2)L
)+9%4
%(97M)+9%4
('720'*
054
N'
3/*+2*9'%
/(
(')90'%B
=/+'Q
Y+9%4
%(97M)+9%4
('720'*
)A/96%
N'
K'(05*'*+64
%2)3/*+2*9'%
2*
Z(5%'
[
'&'*+)
O2+A
A27A
62X'62A//%
8/(
0/(N2%2+4
5*%M/(
0/(+562+4
\
'B7BL
04/35(%2+2)L
/(
/+A'(
)20265(
'&'*+)
'&'*
28
+A'4
5('
*/+
39(('*+64
*/+'%
2*
+A'
792%'62*')B
Y20265(64L
3/*)2%'(
OA'+A'(
)+9%4
%(97M)+9%4
('720'*
)A/96%
N'
K'(05*'*+64
%2)3/*+2*9'%
2*
Z(5%'
T
'&'*+)
O2+A
A27A
62X'62A//%
8/(
0/(N2%2+4
5*%M/(
0/(+562+4
\'B7BL
04/35(%2+2)L
/(
/+A'(
)20265(
'&'*+)
'&'*
28
+A'4
5('
*/+
39(('*+64
*/+'%
2*
+A'792%'62*')
\
OA'*
+A'4
%/
*/+
(5K2%64
20K(/&'
+/
Z(5%'
]^
9K/*
+('5+0'*+
O2+A)4)+'023
)+'(/2%)
5*%
8/66/O2*7
8966
+5K'(
=/+'Q
.A'('
5('
)/0'
'13'K+2/*)
+/
K'(05*'*+
%2)3/*+2*95+2/*
/8
)+9%4
%(97
8/(
Z(5%'
_
'&'*+)
`2B'BL
A4K'(+A4(/2%2)0L
A4K/+A4(/2%2)0L
.4K'
^
%25N'+')
0'662+9)aB
+5K'(aB
b
c/('
K/+'*+
2009*/)9KK('))2&')
)93A
5)
.=R
2*A2N2+/()
`'B7BL
2*8621205N,
56)/
('8'(
+/
+A'
2*%2&2%956
)'3+2/*)
/8
+A'
20"#)
8/(
)K'32823
+4K'
/8
2009*/)9KK('))2&'a
)A/96%
N'
3/*)2%'('%
8/(
'&'*+)
*/+
(')K/*%2*7
+/
)4)+'023
)+'(/2%)B
>(/7('))2/*
+/
9)'
/8
0/('
K/+'*+
2009*/)9KK('))2&')
)A/96%
K(/3''%
0/('
(5K2%64
2*
'&'*+)
O2+A
A27A
62X'62A//%
8/(
0/(N2%2+4
5*%M/(
0/(+562+4
\
'B7BL
04/35(%2+2)L
/(
/+A'(
)20265(
'&'*+)
'&'*
28
+A'4
5('
*/+
39(('*+64
*/+'%
2*
+A'
792%'62*')
\
OA'*
+A')'
'&'*+)
5('
*/+
(')K/*%2*7
+/
)4)+'023
)+'(/2%)B
b
d2+A
6/*7:+'(0
)+'(/2%
5*%
/+A'(
2009*/)9KK('))2&'
9)'L
3/*)2%'(
*''%
8/(
efghijklmnom
qorjsgkoo
K*'90/*25
`>t>L
8/(0'(64
X*/O*
5)
efghijklmnom
kurofoo
K*'90/*25a
K(/KA46512)L
75)+(/2*+')+2*56
K(/+'3+2/*L
5*%
7693/)'
0/*2+/(2*7B
b
J2)3/*+2*95+2/*
/8
)+9%4
%(97M)+9%4
('720'*
2)
*/+
05*%5+'%
8/(
Z(5%'
[MZ(5%'
_
2*865005+/(4
('53+2/*)
5++(2N9+'%
+/
6/356
+90/(
(')K/*)'
`'B7BL
2*865005+/(4
('53+2/*
5+
)2+')
/8
0'+5)+5+23
%2)'5)'
5*%
640KA
*/%')aB
-/*+2*95+2/*
/8
)+9%4
%(97M)+9%4
('720'*
2*
+A2)
)2+95+2/*
)A/96%
N'
N5)'%
9K/*
5
N'*'82+:(2)X
5*564)2)
8/(
+A5+
K5+2'*+B











 !
"#$%&'&%
)**+,$-.$/&01$/
2$0%1&3,4
5/6$74$
86$,14
"$6$7&19
:70/$
3'
1;$
86$,1
<=>)
>?>58
6$74&3,
@ABC
D34$
.3/&'&%01&3,4
?3E&%&19
.0,0F$*$,1
5,9
:70/$
:$,$70G
:+&/0,%$
H37
5,9
:70/$I
J
KLMNOLP
RSONTMOU
VLP
UNWMU
SMX
UYZROLZU
LV
RMT[ZLMNONU
LP
\]^
_MT`
LMUTO
LP
`LPUTMNMW
UaLPOMTUU
LV
bPTSOa
LP
cL[Wade
fSONTMOU
UaL[gX
bT
ThSg[SOTX
`NOa
NZSWNMW
SMX
R[gZLMSPY
V[McONLM
OTUOUi
NMcg[XNMW
LOaTP
XNSWMLUONc
RPLcTX[PTU
SU
XTUcPNbTX
bTgL`e
J
j[URTcOTX
RMT[ZLMNONU
UaL[gX
bT
cLMVNPZTX
`NOa
PSXNLWPSRaNc
NZSWNMW
SMX
LOaTP
NMVTcONL[U
SMX
XNUTSUTkPTgSOTX
STONLgLWNTU
Tlcg[XTXi
SMX
ZSMSWTX
SU
XTUcPNbTX
bTgL`
J
\MNONSg
`LPmk[R
ZSY
NMcg[XT
cgNMNcSg
ThSg[SONLMi
ZLMNOLPNMW
LV
LlYWTMSONLM
hNS
R[gUT
LlNZTOPY
_PTUONMW
SMX
TlTPONLMdi
gSbLPSOLPY
`LPmk[Ri
SMX
aNWak
PTULg[ONLM
no
UcSMe
J
nLMUNXTP
f[gZLMSPY
SMX
\MVTcONL[U
^NUTSUT
nLMU[gOU
:70/$
p
_SUYZROLZSONci
cgNMNcSg
LP
XNSWMLUONc
LbUTPhSONLMU
LMgYq
NMOTPhTMONLM
MLO
NMXNcSOTXd
rL
XLUT
ZLXNVNcSONLMU
PTs[NPTXe
tL`ThTPi
cLMUNXTP
aLgXNMW
UO[XY
XP[WuUO[XY
PTWNZTM
XLUT
SU
cgNMNcSggY
SRRPLRPNSOT
SMX
X[PNMW
XNSWMLUONc
`LPmk[R
VLP
LOaTP
TONLgLWNTUe
H37
:70/$
p
<70/&3F70#;&%
%;0,F$4
3,G9CI
J
KLMNOLP
SMX
cgLUTgY
VLggL`
[R
NM
v
OL
w
XSYU
VLP
cgNMNcSg
UYZROLZUi
R[gUT
LlNZTOPY
_PTUONMW
SMX
TlTPONLMdi
SMX
gSbLPSOLPY
`LPmk[R
SMX
OaTM
SU
cgNMNcSggY
NMXNcSOTXe
J
nLMUNXTP
f[gZLMSPY
SMX
\MVTcONL[U
^NUTSUT
cLMU[gOUe
x,$+*3,&1&4y),1$741&1&0G
z+,F
D&4$04$
<)zDC
:70/$
{
_UYZROLZSONcq
ZTXNcSg
NMOTPhTMONLM
NMXNcSOTXq
gNZNONMW
NMUOP[ZTMOSg
|^]d
tLgX
UO[XY
XP[WuUO[XY
PTWNZTM
XLUT
[MONg
}PSXT
v
PTULg[ONLM
OL
}PSXT
~

\V
OLlNcNOY
`LPUTMUi
OaTM
OPTSO
SU
}PSXT

LP
}PSXT
we

\V
OLlNcNOY
NZRPLhTU
OL
}PSXT
~
OaTM
OaT
XTcNUNLM
OL
PTNMNONSOT
UO[XY
XP[WuUO[XYPTWNZTM`NggbTbSUTX
H37
:70/$
{
<*&G/
13
*3/$701$
,$
49*#13*4CI
J
KLMNOLP
UYZROLZU
XSNgY
SMX
cLMUNXTP
aLURNOSgNSONLMe
J
fPLZROgY
UOSPO
UYUOTZNc
UOTPLNXU
_TeWei
RPTXMNULMT

OL
v
ZWumWuXSY
f
LP
\
Ts[NhSgTMOde
J
TNZSWT
SU
cgNMNcSggY
NMXNcSOTXi
cLMUNXTP
naTUO
no
`NOa
cLMOPSUO
SMX
PTRTSO
NM
kw
`TTmUe











 !
"#$%
'()*'+%,
#-./+0+*%1/
02+%+0*2
3"4,5)%'
*%4
*6')(
0$5#2)'+$%
$6
/')($+4
'*#)(7
8
96
%$
+5#($:)5)%'
;+'-+%
<
'$
=
4*./>
*44+'+$%*2
;$(?"#
/-$"24
@)
0$%/+4)()4
*%4
#($5#'
'()*'5)%'
;+'-
9A
5)'-.2#()4%+/$2$%)
<
'$
B
5,C?,C4*.
/'*(')4
8
96
/'+22
%$
+5#($:)5)%'
;+'-+%
<
'$
=
4*./
4)/#+')
9A
5)'-.2#()4%+/$2$%)
*'
<
'$
B
5,C?,C4*.>
#($5#'2.
/'*('
+55"%$/"##()//+:)
'-)(*#.
/"0-
*/
DEF
+%-+@+'$(/
G)7,7>
+%62+H+5*@
*'
I
5,C?,
9A
$%0)>
5*.
@)

()#)*')4
*'
<
*%4
J
;))?/
*6')(
+%+'+*2
4$/)
*'
'-)
4+/0()'+$%
$6
'-)
'()*'+%,
#($:+4)(
K7
L*"'+$%M
9'
+/
+5#$('*%'
'$
("2)
$"'
/)#/+/
*%4
()6)(
'$
+%62+H+5*@
2*@)2
6$(
,)%)(*2
,"+4*%0)
@)6$()
"/+%,
+%62+H+5*@7
8
N%0)
'-)
#*'+)%'
+/
+5#($:+%,>
,(*4"*22.
'*#)(
/')($+4/
$:)(
OPQ
4*./
*%4
0$%/+4)(
#($#-.2*0'+0
*%'+@+$'+0/>
*%'+6"%,*2/>
$(
*%'+RSTS
'()*'5)%'
G()6)(
'$
0"(()%'
ELLE
,"+4)2+%)/
6$(
'()*'5)%'
$6
0*%0)(R
()2*')4
+%6)0'+$%/K
*
8
L$%/+4)(
S"25$%*(.
*%4
9%6)0'+$"/
U+/)*/)
0$%/"2'/7
8
L$%/+4)(>
*/
%)0)//*(.>
4+/0"//+%,
;+'-
/'"4.
#-./+0+*%7
VWXYZ
\
]W
^
G_(*4)
=M
/):)()
/.5#'$5/`
2+5+'+%,
/)26R0*()
aUb`
$H.,)%
+%4+0*')4K
G_(*4)
BM
2+6)R
'-()*')%+%,
()/#+(*'$(.
0$5#($5+/)`
"(,)%'
+%')(:)%'+$%
+%4+0*')4
c)7,7>
'(*0-)$/'$5.
$(
+%'"@*'+$%dK
S)(5*%)%'2.
4+/0$%'+%")
/'"4.
4(",C/'"4.
(),+5)%7
e]W
VWXYZ
\
]W
^
fgZhZWZ
]W
iZj
gklmn]lgo
iZjpj]WgZiqir
skm]tqXo
uqvZwnsWZXnZiqirxy
8
S($5#'2.
+%+'+*')
)5#+(+0
9A
5)'-.2#()4%+/$2$%)
z
'$
B
5,C?,C4*.
$(
){"+:*2)%'7
8
N@'*+%
S"25$%*(.
*%4
9%6)0'+$"/
U+/)*/)
0$%/"2'/`
0$%/+4)(>
*/
%)0)//*(.>
4+/0"//+%,
;+'-
/'"4.
#-./+0+*%7
8
|$/#+'*2+})
'-)
#*'+)%'7
8
~"##$('+:)
0*()
G)7,7>
$H.,)%K7
8
96
%$
+5#($:)5)%'
;+'-+%
<
'$
=
4*./>
*44+'+$%*2
;$(?"#
/-$"24
@)
0$%/+4)()4
*%4
#($5#'
'()*'5)%'
;+'-
*44+'+$%*2
+55"%$/"##()//+:)
'-)(*#.
/"0-
*/
DEF
+%-+@+'$(/
G)7,7>
+%62+H+5*@
*'
I
5,C?,
9A>
5*.
@)
()#)*')4
*'
<
*%4
J
;))?/
*6')(
+%+'+*2
4$/)
*'
'-)
4+/0()'+$%
$6
'-)
'()*'+%,
#($:+4)(
K
7
L*"'+$%M
("2)
$"'
/)#/+/
*%4()6)('$+%62+H+5*@2*@)26$(,)%)(*2,"+4*%0)@)6$()"/+%,











  
!"#$!%!&'()
*
+",-
/0-
1'/!-"/
!2
!&1345!"67
63'89'$$:
/'1-3
2/-34!82
45-3
;<=
8':2
'"8
,4"2!8-3
13410:$',/!,
'"/!(!4/!,27
'"/!#9"6'$27
'"87
!"
1'3/!,9$'37
'"/!>?@?
/3-'/&-"/
A3-#-3
/4
,933-"/
BCCB
69!8-$!"-2
#43
/3-'/&-"/
4#
,'",-3>3-$'/-8
!"#-,/!4"2D)
'
EFG
IJKLM
IMFMJKN
IOPLKFQM

















































RSJ
EFG
IJKLMT
*
U4"!/43
#43
2:&1/4&2
/0'/
&':
(-
3-$'/-8
/4
8!'330-'V-"/-34,4$!/!2
A'(84&!"'$
1'!"7
,3'&1!"67
43
,0'"6-2
!"
(4W-$
0'(!/2
29,0
'2
!",3-'2-8
#3-X9-",:
45-3
('2-$!"-
43
($448
!"
2/44$D
43
3-$'/-8
/4
(4W-$
1-3#43'/!4"
A29,0
'2
2-12!27
1-3!/4"-'$
2!6"27
'"8
!$-92D)
Y
Z0-"
2:&1/4&2
43
-5'$9'/!4"
!"8!,'/-
'
1-3#43'/!4"
!2
2921-,/-87
,4"29$/
'
2936-4"
-%1-3!-",-8
!"
'(84&!"'$
2936-3:
!&&-8!'/-$:
W!/049/
'":
8-$':)
Y
?[\U]B[B^_`
abcC+B^bBd[
c^da`
a\de
f+\
]B`
e\]a[
+f
bB^[c^bB]_

?[\f+\]^b+B
*
?'/!-"/2
2049$8
(-
/0434960$:
-5'$9'/-8
/4
39$-
49/
'":
'$/-3"'/!5-
-/!4$46:
A-)6)7
8!2-'2-
13463-22!4"7
4/0-3
&-8!,'/!4"27
43
!"#-,/!4"2D7
!",$98!"6
/-2/!"6
#43
,$42/3!8!9&
8!##!,!$-
/4%!"7
-/,)
*
c/-34!82
2049$8
(-
,4"2!8-3-8
!"
/0-
'(2-",-
4#
,$-'3
'$/-3"'/!5-
-/!4$46:7
-5-"
#43
$4W>63'8-
-5-"/27
!"
438-3
/4
13-5-"/
14/-"/!'$
13463-22!4"
/4
0!60-3
63'8-
-5-"/7
!",$98!"6
1-3#43'/!4")
*
d2-
'"'$6-2!,2
,'3-#9$$:g
/0-:
,'"
&'2h
2:&1/4&2
4#
1-3#43'/!4"
'"8
1-3!/4"!/!2)
iPKJJjMKklSNPmPn
oKJpM
PFmMnmPFM
qMJrSJKmPSFksFmMnmPFM
qMJrSJKmPSF
IJKLM
t
Aa!'330-'u
2/44$
#3-X9-",:
4#
vw
45-3
('2-$!"-
1-3
8':D
AC4$!/!2u
'2:&1/4&'/!,g
,$!"!,'$
43
8!'6"42/!,
4(2-35'/!4"24"$:g
B4
842-
&48!#!,'/!4"2)
RSJ
IJKLM
tT
*
U4"!/43
,$42-$:
#43
W432-"!"6
2:&1/4&2)
*
C4"2!8-3
2:&1/4&'/!,
/3-'/&-"/7
!",$98!"6
0:83'/!4"7
-$-,/34$:/-
3-1$',-&-"/7
8!-/'3:
,0'"6-2
A-)6)7
]&-3!,'"
a!-/-/!,
]224,!'/!4"
,4$!/!2
8!-/D7
$41-3'&!8-'"84/0-3
291143/!5-
,'3-
&-'293-2)
*
b#
2:&1/4&2
1-32!2/
,4"2!8-3
,0-,h!"6
$',/4#-33!"g
!#
142!/!5-
/3-'/
'2











 !!
"#$%&'%#$"(#
#($
"#*"+,$%*-
.&,*%
/
0%1(23

45
#%6,$"'%
,#*
#(
"#5%+$"(#7
+(#$"#8%
.&,*%
 
9,#,6%9%#$
3
:;<=>
@
AB",&&C%,D
E$((1
5&%F8%#+G
(5
H
$(
I
('%&
0,E%1"#%
J%&
*,GK
1"9"$"#6
"#E$&89%#$,1
LBM-
AN(1"$"ED
,0*(9"#,1
J,"#K
98+8E
(&
01((*
"#
E$((1-
AO%&5(&,$"(#D
"#',E"'%
"#$%&'%#$"(#
#($
"#*"+,$%*-
P(1*
E$8*G
*&86QE$8*G
&%6"9%#
8#$"1
&%E(18$"(#
$(
.&,*%
RS
T
45
$(U"+"$G
2(&E%#E7
$C%#
$&%,$
,E
.&,*%
V
(&
.&,*%
H3
T
45
$(U"+"$G
"9J&('%E
$(
.&,*%
RSW
$C%#
E$8*G
*&86QE$8*G
&%6"9%#
+,#
0%
&%E89%*
,5$%&
+(9J1%$"(#
(5
E$%&("*
$,J%&3
XY;
:;<=>
@Z
[
N(#E"*%&
EG9J$(9,$"+
$&%,$9%#$7
"#+18*"#6
CG*&,$"(#7
%1%+$&(1G$%
&%J1,+%9%#$7
*"%$,&G
+C,#6%E
A%3637
L9%&"+,#
B"%$%$"+
LEE(+",$"(#
+(1"$"E
*"%$-7
,#*
1(J%&,9"*%
,#*Q(&
08*%E(#"*%3
[
O&(9J$1G
E$,&$
J&%*#"E(#%
 
$(
/
96Q\6Q*,G
O]
(&
4^
%F8"',1%#$3
[
45
%'%#$
"E
#($
&%EJ(#E"'%
2"$C"#
/
$(
V
*,GE
(&
2(&E%#E
*%EJ"$%
J&%*#"E(#%
,$
 
$(
/
96Q\6Q*,G
O]
(&
4^
%F8"',1%#$7
.4
+(#E81$
EC(81*
0%
(0$,"#%*
5(&
+(#E"*%&,$"(#
(5
58&$C%&
2(&\8J7
E8+C
,E
"9,6"#6
,#*Q(&
+(1(#(E+(JG7
$(
+(#5"&9
+(1"$"E
,#*
&81%
(8$
J%&5(&,$"(#7
,#*
J&(9J$
$&%,$9%#$
2"$C
4^
9%$CG1J&%*#"E(1(#%
/
$(
H
96Q\6Q*,G
E$,&$%*3
[
45
E$"11
#(
"9J&('%9%#$
2"$C"#
/
$(
V
*,GE
*%EJ"$%
 
$(
/
96Q\6
4^
9%$CG1J&%*#"E(1(#%7
J&(9J$1G
E$,&$
"998#(E8JJ&%EE"'%E
E8+C
,E
"#51"U"9,0
,$
_
96Q\6

4^7
9,G
0%
&%J%,$%*
,$
/
,#*
I
2%%\E
,5$%&
"#"$",1
*(E%
,$
$C%
*"E+&%$"(#
(5
$C%
$&%,$"#6
J&('"*%&
3
`<abcYdZ
"$
"E
"9J(&$,#$
$(
&81%
(8$
0(2%1
J%&5(&,$"(#
,#*
&%5%&
$(
"#51"U"9,0
1,0%1
5(&
6%#%&,1
68"*,#+%
0%5(&%
8E"#6
"#51"U"9,03
[
N(#E"*%&7
,E
#%+%EE,&G7
*"E+8EE"#6
2"$C
E$8*G
JCGE"+",#
"5
#(
&%E(18$"(#
$(
.&,*%
RS
"#
V
$(
H
*,GE3
[
]#+%
$C%
J,$"%#$
"E
"9J&('"#67
6&,*8,11G
$,J%&
E$%&("*E
('%&
efg
*,GE
,#*
+(#E"*%&
J&(JCG1,+$"+
,#$"0"($"+E7
,#$"58#6,1E7
,#*
,#$"hOiO
$&%,$9%#$
A&%5%&
$(
+8&&%#$
jNNj
68"*%1"#%E
5(&
$&%,$9%#$
(5
+,#+%&h
&%1,$%*
"#5%+$"(#E-3
,
:;<=>
k
Y;
l
A.&,*%
V
B",&&C%,D
E$((1
5&%F8%#+G
(5
em
('%&
0,E%1"#%
J%&
*,GK
:;<=>
k
h

n(&
J,$"%#$E
$&%,$%*
2"$C
OBh 
(&
OBMh
 
"#C"0"$(&E7
C(1*
E$8*G
*&86QE$8*G
&%6"9%#
8#$"1
&%E(18$"(#
$(
.&,*%
RSo
E$8*G*&86QE$8*G&%6"9%#+,#0%&%E89%*
XY;
:;<=>
k
Y;
lZ
[
O&(9J$1G
"#"$",$%
%9J"&"+
4^
9%$CG1J&%*#"E(1(#%
 
$(
/
96Q\6Q*,G
(&
%F8"',1%#$3
[
p(#"$(&
E$((1
5&%F8%#+G
,#*
'(189%
,#*
9,"#$,"#
CG*&,$"(#3











 ! 
"#$#%#&'
)*"+
,-.*
/012
3.-4*
5
0#-..6*-7
"#+*
%6.*-%*&#&'
,8&)*9:*&,*);
<3.-4*
=
>8"#%#)7
)*?*.*
-@48$#&-"
A-#&B
+*?*.2
#"*:)2
A*.#%8&*-"
)#'&)2
3.-4*
5
>8"#%#)7
"#+*C
%6.*-%*&#&'
,8&)*9:*&,*)B
:.'*&%
#&%*.?*&%#8&
#&4#,-%*4;
<3.-4*
=
D*.+8.-%#8&7
#&?-)#?*
#&%*.?*&%#8&
#&4#,-%*42
3.-4*
5
D*.+8.-%#8&7
"#+*C%6.*-%*&#&'
,8&)*9:*&,*)2
:.'*&%
#&%*.?*&%#8&
#&4#,-%*4;
-+%*.
,8$A"*%#8&
8+
)%*.8#4
%-A*.E
D*.$-&*&%"F
4#),8&%#&:*
)%:4F
4.:'G)%:4F
.*'#$*&
+8.
3.-4*
=
#+
%8H#,#%F
48*)
&8%
#$A.8?*
%8
3.-4*
IJ
K#%6#&
 5
4-F)E
C
D*.$-&*&%"F
4#),8&%#&:*
)%:4F
4.:'
+8.
 ;
3.-4*
=
,8"#%#)
#&
A-%#*&%)
%.*-%*4
K#%6
>L1/C5
#&6#@#%8.)
8.
M;
/&F
'.-4*
"-.'*
#&%*)%#&*
A*.+8.-%#8&GN&%*)%#&-"
A*.+8.-%#8&
#&
-&F
A-%#*&%
%.*-%*4
K#%6
N>NE
OPQRS
U
D*.$-&*&%"F
4#),8&%#&:*
)%:4F
4.:'G)%:4F
.*'#$*&E
V
W.'*&%
3N
,8&):"%
-&4
#$-'#&'
-&4G8.
,8"8&8),8AF
-)
-AA.8A.#-%*E
V
N+
)%#""
&8
#$A.8?*$*&%
K#%6#&
M
4-F)B
,8&%#&:*
)%*.8#4)

-&4
A.8$A%"F
-44
+:.%6*.
#$$:&8):AA.*))-&%
-'*&%)
<*E'EB
#&+"#H#$-@
-%
X
$'GY'
NZB
$-F
@*
.*A*-%*4
-%
M
-&4
[
K**Y)
-+%*.
#&#%#-"
48)*
-%
%6*
4#),.*%#8&
8+
%6*
%.*-%#&'
A.8?#4*.;;E
\Q]^_`a7
b&):.*
3N
,8&):"%
%8
.:"*
8:%
@8K*"
A*.+8.-%#8&
-&4
.*+*.
%8
#&+"#H#$-@
"-@*"
+8.
'*&*.-"
':#4-&,*
@*+8.*
:)#&'
#&+"#H#$-@E
N+
A*.+8.-%#8&
#)
):)A*,%*4B
,8&):"%
-
):.'*8&
*HA*.#*&,*4
#&
-@48$#&-"
):.'*.F
#$$*4#-%*"F
K#%68:%
-&F
4*"-F
E
V
c&,*
%6*
A-%#*&%
#)
#$A.8?#&'B
'.-4:-""F
%-A*.
)%*.8#4)
8?*.
def
4-F)
-&4
,8&)#4*.
A.8A6F"-,%#,
-&%#@#8%#,)B
-&%#+:&'-")B
-&4
-&%#CDgD
%.*-%$*&%
<.*+*.
%8
,:..*&%
h>>h
':#4*"#&*)
+8.
%.*-%$*&%
8+
,-&,*.C
.*"-%*4
#&+*,%#8&);E
-
iaj
OPQRS
OSaSPQk
O]_RQalS
m`P
iaj
OPQRS
V
n8&#%8.
-&4
*?-":-%*
"#?*.
+:&,%#8&
%*)%7
/oLB
/1LB
/1DB
-&4
LpE
V
b?-":-%*
+8.
-"%*.&-%#?*
*%#8"8'#*)
<*E'EB
?#.-"
6*A-%#%#)B
4#)*-)*
A.8'.*))#8&B
,8&,8$#%-&%
$*4#,-%#8&);E
qSrQ^_^_s
tSkSuQ^SR
vmwsx
N&+"#H#$-@
)68:"4
&8%
@*
:)*4+8.
$-&-'*$*&%
8+
#$$:&*C.*"-%*4
6*A-%#%#)E
OPQRS
y
t/oL
8.
/1L
zW1h
-&4
I{|}~
#+
@-)*"#&*
&8.$-"B
 EXC
=E!@-)*"#&*#+@-)*"#&*

h8
48)*
$84#+#,-%#8&)E

N+
#%
K8.)*&)B
%6*&
%.*-%
-)
3.-4*
ME
V
>8&%#&:*
1L
$8&#%8.#&'
A*.
A.8%8,8"E
vi

sQRSR
QPSQ
_SR_Q^Skj
Sk`
^_ssSl^_`a^`_aR
]_RQalS`P
QaQSSa^`
qSrQ^_^_stSkSuQ^SR
vmwx_aq\\
rQ^_Sa^s











 !"
#$%&'(#)*
#%,-&'
./
0123
#%,
456789:;
<=
$#>?)<%?
%&'(#)@
0 A!B ACD$#>?)<%?
<=
$#>?)<%?
#$%&'(#)E
FGHIJ
L
MNO.
&'
N2.
0PA!D123
#%,
476Q89:;
<=
$#>?)<%?
%&'(#)@
0PBCD$#>?)<%?
<=
$#>?)<%?
#$%&'(#)*
#%,-&'
./
0 ACD123
#%,
4R6Q89:;
<=
$#>?)<%?
%&'(#)@
0 ACB
PA!D$#>?)<%?
<=
$#>?)<%?
#$%&'(#)E
S T?'(#%?%U)V
,<>W&%U<%X?
>UX,V
,'XY->UX,V
'?Y<(?%
=&'
#%V
W#>?
(??U<%Y
ZV[>
)#\
W'<U?'<#
MNO.
#%,-&'
N2.
0P
D
123
]
$<)<'X$<%
0"
D
123
\<U^&XU
<%<U<#)
=<%,<%Y>
&=
W^&)?>U#><>
M<A?A@
?)?_#U?,
#)`#)<%?
T!aE
#%,
<%
U^?
#$>?%W?
&=
#%V
#)U?'%#U<_?
W#X>?A
bcG
FGHIJ
Ld
e
f?YX)#'
#%,
='?gX?%U
W^?W`<%Y
&=
2h.>
M?AYA@
?_?'V
 
U&
"
,#V>E
X%U<)
?)?_#U<&%>
&=
U^?>?
#'?
<(i'&_<%Y
&'
'?>&)_?,A
e
j=
%&
'?>&)XU<&%
U&
4klmno
 
<%
 
U&
"
,#V>@
W&%><,?'@
#>
%?W?>>#'V@
,<>WX>><%Y
\<U^
>UX,V
i^V><W<#%A
e
j=
?_?%U
<>
i?'><>U?%U
M0"
U&
P
,#V>E
&'
\&'>?%>@
i'&(iU)V
>U#'U
i'?,%<>&%?
 
U&
"
(Y-`Y-,#V
Tp
&'
jq
?gX<_#)?%UA
e
j=
>U<))
%&
<(i'&_?(?%U
\<U^<%
P
U&
C
,#V>
,?>i<U?
 
U&
"
(Y-`Y-,#V
&=
i'?,%<>&%?
Tp
&'
jq
?gX<_#)?%U@
W&%><,?'
#,,<U<&%#)
\&'`
Xi
#%,
>U#'U
i'&(iU
U'?#U(?%U
\<U^
jq
(?U^V)i'?,%<>&)&%?
"
U&
a
(Y-`Y-,#VA
e
j=
>U<))
%&
<(i'&_?(?%U
\<U^<%
P
U&
C
,#V>
,?>i<U?
"
U&
a
(Y-`Y-,#V
&=
jq
(?U^V)i'?,%<>&)&%?@
i'&(iU)V
>U#'U
<((X%&>Xii'?>><_?>
M<A?A@
(VW&i^?%&)#U?
(&=?U<)EA
#
r<>WX>>
\<U^
>UX,V
i^V><W<#%
<=
(VW&i^?%&)#U?
(&=?U<)
<>
%&U
#_#<)#$)?A
stuvwxwyHz
{|c}vI
~
zJ
}{JI
e
p%W?
U^?
i#U<?%U
<>
<(i'&_<%Y@
Y'#,X#))V
U#i?'
>U?'&<,>
&_?'

,#V>
#%,
W&%><,?'
i'&i^V)#WU<W
#%U<$<&U<W>@
#%U<=X%Y#)>@
#%,
#%U<BTT
U'?#U(?%U
M'?=?'
U&
WX''?%U
33
YX<,?)<%?>
=&'
U'?#U(?%U
&=
W#%W?'B
'?)#U?,
<%=?WU<&%>EA
#
FGHIJ


MNO.
&'
N2.
0CA!D123
#%,
4Q89:;
<=
$#>?)<%?
%&'(#)@
0CB"!D
$#>?)<%?
<=
$#>?)<%?
#$%&'(#)*
#%,-&'
./
0PA!D123
#%,
45Q6Q89:;
<=
$#>?)<%?
%&'(#)@
0PA!B !A!D
h&'
?)?_#U<&%>
<%
U'#%>#(<%#>?>
489:;
&'
?)?_#U<&%>
<%
./
4789:;
S Z&),
>UX,V
,'XY->UX,V
'?Y<(?%
,&>?
X%U<)
'?>&)XU<&%
U&
klmno45
S f?>X(?
>UX,V
,'XY->UX,V
'?Y<(?%
<=
?)?_#U<&%>
,&\%Y'#,?
U&
klmno45
\<U^<%
 a
,#V>
#%,
#=U?'
W&(i)?U<&%
&=
>U?'&<,
U#i?'A
S T?'(#%?%U)V
,<>W&%U<%X?
>UX,V
,'XY->UX,V
'?Y<(?%
<=
U^?
?)?_#U<&%>
,&
%&U
,&\%Y'#,?
U&
klmno45
\<U^<%
 a
,#V>A
bcG
FGHIJ

cG
d
e
T'&(iU)V
<%<U<#U?
?(i<'<W
jq
(?U^V)i'?,%<>&)&%?
#U
 
U&
"
(Y-`Y-,#V
&'
?gX<_#)?%UA
e
j=
>U<))
%&
<(i'&_?(?%U
\<U^<%
"
U&
P
,#V>
,?>i<U?
 
U&
"
(Y-`Y-,#V
(?U^V)i'?,%<>&)&%?
jq
&'
?gX<_#)?%U@
i'&(iU)V
>U#'U
U'?#U(?%U
\<U^
<((X%&>Xii'?>><_?
U^?'#iV
M<A?A@
(VW&i^?%&)#U?
(&=?U<)
!AC

 
Y
?_?'V
 "
^&X'>
U^?%
U#i?'
<%
W&%>X)U#U<&%
\<U^
^?i#U&)&YV
W&%>X)UEA
r<>WX>>
\<U^
>UX,V
i^V><W<#%
<=
(VW&i^?%&)#U?
<>
%&U
#_#<)#$)?A
stuvwxwyHz
{|c}vI
~
zJ
}{JI
e
f?gX?>U
Z?i#U&)&YV
W&%>X)U@
#%,
i?'=&'(
#$,&(<%#)
\&'`Xi
#%,
<(#Y<%Y
#>
#ii'&i'<#U?A
e
p%W?
U^?
i#U<?%U
<>
<(i'&_<%Y@
Y'#,X#))V
U#i?'
>U?'&<,>
&_?'

,#V>#%,W&%><,?'i'&i^V)#WU<W#%U<$<&U<W>@#%U<=X%Y#)>@#%,#%U<BTT











 !"
#$%&'()&
(+
#$%&'()&
$#),-.$'/
01234
6
789:
,-
8;:
<=!>?;@
(+
#$%&'()&
),-.$'A
<=!>#$%&'()&
(+
#$%&'()&
$#),-.$'B
$)CD,-
:E
< !>?;@
(+
#$%&'()&
),-.$'A
< !F!>#$%&'()&
(+
#$%&'()&
$#),-.$'/
G H,-
&'&I$J(,)%
()
J-$)%$.()$%&%
<K>?;@
,-
&'&I$J(,)%
()
#('(-L#()
<M>?;@A
N&-.$)&)J'O
C(%P,)J()L&
%JLCO
C-LQD%JLCO
-&Q(.&)F
G R&-.$)&)J'O
C(%P,)J()L&
%JLCO
C-LQD%JLCO
-&Q(.&)
+,-
$)O
P$%&
.&&J()Q
SOT%
'$U
P-(J&-($
789:
$)CD,-
8;:
<">?;@
V
#('(-L#()
<=>?;@
U(JW,LJ
()(J($'
+()C()Q%
,+
PW,'&%J$%(%
X(F&FA
&'&I$J&C
$'Y$'()&
R!Z[
$)C
()
JW&
$#%&)P&
,+
$)O
$'J&-)$J(I&
P$L%&/F
J-&$J.&)J
7-&+&-
J,
PL--&)J
@\\@
QL(C&'()&%
+,-
J-&$J.&)J
,+
P$)P&-]
-&'$J&C
()+&PJ(,)%/F
^4_2`a`ab
c4d4e2`43
fghbi
j)+'(k(.$#
%W,L'C
),J
#&
L%&C+,-
.$)$Q&.&)J
,+
(..L)&]-&'$J&C
W&N$J(J(%F
lmn
od4e2`apmb
pq
lrhs
lfhs
p1
ht
2b
u4bv1aw43
t4dpx
04m412d
0ya32mv4
gp1
lmn
od4e2`apmb
u4bv1aw43z
{
|,)(J,-
$)C
&I$'L$J&
'(I&-
+L)PJ(,)
J&%J}
89:A
8;:A
8;RA
$)C
:EF
{
~I$'L$J&
+,-
$'J&-)$J(I&
&J(,',Q(&%
7&FQFA
I(-$'
W&N$J(J(%A
C(%&$%&
N-,Q-&%%(,)A
P,)P,.(J$)J
.&C(P$J(,)%A
U,-%&)()Q
,+
'(I&-
P(--W,%(%
X&FQFA
N,-J$'
I&()
JW-,.#,%(%[/F
{
H,-
SEV
N$J(&)J%}
&I$'L$J&
L$)J(J$J(I&
SE
I(-$'
',$CA
L$)J(J$J(I&
SE%8QA
,-
SE&8Q
{
H,-
S\V
N$J(&)J%}
&I$'L$J&
L$)J(J$J(I&
S\
I(-$'
',$C
{
\,)%(C&-
P,)%L'J()Q
W&N$J,',Q(%JDj)+&PJ(,L%
(%&$%&
%N&P($'(%J
-&Q$-C()Q
PW$)Q&D(.N'&.&)J$J(,)
()D,+
$)J(I(-$'
.&C(P$J(,)%
+,-
$)O
N$J(&)J
U(JW
$)
&'&I$J&C
SE
I(-$'
',$C
<=!!!
j?D.'
{
\,)%(C&-
P,)%L'J()Q
W&N$J,',Q(%JDj)+&PJ(,L%
(%&$%&
%N&P($'(%J
-&Q$-C()QPW$)Q&D(.N'&.&)J$J(,)()D,+$)J(I(-$'S\.&C(P$J(,)%(+
h^r
b2343
2142
abya32mv4

qp1
2m244m`
pq
^4_2`a`ab
c4d4e2`43
fghbi
am
^
_2`a4m`b











 !"
#$%
'()*+
+,*-
(./)0*10-
23
456789:
;
<,)
#$%=
>(?@
#A/BA=C
D'*+E*?0
F,)
2,?@
#A%
*.-
#$%
*1
*2,'0

HIJKLMNO
PQR
JS
PTR
UVTW
LXO
YZ[\]^_`a
bcNMcNS
XJSdLK
JS
NKNeLMNO
LM
fLINKgXN
h
i,
-,10
j,-(F(/*?(,.1k
h
lF
BmnoBpn
0+0'*?(,.1
)0q)010.?1
1(r.(F(/*.?
>,)10.(.r
2*10-
,.
(.'01?(r*?,)
*11011j0.?s
?@0.
?)0*?
*1
-01/)(20-
F,)
0+0'*?(,.1
(.
?@0
),>
20+,>k
h
<,)
*++
?)*.1*j(.*10
0+0'*?(,.1s
100
(.1?)E/?(,.1
*?
2,??,j
,F
1@*-0-
*)0*
(F
?)*.1*j(.*10
)(10
(1
.,?
(1,+*?0-
2E?
t*?
*.3
?(j0u
,//E)1
(.
10??(.r
,F
0(?@0)
gXvSNLIgXw
fgKgSxfgX
JS
IgwXI
Jy
zHTH{KgeNS
ONvJd|NXILMgJX
HIJKLMNO
PQR
JS
PTR
U}~VTW
LXO
Y[\]^_`a
gy
XJSdLK
LM
fLINKgXN
HIJKLMNO
PQR
JS
PTR
U~fLINKgXN
LXO
Y[Z]^_`a
gy
NKNeLMNO
UVTW
LM
fLINKgXN
h
#,+-
1?E-3
-)Ero1?E-3
)0r(j0.
-,10
E.?(+)01,+E?(,.
?,
Bpn
,)
Bmn

h
lF
?,(/(?3
>,)10.1s
?@0.
?)0*?
*1

-01/)(20-
F,)
0+0'*?(,.1
(.
?@0
),>1
20+,>k
h
lF
?,(/(?3
(jq),'01
?,
Bpn
,)
Bmn

)01Ej0
1?E-3
-)Ero1?E-3
)0r(j0.
*F?0)
/,jq+0?(,.
,F
1?0),(-
?*q0)
;
0rE+*)
*.-
F)0E0.?
/@0/(.r
,F
m<n1
t0krks
0'0)3
 
?,

-*31u
E.?(+
0+0'*?(,.1
,F
?@010
*)0
(jq),'(.r
,)
)01,+'0-k
;
0/,jj0.-
/,.1E+?
@0q*?,+,r(1?
/,.1(-0)
*2-,j(.*+
E+?)*1,E.-s
(./+E-(.r
,qq+0)
*11011j0.?
,F
+('0)
q0)FE1(,.k
;
$,.1(-0)s
*1
.0/011*)3s
-(1/E11(.r
>(?@
1?E-3
q@31(/(*.k
;
lF
0'0.?
(1
q0)1(1?0.?
t
?,

-*31u
,)
>,)10.1s
*.-
(.'01?(r*?,)
1E1q0/?1
?,(/(?3
?,
20
(jjE.0j0-(*?0-
BDs
)0/,jj0.-
?,
1?*)?
q)0-.(1,.0
 
?,

jroro-*3

,)
l%
0E('*+0.?k
;
lF
1?(++
.,
(jq),'0j0.?
>(?@(.

?,

-*31
-01q(?0
 
?,

jroro-*3
,F
q)0-.(1,.0

,)
l%
0E('*+0.?s
/,.1(-0)
*--(?(,.*+
>,)Eq
*.-
?)0*?j0.?
>(?@
l%
j0?@3+q)0-.(1,+,.0

?,
"
jroro-*3k
;
lF
1?(++
.,
(jq),'0j0.?
>(?@(.

?,

-*31
-01q(?0
 
?,

jroro-*3
,F
l%
j0?@3+q)0-.(1,+,.0s
/,.1(-0)
*--(?(,.*+
*2-,j(.*+
>,)Eq
t(./+E-(.r
+('0)
2(,q13u
*.-
(j*r(.r
t(k0ks
+('0)
E+?)*1,E.-us
*.-
/,.1(-0)
1?*)?(.r
(jjE.,1Eqq)011('01
t(k0ks
j3/,q@0.,+*?0
j,F0?(+
!k

 
r
0'0)3
 
@,E)1
?@0.
?*q0)
(.
/,.1E+?*?(,.
>(?@
@0q*?,+,r3
/,.1E+?uk
(1/E11
>(?@
1?E-3
q@31(/(*.
(F
j3/,q@0.,+*?0
j,F0?(+
(1
.,?
*'*(+*2+0k
HXyKggdLf
IcJxKO
WR
fN
xINO~
p00(.1?)E/?(,.1
*?
2,??,j
,F
1@*-0-
*)0*
(F?)*.1*j(.*10
)(10
(1
.,?(1,+*?0-
2E?
t*?
*.3
?(j0u
,//E)1
(.
10??(.r
,F0(?@0)
gXvSNLIgXw
fgKgSxfgX
JS
IgwXI
Jy
zHTH{KgeNS
ONvJd|NXILMgJX
HIJKLMNOPQRJSPTR
h #,+-1?E-3-)Ero1?E-3)0r(j0.-,10
;
0rE+*)*.-F)0E0.?/@0/(.r,Fm<n1t0krks0'0)3 -*31uE.?(+











 !"
#$%&'()*
,-.
/012134567
89
-:;<,=
,>
?,@A=8-A
B@:=,>A.
CDE
:;
C)E
#FG%H'()*
,-.
/012134567
89

A=AI,>A.
#()*
,>
?,@A=8-A
JKLMN
PQRSNJLMSK
LS

TUV
SP
TWV
XYZ[\]^_
` aQRJbQ
RLJcd
cPJefRLJcd
PQeMbQK
Mg
QNQhiLMSKR
cSjKePicQ
LS
TUV
SP
TWV
XYZ[\]^_
jMLkMK
 l
cidR
iKc
igLQP
mSbnNQLMSK
Sg
RLQPSMc
LinQPo
` pQPbiKQKLNd
cMRmSKLMKJQ
RLJcd
cPJefRLJcd
PQeMbQK
Mg
LkQ
QNQhiLMSKR
cS
KSL
cSjKePicQ
LS
TUV
SP
TWV
XYZ[\]^_
jMLkMK
 l
cidR
` pQPbiKQKLNd
cMRmSKLMKJQ
RLJcd
cPJefRLJcd
PQeMbQK
gSP
iKd
miRQ
bQQLMKe
qdrR
Nij
mPMLQPMis
MK
LkQ
itRQKmQ
Sg
iKd
iNLQPKiLMhQ
miJRQo
QNQhiLMSKR
Sg
LkQRQ
iPQ
MbnPShMKe
SP
PQRSNhQco
u
vSKRJNL
kQniLSNSeMRL
wJKNQRR
MKhQRLMeiLSP
MR
kQniLSNSeMRLxy
StLiMK
itcSbMKiN
JNLPiRSJKcs
MKmNJcMKe
zSnnNQP
iRRQRRbQKL
Sg
NMhQP
nQPgJRMSKy
iKc
mSKRMcQP
NMhQP
tMSnRdo
u
vSKRMcQPs
iR
KQmQRRiPds
cMRmJRRMKe
jMLk
RLJcd
nkdRMmMiKo
u
{g
MKhQRLMeiLSP
RJRnQmLR
LS|MmMLd
LS
tQ
MbbJKQ}bQcMiLQcs
nPSbnLNd
MKMLMiLQ
QbnMPMm
{~
bQLkdNnPQcKMRSNSKQ
iL
 
LS
l
befefcid
SP
QJMhiNQKLo
u
{g
KS
MbnPShQbQKL
jMLkMK

LS
"
cidR
cQRnMLQ
 
LS
l
befefcid
bQLkdNnPQcKMRSNSKQ
{~
SP
QJMhiNQKLs
StLiMK
NMhQP
tMSnRd
wMg
ML
kiR
KSL
tQQK
cSKQ
iNPQicdx
iKc
nPSbnLNd
RLiPL
LPQiLbQKL
jMLk
MbbJKSRJnnPQRRMhQ
LkQPind
wbdmSnkQKSNiLQ
bSgQLMNxo
zMRmJRR
jMLk
RLJcd
nkdRMmMiK
Mg
bdmSnkQKSNiLQ
MR
KSL
ihiMNitNQo
B-9=88<,?
@:=.
*E
?A
@A.%
u
KmQ
LkQ
niLMQKL
MR
MbnPShMKes
ePicJiNNd
LinQP
RLQPSMcR
ShQP

cidR
iKc
mSKRMcQP
nPSnkdNimLMm
iKLMtMSLMmRs
iKLMgJKeiNRs
iKc
iKLM}
pvp
LPQiLbQKL
wPQgQP
LS
mJPPQKL
vv
eJMcQNMKQR
gSP
LPQiLbQKL
Sg
miKmQP}PQNiLQc
MKgQmLMSKR
B@:=,>A.
CDE
:;
C)E
#G&'()*

A>A;
-:;<,=
:;
A=AI,>A.
,>
?,@A=8-A
pQPbiKQKLNd
cMRmSKLMKJQ
RLJcd
cPJefRLJcd
PQeMbQK
D,<A
,@
,?:IA
AA>
:=.
;A:<<A-.
:?>,8-8-
=8IA;
?8:@
A,;=
B9
>;,-@,<8-,@A
;8@A
8@
-:>
8@:=,>A.
?>
,>
,-
>8<A
:;@
8-
@A>>8-
:9
A8>A;
8-;A,@8-
>:>,=.8;A>
?8=8;?8-
234567
89
-:;<,=
,>
?,@A=8-A
:;
G'?,@A=8-A
89
#()*
,>
?,@A=8-A
:;
@8-@
:9
B)B=8IA;
.A:<A-@,>8:-
A%%
9AIA;
A=AI,>A.
B*
,-,A
.:@8-
9:;

A,
=AIA=
:9
>;,-@,<8-,@A
;8@A
,@
8-@>;>A.
9:;
>A
-A>
8A@>
=AIA=
:9
>;,-@,<8-,@A
;8@A:;
A,<=A
<,-,A
.:@8-
9:;
@A:-.
=AIA=
:9
>;,-@,<8-,@A
;8@A
8%A%

CDE
:;
C)E
#H%&'()*
,-.
/2134567
89
-:;<,=
,>
?,@A=8-A
:;
CDE
:;
C)E
#G%&'?,@A=8-A
,-.
/0234567
89
A=AI,>A.
#()*
,>
?,@A=8-A
,@
8-@>;>A.
9:;
>A
>8;.
=AIA=
:9
>;,-@,<8-,@A
;8@A
8%A%
CDE
:;
C)E
#$%&'()*
,-.
/012134567
89
-:;<,=
,>
?,@A=8-A
:;
CDE
:;
C)E
#FG%H'()*
,-.
/012134567
89

A=AI,>A.
#()*
,>
?,@A=8-A
:;
>A
>8;.
,-.
9:;>
=AIA=@
:9
>;,-@,<8-,@A
;8@A@
A;<,-A->=
.8@:->8-A
@>.
.;@>.
;A8<A-
*A;8>8@
:;
;A-,=
.@9->8:-
wQNQhiLQc
RQPJb
C-
;,.A
A-A;,=
8.,-A
:;
C-
;,.A
u
vSKRJNL
jMLk
KQnkPSNSeMRLo
u
 SKMLSP
gSP
RMeKR
iKc
RdbnLSbR
LkiL
bid
tQ
PQNiLQc
LS
mkiKeQR
MK
PQKiN
gJKmLMSK
wQoeos
PSJLMKQ
JPMKiNdRMRs
QNQhiLQc
RQPJb
¡¢
iKc











 !"
#$%&'()()%*
#$%&'()()%+
-%#$%&.%-
#$%&'()()%
#/%&$&)#%+
%/%#'$0/1'%
(23&/&)#%+
-%#$%&.%
()
4$()%
04'54'+
0$
5$0'%()4$(&+
$%#%)'
67
#0)'$&.'+
2%-(#&'(0).+
8/4(-
.'&'4.*9
:
;&'(%)'.
.<04/-
3%
'<0$04=</1
%>&/4&'%-
'0
$4/%
04'
&)1
&/'%$)&'(>%
%'(0/0=1
?%9=9+
-(.%&.%
5$0=$%..(0)
0$
()8%#'(0).*9
:
@'%$0(-.
.<04/-
3%
#0).(-%$%-
()
'<%
&3.%)#%
08
#/%&$
&/'%$)&'(>%
%'(0/0=1
%>%)
80$
/0AB=$&-%
%>%)'.
?C$&-%
D*+
()
0$-%$
'0
5$%>%)'
50'%)'(&/
5$0=$%..(0)
'0
<(=<%$
=$&-%
%>%)'9
EFGHI
K
?.%$42
#$%&'()()%
LMNO
'0
 9PQMNO*
O0
-0.%
20-(8(#&'(0).9
RSF
EFGHI
KT
:
U0)('0$
.%$42
#$%&'()()%
A%%V/1
&)-
&)1
&##025&)1()=
.125'02.9
W
68
#$%&'()()%
$%'4$).
'0
3&.%/()%+
$%.42%
('.
$%=4/&$
20)('0$()=
5%$
.'4-1
5$0'0#0/9
W
68
#$%&'()()%
A0$.%).+
-%5%)-()=
0)
'<%
.%>%$('1+
'$%&'
&.
C$&-%
D+
X+
0$
Y9
:
Z0).(-%$
.125'02&'(#
'$%&'2%)'+
()#/4-()=
<1-$&'(0)+
%/%#'$0/1'%
$%5/&#%2%)'+
&)-
-(4$%'(#.9
:
68
3&.%/()%
.%$42
#$%&'()()%
(.
%/%>&'%-
&30>%
)0$2&/+
&)-
'<%$%
(.
&
$(.%
'0
L
 
'0
 9P
Q
3&.%/()%+
#0).(-%$
80//0A()=
$%#022%)-&'(0).
()
'<(.
$0A9
EFGHI
[
?.%$42
#$%&'()()%
L 9P
'0
X9!Q3&.%/()%\
L 9P
'0
X9!QMNO*
]0/-
.'4-1
-$4=^.'4-1
$%=(2%)
4)'(/
$%.0/4'(0)
'0
C$&-%
_`
0$
3&.%/()%9
W 68
'0a(#('1
A0$.%).+
'<%)
'$%&'
&.
C$&-%
X
0$
Y9
W 68
'0a(#('1
(25$0>%.
'0
C$&-%
_`
0$
3&.%/()%+
'<%)
$%.42%
.'4-1
-$4=^.'4-1
$%=(2%)
&8'%$
#025/%'(0)
08
.'%$0(-
'&5%$9
RSF
EFGHI
[T
:
Z0).(-%$
.125'02&'(#
'$%&'2%)'+
()#/4-()=
<1-$&'(0)+
%/%#'$0/1'%
$%5/&#%2%)'+
&)-
-(4$%'(#.9
:
Z&$%84//1
20)('0$
.%$42
#$%&'()()%
%>%$1
D
'0
X
-&1.
&)-
&.
#/()(#&//1
A&$$&)'%-9
:
Z0).4/'
)%5<$0/0=(.'
&)-
#0).(-%$
$%)&/
3(05.1
(8
#/()(#&//1
()-(#&'%-9
:
68
%>%)'
(.
5%$.(.'%)'
3%10)-
X
'0
P
-&1.
0$
A0$.%).+
5$025'/1
.'&$'
5$%-)(.0)%
 
'0
D
2=^V=^-&1
;b
0$
67
%c4(>&/%)'9
:
68
%>%)'
(.
)0'
$%.50).(>%
A('<()
X
'0
P
-&1.
0$
A0$.%).
-%.5('%
5$%-)(.0)%
&'
 
'0
D
2=^V=^-&1
;b
0$
67
%c4(>&/%)'+

#0).(-%$
&--('(0)&/
A0$V45
9
:
b)#%
'<%
5&'(%)'
(.
(25$0>()=+
=$&-4&//1
'&5%$
.'%$0(-.
0>%$
def
-&1.
&)-
#0).(-%$
5$05<1/&#'(#
&)'(3(0'(#.+
&)'(84)=&/.+
&)-
&)'(B;g;
'$%&'2%)'
?$%8%$
'0
#4$$%)'
OZZO
=4(-%/()%.
80$
'$%&'2%)'
08
#&)#%$B











 !"
#$%&'$(
*+,$-'*.+/01
&
2
34$+
$5$+'
#$'6#+/
'.
7&/$%*+$8
#$/69$
/'6(:
(#6;</'6(:
#$;*9$+
&+(
#.6'*+$
/$#69
-#$&'*+*+$
9.+*'.#*+;
=$#
/'6(:
=#.'.-.%1
>?@AB
D
E?
F
GH#&($
IJ
/$#69
-#$&'*+*+$
KI1!L7&/$%*+$M
KI1!
'.
N1!LOPQ0
GH#&($
RJ
/$#69
-#$&'*+*+$
KN1!LOPQ0
S$#9&+$+'%:
(*/-.+'*+6$
/'6(:
(#6;</'6(:
#$;*9$+1
TE?
>?@AB
D
E?
FU
2
V&#$,6%%:
9.+*'.#
/$#69
-#$&'*+*+$
.+
(&*%:
7&/*/1
2
V.+/6%'
+$=4#.%.;*/'
&+(
-.+/*($#
#$+&%
7*.=/:
*,
-%*+*-&%%:
*+(*-&'$(1
2
S#.9='%:
/'&#'
=#$(+*/.+$
 
'.
W
9;<X;<(&:
SY
.#
Z[
$\6*5&%$+'1
2
Z,
$5$+'
*/
+.'
#$/=.+/*5$
]*'4*+
I
'.
^
(&:/
.#
].#/$+/
($/=*'$
=#$(+*/.+$
&'
 
'.
W
9;<X;<(&:
SY
.#
Z[
$\6*5&%$+'8
&((*'*.+&%
].#X6=
/4.6%(
7$
-.+/*($#$(
&+(
=#.9='
'#$&'9$+'

]*'4


&+
*996+./6==#$//*5$
*+
-.+/6%'&'*.+
]*'4
&
+$=4#.%.;*/'
1
2
Y+-$
'4$
=&'*$+'
*/
*9=#.5*+;8
;#&(6&%%:
'&=$#
/'$#.*(/
.5$#
_`a
(&:/
&+(
-.+/*($#
=#.=4:%&-'*-
&+'*7*.'*-/8
&+'*,6+;&%/8
&+(
&+'*bScS
'#$&'9$+'
G#$,$#
'.
-6##$+'
QVVQ
;6*($%*+$/
,.#
'#$&'9$+'
.,
-&+-$#b
#$%&'$(
*+,$-'*.+/01
&
def
>?@AB
G#$,$#
'.
QVZ
VgVhi
5
^1!
,.#
($,*+*'*.+
.,
/$5$#*':<;#&($
($=$+(*+;
.+
':=$
.,
/X*+
#&/40
>BeB?@j
>klA@emB
TE?
def
>?@ABU
2
n.+*'.#
,.#
/*;+/
&+(
/:9='.9/
.,
($#9&'*'*/
G#&/4
&+(
=#6#*'6/01
2
o.%(
/'6(:
(#6;
*,
p'$5$+/bc.4+/.+
p:+(#.9$
Gpcp08
g.q*-
i=*($#9&%
Q$-#.%:/*/
GgiQ08
.#
.'4$#
/$5$#$
-6'&+$.6/
&(5$#/$
#$&-'*.+
GpVhr0
*/
/6/=$-'$(
2
S$#9&+$+'%:
(*/-.+'*+6$
/'6(:
(#6;/
*,
pcp8
giQ
.#
pVhr
*/
-.+,*#9$(s
>?@AB
t
Q.
(./$
9.(*,*-&'*.+/1
TE?
>?@AB
tU
2
V.+/*($#
/:9='.9&'*-
'#$&'9$+'8
*+-%6(*+;
.#&%
&+'*=#6#*'*-/
G$1;18
(*=4$+4:(#&9*+$
.#
4:(#.q:u*+$0
&+(
'.=*-&%
'4$#&=:
G$1;18

$9.%%*$+'8
%.'*.+8
.#
*+/'*'6'*.+&%
/'&+(&#(
01
v@wx
E?
yB?z@{l{lw
|lemjkAle}
~Bzxl}ElA
>?@AB


.#
=$#/*/'$+'
GK 
]$$X0
H#&($
W
$5$+'/8
4.%(
/-4$(6%$(
/'6(:
(#6;</'6(:
#$;*9$+
6+'*%
#$/.%6'*.+
'.
H#&($

.#
7&/$%*+$1

Z,'.q*-*':].#/$+/8'4$+'#$&'&/
TE?
>?@AB
U
2
Y7'&*+
$#9&'.%.;:
-.+/6%'1
2
V.+/*($#
/:9='.9&'*-
'#$&'9$+'8
*+-%6(*+;
.#&%
&+'*=#6#*'*-/
G$1;18
(*=4$+4:(#&9*+$
.#
4:(#.q:u*+$0
&+(
'.=*-&%
'4$#&=:
G$1;18
6#$&











 !"
#$%&'
)*
+
,-
./0121.3
145$/6'7
./
#$%&'
89
/$
:%7';1<'=
.>'<
$'7?4'
&$?@A7.?&3
$'@14'<
%-.'$
2/45;'.1/<
/-
7.'$/1&
.%5'$*
2$'%4B*
C
D/<71&'$
4/&'$%.'E7.$'<@.>
./512%;
7.'$/1&*
C
,-
</
145$/6'4'<.
/-
$%7>A7F1<
;'71/<7
/22?$7
G1.>1<
)
./
H
&%37
/$
17
G/$7'<1<@
&'751.'
7345./4%.12
.$'%.4'<.
%<&A/$
?7'
/-
4/&'$%.'
7.$'<@.>
./512%;
7.'$/1&=
2/<71&'$=
%7
<'2'77%$3=
&172?771<@
G1.>
7.?&3
5>37121%<
%<&
5$/45.;3
7.%$.
737.'412
7.'$/1&7
7?2>
%7
5$'&<17/<'
 
./
I
4@AF@A&%3
JK
/$
,L
'M?16%;'<.*
,-
N
)!O
:/&3
7?$-%2'
%$'%
17
1<6/;6'&=
2/<71&'$
1<1.1%.1/<
/-
737.'412
7.'$/1&7
5$/45.;3*
C
D/<71&'$
7F1<
:1/573
1-
.>'
'6'<.
17
5'$717.'<.
-/$
N 
G''F
/$
$'2?$7*
PQRST
V
WQ
X
YWQ
PQRST
VZ
[/;&
7.?&3
&$?@A7.?&3
$'@14'<
?<.1;
$'7/;?.1/<
./
#$%&'
89
/$
:%7';1<'*
,-
./0121.3
145$/6'7
./
#$%&'
89
/$
:%7';1<'=
.>'<
$'7?4'
&$?@A7.?&3
$'@14'<
%-.'$
2/45;'.1/<
/-
7.'$/1&
.%5'$*
,-
./0121.3
G/$7'<7=
.>'<
.$'%.
%7
#$%&'
\*
YWQ
PQRST
X
]WQ
^_`TabcQTRbTd_defZ
J'$4%<'<.;3
&172/<.1<?'
7.?&3
&$?@A7.?&3
$'@14'<*
YWQ
PQRST
V
WQ
X
]WQ
^_`TabcQTRbTd_defZ
C
D/<7?;.
g'$4%./;/@3*
C
J$/45.;3
1<1.1%.'
'451$12
,L
4'.>3;5$'&<17/;/<'
 
./
I
4@AF@A&%3
/$
'M?16%;'<.*
C
D/<71&'$
>/751.%;1h%.1/<*
C
i/<1./$
'0.'<.
/-
$%7>
jk?;'
/-
l1<'7m*
C
D/<71&'$
7F1<
:1/573
n5$'-'$%:;3
4/$'
.>%<
 B
%7
2;1<12%;;3
-'%71:;'*
C
K<2'
.>'
5%.1'<.
17
145$/61<@=
@$%&?%;;3
.%5'$
7.'$/1&7
/6'$
opq
&%37
%<&
2/<71&'$
5$/5>3;%2.12
%<.1:1/.127=
%<.1-?<@%;7=
%<&
%<.1EJrJ
.$'%.4'<.
n$'-'$
./
2?$$'<.
lDDl
@?1&';1<'7
-/$
.$'%.4'<.
/-
2%<2'$E
$';%.'&
1<-'2.1/<7B*
%
C
D/<71&'$=
%7
<'2'77%$3=
&172?771<@
G1.>
7.?&3
5>37121%<*
sdSWtQ_dWuRbcv
n'*@*=
>35'$.>3$/1&174=
.>3$/1&1.17=
>35/.>3$/1&174=
w35'
 
&1%:'.'7
4';;1.?7=
>35/5>371.17=
xdv
PQRST
n&'5'<&1<@
/<
.>'
.35'
/-
'<&/2$1</5%.>3=
$'-'$
./
lD,
DwDyz
6H*!
-/$
&'-1<1<@
.>'
DwD
@$%&'A7'6'$1.3B
PTdTQR^
P{_SRdtT
YWQ
xdv
PQRSTZ
C
D/<71&'$
2/<7?;.1<@
%<
'<&/2$1</;/@17.
-/$
'<&/2$1<'
'6'<.7*
C
D/<71&'$=
%7
<'2'77%$3=
&172?771<@
G1.>
7.?&3
5>37121%<*
C
i/<1./$
5%.1'<.7
-/$
71@<7
%<&
7345./47
/-
'<&/2$1</5%.>1'7*
l/<E
75'21-12
7345./47
1<2;?&'
>'%&%2>'=
-%.1@?'=
:'>%61/$
2>%<@'7=
2>%<@'&
4'<.%;
7.%.?7=
6'$.1@/=
%:&/41<%;
5%1<=
?<?7?%;
:/G';











 !"
#$%&'()
+,-./&+(&$)
+,-.01&$)
#.+,'23(&,3)

+#,',+#,%&$)
4&(0$-
5&2-/
60'(
$3/
72$832((9
:
;$'&23'(
(#,0-/
%2
'#,1,0<#-.
24$-0$'2/
',
10-2
,0'
$3.
$-'213$'&42
2'&,-,<.
=29<9)
/&(2$(2
+1,<12((&,3
&36-0/&3<
%1$&3
>2'$('$(2()
,1
&3526'&,3(?9
:
@2+23/&3<
,3
'#2
(0(+26'2/
23/,61&3,+$'#.)
>,3&',1
$3/
24$-0$'2
'#.1,&/
5036'&,3
'2('(A
BCD)
5122
BE
$3/
5122
BF
$3/
,'#21
12-24$3'
23/,61&32
$3/
12-$'2/
-$%(
=29<9)
%-,,/
<-06,(2
$3/
82',32
-242-()
D<G 6?9
:
H342('&<$',1(
(#,0-/
$(8
(0%I26'(
7&'#
23/,61&3,+$'#&2(
7#,
>$.
12J0&12
+1,-,3<2/
,1
6,3'&302/
#,1>,3$-
12+-$62>23')
',
6,3(0-'
'#2&1
+1&>$1.
6$12
+#.(&6&$3(
,1
23/,61&3,-,<&('(
$%,0'
501'#21
>,3&',1&3<
$3/
'12$'>23'
$5'21
6,>+-2'&,3
,5
'#2
('0/.9
:
H5
$
+$'&23'
2K+21&2362(
$3
GL
'#$'
&(
'#,0<#'
',
%2
+,((&%-.
,5
$0',&>>032
3$'012
=29<9)
'#.1,&/&'&()
+$3612$'&'&()
#.+,+#.(&'&()
,1
/&$%2'2(
&3(&+&/0(?)
'#2
&342('&<$',1
(#,0-/
(23/
$
%-,,/
($>+-2
5,1
$++1,+1&$'2
$0',&>>032
$3'&%,/.
'2('&3<9
#.+,+&'0&'$1&(>)
$3/
$/123$-
&3(055&6&236.M
2K,61&32
2423'
,5
$>.-$(2N-&+$(2
&3612$(2/
$-(,&36-0/2/
&3
'#&(
(26'&,3?
OPQRS
U
V,
/,(2
>,/&5&6$'&,3(9
WXP
OPQRS
U
YZ[\]^RZ[_
`aXbS
cZ`a
Qbdef`XeQ`Z\
ghi
S]SjQ`ZX[kl
:
m,3&',1
+$'&23'
7&'#
$++1,+1&$'2
23/,61&32
5036'&,3
'2('(9
:
n,1
(0(+26'2/
#.+,+#.(&'&(N#.+,+&'0&'$1&(>)
6,3(&/21
6,3(0-'$'&,3
,5
$3
23/,61&3,-,<&('
',
<0&/2
$((2((>23'
,5
2$1-.o>,13&3<
GpBD)
6,1'&(,-)
BCD
$3/
5122
BFM
$-(,
6,3(&/21
<,3$/,'1,+&3()
(2K
#,1>,32()
$3/
+1,-$6'&3
-242-()
$(
72--
$(
6,(.3'1,+&3
('&>0-$'&,3
'2('
='#,0<#
&'
>$.
3,'
%2
0(250-
&3
/&$<3,(&3<
2$1-.
(26,3/$1.
$/123$-
&3(055&6&236.?9
:
H5
BCD
q
!9r
s
ttV)
,1
BCD
uv
s
wtV)
,1
6,3(&('23'-.
,0'
,5
1$3<2
&3
v
(0%(2J023'
>2$(012>23'()
&36-0/2
5122
BF
$'
(0%(2J023'
6.6-2(
$(
6-&3&6$--.
&3/&6$'2/
$3/
6,3(&/21
6,3(0-'$'&,3
,5
$3
23/,61&3,-,<&('9











  !
"#$%&
(
)*+
-+./0
1
02/*3+42*5.678
*670+
67.2
785*678+*4/49:
.2/
;850
 
/4.<0609
:0==46>9?
7*=/
96>/8
/+>@A96>/8
+0@4:02
/*90
>264=
5.64026
49
3=4243.==8
96.<=0B
C
DE
6*F43468
G*+9029?
6702
6+0.6
.9
-+./0
H
*+
-+./0
IB
J6>/8
/+>@A96>/8
+0@4:02
3.2
<0
+09>:0/
*230
0K026
96.<4=4L09
.2/
.E60+
3*:5=064*2
*E
960+*4/
6.50+B
M.640269
G467
02/*3+42*5.67409
G7*
:.8
+0N>4+0
5+*=*2@0/
*+
3*2642>0/
960+*4/
+05=.30:026
O0B@B?
./+02.=
429>EE4340238P
3.2
<0
+06+0.60/
G467
96>/8
/+>@A96>/8
+0@4:02
*2
670
E*==*G42@
3*2/464*29Q
 B ;70
0K026
96.<4=4L09
.2/
49
3*26+*==0/B
1B ;70
5.64026
49
3=4243.==8
96.<=0
.9
50+
42K0964@.6*+
*+
6+0.642@
5789434.2R9
3=4243.=
S>/@0:026B
HB T*909
*E
5+0/249*20
.+0
UVW
:@A/.8
*+
0N>4K.=026B
XY#
"#$%&
(
Z[\]^_%[\`
abYc&
d[ab
cefgaYf$a[]
&\%Y]#[\Yg$abehi
j
k*29>=6
02/*3+42*=*@496
6*
@>4/0
0K.=>.64*2
*E
02/*3+420
E>2364*2
.2/?
.9
42/43.60/
<8
9>950360/
02/*3+42*5.678
.2/
.9
3=4243.==8
42/43.60/?
3*294/0+
546>46.+8
93.2B
j
)*+
.==
5.640269
G467
.<2*+:.=
02/*3+420
G*+l
>5?
0F3056
67*90
G467
49*=.60/
785*678+*4/49:
*+
;850
 
Tm?
.2/
.9
@>4/0/
<8
.2
02/*3+42*=*@496?
3*294/0+
97*+6n60+:
3*+643*960+*4/9
O0B@B?
 
6*
1
:@Al@A/.8
:0678=5+0/249*=*20
*+
Do
0N>4K.=026P
.2/
5+*:56
42464.64*2
*E
6+0.6:026
G467
+0=0K.26
7*+:*20
+05=.30:026
O0B@B?
78/+*3*+649*20?
90F
7*+:*209PB
j
D9*=.60/
785*678+*4/49:
:.8
<0
6+0.60/
G467
+05=.30:026
670+.58?
G467*>6
96>/8
/+>@A96>/8
+0@4:02
4260++>564*2?
.2/
G467*>6
3*+643*960+*4/9B
j
D9*=.60/
;850
 
/4.<0609
:0==46>9
OTmP
:.8
<0
6+0.60/
G467
.55+*5+4.60
/4.<0643
670+.58?
G467*>6
96>/8
/+>@A96>/8
+0@4:02
4260++>564*2?
.2/
G467*>6
3*+643*960+*4/9B
p2=8
7*=/
96>/8
/+>@A96>/8
+0@4:02
42
906642@
*E
7850+@=830:4.
G702
/4.@2*9643
G*+l>5
49
5*9464K0
E*+
/4.<0643
l06*.34/*949B
j
p230
5.640269
*2
960+*4/9
.+0
4:5+*K42@?
@+./>.==8
6.50+
4::>2*9>55+0994K0
960+*4/9
O.9
.55+*5+4.60
.2/
G467
@>4/.230
*E
02/*3+42*=*@496P
*K0+
qrs
/.89
.2/
3*294/0+
5+*578=.3643
.264<4*6439?
.264E>2@.=9?
.2/
.264nMtM
6+0.6:026
O+0E0+
6*
3>++026
ukku
@>4/0=4209
E*+
6+0.6:026
*E
3.230+n+0=.60/
42E0364*29PB
.
j
)*+
5.640269
G467
2*+:.=
02/*3+420
G*+l>5
O=.<*+.6*+8
.99099:026
*+
mvD
93.29P?
+050.6
=.<*+.6*+8
.99099:0269AmvD
.9
3=4243.==8
42/43.60/B











   
!"#$%
'
("
)
*+,
.,/01
2
+,
3
140+5,64+7/89:
+891,
89/4
9:7+89:,+606;<
/40
=:71
 
06/>181;
<1??68@;A
9+?0
;8@0:
0,@BC;8@0:
,1B6<14
0+;1
@486?
140+5,64+7/89:
;:<78+<D;E
/,1
5+48,+??10F
G8@0:
0,@BC;8@0:
,1B6<14
5/4
>1
,1;@<10
+451
1H148
;8/>6?6I1;
/40
/J81,
5+<7?186+4
+J
;81,+60
8/71,F
K/86148;
L689
140+5,64+7/8961;
L9+
</:
,1M@6,1
7,+?+4B10
+,
5+4864@10
;81,+60
,17?/51<148
D1FBFA
/0,14/?
64;@JJ656145:E
5/4
>1
,18,1/810
L689
;8@0:
0,@BC;8@0:
,1B6<14
+4
891
J+??+L64B
5+40686+4;N
 F =91
1H148
;8/>6?6I1;
/40
6;
5+48,+??10F
OF =91
7/86148
6;
5?6465/??:
;8/>?1
/;
71,
64H1;86B/8+,
+,
8,1/864B
79:;656/4P;
5?6465/?
Q@0B1<148F
2F R+;1;
+J
7,1046;+41
/,1
STU
<BC0/:
+,
1M@6H/?148F
V("
!"#$%
'
("
)W
X
Y+4;@?8
140+5,64+?+B6;8
8+
B@601
1H/?@/86+4
+J
140+5,641
J@4586+4
/40A
/;
64065/810
>:
;@;715810
140+5,64+7/89:
/40
/;
5?6465/??:
64065/810A
5+4;601,
768@68/,:
;5/4F
Z+;768/?6I/86+4
,15+<<14010F
X
*+,
/??
7/86148;
L689
/>4+,</?
140+5,641
L+,[
@7A
1\5178
89+;1
L689
6;+?/810
9:7+89:,+606;<
+,
=:71
 
R]A
/40
/;
B@6010
>:
/4
140+5,64+?+B6;8A
7,+<78?:
64686/81
1<76,65
^_
<189:?7,1046;+?+41
 
8+
O
<BC[BC0/:
+,
1M@6H/?148A
/;
L1??
/;
,1?1H/48
9+,<+41
,17?/51<148
D1FBFA
9:0,+5+,86;+41A
;1\
9+,<+41;EF
X
*+,
/0,14/?
5,6;6;A
;1H1,1
019:0,/86+4A
9:7+814;6+4A
+,
;9+5[A
6<<106/81?:
64686/81
^_
5+,865+;81,+60;
L689
<641,/?+5+,865+60
/586H68:F
X
^;+?/810
9:7+89:,+606;<
</:
>1
8,1/810
L689
,17?/51<148
891,/7:A
L689+@8
;8@0:
0,@BC;8@0:
,1B6<14
6481,,@786+4A
/40
L689+@8
5+,865+;81,+60;F
X
^;+?/810
=:71
 
06/>181;
<1??68@;
</:
>1
8,1/810
L689
/77,+7,6/81
06/>1865
891,/7:A
L689+@8
;8@0:
0,@BC;8@0:
,1B6<14
6481,,@786+4A
/40
L689+@8
5+,865+;81,+60;F
`4?:
9+?0
;8@0:
0,@BC;8@0:
,1B6<14
64
;18864B
+J
9:71,B?:51<6/
L914
06/B4+;865
L+,[@7
6;
7+;686H1
J+,
06/>1865
[18+/560+;6;F
X
`451
7/86148;
+4
;81,+60;
/,1
6<7,+H64BA
B,/0@/??:
8/71,
6<<@4+;@77,1;;6H1
;81,+60;
D/;
/77,+7,6/81
/40
L689
B@60/451
+J
140+5,64+?+B6;8E
+H1,
abc
0/:;
/40
5+4;601,
7,+79:?/5865
/486>6+865;A
/486J@4B/?;A
/40
/486dKeK
8,1/8<148
D,1J1,
8+
5@,,148
fYYf
B@601?641;
J+,
8,1/8<148
+J
5/451,d,1?/810
64J1586+4;EF
g<:?/;1Ch67/;1
645,1/;10
R+;1
]+06J65/86+4;
D.141,/?
.@60/451EN
4+41
R+;1
]+06J65/86+4;
D.,/01
 EN
f+
0+;1
<+06J65/86+4;
R+;1]+06J65/86+4;D.,/01OA2+,3EN
^45+4;@?8/86+4L689,1?1H/487/45,1/865
;7156/?6;85+4;601,5+4864@64B;8@0:
0,@BC;8@0:,1B6<146J4+
5?6465/?C,/06+?+B651H601451+J7/45,1/8686;
i6<7,+H1<14864/<:?/;1C?67/;1F
*+,
g4:
.,/01
Xjkl
<+01;8
/;:<78+</865
1?1H/86+4;
64
;1,@<
/<:?/;1
/40
?67/;1A
5+,865+;81,+60
8,1/8<148
6;
4+8
64065/810
/;
?+4B
/;
891,1
/,1
4+
+891,
;6B4;
+,
;:<78+<;
+J
7/45,1/865
64J?/<</86+4F
Xmn6;+?/8101?1H/86+4+J14I:<1;L689+@81H601451+J7/45,1/8686;A
5+4864@16<<@4+891,/7:F
XoppqppJ+,;6B4;C;:<78+<;+J7/45,1/8686;
Xrksptuql/77,+7,6/8106/B4+;86581;864BD1FBA/>0+<64/?Y=L689
5+48,/;8A]vYK6J5?6465/?;@;7656+4+J7/45,1/8686;/404+,/06+?+B65
1H601451+4Y=E
Xrksptuql+891,5/@;1;+J1?1H/810/<:?/;1C?67/;1











  !
"#$%&
()*#+&)%,%,-
./-&
0/1,2,#)%,/*-
34&*&+)5
4$,1)*#&67
*/*&
./-&
0/1,2,#)%,/*-
34+)1&
 67
8/
1/-&
9/1,2,#)%,/*-
./-&
0/1,2,#)%,/*-
34+)1&
!67
:/51
-%$1;
1+$<=-%$1;
+&<,9&*
1/-&
$*%,5
+&-/5$%,/*
%/
4+)1&
>?@
A/*-,1&+
+&-$9B%,/*
/2
-%$1;
1+$<=-%$1;
+&<,9&*
,2
*/
#5,*,#)5=+)1,/5/<,#
&C,1&*#&
/2
B)*#+&)%,%,-
D
,9B+/C&9&*%
,*
)9;5)-&=5,B)-&
,*
#/*-$5%)%,/*
E,%F
+&5&C)*%
B)*#+&)%,#
-B&#,)5,-%
./-&
0/1,2,#)%,/*
34+)1&
G
/+
H67
(&+9)*&*%5;
1,-#/*%,*$&
-%$1;
1+$<=-%$1;
+&<,9&*
I/+
"*;
4+)1&
JA/*-,1&+
<)-%+/&*%&+/5/<;
+&2&++)5
I/+
4+)1&
 7
JKL
F;1+)%,/*
J0)*)<&
B&+
)9;5)-&=5,B)-&
,*#+&)-&1
3)-;9B%/9)%,#6
I/+
4+)1&
!MG
/+
H7
J(+/9B%5;
-%)+%
-;-%&9,#
-%&+/,1-
B+&1*,-/*&
 
%/
!
9<=N<=1);
(O
/+
KL
&P$,C)5&*%
JKL
F;1+)%,/*











  !
"#$%&'&()*)'+
,-.0123456
74-
1.-
76
3080-65
-.
308702
61269:;30-0<
;15
;4-.1.802
164=.9;-:>?
6@234501A
B>;<-:610;
C=;D0<
;15
C4033;01E
F;==6G
HI+
K%LM#
,56961501A
.1
-:6
->96
.N
164=.-.@020->?
=6N6=
-.
OPQ
PRPST
DUVW
N.=
56N0101A
-:6
PRP
A=;56X<6D6=0->G
K#I#%LY
K$)MLI*#
Z&%
HI+
K%LM#[
\
]^_
R_SO`aT_`T
BbTcQRQ`?
dT_BSOTORcb
eQ`P^ORQOfT
]^_
SOb
C_SeT
\
d;-061-<
<:.435
76
6D;34;-65
-.
=436
.4-
;1>
;3-6=1;-0D6
6-0.3.A>
,6VAV?
50<6;<6
9=.A=6<<0.1?
01N62-0.1<?
86-;7.302
<>15=.86<?
.=
86502;-0.1<GV
\
B.10-.=
9;-061-
N.=
A616=;3
<>89-.8<
,:6;5;2:6?
1;4<6;?
D6=-0A.?
76:;D0.=
2:;1A6?
.=
g6;h16<<GV
\
P.1<056=
;99=.9=0;-6
50;A1.<-02
-6<-01A
,6VAV?
6362-=.8>.A=;8
;15
16=D6
2.1542-0.1
01D6<-0A;-0.1<GV
\
d6=N.=8
<>89-.8;-02
-=6;-861-
g0-:
O64=.3.A>
2.1<43-
;<
;99=.9=0;-6V











  !
"#$%&
(
)*
,*-.
/*,0102340*5-6
78#
"#$%&
(9
:
;..
<=5>
?@3,.A
@.2*//.5,340*5-
3B*C.6
D@.34
/0E,
-0F5-G->/H4*/-
3-
?@3,.
 
I.6F6
E*--
*1
,..H
4.5,*5
@.1E.J.-
*@
H3@.-4K.-03L
"#$%&
M
N*@
32O4.
/*4*@
5.O@*H34K0.-
*@
5.O@*4*J0204>P
K*E,
-4O,>
,@OFG-4O,>
@.F0/.5
,*-.
O540E
@.-*EO40*5
4*
?@3,.
QRS
N*@
-.5-*@>
5.O@*H34K>G5.O@*H34K02
H305P
2*5-0,.@
K*E,05F
-4O,>
,@OFG-4O,>
@.F0/.5
,*-.
O540E
@.-*EO40*5
4*
?@3,.
QRS
T1
4*J0204>
U*@-.5-P
4K.5
4@.34
3-
?@3,.
V
*@
!6
W.@/35.54E>
,0-2*5405O.
-4O,>
,@OFG-4O,>
@.F0/.5
01
?@3,.
X
0/=Y
,*.-
5*4
@.-*EC.
4*
?@3,.
QR
U04K05
VZ
,3>-
6
78#
"#$%&
M9
:
[*5-0,.@P
3-
5.2.--3@>P
,0-2O--05F
U04K
4K.
-4O,>
HK>-020356
:
\B4305
).O@*E*F>
2*5-OE46
:
;.5-*@>
5.O@*H34K>G5.O@*H34K02
H305
/3>
B.
/353F.,
B>
3HH@*H@034.
/.,02340*5-
I.6F6P
F3B3H.5405
*@
,OE*J.405.L6
:
W@*/H4E>
-43@4
->-4./02
-4.@*0,-
H@.,50-*5.
 
4*
X
/FG]FG,3>
W\
*@
T^
._O0C3E.546
:
T1
5*
0/H@*C./.54
U04K05
X
4*
V
,3>-
,.-H04.
 
4*
X
/FG]FG,3>
H@.,50-*5.
W\
*@
T^
._O0C3E.54P
2*5-0,.@
3,,040*53E
U*@]OH
35,
H@*/H4E>
4@.34
U04K
3,,040*53E
0//O5*-OHH@.--0C.
4K.@3H>
I.6F6P
T^
T?

*4K.@
0//O5*-OHH@.--0C.
,.H.5,05F
*5
4K.
-H.20102
0/=YL6
"#$%&
`
8#
a
78#
"#$%&
`
8#
a9
W.@/35.54E>
,0-2*5405O.
-4O,>
,@OFG-4O,>
@.F0/.56
78#
"#$%&
`
8#
a9
:
[*5-0,.@P
3-
5.2.--3@>P
,0-2O--05F
U04K
-4O,>
HK>-020356
:
\B4305
).O@*E*F>
2*5-OE46
:
[*5-0,.@
K*-H043E0b340*56
:
W@*/H4E>
0504034.
./H0@02
T^
/.4K>EH@.,50-*E*5.
 
4*
X
/FG]FG,3>
*@
._O0C3E.546
:
T1
5*
0/H@*C./.54
U04K05
X
4*
V
,3>-
,.-H04.
T^
2*@402*-4.@*0,-P
2*5-0,.@
3,,040*53E
U*@]OH
35,
H@*/H4E>
4@.34
U04K
3,,040*53E
0//O5*-OHH@.--354-
I.6F6P
T^
T?

*@
*4K.@
0//O5*-OHH@.--0C.
,.H.5,05F
*5
4K.
-H.20102
0/=YL6
\52.
-43BE.P
F@3,O3EE>
43H.@
-4.@*0,-
*C.@
cde
,3>-6
f&#ghi&#$j
k&l#8m8n8#
okp
"#$%&
"&k&#$j
"lg%$kq&
78#
okp
"#$%&9
:
DK.
H@*/H4
,03F5*-0-
*1
0//O5.r/.,034.,
H.@0HK.@3E
5.O@*/*4*@
->5,@*/.-0-0/H*@4354P-052.2.@4305H340.54-/3>O5H@.,0243BE>











  !
"#$"%&"'("
*(+,"
-"(./$"'0*,&.'0
,1*,
(*'
%"0+2,
&'
0+30,*',&*2
/.%3&-&,4
.%
&'
,1"
5.%0,
(*0"6
-"*,17
8$"(&*2
(*%"
01.+2-
3"
,*9"'
:.%
("%,*&'
0"',&'"2
04/$,./0
,1*,
/*4
$%"-&(,
*
/.%"
0";"%"
.+,(./"6
0+(1
*0
$%./&'"',
-40$1*<&*6
%*$&-24
$%.<%"00&;"
5"*9'"006
*'-
0&<'0
.:
%"0$&%*,.%4
&'0+::&(&"'(4
.%
*+,.'./&(
&'0,*3&2&,47
=
>*,&"',0
01.+2-
3"
";*2+*,"-
,.
%+2"
.+,
*'4
*2,"%'*,&;"
",&.2.<4
?"7<76
-&0"*0"
$%.<%"00&.'6
&':"(,&.'06
/",*3.2&(
04'-%./"0
.%
/"-&(*,&.'0@7
A,
01.+2-
3"
'.,"-
,1*,
,1"
-&*<'.0&0
.:
&//+'"B/"-&*,"-
$"%&$1"%*2
'"+%./.,.%
04'-%./"0
(*'
3"
$*%,&(+2*%24
(1*22"'<&'<
&'
$*,&"',0
5&,1
+'-"%24&'<
(*'("%6
-+"
,.
,1"
/+2,&$2"
$.,"',&*2
(.':.+'-&'<
"::"(,0
.:
(*'("%
?*'-
&,0
,%"*,/"',0@
,1%.+<1.+,
,1"
'"+%*#&07
C&;"'
,1"
&/$.%,*'("
.:
$%./$,
*'-
*((+%*,"
-&*<'.0&06
&,
&0
"00"',&*2
,.
1*;"
*
2.5
,1%"01.2-
,.
.3,*&'
*
D"+%.2.<4
(.'0+2,7
=
D"+%.$140&.2.<&(
-&*<'.0,&(
,"0,&'<
?"7<76
"2"(,%./4.<%*/
*'-
'"%;"
(.'-+(,&.'
&';"0,&<*,&.'06
*'-
E%"$",&,&;"
0,&/+2*,&.'F
&:
/4*0,1"'&*
&0
0+0$"(,"-@
*%"
%.+,&'"24
&'-&(*,"-
+$.'
0+0$&(&.'
.:
0+(1
(.'-&,&.'0
*'-
/*4
3"
3"0,
:*(&2&,*,"-
34
/"*'0
.:
*
D"+%.2.<4
(.'0+2,*,&.'7
=
A,
&0
&/$.%,*',
,.
(.'0&-"%
,1*,
,1"
+0"
.:
0,"%.&-0
*0
,1"
$%&/*%4
,%"*,/"',
.:
C+&22*&'BG*%%"
&0
'.,
,4$&(*224
(.'0&-"%"-
"::"(,&;"7
>*,&"',0
%"H+&%&'<
,%"*,/"',
01.+2-
3"
0,*%,"-
5&,1
AI
AC
*'-
:.22.5"-
34
$2*0/*$1"%"0&0
&:
'.,
%"0$.'0&;"
,.
AI
AC7
JKLMN
P
?C+&22*&'BG*%%"
QCGRS
/&2-
04/$,./0@
?T4*0,1"'&*
<%*;&0
QTCRS
*04/$,./*,&(
.%
/&2-
04/$,./0U
(2&'&(*2
.%
-&*<'.0,&(
.30"%;*,&.'0
.'24U
&',"%;"',&.'
'.,
&'-&(*,"-@
D.
-.0"
/.-&:&(*,&.'07
VWK
JKLMN
PX
=
Y.'0&-"%6
*0
'"("00*%46
-&0(+00&'<
5&,1
,1"
0,+-4
$140&(&*'7
=
Y*%"
01.+2-
3"
,*9"'
,.
/.'&,.%
$*,&"',0
:.%
0"',&'"2
04/$,./0
.:
*
$.,"',&*2
-"(./$"'0*,&.'
*0
-"0(%&3"-
*3.;"7
Z3,*&'
*
D"+%.2.<4
(.'0+2,7
[\]MKW^N[
?0+(1
*0
C+&22*&'B
G*%%"
*'-
/4*0,1"'&*
<%*;&0@
JKLMN
_
?CGS
/.-"%*,"
04/$,./0U
2&/&,&'<
&'0,%+/"',*2
`ab@
?TCS
/.-"%*,"U
/&'&/*26
2.(*2.%'.'&';*0&;"
c.2-
0,+-4
-%+<d0,+-4
%"<&/"'
-.0"
+',&2
%"0.2+,&.'
,.
C%*-"
efg
>"%/*'"',24
-&0(.',&'+"
0,+-4
-%+<d0,+-4
%"<&/"'
&:
&,
-."0
'.,
%"0.2;"
,.
C%*-"
ef
5&,1&'
hi
-*40
.%
&:
,1"%"
*%"
0&<'0
.:
%"0$&%*,.%4&'0+::&(&"'(4.%*+,.'./&(
VWK
JKLMN
_X
=
Y.'0&-"%6
*0
'"("00*%46
-&0(+00&'<
5&,1
,1"
0,+-4
$140&(&*'7
=
Y*%"
01.+2-
3"
,*9"'
,.
/.'&,.%
$*,&"',0
:.%
0"',&'"2
04/$,./0
.:
*
$.,"',&*2
-"(./$"'0*,&.'
*0
-"0(%&3"-
*3.;"7
=
Z3,*&'
*
D"+%.2.<4
(.'0+2,
=
8"'0.%4
'"+%.$*,14d'"+%.$*,1&(
$*&'
/*4
3"
/*'*<"-
34
*$$%.$%&*,"











  !
"#$%&'%#$"(#
"#*"+,$%*-
."/"$"#0
,0%1,22&(2&",$%
"#3$&4/%#$,.
5678
"#3$,9"."$:;
/%*"+,$"(#3
<%;0;=
0,9,2%#$"#
(&
*4.(>%$"#%8;
?@ABCDEFGA
IJAKGBL
M
N$%&("*3
/,:
9%
34++%33O4..:
43%*
$(
$&%,$
/:,3$P%#",
0&,'"3;
Q$
"3
"/2(&$,#$
$(
+(#3"*%&
$P,$
3$%&("*
$P%&,2:
<%32%+",..:
R"$P
P"0P
*(3%38
/,:
&%34.$
"#
$&,#3"%#$
R(&3%#"#0
(O
/:,3$P%#",
,#*
3P(4.*
$:2"+,..:
9%
,*/"#"3$%&%*
"#
,
/(#"$(&%*
3%$$"#0
4#*%&
342%&'"3"(#
(O
,
+(#34.$"#0
#%4&(.(0"3$;
S
T,$"%#$3
4#,9.%
$(
$(.%&,$%
3$%&("*3
/,:
9%
+,#*"*,$%3
O(&
$&%,$/%#$
R"$P
2.,3/,2P%&%3"3
(&
QU
QV;
N4+P
*%+"3"(#3
,&%
9%3$
/,*%
"#
+(#34.$,$"(#
R"$P
,
#%4&(.(0"3$=
$,W"#0
"#$(
,++(4#$
$P%
4#"X4%
#%%*3
(O
%,+P
2,$"%#$;
S
QO
/:,3$P%#",
0&,'"31."W%
#%4&($(>"+"$:
"3
2&%3%#$=
+(#3"*%&
3$,&$"#0
5YPZ
"#P"9"$(&
$P%&,2:
"#
,**"$"(#
$(
3$%&("*3;
N4+P
$P%&,2:=
"O
34++%33O4.=
+,#
,.3(
3%&'%
$(
&%"#O(&+%
$P%
*",0#(3"3;
S
5'("*
/%*"+,$"(#3
$P,$
+,#
R(&3%#
/:,3$P%#",
0&,'"3
I[G\\AGF]^AJJEL
S
Q$
"3
"/2(&$,#$
$(
+(#3"*%&
P%&%
$P,$
$P%
43%
(O
3$%&("*3
,3
$P%
2&"/,&:
$&%,$/%#$
(O
V4"..,"#1_,&&%
"3
#($
$:2"+,..:
+(#3"*%&%*
%OO%+$"'%;
S
T,$"%#$3
&%X4"&"#0
$&%,$/%#$
3P(4.*
9%
3$,&$%*
R"$P
QU
QV
,#*
O(..(R%*
9:
2.,3/,2P%&%3"3
"O
#($
&%32(#3"'%
$(
QU
QV;
`abcd
f
ga
h
<V&,*%
i
V_j
3%'%&%
3:/2$(/3-
."/"$"#0
3%.O
+,&%
567-
V&,*%
k
V_j
."O%1
$P&%,$%#"#0
+(#3%X4%#+%3-
4&0%#$
"#$%&'%#$"(#
"#*"+,$%*-
"#$49,$"(#8
<V&,*%
i
lVj
3%'%&%
(&
/%*"+,..:
3"0#"O"+,#$
94$
#($
"//%*",$%.:
."O%1
$P&%,$%#"#0-
P(32"$,."m,$"(#(&
nga
`abcd
fo
p(.*
3$4*:
*&40q3$4*:
&%0"/%#
*(3%
4#$".
&%3(.4$"(#
$(
V&,*%
rst
T%&/,#%#$.:
*"3+(#$"#4%
3$4*:
*&40q3$4*:
&%0"/%#
"O
V&,*%
i
"/5Z
*(%3
#($
&%3(.'%
$(
V&,*%
rs
R"$P"#
iu
*,:3
(&
"O
$P%&%
,&%
3"0#3
(O
&%32"&,$(&:
"#34OO"+"%#+:
(&
,4$(#(/"+
"#3$,9"."$:;
nga
`abcd
ho
nga
`abcd
f
ga
h
vwdxdad
ga
yz{d|}~adb}dz
dxd}wo
M
Y(#3"*%&=
,3
#%+%33,&:=
*"3+433"#0
R"$P
3$4*:
2P:3"+",#;
M
%+(//%#*
P(32"$,."m,$"(#;
M
l(#"$(&
3:/2$(/3
,#*
(9$,"#
%4&(.(0:
+(#34.$;
?@ABCDEFGA
IJAKGBL
M
N$%&("*3
/,:
9%
34++%33O4..:
43%*
$(
$&%,$
/:,3$P%#",
0&,'"3;
P%:
3P(4.*
$:2"+,..:
9%
,*/"#"3$%&%*
"#
,
/(#"$(&%*
3%$$"#0
4#*%&
342%&'"3"(#
(O
,
+(#34.$"#0
#%4&(.(0"3$;
M
T,$"%#$3
4#,9.%
$(
$(.%&,$%
3$%&("*3
/,:
9%
+,#*"*,$%3
O(&
$&%,$/%#$
R"$P
2.,3/,2P%&%3"3
(&
QU
QV;
M
QO
/:,3$P%#",
0&,'"31."W%
#%4&($(>"+"$:
2&%3%#$=
+(#3"*%&
3$,&$"#0
5YPZ
"#P"9"$(&
$P%&,2:
"#
,**"$"(#
$(
3$%&("*3;
N4+P
$P%&,2:=
"O
34++%33O4.=
+,#
,.3(
3%&'%
$(
&%"#O(&+%
$P%
*",0#(3"3;
I[G\\AGF]^AJJEL











  !
"#$%$&'()*$&
$,
-.*/)*&'
0$/"*)(%*1()*$&
*&2*3()-24
%*5*)*&'
/-%,
3(#-
6784
9#(2-
:
;9<
%*,-=
)0#-()-&*&'
3$&/->?-&3-/4
?#'-&)
*&)-#@-&)*$&
*&2*3()-2A
B-#5(&-&)%C
2*/3$&)*&?-
/)?2C
2#?'D/)?2C
#-'*5-&E
F
G)
*/
*5"$#)(&)
)$
3$&/*2-#
0-#-
)0()
)0-
?/-
$,
/)-#$*2/
(/
)0-
"#*5(#C
)#-()5-&)
$,
9?*%%(*&=H(##-
*/
&$)
)C"*3(%%C
3$&/*2-#-2
-,,-3)*@-E
F
B()*-&)/
#->?*#*&'
)#-()5-&)
/0$?%2
I-
/)(#)-2
J*)0
GK
G9
(&2
,$%%$J-2
IC
"%(/5("0-#-/*/
*,
&$)
#-/"$&/*@-
)$
GK
G9E
LMNOPQRSTSU
VWM
YQPRZ
YZWZQP[
Y\SRPWOZ
7*/3$&)*&?-
2#?'
"-#5(&-&)%C
*,
I*$"/C=
"#$@-&
*55?&-=5-2*()-2
5C$3(#2*)*/E
]NQ
VWM
YQPRZ^
F
_0-
"#$5")
2*('&$/*/
$,
*55?&-=5-2*()-2
5C$3(#2*)*/
*/
*5"$#)(&)`
"(#)*3?%(#%C
*&
"()*-&)/
J*)0
I(/-%*&-
3(#2*$"?%5$&(#C
2*/-(/-
(&2
#-2?3-2
3(#2*(3
,?&3)*$&E
F
a$&/*2-#`
(/
&-3-//(#C`
2*/3?//*&'
J*)0
)0-
/)?2C
"0C/*3*(&E
F
;$&*)$#
"()*-&)/
,$#
/*'&/
(&2
/C5")$5/
$,
5C$3(#2*)*/
b&-J
$&/-)
$#
J$#/-&*&'
30-/)
"(*&`
(##0C)05*(`
/0$#)&-//
$,
I#-()0`
"-#*"0-#(%
-2-5(AE
6/
/$5-
/C5")$5/
3(&
$@-#%("
J*)0
%?&'
)$.*3*)*-/`
/*5?%)(&-$?/%C
-@(%?()-
,$#
(&2
#?%-
$?)
"?%5$&(#C
)$.*3*)C
(/
J-%%
(/
$)0-#
3(?/-/
b-E'E`
"?%5$&(#C
-5I$%*/5`
3$&'-/)*@-
0-(#)
,(*%?#-`
5(%*'&(&)
"-#*3(#2*(%
-,,?/*$&AE
6
a(#2*$%$'C
3$&/?%)()*$&
/0$?%2
I-
$I)(*&-2
-(#%C`
J*)0
"#$5")
(//-//5-&)
$,
J0-)0-#
(&2
J0-&
)$
3$5"%-)-
(
3(#2*(3
I*$"/C`
*&3%?2*&'
(&C
$)0-#
2*('&$/)*3
"#$3-2?#-/E
F
G&*)*(%
J$#c=?"
/0$?%2
*&3%?2-
3%*&*3(%
-@(%?()*$&`
HdB`
3(#2*(3
-&1C5-/`
ea9`
-30$3(#2*$'#(5
beafgA`
5$&*)$#*&'
$,
$.C'-&()*$&
@*(
"?%/-
$.*5-)#C
b#-/)*&'
(&2
-.-#)*$&A`
(&2
(22*)*$&(%
%(I$#()$#C
J$#c=?"
(/
*&2*3()-2E
h"*#(%
a_
$#
3(#2*(3
;iG
3(&
3$5"%-5-&)
eafg
)$
(//-//
J(%%
5$)*$&
(I&$#5(%*)*-/
J0-&
&--2-2E
B()*-&)/
/0$?%2
I-
)0$#$?'0%C
-@(%?()-2
)$
#?%-
$?)
(&C
(%)-#&()*@-
-)*$%$'C
b-E'E`
2*/-(/-
"#$'#-//*$&`
$)0-#
5-2*3()*$&/`
$#
*&,-3)*$&/A
YQPRZ
j
d$
2$/-
5$2*,*3()*$&/
#->?*#-2
?&%-//
]NQ
YQPRZ
j
kWN
RZlSWSTSmZ
lSWRSWnUo^











  !
"#$%&'()&#(*+
)-
&*./
$%&'()&$01
+.*2*+#.
)-
/*#32)$(*+
)4$5-6#(*)2$
)2.%1
*2(5-652(*)2
2)(
*2/*+#(5/7
08-5#(
&%)+#-/*(*$
9*(:
&*./
$%&'()&$
#$
;-#/5
<=
+.*2*+#.
$>$'*+*)2
*$
:*3:?
*2
9:*+:
+#$5
:)./
$(>/%
/->3@$(>/%
-53*&52
/)$5
/>-*23
/*#32)$(*+
9)-AB>'
C)-
)(:5-
5(*).)3*5$=
DC
$(>/%
/->3@$(>/%
-53*&52
*$
:5./?
-5$>&5
#C(5-
+)&'.5(5
-5$).>(*)2
()
;-#/5
E=
B
F)2*()-
#2/
+.)$5.%
C)..)9
>'
*2
<
()
G
/#%$
C)-
+.*2*+#.
$%&'()&$?
HIJ?
+#-/*#+
52K%&5$?
LM;?
LMNO?
'>.$5
)P*&5(-%
"-5$(*23
#2/
5P5-(*)27?
#2/
.#4)-#()-%
9)-AB>'
#$
+.*2*+#..%
*2/*+#(5/=
B
M)2$*/5-
>$*23
$(5-)*/$
*C
+.*2*+#.
$>$'*+*)2
*$
:*3:=
QRSTU
WX
Y
ZR
[
";-#/5
<\
]%&'()&$
9*(:
&)/5-#(5
#+(*6*(%
)-
5P5-(*)27

";-#/5
^\
]565-5
9*(:
$%&'()&$
#(
-5$(
)-
9*(:
&*2*&#.
#+(*6*(%
)-
5P5-(*)21
*2(5-B
652(*)2
*2/*+#(5/1
259
)2$5(
)C
$%&'()&$07
";-#/5
G\
_*C5B
(:-5#(52*23
+)2$5B
`>52+5$1
>-352(
*2(5-652(*)2
*2/*+#(5/
"5=3=?
+)2(*2>)>$
Da
(:5-#'%
)-
&5+:#2*+#.
:5&)/%2#&*+
$>'')-(77
0
M)2$*/5-
b259
)2$5(
)C
$%&'()&$c
#$
-5C5--*23
()
'#(*52($
9*(:
'-*)-
5'*$)/5
)C
&%)+#-/*(*$=
BDC
;-#/5
<
BB
N)./
$(>/%
/->3@$(>/%
-53*&52
/)$5
>2(*.
-5$).>(*)2
()
;-#/5
E=
DC
()P*+*(%
-#'*/.%
*&'-)65$
()
;-#/5
E?
(:52
(:5
/5+*$*)2
()
-5*2*(*#(5
$(>/%
/->3@$(>/%
-53*&52
9*..
45
4#$5/
>')2
(-5#(*23
':%$*+*#2d$
+.*2*+#.
e>/3&52(
#2/
#C(5-
+)&'.5(*)2
)C
$(5-)*/
(#'5-=
DC
()P*+*(%
/)5$
2)(
-#'*/.%
*&'-)65?
'5-&#252(.%=
/*$+)2(*2>5
$(>/%
/->3@$(>/%
-53*&52=
DC
;-#/5
^BG?
'5-&#252(.%
/*$+)2(*2>5
$(>/%
/->3@$(>/%
-53*&52=
fZR
QRSTU
Wg[h
i
F)2*()-
$%&'()&$
/#*.%?
:)$'*(#.*K5=
i
J-)&'(.%
$(#-(
Da
&5(:%.'-5/2*$).)25
<
()
G
&3@A3@/#%
)-
5`>*6#.52(
#C(5-
M#-/*).)3%
+)2$>.(#(*)2
:#$
/5(5-&*25/
9:5(:5-
#2/
9:52
()
+)&'.5(5
/*#32)$(*+
'-)+5/>-5$
*2+.>/*23
#
+#-/*#+
4*)'$%=
i
]>'')-(*65
+#-5
"5=3=?
)P%3527=
i
DC
2)
*&'-)65&52(
9*(:*2
<
()
^
/#%$
/5$'*(5
Da
&5(:%.'-5/2*$).)25
#(
<
()
G
&3@A3@/#%?
'-)&'(.%
$(#-(
*&&>2)$>''-5$$*65
(:5-#'%
$>+:
#$
8Ij
*2:*4*()-$
"5=3=?
*2C.*P*&#4
#(
k
&3@A3
Da?
&#%
45
-5'5#(5/
#(
<
#2/
l
955A$
#C(5-
*2*(*#.
/)$5
#(
(:5
/*$+-5(*)2
)C
(:5
(-5#(*23
'-)6*/5-
7=
M#>(*)2\
D(
*$
*&')-(#2(
()
->.5
)>(
$5'$*$
#2/
-5C5-
()
*2C.*P*&#4
.#45.
C)-
3525-#.
3>*/#2+5
45C)-5
>$*23
*2C.*P*&#4=
D2C.*P*&#4
*$
+)2(-#*2/*+#(5/
C)-
'#(*52($
9:)
:#65
:5#-(
C#*.>-5=
i
O2+5
(:5
'#(*52(
*$
*&'-)6*23?
3-#/>#..%
(#'5-
$(5-)*/$
)65-
mno
/#%$
#2/
+)2$*/5-
'-)':%.#+(*+
#2(*4*)(*+$?
#2(*C>23#.$?
)-
#2(*BJpJ
(-5#(&52(
"-5C5-
()
+>--52(
IMMI
3>*/5.*25$
C)-
(-5#(&52(
)C
+#2+5-B
-5.#(5/
*2C5+(*)2$7=
#











  !
"#$%&'&%()$*#+#$%&'&%
-.)$*#(+#$%&'&%/0
12#
34567
372745*
38&65297
:$4
12#
34567;
<
=>?@A>B
DEA@F?AG
H>B
G@I?G
E?J
GKLDA>LG
>H
D>MKNLK>G@A@GO
PKD@QEMMKR
LSGQMF
TFEU?FGGNDE@?
>QQSBG
@?
DB>V@LEM
LSGQMFG
@?QMSJ@?I
SDDFB
EBLGR
AW@IWGR
GW>SMJFBGR
W@DGR
?FQU
E?J
XEQUR
XSA
BEBFMK
EHHFQAG
AWF
FVABFL@A@FG
@?QMSJ@?I
WE?JG
E?J
H@?IFBGY
EMG>
J@HH@QSMAK
XBFEAW@?I
E?JN>B
AB>SXMF
GTEMM>T@?I
QE?
>QQSB
E?J
DB>IBFGG
BED@JMKO
Z?QBFEGFJ
IF?FBEM
HFFM@?IG
>H
A@BFJ?FGG
E?J
HEA@ISF
LEK
>QQSBR
E?J
AWFBF
QE?
XF
?FT[>?GFA
HEMM@?IR
J@HH@QSMAK
IFAA@?I
SD
HB>L
E
HEMMR
E?J
AB>SXMF
QM@LX@?I
GAE@BGR
GAE?J@?I
SD
HB>L
E
GFEAFJ
D>G@A@>?R
E?JN>B
BFEQW@?I
SDO
<
ZH
D>MKNLK>G@A@G
@G
GSGDFQAFJR
E
\FSB>M>IK
Q>?GSMAEA@>?
GW>SMJ
XF
>XAE@?FJ
FEBMKR
T@AW
DB>LDA
IS@JE?QF
>?
J@EI?>GA@Q
DB>QFJSBFGO
=K>QEBJ@A@G
LEK
Q>[>QQSB
T@AW
D>MKNLK>G@A@GY
BFHFB
A>
IS@JE?QF
S?JFB
=K>QEBJ@A@GO
]@^F?
XBFEAW@?I
Q>LDM@QEA@>?GR
BFHFB
A>
IS@JE?QF
S?JFB
_?FSL>?@A@GNZ`aO
]@^F?
D>GG@X@M@AK
>H
E?
FV@GAF?A
bXSA
DBF^@>SGMK
S?U?>T?c
ESA>@LLS?F
J@G>BJFBR
Q>?G@JFB
dWFSLEA>M>IK
Q>?GSMAEA@>?O
<
e>?G@JFBR
EG
?FQFGGEBKR
J@GQSGG@?I
T@AW
AWF
GASJK
DWKG@Q@E?O
<
Z?@A@EM
T>BU[SD
GW>SMJ
@?QMSJF
QM@?@QEM
F^EMSEA@>?R
QBFEA@?F
U@?EGFR
EMJ>MEGFR
`afR
gh\NQBFEA@?@?FR
FBKAWB>QKAF
GFJ@LF?AEA@>?
BEAF
>B
e[BFEQA@^F
DB>AF@?
MF^FMR
SB@?F
LK>IM>X@?R
E?J
EJJ@A@>?EM
MEX>BEA>BK
T>BU[SD
EG
@?J@QEAFJR
@?QMSJ@?I
E
?SLXFB
>H
D>GG@XMF
BWFSLEA>M>I@QEMNE?A@X>JK
AFGAG
b@OFOR
Q>?G@JFB
TWFAWFB
E
BWFSLEA>M>I@GA
Q>?GSMAEA@>?
@G
@?J@QEAFJ
E?J
Q>SMJ
IS@JF
?FFJ
H>B
BWFSLEA>@J
HEQA>BR
E?A@?SQMFEB
E?A@X>JKR
E?A@[GL>>AW
LSGQMFR
E?A@GK?AWFAEGF
iGSQW
EG
E?A@[j>[ kR
E?JN>B
G@I?EM[BFQ>I?@A@>?
DEBA@QMF
E?A@X>J@FGcO
e>?H@BLEA>BK
AFGA@?I
LEK
@?QMSJF
FMFQAB>LK>IBEDWKR
?FB^F
Q>?JSQA@>?
GASJ@FGR
=dZ
>H
AWF
LSGQMFGR
E?JN>B
E
LSGQMF
X@>DGKO
e>?G@JFB
gEB@SL











 !"
#
$%&''(%
*(+
,-&'.&/0(1
(*
23$45&60&
(+
23$45(10&7
8&/0,1/$
$5(.'2
9,
/5(+(.65'3
,-&'.&/,2
/(
+.',
(./
&13
&'/,+1&/0-,
,/0('(63
:,767;
20$,&$,
4+(6+,$$0(1;
(/5,+
<,20=&/0(1$;
(+
01*,=/0(1$>7
?@ABC
E
:<0'2
4&01>
FG(
2($,
<(20*0=&/0(1$7
HI@
?@ABC
EJ
#
K(10/(+
&12
='($,'3
*(''(%
.4
01
!
/(
L
2&3$
*(+
='010=&'
$3<4/(<$
&12
010/0&/,
,-&'.&/0(1
&$
='010=&''3
0120=&/,27
#
M(1$02,+
G,.+('(63
=(1$.'/7
#
M(1$02,+;
&$
1,=,$$&+3;
20$=.$$016
%0/5
/5,
$/.23
453$0=0&17
?@ABC
N
:<(2,+&/,
4&01
&$$(=0&/,2
%0/5
%,&O1,$$P
4&01
'0<0/016
01$/+.<,1/&'
&=/0-0/0,$
(*
2&0'3
'0-016
QRST$U>
V('2
$/.23
2+.6W$/.23
+,60<,1
2($,
.1/0'
+,$('./0(1
/(
X+&2,
YZ[
F8,+<&1,1/'3
20$=(1/01.,
$/.23
2+.6W$/.23
+,60<,1
0*
0/
2(,$
1(/
+,$('-,
/(
X+&2,
YZ
%0/501
\"
2&3$
(+
0*
/5,+,
&+,
$061$
(*
+,$40+&/(+3
01$.**0=0,1=37
HI@
?@ABC
NJ
#
K(10/(+
$3<4/(<$
2&0'3
&12
=(1$02,+
5($40/&'0]&/0(17
#
^9/&01
G,.+('(63
=(1$.'/;
&12
010/0&/,
,-&'.&/0(17
#
M(1$02,+;
&$
1,=,$$&+3;
20$=.$$016
%0/5
/5,
$/.23
453$0=0&17
#
_*
='010=&'
=(.+$,
0$
+&402'3
4+(6+,$$0-,
:4&+/0=.'&+'3
0*
20**0=.'/3
9+,&/5016
&12W(+
/+(.9',
$%&''(%016>;
4+(<4/'3
$/&+/
_`
<,/53'4+,210$('(1,
!
/(
L
<6WO6W2&3
$3$/,<0=
$/,+(02$
&'(16
%0/5
+,=,0-016
014./
*+(<
G,.+('(63
=(1$.'/&1/
#
_*
='010=&'
=(.+$,
0$
abc
+&402'3
4+(6+,$$0-,;
$/&+/
$3$/,<0=
$/,+(02$
:,767;
4+,210$(1,
 
/(
!
<6WO6W2&3
8^
(+
_`
,d.0-&',1/>P
0*
1(
0<4+(-,<,1/
%0/501
!
/(
\
2&3$;
=(1/01.,
&220/0(1&'
%(+O
.4
&12
$/&+/
/+,&/<,1/
%0/5
_`
<,/53'4+,210$('(1,
!
/(
L
<6WO6W2&3
#
_*
&*/,+
$/&+/
(*
_`
<,/53'4+,210$('(1,
&/
!
/(
L
<6WO6W2&3
/5,+,
0$
1(
0<4+(-,<,1/
%0/501
!
/(
\
2&3$;
=(1$02,+
$/&+/
(*
0<<.1($.44+,$$0-,
/5,+&43
$.=5
&$
eGf
015090/(+$
:,767;
01*'0g0<&9
&/
h
<6WO6

_`;
<&3
9,
+,4,&/,2
&/
!
&12
i
%,,O$
&*/,+
010/0&'
2($,
&/
/5,
20$=+,/0(1
(*
/5,
/+,&/016
4+(-02,+
>7
M&./0(1j
_/
0$
0<4(+/&1/
/(
+.',
(./
$,4$0$
&12
+,*,+
/(
01*'0g0<&9
'&9,'
*(+
6,1,+&'
6.02&1=,
9,*(+,
.$016
01*'0g0<&97
#
^1=,
/5,
4&/0,1/
0$
0<4+(-016;
6+&2.&''3
/&4,+
$/,+(02$
(-,+











 ! 
"
#$%
'()*
(+'
,-+*.'/0
10-12)3(,4.,
(+4.5.-4.,*6
(+4.78+9(3*6
-0
(+4.:
;<;
40/(4=/+4
>0/7/0
4-
,800/+4
?@@?
98.'/3.+/*
7-0
40/(4=/+4
-7
,(+,/0:0/3(4/'
.+7/,4.-+*AB
(
CDEFG
I
JD
K
>L0('/
MN
1(.+
(**-,.(4/'
O.42
*/P/0/
O/(Q+/**R
3.=.4.+9
*/37:
,(0/
STU*
L0('/
VN
3.7/:
420/(4/+.+9
,-+*/W8/+,/*R
809/+4
.+4/0P/+4.-+
.+'.,(4/'A
XJD
CDEFG
IY
Z-3'
*48')
'089[*48')
0/9.=/+
'-*/
8+4.3
0/*-384.-+
4-
L0('/
\]^
;/0=(+/+43)
'.*,-+4.+8/
*48')
'089[*48')
0/9.=/+
.7
L0('/
M
.=S_
'-/*
+-4
0/*-3P/
4-
L0('/
\]
O.42.+
M`
'()*
-0
.7
42/0/
(0/
*.9+*
-7
0/*1.0(4-0)
.+*877.,./+,)B
XJD
CDEFG
KY
:;/0=(+/+43)
'.*,-+4.+8/
*48')
'089[*48')
0/9.=/+B
XJD
CDEFG
I
JD
K
abGcGDG
JD
defGghiDGEhGjejk
GcGjhblY
"
m-+.4-0
*)=14-=*
,3-*/3)R
0/,-==/+'
2-*1.4(3.n(4.-+B
"
o54(.+
?/80-3-9)
,-+*8346
(+'
,-=13/4/
7833
/P(38(4.-+B
"
@-+*.'/06
(*
+/,/**(0)6
'.*,8**.+9
O.42
42/
*48')
12)*.,.(+B
"
;0-=143)
*4(04
pq
=/42)310/'+.*-3-+/
!
4-
V
=9[Q9['()
*)*4/=.,
*4/0-.'*
(3-+9
O.42
0/,/.P.+9
.+184
70-=
?/80-3-9)
,-+*834(+4B
"
p7
(74/0
*4(04
-7
pq
=/42)310/'+.*-3-+/
(4
!
4-
V
=9[Q9['()
42/0/
.*
+-
.=10-P/=/+4
O.42.+
!
4-
M
'()*6
,-+*.'/0
*4(04
-7
.==8+-*8110/**.P/
42/0(1)
*8,2
(*
r?s
.+2.5.4-0*
>/B9B6
.+73.t.=(5
(4
u
=9[Q9

pq6
=()
5/
0/1/(4/'
(4
!
(+'
v
O//Q*
(74/0
.+.4.(3
'-*/
(4
42/
'.*,0/4.-+
-7
42/
40/(4.+9
10-P.'/0
AB
@(84.-+N
p4
.*
.=1-04(+4
4-
083/
-84
*/1*.*
(+'
0/7/0
4-
.+73.t.=(5
3(5/3
7-0
9/+/0(3
98.'(+,/
5/7-0/
8*.+9
.+73.t.=(5B
"
@-+*.'/0
O2/42/0
1(4./+4
=()
0/W8.0/
pq
pL6
13(*=(12/0/*.*B
"
o+,/
42/
1(4./+4
.*
.=10-P.+96
90('8(33)
4(1/0
*4/0-.'*
-P/0
#$%
'()*
(+'
,-+*.'/0
10-12)3(,4.,
(+4.5.-4.,*6
(+4.78+9(3*6
-0
(+4.:;<;
40/(4=/+4
>0/7/0
4-
,800/+4
?@@?
98.'/3.+/*
7-0
40/(4=/+4
-7
,(+,/0:
0/3(4/'
.+7/,4.-+*AB
(
o42/0
p==8+/
m/'.(4/'
w/(,4.-+*
T-*/
m-'.7.,(4.-+*
>S+)
L0('/AN
x?-4/
.4
.*
1-**.53/
42(4
/P/+4*
O.42
(+
.+73(==(4-0)
-0
.==8+/
=/'.(4/'
=/,2(+.*=
,-83'
-,,80
.+
+/(03)
(33
-09(+*6
*-=/
-7
42/=
(0/
+-4
+-4/'
*1/,.7.,(33)
.+
42/*/
98.'/3.+/*
T-*/
m-'.7.,(4.-+*
>L0('/
 AN
?-
'-*/
=-'.7.,(4.-+*
T-*/
m-'.7.,(4.-+*
>L0('/
!AN
Z-3'
*48')
'089[*48')
0/9.=/+
8+4.3
0/*-384.-+
4-
\yz{|}
 
-0
5(*/3.+/B
p7
4-t.,.4)
O-0*/+*6
42/+40/(4(*L0('/M-0L0('/VB~48')
S+)
L0('/
:
r2-0-892
/P(38(4.-+
4-
083/
-84
(+)
(34/0+(4.P/
/4.-3-9)
>/B9B
'.*/(*/
10-90/**.-+6
,-+,-=.4(+4
=/'.,(4.-+*
(+'
.+7/,4.-+*A
:
@-+*834(4.-+
O.42
0/3/P(+4
*1/,.(3.*4
:
r0/(4
(,,-0'.+93)6
(*
1/0
.+*4.484.-+(3
*4(+'(0'
L0('/
 
:
m-+.4-0
(*
,3.+.,(33)
.+'.,(4/'
L0('/
!6M6V
:
r0/(4
(,,-0'.+93)
(*
1/0
.+*4.484.-+(3
*4(+'(0'6
(110-10.(4/
,3.+.,(3
10(,4.,/
98.'/3.+/*6
(+'
-42/0
*-,./4)
98.'/3.+/*
>/B9B6
?@@?6











 !!
"#$%&
()*+",-./"0
1..2
!3 4
56"/"7-/7
899*/:
%;:+2<.-/,
10.+2-/7
#/,-=.)>
$-):
(??:+,@A
=>
6-+;":0
B.@,.C
6DE
=FD#
G-H:I
J*-)"/+:
D.+*9:/,
!33K
J*-)"/+:
?.I
8/)*@,I>L
DI*7
8/)*+:)
G-H:I
8/M*I>
N
BI:9"I2:,-/7
%0-/-+"0
(H"0*",-./E
#%;(
#+:,>0+;.0-/:
:@,:I"@:O
#DG
#+,-H-,-:@
.?
)"-0>
0-H-/7O
#(
#)H:I@:
:H:/,O
#GB
#02"0-/:
<;.@<;","@:
,:@,O
#GP
#0"/-/:
"9-/.,I"/@?:I"@:O
#$P
#@<"I,",:
"9-/.,I"/@?:I"@:O
1QR
10..)
*I:"
/-,I.7:/O
%P
%.9<*,:)
,.9.7I"<;>O
%P%#(
%.99./
P:I9-/.0.7>
%I-,:I-"
?.I
#)H:I@:
(H:/,@O
8GD
8/,:I@,-,-"0
0*/7
)-@:"@:O
-9#(
-99*/:S9:)-",:)
")H:I@:
:H:/,O
8J
899*/.70.=*0-/O
8T
8/,I"H:/.*@O
J8
J"@,I.-/,:@,-/"0O
GFP
G-H:I
?*/+,-./
,:@,@O
GGR
G.C:I
0-9-,
.?
/.I9"0O
6U8
6"7/:,-+
I:@./"/+:
-9"7-/7O
R%8
R",-./"0
%"/+:I
8/@,-,*,:O
R%%R
R",-./"0
%.9<I:;:/@-H:
%"/+:I
R:,C.I2O
BVB
WXYZ[\]^_`a_
cad\eY]aa
</:*9./-"
f?.I9:I0>
2/.C/
"@
WXYZ[\]^_`a_
]gdaXaa
</:*9./-"hO
B&
1>
9.*,;O
Pi
PI--.).,;>I./-/:O
Pj
P;>I.k-/:O
P1
P.,"0
=-0-I*=-/O
PRF
P*9.I
/:+I.@-@
?"+,.IO
P$l
P;>I.-)S@,-9*0",-/7
;.I9./:O
QGR
Q<<:I
0-9-,
.?
/.I9"0E
)I*7m@,*)>
I:7-9:/
+"/
=:
I:@*9:)
./+:
:H:/,
@,"=-0-n:@
,.
JI"):
op
"?,:I
+.9<0:,-./
.?
@,:I.-)
,"<:IE
%./@-):I
C;:,;:I
@,*)>
)I*7m@,*)>
I:7-9:/
@;.*0)
=:
<:I9"/:/,0>
)-@+./,-/*:)
-/
JI"):
!
:H:/,@
C-,;
;-7;
0-2:0-;..)
?.I
9.I=-)-,>
"/)m.I
9.I,"0-,>
C;:/
,;:>
).
/.,
I"<-)0>
-9<I.H:
,.
JI"):
q 
*<./
,I:",9:/,
C-,;
@>@,:9-+
@,:I.-)@
"/)
?.00.C-/7
?*00
,"<:I
D.@:
6.)-?-+",-./
fJI"):
ihL
l.0)
@,*)>
)I*7m@,*)>
I:7-9:/

D.@:
6.)-?-+",-./
fJI"):
jhL
D-@+./,-/*:
@,*)>
)I*7m@,*)>
I:7-9:/
($6&h











 !"
#$%&'()$*+,-./,0
+,.2/()$'
3,4,5(/6
75.0,
)%
/8,
94,$/
:;<#
<=<>9
4,5'()$
?@AB
C)',
D)0(%(2./()$'
=)E(2(/6
D.$.F,G,$/
>$675.0,
HIJIKLM
HOPQLJRI
S)5
>$6
75.0,T
U
VLJLWI
XIK
PJYZPZOZP[JLM
YZLJQLKQ
LZ
Z\I
QPYRKIZP[J
[]
PJ^IYZPWLZ[K_
U
V[JPZ[K
XLZPIJZY
][K
YPWJY
LJQ
Y`aXZ[aY
[]
PJ]OYP[JbKIMLZIQ
KILRZP[JY
cI_W_d
]I^IK
LJQe[K
Y\LfPJW
R\PMMYd
]MOY\PJW
LJQe[K
PZR\PJWd
LMZIKLZP[JY
PJ
\ILKZ
KLZI
LJQ
gM[[Q
XKIYYOKId
Q`YXJIL
[K
R\IYZ
QPYR[a][KZd
[K
YfPJ
KLY\IYh
LJQ
LJLX\`MLiPY
cI_W_d
WIJIKLMPjIQ
OKZPRLKPLd
LJWP[IQIaLd
k\IIjPJWd
\`X[ZIJYP[Jd
[K
ZLR\`RLKQPLh_
75.0,
l
)5
m
S)5
75.0,
lT
n\I
PJ]OYP[J
KLZI
[]
YZOQ`
QKOWeYZOQ`
KIWPaIJ
aL`
gI
QIRKILYIQ
g`
opq
[K
ZIaX[KLKPM`
PJZIKKOXZIQ
OJZPM
KIY[MOZP[J
[]
Z\I
I^IJZ_
S)5
75.0,
mT
n\I
PJ]OYP[J
KLZI
[]
YZOQ`
QKOWeYZOQ`
KIWPaIJ
aL`
gI
QIRKILYIQ
opq
[K
ZIaX[KLKPM`
PJZIKKOXZIQ
OJZPM
KIY[MOZP[J
[]
Z\I
I^IJZ_
rOgYIsOIJZ
PJ]OYP[JY
aL`
gI
WP^IJ
LZ
opq
[]
Z\I
PJPZPLM
PJ]OYP[J
KLZI_
S)5
75.0,
l
)5
mT
U
tRIZLaPJ[X\IJ
LJQe[K
LJZP\PYZLaPJIY
aL`
gI
LQaPJPYZIKIQ
XIK
PJYZPZOZP[JLM
YZLJQLKQ
LZ
Z\I
QPYRKIZP[J
[]
Z\I
PJ^IYZPWLZ[K_
U
u[JYPQIK
XKIaIQPRLZP[J
XIK
PJYZPZOZP[JLM
YZLJQLKQ
XKP[K
Z[
YOgYIsOIJZ
Q[YIY_
U
rZIK[PQY
Y\[OMQ
J[Z
gI
OYIQ
][K
K[OZPJI
XKIaIQPRLZP[J
[]
HKLQI
vw
PJ]OYP[J
KILRZP[JY_
75.0,
x
)5
y
S)5
75.0,
x
)5
yT
zIKaLJIJZM`
QPYR[JZPJOI
YZOQ`
QKOWeYZOQ`
KIWPaIJ_
S)5
75.0,
x
)5
yT
U
VLJLWI
YI^IKI
PJ]OYP[JbKIMLZIQ
KILRZP[JY
XIK
PJYZPZOZP[JLM
YZLJQLKQY
cI_W_d
{V
IXPJIX\KPJId
][MM[kIQ
g`
{|
QPX\IJ\`QKLaPJI
LJQ
]La[ZPQPJId
LJQ
{|
WMOR[R[KZPR[PQh_
unut}
u[aa[J
nIKaPJ[M[W`
uKPZIKPL
][K
tQ^IKYI
}^IJZY~
{V
PJZKLaOYROMLK~
{|
PJZKL^IJ[OY~
u{
LZP[JLM
uLJRIK
{JYZPZOZI_











 !"
#$%&'(()%*+,*-./0*-
2*/30.$%4
5*6*7.08
97/-*
$:
0;*
<6*%0
=#>'
>?>@<
6*74.$%
ABCD
E$4*
,$-.:.3/0.$%4
?$F.3.08
,/%/G*(*%0
@%897/-*
HIJKL
NIOK
PIQRSRTUJRIVO
UWK
VIJ
WKXYRWKQ
SIW
Z[O
VIJ
QKKPKQ
JI
\K
WK]UJKQ
JI
OJYQ^
JWKUJPKVJ
_R`K`a
KbKVJO
QYK
JI
YVQKW]^RVc
QROKUOKd
IW
SIW
]U\IWUJIW^
U\VIWPU]RJRKO
VIJ
QKKPKQ
JI
\K
T]RVRTU]]^
ORcVRSRTUVJ`
eWKUJ
UTTIWQRVc]^a
UO
fKW
RVOJRJYJRIVU]
OJUVQUWQ`
97/-*
g
HI
QIOK
PIQRSRTUJRIVO`
eWKUJ
UTTIWQRVc]^a
UO
fKW
RVOJRJYJRIVU]
OJUVQUWQ`
97/-*
h
iI]Q
OJYQ^
QWYcjOJYQ^
WKcRPKV
YVJR]
WKOI]YJRIV
JI
klmnop
 
IW
\UOK]RVK`
eWKUJ
UTTIWQRVc]^a
UO
fKW
RVOJRJYJRIVU]
OJUVQUWQ`
97/-*
q
iI]Q
OJYQ^
QWYcjOJYQ^
WKcRPKV
YVJR]
WKOI]YJRIV
JI
klmnop
 
IW
\UOK]RVK`
rIW
Z[O
JsUJ
QItVcWUQK
JI
klmnop
!
tRJsRV
u
QU^O
IW
WKOI]bK
JI
klmnop
 
IW
\UOK]RVK
tRJsRV
 "
QU^Oa
WKOYPK
OJYQ^
QWYcjOJYQ^
WKcRPKV
UQPRVROJWUJRIV`
vJsKWtROKa
QROTIVJRVYK
OJYQ^
QWYcjOJYQ^
WKcRPKV`
eWKUJ
UTTIWQRVc]^a
UO
fKW
RVOJRJYJRIVU]
OJUVQUWQ`
97/-*
w
NROTIVJRVYK
OJYQ^
QWYcjOJYQ^
WKcRPKV
_HIJKL
rIW
xWUQK
"
]U\Oa
QKTRORIV
JI
QROTIVJRVYK
OsIY]Q
\K
\UOKQ
IV
UTTIPfUV^RVc
T]RVRTU]
ORcVOjO^PfJIPOa
JsK
yVbKOJRcUJIWzO
T]RVRTU]
{YQcPKVJa
UVQ
TIVOY]JUJRIV
tRJs
JsK
|fIVOIW`d`
eWKUJ
UTTIWQRVc]^a
UO
fKW
RVOJRJYJRIVU]
OJUVQUWQ`
HIJKL
ZO
Uff]RTU\]Ka
SIW
KUW]^
fsUOK
OJYQRKOa
JsK
SI]]ItRVc
OKVJKVTK
PU^
\K
UQQKQL
}ZV^
KbKVJ
cWKUJKW
JsUV
IW
KXYU]
JI
xWUQK
!a
f]KUOK
QROTYOO
tRJs
|JYQ^
~s^ORTRUV`
Z[
ZQbKWOK
KbKVJ
eZ[
IPPIV
eKWPRVI]Ic^
WRJKWRU
SIW
ZQbKWOK
[bKVJO
Hy
HUJRIVU]
UVTKW
yVOJRJYJK`











 !"
#$%&'(()*+,-
/0

12)34)*56
71
'+28
172
+429':4;'<
;7*7=>)2'(6
127;
(77:)+
+'='
'52788
;4:=,(:)
=4;742
=6()8
?*@ABB$C
875
(=DEFGHIJK
ILMIFNO
;FG+2'
?PQ#%#C
5,7;8
RSFTUFMIV
HMGHIJOLS
JD
LPFSJKK
RSFTUFMIV
JKK
5=5
WSJGFX
'KK
5=5')
/SJGFX
M
?YC
/SJGF
A
LS
Z
M
?YC
[\]^_`ab\c]defgh
d\]^_
jhbk
d\ll\m
non
p! q"r
  
psqor
tmh]l\mfefu
d
[\ll\m
  o
pvqwr
!n
psqxr
ykua_\mfz
[\ll\m
xv
pvq r
!
p{sq r
|huafbze\bk}
e_\bzdfd}
zmc
lhcfzuefmz~
cfu\bchbu
y
md\ll\m
 w
psqnr
o
psq r

fmdbhzuhc`
fmdbhzuhc
}
d
[\ll\m
!oo
pwq r
nx
p!qvr
haze\f~fzbk
cfu\bchbu
hazefefu
}
d
md\ll\m
!"
psqwr
 !
psqor
yfzbb_\hz
jhbk
d\ll\m
ox 
p nqvr
 x
psqnr
c\lfmz~
azfm

jhbk
d\ll\m
vwv
p !qr
"v
p qwr
zueb\fmehuefmz~
cfu\bchbu
[\~fefu

md\ll\m
!w
psqxr
 s
psqvr
ka\e_kb\fcful

jhbk
d\ll\m
vs"
p sq r
"
psq!r
kahbe_kb\fcful

[\ll\m
 v
poqnr
s
_kb\fcfefu

md\ll\m
!v
psqwr
!
p{sq r
cbhmz~
fmu]fdfhmdk
md\ll\m
 w
psqnr
v
p{sq r
kah
 
cfzhehu
lh~~fe]u
|zbh
 
p{sq r
 
p{sq r
ka\a_kufefu`ka\afe]fezbful
|zbh
!
p{sq r
!
p{sq r
mc\dbfmh
cfu\bchbu
yfzhehu
fmufafc]u
|zbh
 
p{sq r
 
p{sq r
~\\c
dbhzefmfmh
fmdbhzuhc
[\ll\m
 s"
pvq"r
v
p{sq r
yku]bfz
[\ll\m
vx
p qvr
s
|hmz~
zmc
]bfmzbk
cfu\bchbu
ha_bfefu

md\ll\m
x
psqvr
!
p{sq r











 !"
#$%
&'()*+,-./
-12-*34
5*+678
9:;<=<>
%?$5#
@A*BC*2-D
,2+,-.41A
.(
1:*A.//
@A*BC*2-D
.//
%'%
EA.+*F
8//
%'%8G
HA.+*F
2
9I>
HA.+*
J
1A
K
2
9I>
LMNO
Q
RSTU
VWXXWY
Z[\
] "^\_
 [
]\^"_
`TaTbcaN
Q
RSTU
VWXXWY
d!e
] \^[_
 
]f\^ _
gbhOc
NiSMcN
jWXXWY
Zk
] ^"_
 
]f\^ _
lSTXMcbcbN
mYVWXXWY
!!
]\^k_
!
]f\^ _
nobY
MYp
NaQVacMYSWaN
cbNNaS
pbNWTpSTN
`SXqObhWbp
Q
LMTS
d
]f\^ _
\
jMTpbMV
pbNWTpSTN
rUWVMTpbcbN
LMTS
 
]f\^ _
 
]f\^ _
`UTSsbM
RSTU
VWXXWY
Z Z
] d^[_
 \
]\^d_
tSYSTMu
pbNWTpSTN
MYp
MpXbYbNcTMcbWY
NbcS
VWYpbcbWYN
vSpSXM
qSTbqOSTMu
Q
jWXXWY
!w 
]w^k_
w
]\^d_
mqqST
TSNqbTMcWTU
cTMVc
bYxSVcbWYN
Q
RSTU
VWXXWY
Z\k
] d^e_
"
]\^!_
`YSaXWYbM
QyV
jWXXWY
!"w
][^w_
 \"
]d^e_
vTMu
VMYpbpbMNbN
jWXXWY
"Z
]!^ _
\
lSYcMu
MYp
WTMu
NWxc
cbNNaS
bYxSVcbWYN
Q
jWXXWY
e\
] ^k_
 
]f\^ _
zYxSVcbWYN
MYp
bYxSNcMcbWYN
zYxuaSY{M
jWXXWY
Zk
] ^"_
!
]f\^ _
rUMuhbM
jWXXWY
 k[
]e^w_
!
]f\^ _
rUWNbcbN
mYVWXXWY
"
]\^!_
 
]f\^ _
raNVauWNoSuScMu
MYp
VWYYSVcb|S
cbNNaS
pbNWTpSTN
`WuUXUWNbcbN
p
gWc
pScSTXbYSp
}
}
gST|WaN
NUNcSX
pbNWTpSTN
rUMNcOSYbM
hTM|bN
S
gWc
pScSTXbYSp
}
}
zY~aTUy
qWbNWYbYhy
MYp
qTWVSpaTMu
VWXqubVMcbWYN
zYxaNbWY
TSuMcSp
TSMVcbWY
Q
jWXXWY
Zw
] ^"_
e
]\^!_
uWWp
MYp
uUXqOMcbV
NUNcSX
pbNWTpSTN
zXXaYS
cOTWXQWVUcWqSYbM
V
LMTS
!
]f\^ _
 
]f\^ _
Q
lSYWcSN
M
XSpbVMu
VWYVSqc^
V
McMu
S|SYcN
OM|S
QSSY
TSqWTcSp^
p
`WuUXUWNbcbN]xMcMu_iMNWQNST|SpbYMqMcbSYccTSMcSpibcOpaT|MuaXMQxTWXMYWYhWbYhNcTMSYSVM}NqWYNWTSpVubYbVMuNcapUWacNbpSWxcOSqWWuSp
pMcMNSc^











 !"
#
$#%&'(#)
+'#,-#./0
+'&1
23('45#.#/463%&.3&'#)
/78.8/47
3(-)8#3
&-(38)#
&+
(9#
%&&7#)
)4(43#(
83
'4'#:
;8(9
.&
#<#.(3
4(
='4)#
>!?
2@$A
4)<#'3#
)'-B
'#4/(8&.C
2DE
A
474.8.#
418.&('4.3+#'43#C
2FE
A
43%4'(4(#
418.&('4.3+#'43#C
GHIJF
A
G&-./87
+&'
H.(#'.4(8&.47
I'B4.834(8&.3
&+
J#)8/47
F/8#./#3C
GEG
A
G&11&.
E&K8/8(0
G'8(#'84C
GEG2L
A
G&11&.
E#'18.&7&B0
G'8(#'84
+&'
2)<#'3#
L<#.(3C
@GI
A
)4(4
/-(6&++C
HD@
A
8.(#'3(8(847
7-.B
)83#43#C
J#)@$2
A
J#)8/47
@8/(8&.4'0
+&'
$#B-74(&'0
2/(8<8(8#3C
M
A
(&(47
.-1N#'
&+
%4(8#.(3C
OE
A
%'#+#''#)
(#'1C
FIG
A
303(#1
&'B4.
/7433

ICF_001.pdf: 
	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
	BKL
ME)NO3+/+,PQR7R
STBM
F2)*0/-/UVW0>40NX),+VNNU,+4Y+.Z[0),/,Y)X)/)0,),
40NX),8/)0,\)/YFX*8/)]+EY+38[)+5),-UX^+./5\)/Y
+[8/0.+**U*83483.),0N8$44'03_)*)83WE38./483.),0N85
$_E4'
STM
4*),).8*4+,/+3
40Y03/1 F>>+./+V[8/)+,/
40,5+,/6+35)0,19%:&;: 9 &
ab

T
S	
	c
SbSTd
E)NO3+/+,PQ7PXW[Y0,+8/ %9"e9e&&%03+N8)*E)NR<3+/+,f,)YR<0]
EY)5.0,5+,/>03NV+5.3)X+583+5+83.Y5/UVW8,V)5V+5)<,+V/0Y+*[W0UV+.)V+)>W0U\0U*V*)Z+
/0X+8[83/0>/Y+3+5+83.Y5/UVWR
J0U83+X+),<85Z+V/0/8Z+[83/),83+5+83.Y5/UVW8//Y+8/)0,8*,5/)/U/+50>+8*/Y$'R
Q+NX+350>/Y+5/UVW/+8N\)**/8*Z\)/YW0U8X0U//Y+),>03N8/)0,V+5.3)X+V),/Y)5V0.UN+,/R
-0N+[+0[*+Y8]+[+350,8*P3+*)<)0U5P03+/Y).8*X+*)+>5/Y8/N8W*)N)//Y+Z),V50>N+V).8*03
3+5+83.Y/3+8/N+,/5/Y+W\0U*V\8,//03+.+)]+$5U.Y85X*00V/38,5>U5)0,5'RE8Z+/Y+/)N+,++V+V
/085Z8,WgU+5/)0,58,VV)5.U55/Y)55/UVW\)/Y5/8>>P8,V\)/YW0U3>8N)*WP>3)+,V5P8,V
[+350,8*Y+8*/Y.83+[30])V+35RE8Z),<[83/),3+5+83.Y8//Y+)5W0U3.Y0).+R
>/Y+),V)])VU8*X+),<85Z+V/0[83/).)[8/+),/Y)53+5+83.Y5/UVW)5,0/8X*+/0<)]+.0,5+,//0X+
),/Y)55/UVWPW0U83+X+),<85Z+V/0<)]+[+3N)55)0,>03/Y)5[+350,85/Y+)3V+.)5)0,N8Z+3REY+
/+3NhW0Ui3+>+35/0W0U85/Y+V+.)5)0,N8Z+38,V:03/Y+),V)])VU8*X+),<85Z+V/0[83/).)[8/+),
/Y)53+5+83.YP/Y30U<Y0U//Y+3+N8),V+30>/Y)5V0.UN+,/R
T
S	b
	
jbST
J0UN8W.Y005+,0/
/0
/8Z+
[83/
),/Y)55/UVW
>038,W
3+850,R
>W0U
^0),
/Y)5
5/UVWPW0U
N8W
.Y8,<+
W0U3N),V8,V5/0[[83/).)[8/),<),/Y+5/UVW8/8,W/)N+8,V>038,W3+850,R,+)/Y+3.85+PW0U
\)**,0/*05+8,WX+,+>)/5/0\Y).YW0U83+0/Y+3\)5++,/)/*+VR0\+]+3P/0X+5++,8//Y+PW0U
NU5/X+/8Z),<[83/),85/UVW0383+X+),<.0,5)V+3+V>0385/UVWR>W0UV0.Y005+/0*+8]+/Y+
5/UVWP[*+85+),>03NW0U35/UVW/+8N/0+,5U3+858>+\)/YV38\8*>30N/Y+3+5+83.YR
abTbSTcL
d
EY)53+5+83.Y)5X+),<V0,+/05/UVW/Y+58>+/W8,V+>>+./)]+,+550>/Y+.0NX),8/)0,0>VU3]8*UN8X
$>03N+3*WZ,0\,85QD7%";e'8,V/3+N+*)NUN8X\)/Y8,V\)/Y0U//38,583/+3)8*.8/Y+/+3
.Y+N0+NX0*)k8/)0,$EF4D'P38V)0>3+gU+,.W8X*8/)0,$G(F'P03.3W08X*8/)0,R
7+[+,V),<0,/)N+\Y+,W0U83++,/+3),</Y+5/UVWPW0U\)**X+/3+8/+V\)/YVU3]8*UN8X8,V
/3+N+*)NUN8X0,*W03\)/Y.0NX),8/)0,0>VU3]8*UN8X8,V/3+N+*)NUN8X\)/YEF4DPG(F03
.3W08X*8/)0,R
lmnpqrnsmtuvwxuyz
lmn{||m}~{{stxzuxu


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>=?
@	A	

4B-CDDB2EFD42EDCE4G4EGFC-CEF4-DH7I
D3+J+*)JKJ8L)58,+MN+3)J+,/8*O3K</P8/P85,0/L++,8NN30Q+OLR/P+HS-S(00O8,O73K<
EOJ),)5/38/)0,$(7E'SE*/P0K<P/3+J+*)JKJ8L)5,0/8NN30Q+OLR/P+(7ET)/P85L++,+Q8*K8/+O
),8,KJL+30>.*),).8*5/KO)+5T8,O0Q+3&999N8/)+,/5TJ05/0>UP0JP8OJ+*8,0J8S
D3+J+*)JKJ8L)55)J)*83),P0U)/U03V5/08,0/P+3O3K<$.8**+O)N)*)JKJ8L'UP).PU853+.+,/*R
8NN30Q+OLR/P+(7ES
D3+J+*)JKJ8L
P85L++,
/+5/+O),
8
5J8**
<30KN0>
N8/)+,/5U)/P
*)Q+3
.8,.+3
03P+N8/0.+**K*83.8,.+3$44'8,O),<+,+38*U85U+**/0*+38/+OS
7K3Q8*KJ8L)58,),Q+5/)<8/)0,8*O3K<O+5)<,+O/0L005//P+L0ORW5)JJK,+5R5/+JLR/83<+/),<
8N30/+),0,/KJ03.+**5.8**+O27G&S27G&,03J8**RJ8),/8),5/P+L8*8,.+0>/P+)JJK,+
5R5/+JS,.8,.+3T27G&P+*N5/KJ035+Q8O+O+/+./)0,8,O+*)J),8/)0,LR/P+)JJK,+5R5/+JS
7K3Q8*KJ8LJ8R),.3+85+/P+)JJK,+5R5/+JW58L)*)/R/0)O+,/)>R8,OO+5/30R.8,.+3.+**5S
X,Q+5/)<8/)0,8*YJ+8,5/P8/OK3Q8*KJ8LP85,0/L++,8NN30Q+OLR/P+(00O8,O73K<
EOJ),)5/38/)0,$(7E'85+)/P+38N3+5.3)N/)0,030Q+3/P+.0K,/+3O3K<S
>R0K3+.+)Q+DE4CT85J8**.8/P+/+3U)**L+N*8.+O),/0/P+83/+3R8//P+<30),8,O.P+J0/P+38NR
U)**L+),Z+./+OO)3+./*R),/0/P+*)Q+3SEJ8/+3)8*UP).P.*05+50>>/P+Q+55+*55KNN*R),<L*00O/0
/P+/KJ03)58*50),Z+./+OS>R0K3+.+)Q+F(ETR0KU)**L+NK//05*++N8,O8,++O*+U)**O)3+./*R
L+N*8.+O),/0/P+/KJ038,OR0K3/KJ03U)**L+LK3,/$03N83/0>)/'S>R0K3+.+)Q+.3R08L*8/)0,T
R0KU)**L+NK//05*++N8,O8,++O*+U)**L+NK/O)3+./*R),/0/P+/KJ038,O/P+/KJ03U)**L+>30[+,
$03N83/0>)/'SDE4CTF(ET8,O.3R08L*8/)0,83+5/8,O83ON30.+OK3+5/P8/83+K5+O/0/3+8//KJ035S
0U+Q+3T),/P)55/KORF(E8,O.3R08L*8/)0,U)**L+K5+O),03O+3/05/)JK*8/+8,)JJK,+
3+5N0,5+T38/P+3/P8,.0JN*+/++38O).8/)0,0>/P+*+5)0,85N+35/8,O83O0>.83+),O).8/)0,SB,.+)/
)5O+/+3J),+OUP).PN30.+OK3+R0KU)**3+.+)Q+R0K3O0./03U)**+MN*8),/P+N30.+OK3+),>K**
O+/8)*S
DP)5)5/P+>)35/5/KOR),UP).PL0/PO3K<5/8V+,/0<+/P+3U)**L+/+5/+O),.0JL),8/)0,U)/PDE4CT
F(ET03.3R08L*8/)0,TUP).P)5/P+J8),<08*0>/P)55/KORS
\]^^
_`ab
b]_^c
I0K83+L+),<85V+O/0/8V+N83/),/P)55/KORL+.8K5+R0KP8Q+8OQ8,.+OP+N8/0.+**K*83.8,.+3
$44'03L)*)83R/38./.8,.+3/P8/P85,0/3+5N0,O+O/00/P+3/RN+50>/P+38NRT8,OR0K3O0./03P85
O+/+3J),+O/P8/R0K83+,0/8.8,O)O8/+>03*)Q+3/38,5N*8,/8/)0,S
]
\ @^
A\AAb]_^c
EL0K/!9N+0N*+U)**/8V+N83/),/P)55/KORS
defhijfkelmnopmqr
defstteuvswxsyklprzm{z|p|m


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
	

	KLM
NOPQ
R+>03+S0TU+<),/V)55/TWSXS0TY)**V8Z+5+Z+38*+[8\58,W/+5/5/0\8]+5T3+S0T83++*)<)U*+
>03/V)55/TWS^EV++[8\58,W/+5/583+_83/0>3+<T*83.8,.+3.83+8,W\8SU+W0,++Z+,)>S0TW0
,0/`0),/V+5/TWS^>S0T3+.+,/*SV8W50\+0>/V+/+5/5X/V+S\8S,0/,++W/0U+3+_+8/+W^J0T
\T5/_30Z)W+858\_*+/T\03/)55T+>038,4*8U/0+Z8*T8/+^EV+/)55T+\8SU+>30\8_3+Z)0T5
5T3<+3S03U)0_5S^>,0,+)58Z8)*8U*+XY+Y)**85]S0T/0T,W+3<08U)0_5S/0_30Z)W+8>3+5V
58\_*+^
Q
a
>/V++[8\5X/+5/58,W_30.+WT3+55V0Y/V8/S0T.8,U+),/V+5/TWSX8,WS0T.V005+/0/8]+_83/X
/V+,S0TY)**U+<),/3+8/\+,/^
R+>03+S0TU+<),/3+8/\+,/XS0TY)**V8Z+8U)0_5S0>S0T3/T\03T5),<8,++W*+^
,/V)55/TWSX/V+38_SY)**U+W)Z)W+W),/0.S.*+5X+8.V*85/),< bW8S5^E3+8/\+,/),Z0*Z+5
3+.+)Z),</3+\+*)\T\8U8,WWT3Z8*T\8U/V30T<V8,60,W8S&0>+8.V.S.*+^J0TY)**3+.+)Z+
/3+\+*)\T\8U>03T_/0%.S.*+5^
C,.+S0TV8Z+.0\_*+/+%.S.*+50>5/TWS/V+38_SS0TY)**.0,/),T+/03+.+)Z+WT3Z8*T\8U0,*SX
T,/)*S0T3W)5+85+Y035+,5X03S0T+[_+3)+,.+),/0*+38U*+5)W++>>+./5^
OQQca
J0TY)**U+85]+W/0T,W+3<00_/)0,8*/T\03U)0_5)+5WT3),<.S.*+ 0,W8Sb$W8S;d'8,W8>/+3
S0TV8Z+.0\_*+/+W/V+/V)3W.S.*+$W8Sbe'0>/3+\+*)\T\8U8,WWT3Z8*T\8U^
OQQcPfa
C,W8S;dS0TY)**3+.+)Z+/V+EF4DXG(F03.3S08U*8/)0,_30.+WT3+^J0TY)**V8Z+/Y0
8WW)/)0,8*U)0_5)+50>S0T3/T\03g0,+WT3),<EF4DXG(F03.3S08U*8/)0,_30.+WT3+8,W8,
0_/)0,8*0,+8>/+3S0TV8Z+.0\_*+/+W/V+/V)3W.S.*+$W8Sbe'^
hKM
LKijKLjkAl
J0TY)**U+5++,>0358>+/S>0**0YT_Z)5)/58__30[)\8/+*Sd98,W!9W8S58>/+3.0\_*+/)0,0>/V+
5/TWS/3+8/\+,//0855+55>03_055)U*+W+*8S+W030,<0),<5)W++>>+./58,W0Z+38**.*),).8*5/8/T5^
F//V)5Z)5)/XS0TY)**V8Z+U85).U*00W/+5/585Y+**85U*00W.0**+./+W>033+5+83.V_T3_05+5^>
S0T83+T,8U*+/03+/T3,>03/V)5Z)5)/XY+Y)**0U/8),/V+),>03\8/)0,>30\S0TUS/+*+_V0,+03+
\8)*^
F>/+3/V)558>+/SZ)5)/XY+Y)**.8**S0T03+\8)*8__30[)\8/+*S0,.++Z+3Sd\0,/V5/085]8U0T/
S0T3V+8*/V8,W8U0T/8,S0/V+3\+W).8/)0,5S0T\8SV8Z+/8]+,>03S0T3.8,.+3^>S0T5/)**V8Z+
T,3+50*Z+WV+8*/V)55T+5X.8T5+WUS5/TWSW3T<XS0TY)**U+),Z)/+W/0>038WW)/)0,8*/+5/58,W
/3+8/\+,/^
LM	B
	m
noprstpuovwxyzw{|
nop}~~o}}uvz|wzw


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
K
L )5/03M8,NOPM5).8*+Q8R
L G+S)+T0>.U33+,/R+N).8/)0,58,N/3+8/R+,/5
L G0U/),+8,N3+5+83.PV*00N/+5/5
L G+5+83.P3+./8*5T8VW
L EUR03V)0O5M
L E3+R+*)RUR8V),>U5)0,
L 7U3S8*UR8V),>U5)0,
X
L G0U/),+8,N3+5+83.PV*00N/+5/5
KY
L G0U/),+8,N3+5+83.PV*00N/+5/5
??
L G0U/),+V*00N/+5/5
	?
K
L )5/03M8,NOPM5).8*+Q8R
L G+S)+T0>.U33+,/R+N).8/)0,58,N/3+8/R+,/5
L G0U/),+8,N3+5+83.PV*00N/+5/5
L G+5+83.P3+./8*5T8VW
L E3+R+*)RUR8V),>U5)0,
L 7U3S8*UR8V),>U5)0,
X
Z[\]
L G0U/),+8,N3+5+83.PV*00N/+5/5
L G(F:EF4D:43M08V*8/)0,$T)**V+N+/+3R),+N
VMM0U35/UNMN0./03'8,N/UR03V)0O5MNU3),<
/P)5O30.+NU3+$)>M0U83+855)<,+N/0/P)5
/3+8/R+,/'

L EUR03V)0O5M$0O/)0,8*'$)>M0U83+855)<,+N/0
N3U</3+8/R+,/0,*M'
KY
L G0U/),+V*00N/+5/5
??
L G0U/),+V*00N/+5/5
	[
K
L )5/03M8,NOPM5).8*+Q8R
L G+S)+T0>.U33+,/R+N).8/)0,58,N/3+8/R+,/5
L G0U/),+8,N3+5+83.PV*00N/+5/5
^_`bcd`e_fghijgkl
^_`mnn_opmqrmsefjltgutvjvg


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
K E3+L+*)LML8N),>M5)0,
K 7M3O8*ML8N),>M5)0,
K 4E-.8,
P
K G0M/),+8,Q3+5+83.RN*00Q/+5/5
S=
K G0M/),+N*00Q/+5/5
??
K G0M/),+N*00Q/+5/5
	T
S
UP=V
K )5/03W8,QXRW5).8*+Y8L
K G+O)+Z0>.M33+,/L+Q).8/)0,58,Q/3+8/L+,/5
K G0M/),+8,Q3+5+83.RN*00Q/+5/5
K G+5+83.R3+./8*5Z8N[
K EML03N)0X5W$0X/)0,8*'
K E3+L+*)LML8N),>M5)0,
K 7M3O8*ML8N),>M5)0,
P
K G0M/),+8,Q3+5+83.RN*00Q/+5/5
S=
K G0M/),+N*00Q/+5/5
??
K G0M/),+N*00Q/+5/5
\]	
S
K )5/03W8,QXRW5).8*+Y8L
K G+O)+Z0>.M33+,/L+Q).8/)0,58,Q/3+8/L+,/5
K G0M/),+8,Q3+5+83.RN*00Q/+5/5
K 7M3O8*ML8N),>M5)0,
K 4E5.8,$+O+3W^Z++_5>30L/R)3Q.W.*+'
[G+./8*5Z8N5Z)**N+M5+Q/05/MQWL).30N+5*)O),<),W0M3<M/`),.*MQ),<5+aM+,.+0>L).30N)8*
<+,+5b
cd
J0MZ)**R8O+N*00QQ38Z,QM3),</R+5/MQWbER+5+58LX*+5Z)**N+Q38Z,/0L0,)/03W0M3R+8*/R
QM3),</R+5/MQW8/+O+3WO)5)//0/R+4*),).8*4+,/+3$8N0M/e/+85X00,58/+8.RO)5)/'8,Q>03
3+5+83.RXM3X05+5$8N0M/&;/8N*+5X00,5'
fghjklhmgnopqrost
fghuvvgwxuyzu{mnrt|o}|~r~o


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
KL	

B
>M0N83+8O*+/0O+.0P+Q3+<,8,/RS+S)**85TM0N/0U8V+8Q3+<,8,.M/+5/O+>03+5/83/),</U)5
5/NWMXJ0NS)**,++W/0Q38./).+8,+>>+./)V+>03P0>O)3/U.0,/30*O+>03+5/83/),<5/NWM/3+8/P+,/R
WN3),<5/NWM/3+8/P+,/R8,W>03YP0,/U58>/+3M0N>),)5U5/NWM/3+8/P+,/$/U+3+5/3)./+WQ+3)0W'X>
M0NO+.0P+Q3+<,8,/R/U+3+P8MO+N,T,0S,3)5T5/0/U+>+/N503N,O03,.U)*WR033)5T5/U8/S+
W)W,0/8,/).)Q8/+XEU+3+P8MO+*0,</+3P+>>+./50>/U+/3+8/P+,/O+),<5/NW)+W/U8/.0N*W
),.3+85+/U+3)5T0>U83P/08>+/N5XJ0NPN5//+**/U+5/NWMW0./03)>M0N3O)3/U.0,/30*P+/U0W
>8)*5WN3),</U+3+5/3)./+WQ+3)0WX>M0N/U),T03T,0SM0NU8V+O+.0P+Q3+<,8,/WN3),</U+
3+5/3)./+WQ+3)0WRQ*+85+.0,/8./5/NWM/+8P85500,85Q055)O*+X
>M0N83+85+ZN8**M8./)V+Q+350,S)/U8Q83/,+38O*+/0O+.0P+Q3+<,8,/R)/)5)PQ03/8,//U8/M0N3
Q83/,+3,0/O+.0P+Q3+<,8,/WN3),</U+3+5/3)./+WQ+3)0WXEU+3+P8MO+N,T,0S,3)5T5/08>+/N5
033)5T5S+W)W,0/8,/).)Q8/+XJ0N8,WM0N3Q83/,+3PN5/O0/U8<3++/0N5+O)3/U.0,/30*)>M0N
S8,//0/8T+Q83/),/U)55/NWMX>M0N/U),TM0N3Q83/,+3U85O+.0P+Q3+<,8,/WN3),</U+3+5/3)./+W
Q+3)0WRQ*+85+.0,/8./5/NWM/+8P85500,85Q055)O*+X>M0N8,WM0N3Q83/,+3Q*8,>03M0N3Q83/,+3
/0O+.0P+Q3+<,8,/8>/+3/U+3+5/3)./+WQ+3)0WRQ*+85+W)5.N55/U)5S)/U/U+5/NWM/+8PX
D>>+./)V+>03P50>O)3/U.0,/30*),.*NW+1
[
8O5/),+,.+
[
),/38N/+3),+W+V).+$I7'
[
U03P0,8*\O)3/U.0,/30*Q)**5R),]+./)0,5R03)PQ*8,/5^
[
/NO8**)<8/)0,
[
V85+./0PM
_
	
A

	

```a
EU+>0**0S),<83+5)W++>>+./5/U8/U8V+O++,8550.)8/+WS)/UE3+P+*)PNP8O1
b 7)833U+8
b G85U
b 23N3)/N5$)/.U),<'
b (8/)<N+
b 8N5+8
b 60P)/),<
b F,03+Z)8$*0550>8QQ+/)/+'
b +8W8.U+
b FOW0P),8*28),
b cN5.*+Q8),
defhijfkelmnopmqr
defstteuvswxsyklprzm{z|p|m


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
K FL/0)MML,+.N8,<+5/0/N+O)/L)/83P<*8,Q*+8Q),</0N03M0,8*.N8,<+5R
K ,>*8MM8/)0,0>/N+O83/0>/N+),/+5/),+S,0T,85/N+.0*0,TN).N.8,*+8Q/0),>+./)0,U
V*00Q),/N+5/00*5U8VQ0M),8*O8),8,Q/N)5M8P*+8Q/08/+83),/N+T8**0>/N+),/+5/),+
TN).N.8,V+5+3)0L58,Q*)>+/N3+8/+,),<REN)5)58*50S,0T,85W.0*)/)5XR40*)/)5N85/N+
O0/+,/)8*/0V+*)>+/N3+8/+,),<8,Q3+YL)3+O30*0,<+QN05O)/8*)Z8/)0,5RF5O83/0>)/5
M8,8<+M+,/)/M8P3+YL)3+/3+8/M+,/T)/N5/+30)Q5TN).NM8PO*8.+P0L8/),.3+85+Q3)5S
>035+[+3+),>+./)0,5R
K ,>*8MM8/)0,),/N+*L,<5$O,+LM0,)/)5'1-PMO/0M5M8P),.*LQ+VL/83+,0/*)M)/+Q/08
,+T03T035+,),<.0L<NU5N03/,+550>V3+8/NO055)V*PT)/N>+[+3R23+*)M),83PQ8/8
5L<<+5/+Q/N8//N+3+M8PV+/N+/+,Q+,.P0>N)<N+3>3+YL+,.P8,Q5+[+3)/P),\8O8,+5+
O8/)+,/5.0MO83+QT)/N,0,\8O8,+5+O8/)+,/51E+**P0L35/LQPQ0./033)<N/8T8P)>P0L
N8[+8,P0>/N+5+5PMO/0M585)/M8P,++Q/0V+/3+8/+QL3<+,/*PR
K ])Q,+PO30V*+M51J0LM8PN8[+8,),.3+85+0>.3+8/),),+*+[+*5),8V*00Q/+5/$.3+8/),),+
)58O30/+),M83S+3/N8/M+85L3+5S)Q,+P>L,./)0,'VL/,0/N8[+8,P5PMO/0M503>++*
L,T+**RH+55.0MM0,*P8O8/)+,/M8P+^O+3)+,.+,+ON3)/)5TN).N)58,),>*8MM8/)0,0>
/N+S)Q,+P5/N8/5/0O5/N+S)Q,+P5>30MT03S),<O30O+3*PR
K ,>*8MM8/)0,0>/N+O8,.3+85$O8,.3+8/)/)5'R28,.3+8/)/)5L5L8**P.8L5+55PMO/0M50>
O+35)5/+,/LOO+38VQ0M),8*O8),$50M+/)M+5M8Q+T035+VP+8/),<8,QQ3),S),<'U,8L5+8U
[0M)/),<8,Q<+,+38*T+8S,+55R28,.3+8/)/)5L5L8**P5+//*+5T)/N5)MO*+M+85L3+5UVL/)/
.8,V+85+3)0L5.0,Q)/)0,8,Q.8,V+>8/8*RJ0L5N0L*Q)MM+Q)8/+*P/+**P0L35/LQPQ0./03
)>P0LQ+[+*0O8,PL,L5L8*5PMO/0M5RJ0LM8P<+/8,),.3+85+0>*)O85+8,Q8MP*85+
*+[+*5),8V*00Q/+5/$3+*8/+Q/0/N+O8,.3+85'VL/,0/N8[+8,P5PMO/0M503>++*L,T+**R
H)O85+8,Q8MP*85+83++,ZPM+503O30/+),M83S+35/N8/M+85L3+/N+>L,./)0,0>P0L3
O8,.3+85RI,.0MM0,*P/N+5+),.3+85+5M8PV+8550.)8/+QT)/NO8,.3+8/)/)5R
K ,>*8MM8/)0,0>/N+*)[+3TN).N)58*50S,0T,85N+O8/)/)5R,+^/3+M+.85+5/N)5M8P3+5L*/
),*)[+3>8)*L3+8,QQ+8/NR
K C..85)0,8**PP0L.8,8*50<+/85S),385N3+*8/+Q/0/N+/3+8/M+,/8,Q/N)5.8,8*503+5L*/),
5+[+3+8,Q*)>+/N3+8/+,),<5PMO/0M5R
K 230V*+M53+*8/+Q/0E3+M+*)MLM8V),>L5)0,
K EN+3+)583+M0/+.N8,.+/N8/P0LM8PN8[+85+3)0L58**+3<).3+8./)0,$8,8ONP*8^)5'/0
E3+M+*)MLM8VRF,8ONP*8^)5M8P.8L5+85+3)0L5Q30O),V*00QO3+55L3+UQ)>>).L*/P),
V3+8/N),<U5+[+3+N)[+5U8,Q50M+/)M+5Q+8/NRJ0L3Q0./03T)**M0,)/03P0L[+3P.*05+*P
8>/+3P0L3+.+)[+/N+E3+M+*)MLM8V8,QT)**N8[+M+Q).8/)0,58[8)*8V*+/0/3+8/8,P
8**+3<).3+8./)0,5/N8/M)<N/0..L3RH+555+3)0L58**+3<).3+8./)0,5U5L.N855S),385NT)/N
03T)/N0L/)/.N),<8,Q5T+**),<UM8P8*500..L3T)/N),N0L35/0Q8P58>/+33+.+)[),</N+
E3+M+*)MLM8VREN+5++>>+./5L5L8**P<+/V+//+3T)/N0L//3+8/M+,/R
_`a
b05/0>/N+O055)V*+5)Q++>>+./5*)5/+QV+*0T83+M)*Q/0M0Q+38/+R0T+[+3U50M+5)Q++>>+./5
.8,V+[+3P5+3)0L58,Q*)>+/N3+8/+,),<8,QM8P+[+,3+5L*/),Q+8/NR-0M+5)Q++>>+./5Q0,0/
,++Q/3+8/M+,/TN)*+0/N+35<+,+38**P<+/V+//+3T)/N/3+8/M+,/R-0M+O8/)+,/5M8P,++Q/0Q+*8P
cdeghiejdklmnolpq
cderssdturvwrxjkoqylzy{o{l


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
K05+50>KL3M8*LN8O/08**0P/Q+5)K++>>+./5/0<+/O+//+3REQ+N05/)NS03/8,/S055)O*+5)K+
+>>+./5TPQ).Q83+*)5/+KO+*0PTN8U0..L3O+.8L5+0>/Q+P8UKL3M8*LN8OP03V50,/Q+)NNL,+
5U5/+N8,K/Q+UQ8M+O++,5++,),S8/)+,/5/3+8/+KP)/QKL3M8*LN8O),.*),).8*5/LK)+5R-)K++>>+./5
*)V+/Q+5+Q8M+8*50O++,5++,),.*),).8*5/LK)+5P)/Q0/Q+3K3L<5/Q8/83+M+3U5)N)*83/0
KL3M8*LN8ORW8,8<+N+,/0>/Q+5+5)K++>>+./5N8U3+XL)3+/Q+8KN),)5/38/)0,0>K3L<55L.Q85
5/+30)K5030/Q+38<+,/5/Q8/.8,8>>+./U0L3)NNL,+5U5/+N8,K3+KL.+),>*8NN8/)0,R
YZZ
[@@\]\Z^_Z[@Z\`
a 7)833Q+8T
a G85Q:K3U)/.QU5V),T
a H)M+3S30O*+N51,.3+85+5),/Q+O*00K*+M+*0>5LO5/8,.+5.8**+K+,bUN+5>0L,K
P)/Q),U0L3*)M+3.+**5REQ++,bUN+.Q8,<+583+L,*)V+*U/0N8V+U0L>++*L,P+**T
Q0P+M+3T)>/Q+5+O*00K+,bUN+*+M+*5O+.0N+M+3UQ)<QTU0L35/LKUK0./03N8U,++K
/05/0S/Q+5/LKUN+K).8/)0,RJ0LN8UK+M+*0S),>*8NN8/)0,0>/Q+*)M+3.8**+K
Q+S8/)/)5cQ0P+M+3T/Q)5)5L,.0NN0,R-)<,58,K5UNS/0N50>/Q)5),.*LK+U+**0P),<
0>/Q+5V),03PQ)/+50>/Q++U+5TK83VL3),+T5+M+3+,8L5+88,KM0N)/),<TS8),),/Q+
LSS+33)<Q/5)K+0>U0L38OK0N+,T5V),)/.Q),+55T,0/>++*),<QL,<3U8,KO*++K),<03
O3L)5),<N03++85)*U/Q8,,03N8*R
a (++*),</)3+K
a 8L5+8
a 60N)/),<
a FOK0N),8*S8),
a F..LNL*8/)0,0>>*L)K.8L5),<5P+**),<
a ISS+33+5S)38/03U/38./),>+./)0,5
a 7+.3+85+K8SS+/)/+
a -Q03/,+550>O3+8/Q
a 40L<Q
a (+M+3
	ZZ
[@@\]\Z^_dZ[[@Z\`
a ,>*8NN8/)0,),/Q+*L,<5$S,+LN0,)/)5'15UNS/0N5N8U),.*LK+OL/83+,0/*)N)/+K
/08,+P03P035+,),<.0L<QT5Q03/,+550>O3+8/QS055)O*UP)/Q>+M+3R23+*)N),83U
K8/85L<<+5/+K/Q8//Q+3+N8UO+/Q+/+,K+,.U0>Q)<Q+3>3+XL+,.U8,K5+M+3)/U),
e8S8,+5+S8/)+,/5.0NS83+KP)/Q,0,e8S8,+5+S8/)+,/51/+**U0L35/LKUK0./033)<Q/
fghjklhmgnopqrost
fghuvvgwxuyzu{mnrt|o}|~r~o


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
	KK
L@@MNMKOPQKLL@KMR
8S8T)>T0UV8W+8,T0>/V+5+5TXY/0X585)/X8T,++Z/0[+/3+8/+ZU3<+,/*T\
] H0S/VT30)Z$TY0/VT30)Z)5X'1/V)5)5SV+,/V+/VT30)Z<*8,ZY30ZU.+5*+55/VT30)Z
V03X0,+/V8,)/5V0U*ZSV).V.8U5+5/V+X+/8[0*)5X/03U,/005*0S\-TXY/0X5X8T
),.*UZ+[U/83+,0/*)X)/+Z/0>8/)<U+^),.3+85+Z5+,5)/)W)/T/0.0*Z^.0,5/)Y8/)0,^Z3T
5_),^U,+`Y*8),+ZS+)<V/<8),^YU>>T>8.+^XU5.*+S+8_,+55^5*0SV+83/38/+^/V),,),<
V8)3^)XY8)3+ZX+X03T\EV+.0,Z)/)0,.8,[+/3+8/+ZS)/V3+Y*8.+X+,//VT30)Z
V03X0,+\
] )<V/VT30)Z$TY+3/VT30)Z)5X'1/V)5)5SV+,/V+/VT30)Z<*8,ZY30ZU.+5/00XU.V
/VT30)ZV03X0,+\-TXY/0X5),.*UZ+8,`)+/T03,+3W0U5,+55^S+)<V/*055^>3+aU+,/
8,Z*005+[0S+*X0W+X+,/5^[3+8/V*+55,+55^>++*),<V0/8,ZY055)[*TV8W),<V+83/
Y8*Y)/8/)0,5\7+Y+,Z),<0,/V+5+W+3)/T0>/V+5TXY/0X5^/3+8/X+,/X8T),.*UZ+bU5/
X0,)/03),</V+5TXY/0X5^/3+8/),</V+5TXY/0X5/V+X5+*W+58,Z:03<)W),<X+Z).),+
/0[*0._/V+/VT30)ZV03X0,+\
] c)Z,+TY30[*+X51T0UX8TV8W+8,),.3+85+0>.3+8/),),+*+W+*5),8[*00Z/+5/
$.3+8/),),+)58Y30/+),X83_+3/V8/X+85U3+5_)Z,+T>U,./)0,'[U/,0/V8W+8,T
5TXY/0X503>++*U,S+**\I,.0XX0,*T8Y8/)+,/X8T+`Y+3)+,.+,+YV3)/)5SV).V)5
8,),>*8XX8/)0,0>/V+_)Z,+T5/V8/5/0Y5/V+_)Z,+T5>30XS03_),<Y30Y+3*T\
] +3W0U55T5/+XY30[*+X515TXY/0X5.8,),.*UZ+U,U5U8*S+8_,+550>*+<5^83X5^03
>8.+^UX[,+5503/),<*),<),V8,Z503>++/\,383+5)/U8/)0,5/V+3+)5/V+Y0/+,/)8*>03
/V+),>*8XX8/)0,0>/V+,+3W0U55T5/+X/0[+5+W+3+8,Z.8U5+Z8X8<+/0/V+,+3W+
.+**5
03
[3+8_Z0S,
),
/V+
.0XXU,).8/)0,
[+/S++,
,+3W+5
8,Z
XU5.*+51
/+**
T0U3
5/UZT
Z0./033)<V/8S8T)>T0UV8W+Y30[*+X55S8**0S),<^)>T0U5/83//0>++*S+8_W+3T
aU)._*T8,ZT0U83+V8W),</30U[*+[3+8/V),<\
] ,>U5)0,G+*8/+ZG+8./)0,513+8./)0,5X8T0..U3ZU3),<038>/+3/V+),>U5)0,0>5/UZT
X+Z).8/)0,\EV+3+8./)0,X8T.8U5+>+W+303.V)**58,Z8.V8,<+),[*00ZY3+55U3+03
Z)>>).U*/T),[3+8/V),<SV).VX)<V/[+5+3)0U5\E+**T0U35/UZTZ0./033)<V/8S8T)>
T0U+`Y+3)+,.+8,T0>/V+5+5TXY/0X5+W+,)>)/V85[++,5+W+38*Z8T58>/+3/V+
),>U5)0,V85[++,.0XY*+/+Z\
] ,>*8XX8/)0,0>/V+),/+5/),+$.0*)/)5'\/X8T.8U5+8[Z0X),8*Y8),8,ZZ)833V+8S)/V
03S)/V0U/[*00Z\(+W+3X8T[+Y3+5+,/\/X8T3+aU)3+T0U/03+.+)W+8ZZ)/)0,8*
>*U)Z5\>*+>/U,/3+8/+Z^),383+0..85)0,5/V)5X8T*+8Z/08/+83),/V+S8**0>/V+
),/+5/),+SV).V.8,[+5+3)0U58,Z*)>+/V3+8/+,),<\E+**T0U35/UZTZ0./033)<V/8S8T
)>T0UV8W+8,T0>/V+5+5TXY/0X5\
] FV0835+W0).+
] 28),>U*U3),8/)0,
] )<V/5S+8/5
defhijfkelmnopmqr
defstteuvswxsyklprzm{z|p|m


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@>
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
	KK
=>>LMLKNOPK==>KLQ
R 2,+ST0,)8
R C38*/U3S5U
R 7+,/8*8,V038*50?//)55S+),?+./)0,
R 28),),TS5.*+58,VW0),/5
R ,?*S+,X8Y
ZKK
=>>LMLKNO=P[KLQ
R ,?*8TT8/)0,0?/U+\8,.3+85$\8,.3+8/)/)5'Y28,.3+8/)/)5S5S8**].8S5+55]T\/0T50?
\+35)5/+,/S\\+38^V0T),8*\8),$50T+/)T+5T8V+_035+^]+8/),<8,VV3),`),<'a
,8S5+8ab0T)/),<8,V<+,+38*_+8`,+55Y28,.3+8/)/)5S5S8**]5+//*+5_)/U5)T\*+
T+85S3+5^S/)/.8,^+85+3)0S5.0,V)/)0,8,V.8,^+?8/8*YJ0S5U0S*V)TT+V)8/+*]
/+**]0S35/SV]V0./03)?]0SV+b+*0\8,]0?/U+5+5]T\/0T5YJ0ST8]<+/8,),.3+85+
0?*)\85+8,V8T]*85+*+b+*5),8^*00V/+5/$3+*8/+V/0/U+\8,.3+85'^S/,0/U8b+8,]
5]T\/0T503?++*S,_+**YH)\85+8,V8T]*85+83++,X]T+503\30/+),T83`+35/U8/
T+85S3+/U+?S,./)0,0?]0S3\8,.3+85YI,.0TT0,*]/U+5+),.3+85+5T8]^+
8550.)8/+V_)/U\8,.3+8/)/)5Y
R F**+3<).3+8./)0,51EU+5+.8,.8S5+5_+**),<0?/U+?8.+a*)\58,V/U308/a^3+8/U),<
V)??).S*/)+58*0,<_)/UU)b+503,+//*+*)`+385UYJ0S5U0S*V)TT+V)8/+*]/+**]0S3
5/SV]V0./03)?]0SV+b+*0\8,]0?/U+5+5]T\/0T5Y
R 230^*+T5_)/U]0S38V3+,8*<*8,V5$FV3+,8*,5S??).)+,.]'1T8].8S5+5/0T8.U
\8),5a
b0T)/),<a
TS5.*+
_+8`,+55
8,V
?8/)<S+a
V+\3+55)0,a
*0_
^*00V
\3+55S3+a
_+)<U/
*055a`)V,+]\30^*+T5a8,V.U8,<+5),T00V8,V\+350,8*)/]YEU+5+.0T\*).8/)0,5
T8]^+\+3T8,+,/8,VT8]3+cS)3+U03T0,+3+\*8.+T+,/
R 230^*+T5_)/U/U+\)/S)/83]<*8,V$U]\0\)/S)/83)5T'1]\0\)/S)/83)5T3+?+35/0
V+.3+85+V0S/\S/0?U03T0,+5?30T/U+\)/S)/83]<*8,V),/U+^38),8,VT8]^+.8S5+V
^]),?*8TT8/)0,0?/U+\)/S)/83]<*8,V$U]\0\U]5)/)5'Y-]T\/0T5T8]),.*SV+
U+8V8.U+5a/U)35/),+55a8,V/30S^*+5++),<03V0S^*+b)5)0,a*+8`8<+0?^3+85/T)*`03
)33+<S*83\+3)0V5),_0T+,YEU+5+.0T\*).8/)0,5T8]^+\+3T8,+,/8,VT8]3+cS)3+
U03T0,+3+\*8.+T+,/Y
R ,?*8TT8/)0,0?/U+TS5.*+5038550.)8/+V/)55S+5a5S.U85^*00Vb+55+*5/U8/5S\\*]
/U+TS5.*+5$d]05)/)5:\0*]T]05)/)5'Y-]T\/0T5.8,),.*SV+TS5.*+_+8`,+558,V
8.U+5a/)3+V?++*),<_U+,5/8,V),<03_8*`),<aTS5.*+\8),8,V503+,+55/U8/V0+5,0/
3+50*b+8?/+38?+__++`5Y
efgijkglfmnopqnrs
efgtuufvwtxytzlmqs{n|{}q}n


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+==0>?@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
KK
=L@@@MNMOPL=KQOMR
S ETU+&7)8V+/+5W+**)/X5YZ).ZW8T.8X5+),.3+85+[V*00[<*X.05+*+\+*5$.8**+[
]ZTU+3<*T.+W)8^'15TWU/0W5W8T),.*X[+Y+)<Z/*055_),.3+85+[X3),8/)0,_),.3+85+[
/Z)35/_8,[),.3+85+[ZX,<+3`ETU+&[)8V+/+5Y)**3+aX)3+3+U*8.+W+,/0>),5X*),
/Z30X<Z),b+./)0,`E+**T0X35/X[T[0./033)<Z/8Y8T)>T0XZ8\+8,T0>/Z+5+
5TWU/0W5`
S 230V*+W5Y)/Z/Z+U)/X)/83T<*8,[$ZTU0U)/X)/83)5W'1ZTU0U)/X)/83)5W3+>+35/0
[+.3+85+[0X/UX/0>Z03W0,+5>30W/Z+U)/X)/83T<*8,[),/Z+V38),8,[W8TV+.8X5+[
VT),>*8WW8/)0,0>/Z+U)/X)/83T<*8,[$ZTU0UZT5)/)5'`-TWU/0W5W8T),.*X[+
Z+8[8.Z+5_/Z)35/),+55_8,[/30XV*+5++),<03[0XV*+\)5)0,_*+8c8<+0>V3+85/W)*c03
)33+<X*83U+3)0[5),Y0W+,`EZ+5+.0WU*).8/)0,5W8TV+U+3W8,+,/8,[W8T3+aX)3+
Z03W0,+3+U*8.+W+,/`
S ,>*8WW8/)0,0>/Z+Z+83/WX5.*+$WT0.83[)/)5'`-TWU/0W5.8,),.*X[+.Z+5/U8),_
38U)[038V,03W8*Z+83/V+8/_5Z03/,+550>V3+8/Z8,[5Y+**),<0>T0X3*+<5`E+**T0X3
5/X[T[0./033)<Z/8Y8T)>T0X+dU+3)+,.+8,T0>/Z+5+5TWU/0W5`
S ,>*8WW8/)0,0>/Z+W+WV38,+5X330X,[),</Z+Z+83/
S e30Y/Z50>/),T.0**+./)0,50>),>*8WW8/03T.+**5),[)>>+3+,/U83/50>/Z+V0[T
S ,>*8WW8/)0,0>/Z+W)[[*+*8T+30>/Z++T+8,[0/Z+3+\+,/5),\0*\),</Z++T+$+`<`
),>*8WW8/)0,0>/Z+.03,+88,[0U/).,+3\+5'
S ,>*8WW8/)0,0>/Z+V38),03/Z+W+WV38,+5/Z8/.0\+3/Z+V38),8,[5U),8*.03[
S 83[+,),<8,[/)<Z/+,),<0>/Z+5c),8,[.0,,+./)\+/)55X+58,[*0550>5c),.0*03
S 2+WUZ)<0)[8,[Z+W8/0*0<).8*+\+,/5$+`<`_8V,03W8*V3+8c[0Y,0>/Z+3+[V*00[
.+**58,[*0Y*+\+*50>U*8/+*+/5'
S ,>*8WW8/)0,
0>
/Z+
V*00[
\+55+*5
8,[
3Z+XW8/0*0<).8*
+\+,/5
$),>*8WW8/03T
[)503[+3
.8X5),<WX5.*+U8),8,[5/)>>,+558,[8X/0)WWX,+83/Z3)/)5'`
,8[[)/)0,/0/Z+U055)V*+3)5c5)[+,/)>)+[),U8/)+,/5/3+8/+[Y)/Z[X3\8*XW8V_0/Z+3)WWX,+
W+[)8/+[5)[++>>+./583+U055)V*+/Z8/Z8\+,0/V++,0V5+3\+[8,[.8,3+5X*/),),>*8WW8/03T5)[+
+>>+./5),8,T03<8,03/)55X+`
EZ+3+)583+W0/+.Z8,.+/Z8/T0XW8T[+\+*0U,+Y8**+3<)+5/0U3+\)0X5*T+dU05+[5XV5/8,.+5_
0/Z+3/Z8,7X3\8*XW8V03E3+W+*)WXW8V`(03+d8WU*+_)/)5U055)V*+/Z8/T0X.0X*[[+\+*0U8,
8**+3<T/05Z+**>)5Z036.0,/385/YZ)*+/8c),<7X3\8*XW8V03E3+W+*)WXW8V`EZ+5+8**+3<)+5
W8TV+5+\+3+8,[*)>+/Z3+8/+,),<`
fghjklhmgnopqrost
fghuvvgwxuyzu{mnrt|o}|~r~o


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?>@
A	B	

4C-DEEC2FGE42FEDF4H4FHGD-DFG4-EI7J
	KLMN
BO
BBO
P
Q FRS0T),8*U8),
Q (+V+3
Q 8W5+88,S:03V0T)/),<
Q FRS0T),8*?*W)SRW)*SWU
$F5.)/+5'
Q X*++S),<$8/.8/Y+/+3
),5+3/)0,5)/+'
Q F**+3<Z/0)0S),+
.0,/385/8<+,/
Q H)V+3?8)*W3+
Q [)S,+Z?8)*W3+
Q H)V+38R5.+55?03T8/)0,
Q -/0T8.Y03SW0S+,8*
W*.+3
Q 28,.3+8/)/)5
Q 4Y0*+.Z5/)/)5$)33)/8/)0,
0?/Y+<8**R*8SS+3'
Q F3/+3)8*),\W3Z8/
.8/Y+/+3),5+3/)0,5)/+
KLMN
EY+3)5]5?30T/Y+38S)0?3+^W+,.Z03T).30_8V+8R*8/)0,U30.+SW3+)/5+*?),.*WS+85T8**.Y8,.+
0?R*++S),<`),\W3Z/0/Y+,03T8**)V+3/)55W+`8,S3+<30_/Y0?/Y+/WT03aF,),?+./)0,`.8**+S8,
8R5.+55`.8,S+V+*0U),/Y+/3+8/+S/WT03`8,ST8Z3+^W)3+8,/)R)0/).58,S:03UW//),<8/+TU0383Z
/WR+),/Y+8R5.+55/0S38),)/aEY+3+5Y0W*SR+T),)T8*S)5.0T?03/?30T/Y+8R*8/)0,U30.+SW3+
)/5+*?SW3),</Y+8R*8/)0,U30.+SW3+`R+.8W5+Z0W_)**R+b85*++UcW,S+3<+,+38*8,+5/Y+5)8aEY+
*+,</Y0?/)T+Z0W_)**,++S/0R+),/Y+Y05U)/8*_)**V83ZRW/_)**R++5/)T8/+SRZZ0W3S0./035a
EY)5_)**R+S)5.W55+S_)/YZ0W),<3+8/+3S+/8)*U3)03/0/Y+U30.+SW3+a/)5/Y+),/+,/0?/Y)5/3)8*
/0W5+G(F/05/)TW*8/+/Y+)TTW,+5Z5/+TaG(F_)**),/+,/)0,8**Z/3+8/0,*ZU83/0?/Y+/WT03$5'`
+V+,)?/Y8/U83/).W*83/WT03.8,/+.Y,).8**ZR++38S).8/+Sa
	PKLMN
EY+3)5]5?30T.3Z08R*8/)0,U30.+SW3+)/5+*?),.*WS+85T8**.Y8,.+0?R*++S),<`),\W3Z/0/Y+
,03T8**)V+3/)55W+`8,S3+<30_/Y0?/Y+/WT03a+3V+S8T8<+T8Z3+5W*/a40TU*+/+*Z?30d+,
,+3V+5.8,.8W5+T0/03_+8],+5503,WTR,+55),/Y+83+85WUU*)+SRZ/Y+,+3V+5aEY+3+5Y0W*SR+
T),)T8*S)5.0T?03/?30T/Y+.3Z08R*8/)0,U30.+SW3+)/5+*?SW3),</Y+U30.+SW3+`R+.8W5+Z0W_)**
R+b85*++UcW,S+3<+,+38*8,+5/Y+5)8a(0**0_),<U+3.W/8,+0W5.3Z0/Y+38UZ`Z0W5Y0W*SR+8R*+/0
3+5WT+Z0W3W5W8*8./)V)/)+5_)/Y),0,+/0/Y3++S8Z5a?Z0WY8V+Y8S0U+,.3Z08R*8/)0,`Z0W
5Y0W*SR+8R*+/03+5WT+Z0W3W5W8*8./)V)/)+5_)/Y),5+V+,/0&9S8Z5aJ0W5Y0W*S8V0)S*)?/),<
Y+8VZ0R\+./5?038/*+85/" Y0W35aEY)5_)**R+S)5.W55+S_)/YZ0W),<3+8/+3S+/8)*U3)03/0/Y+
U30.+SW3+a/)5/Y+),/+,/0?/Y)5/3)8*/0W5+43Z08R*8/)0,/05/)TW*8/+/Y+)TTW,+5Z5/+Ta
43Z08R*8/)0,_)**),/+,/)0,8**Z/3+8/0,*ZU83/0?/Y+/WT03$5'`+V+,)?/Y8/U83/).W*83/WT03.8,
/+.Y,).8**ZR++38S).8/+Sa
efgijkglfmnopqnrs
efgtuufvwtxytzlmqs{n|{}q}n


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
LMN
O3P)5),<03Q*++R),<8//S+,++R*+5)/+T383+*U),?+./)0,VFS)5)5/3+8/+RW)/SQ8,R8<+5XY3+55P3+
8,RX)?),?+./)0,X8,/)Q)0/).Z+R).),+5V(03Z03+),?03Z8/)0,8Q0P/3)5[58,R5)R++??+./5X85[U0P3
5/PRU/+8ZV
ML
?U0P3R0./03R+/+3Z),+5)/)558?+XW+W)**0Q/8),8Y)+.+0?U0P3/PZ03$Q)0Y5U'Q+?03+U0PQ+<),
8,U5/PRU/S+38YUX0,R8U;\8,RR8U]^P5),<8,++R*+W)/SZ),)Z8*3)5[/0U0PVK0PW)**Q+
<)_+,*0.8*8,+5/S+5)8$,PZQ),<Z+R).),+'8,R85+R8/)_+Y3)03/0/S+Q)0Y5UVFS+Q)0Y5UW)**Q+
/8[+,/S30P<S8,++R*+YP//S30P<S/S+5[),),/0U0P3/PZ03VG?/+3/S+Y30.+RP3+X/S+,P35+5W)**
W8/.SU0P3Q*00RY3+55P3+8,R0/S+3_)/8*5)<,5VFS+Q85+*),+Q)0Y5U)5Z8,R8/03UX8,RU0P.8,,0/
Y83/).)Y8/+),/S)55/PRU)?U0PR0,0/8<3++/0/S)5Q)0Y5UVFS+R8U;\Q)0Y5U)50Y/)0,8*)?U0P83+
855)<,+R?03R3P<50,*U/3+8/Z+,/V?U0P83+855)<,+R/08RR)/)0,8*Y30.+RP3+X/S+R8U;\Q)0Y5U
W)**Q+Y+3?03Z+RRP3),<FG4E:H(G:43U08Q*8/)0,Y30.+RP3+VFS+R8U]^Q)0Y5U)50Y/)0,8*V?
/S+?)35/Q)0Y5U)5/00R)??).P*/03)?U0P+`Y+3)+,.+/00ZP.SR)5.0Z?03/8583+5P*/0?)/XU0PW)**
Q+8Q*+/0.0,/),P+0,/S+Y30/0.0*W)/S0P/P,R+3<0),</S+8RR)/)0,8*Q)0Y5UV0W+_+3X8,8//+ZY/
8//S+?)35/Q)0Y5U)5,++R+R/0+,/+3/S)55/PRUVFS+3+83+0/S+35/PR)+58/WS).SZ8U8*50Q+
0Y/)0,5?03U0PX8,RWS).SR0,0/),_0*_+Q)0Y5)+5V
FS)5Y30.+RP3+P5P8**U.8P5+50,*UQ3)+?R)5.0Z?03/8//S+5)/+?30ZWS).S/S+Q)0Y5U)5/8[+,V
H83+*UX),?+./)0,03Q*++R),<Z8U0..P38//S+,++R*+5)/+V

O)0Y5UW)**Q+Y+3?03Z+RP,R+35+R8/)0,V-+R8/)0,Z8U.8P5+S+8R8.S+X,8P5+88,RR30W5),+55V
FS+5+5)R++??+./5P5P8**U<08W8UaP).[*UV
NM
K0PZ8U+`Y+3)+,.+50Z+Z),035[),)33)/8/)0,?30Z/S++*+./30R+5V
	
?.0,/385/RU+)5P5+RX/S+3+)583)5[?038**+3<).3+8./)0,/0/S+RU+V283/).)Y8,/5Z)<S/+`Y+3)+,.+
S)_+5X)/.S),<XS+8R8.S+XR)??).P*/UQ3+8/S),<X),.3+85+RS+83/38/+8,R5W+**),<V?U0P83+8**+3<).
/0035+,5)/)_+/0Z+R).8/)0,5X.0,/385/RU+X)0R),+X035S+**?)5SXY*+85+,0/)?UU0P35/PRUR0./03V?
U0PS8_+S8R[)R,+U?8)*P3+030/S+3[)R,+UY30Q*+Z5),/S+Y85/XY*+85+,0/)?UU0P35/PRUR0./03
b
F+ZY0383U.0,?P5)0,8,RZ+Z03U*055XR)cc),+55XR)??).P*/UY855),<P3),+XQ3P)5),<03503+,+55
?30Z/S+6R3)YX,8P5+8X8,R_0Z)/),<X5S)_+3),<8,R?++*),<.0*RX503+/S308/RP+/0/S+Q3+8/S),<
/PQ+
d
FS+3+)5,03)5[3+*8/+R/0P3),+.0**+./)0,
efgijkglfmnopqnrs
efgtuufvwtxytzlmqs{n|{}q}n


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K

7L3),<M0L3N83/).)N8/)0,),/O)53+5+83.O5/LPMQM0LR)**S++TN05+P/038P)8/)0,?30U4F5.8,5
8,P4F<L)P+PS)0N5)+5V
?M0L83+855)<,+P/0H(G0343M08S*8/)0,Q/O+5+N30.+PL3+58*50U8MS+P0,+SM85N+.)8*)5/
L5),</O+4F5.8,,+3/0<L)P+H(G0343M08S*8/)0,/0+,5L3+8..L38.MV
FO+8U0L,/0?38P)8/)0,+TN05L3+M0LU8M3+.+)W+?30U4F5.8,5L5+P/0+W8*L8/+M0L3P)5+85+Q
03<L)P+S)0N5)+5QH(G0343M08S*8/)0,)5+XL8*/08NN30T)U8/+*M!3+UVG3+U)58L,)/0?
8S503S+P38P)8/)0,V
EW+3MP8MQN+0N*+83++TN05+P/0*0R*+W+*50?38P)8/)0,/O8/.0U+?30U/O+5L,8,P/O+
+,W)30,U+,/830L,P/O+UVFO+8W+38<+N+350,),/O+J,)/+P-/8/+53+.+)W+5838P)8/)0,+TN05L3+
0?9V;3+UN+3M+83?30U/O+5+50L3.+5VFO)5/MN+0?38P)8/)0,)5.8**+PYS8.Z<30L,P38P)8/)0,V[
FO)55/LPMR)**+TN05+M0L/0U03+38P)8/)0,/O8,M0L<+/?30U+W+3MP8MS8.Z<30L,P38P)8/)0,V
00,+Z,0R5?035L3+RO+/O+3+TN05L3+/0/O+5+*0R8U0L,/50?38P)8/)0,)5O83U?L*/0M0L3
S0PMV
FO+4F5.8,5
/O8/
M0L
<+/
),
/O)5
5/LPM
R)**
+TN05+
M0L
/0
/O+
30L<O*M
/O+
58U+
8U0L,/
0?
38P)8/)0,
85;9M+8350?S8.Z<30L,P38P)8/)0,V\+),<+TN05+P/0/00UL.O38P)8/)0,.8,.8L5+O83U?L*5)P+
+??+./55L.O858,),.3+85+),/O+3)5Z0?.8,.+3VFO+3)5ZP+N+,P50,O0RUL.O38P)8/)0,M0L83+
+TN05+P/0V2*+85+S+8R83+/O8/8S0L/%90L/0?&99N+0N*+$%9]'R)**<+/.8,.+3PL3),</O+)3
*)?+/)U+Q8,P
 9
0L/
0?
&99
$ 9]'
R)**
P)+
?30U
.8,.+3V
FO+
3)5Z
0?
<+//),<
.8,.+3
?30U
/O+
38P)8/)0,
+TN05L3+),/O)55/LPM)59V!0L/0?&99$9V!]'8,P0?<+//),<8?8/8*.8,.+3)59V^0L/0?&99$9V^]'V
?M0L83+855)<,+P/0FG4EN30.+PL3+QM0LR)**S++TN05+P/0U03+38P)8/)0,?30U0,+FG4E
N30.+PL3+8,PM0L3/0/8*+TN05L3+U8MS+&_V 3+U$30L<O*M/O+58U+8U0L,/0?38P)8/)0,85^%
M+8350?S8.Z<30L,P38P)8/)0,'VFO+3)5Z0?<+//),<.8,.+3?30U/O+38P)8/)0,+TN05L3+),/O)5.85+
R)**),.3+85+/0&V_0L/0?&99$&V_]'8,P0?<+//),<8?8/8*.8,.+3/09V`0L/0?&99$9V`]'V
K0LU8M,0/N83/).)N8/+),/O)55/LPM)?M0L83+N3+<,8,/V?M0L83+8S*+/0S+.0U+N3+<,8,/QR+
R)**N+3?03U8N3+<,8,.M/+5/S+?03++TN05),<M0L/038P)8/)0,VK0LUL5//+**L5)?M0LU8MO8W+
S+.0U+N3+<,8,/R)/O),/O+N3+W)0L5&%P8M5S+.8L5+/O+N3+<,8,.M/+5/)5L,3+*)8S*+PL3),</O8/
/)U+V

Ca
	

bcdef
FO+8)U0?/O)55/LPM)5/05++)?/O)5+TN+3)U+,/8*/3+8/U+,/R)**.8L5+M0L3/LU035/05O3),ZVg+
P0,0/Z,0R)?M0LR)**3+.+)W+N+350,8*QU+P).8*S+,+?)/?30U/8Z),<N83/),/O)55/LPMVFO+5+
N0/+,/)8*S+,+?)/5.0L*P),.*LP+5O3),Z),<0?M0L3/LU0303*+55+,),<0?M0L35MUN/0U5Q5L.O85
N8),Q/O8/83+.8L5+PSM/O+.8,.+3V\+.8L5+/O+3+)5,0/UL.O),?03U8/)0,8S0L//O+P3L<h5+??+./
0,M0L3.8,.+3QR+P0,0/Z,0R)?M0LR)**S+,+?)/?30U/8Z),<N83/),/O)55/LPMQ8*/O0L<O/O+
Z,0R*+P<+<8),+P?30U/O)55/LPMU8MO+*N0/O+35),/O+?L/L3+RO0O8W+.8,.+3V
Ci
	j
B
,5/+8P0?S+),<),/O)55/LPMQM0LO8W+/O+5+0N/)0,5k
l m+//),</3+8/U+,/03.83+?03M0L3.8,.+3R)/O0L/S+),<),85/LPM
noprstpuovwxyzw{|
nop}~~o}}uvz|wzw


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
L F8M),<N83/),8,0/O+35/PQR
L S+//),<.0T?03/.83+U8*50.8**+QN8**)8/)V+.83+WFO)5/RN+0?.83+O+*N53+QP.+N8),U
/)3+Q,+55U8NN+/)/+N30X*+T58,Q0/O+3N30X*+T5.8P5+QXR/O+.8,.+3W/Q0+5,0//3+8//O+
.8,.+3Q)3+./*RW,5/+8QU)//3)+5/0)TN30V+O0YR0P?++*W40T?03/.83+/3)+5/0M++NR0P85
8./)V+8,Q.0T?03/8X*+85N055)X*+W
2*+85+/8*M/0R0P3Q0./038X0P//O+5+8,Q0/O+30N/)0,5W

Z[\
K0P3Q0./03T8RQ+.)Q+/05/0NR0P3/O+38NR?03/O+?0**0Y),<3+850,51
L )?O+:5O+X+*)+V+5/O8/)/)5),R0P3X+5/),/+3+5/
L )?R0P3Q)5+85+.0T+5X8.MQP3),</3+8/T+,/
L )?R0PO8V+5)Q++??+./5?30T/O+/3+8/T+,//O8/R0P3Q0./03/O),M583+/005+V+3+
L )?,+Y),?03T8/)0,5O0Y5/O8/8,0/O+3/3+8/T+,/Y0P*QX+X+//+3?03R0P
L )?O+:5O+Q+.)Q+5/0.*05+/O+N30/0.0*
,/O)5.85+UR0PY)**X+),?03T+Q0?/O+3+850,/O+38NR)5X+),<5/0NN+QW
K0P.8,5/0N/8M),<N83/),/O+5/PQR8/8,R/)T+W0Y+V+3U)?R0PQ+.)Q+/05/0N/8M),<N83/),/O+
5/PQRUY+Y0P*Q*)M+R0P/0/8*M/0/O+5/PQRQ0./038,QR0P33+<P*83Q0./03?)35/W
?R0PQ+.)Q+8/8,R/)T+/0Y)/OQ38YR0P3.0,5+,//0N83/).)N8/+),/O+/3)8*UY+Y)**,0/.0**+./
8,R 8QQ)/)0,8*T+Q).8*),?03T8/)0,8X0P/R0PW0Y+V+3U8..03Q),</0(7G<P)Q+*),+5U
),?03T8/)0,.0**+./+Q0,R0PPN/0/O8/N0),/T8R5/)**X+N30V)Q+Q/0]+QTTP,+U,.W03
Q+5)<,8/+Q3+N3+5+,/8/)V+5W?R0PY)/OQ38YR0P3.0,5+,/8,Q*+8V+/O+/3)8*U8,R58TN*+50?R0P35
/O8/O8V+X++,0X/8),+Q?03/O+5/PQR8,Q5/03+Q8//O+4.8,X+Q+5/30R+QPN0,3+^P+5/W
0Y+V+3U8,R58TN*+58,QQ8/8<+,+38/+Q?30T/O+58TN*+5/O8/O8V+8*3+8QRX++,Q)5/3)XP/+Q/0
0/O+33+5+83.O+3503N*8.+Q),/O+3+5+83.OQ8/8X85+5.8,X+3+.8**+Q8,QQ+5/30R+QW
	
C	

FO+8/)0,8*,5/)/P/+50?+8*/O$'3+V)+Y55/8??3+5+83.O+358/*+85/R+83*R?03.0,?*)./5
0?),/+3+5/WFO)5N30.+55)5Q+/8)*+Q),8230/0.0*H+V)+YSP)Q+WK0PT8R85MR0P33+5+83.O/+8T
?038.0NR0?/O+230/0.0*H+V)+YSP)Q+03?03T03+),?03T8/)0,W]+TX+350?/O+3+5+83.O/+8T
YO0Q0,0/Y03M?0383++_N+./+Q/0?0**0Y/O+5+<P)Q+*),+5XP//O+RQ0,0/,++Q/03+N03/
/O+)3N+350,8*?),8,.+5/0/O+W
]+TX+350?/O+3+5+83.O/+8TY03M),<0,/O)55/PQRT8RO8V+PN/0`&aU9990?5/0.M),/O+
.0TN8,)+5/O8/T8M+N30QP./5P5+Q),/O)55/PQRWFO)5)58**0Y+QP,Q+3?+Q+38*3P*+58,Q)5,0/8
.0,?*)./0?),/+3+5/W
bcdfghdicjklmnkop
bcdqrrcstquvqwijnpxkyxznzk


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
FL+8/)0,8*,5/)/M/+50?+8*/L8,N/L+3+5+83.L/+8O?03/L)55/MNP83+M5),</3+O+*)OMO8Q8,N
NM3R8*MO8QN+R+*0S+NQPT+NOOM,+U,.V/L30M<L8W0),/5/MNPX)/LP0M33+5+83.L+358,N/L+
.0OS8,PVFL+.0OS8,P8*50S30R)N+5?),8,.)8*5MSS03/?03/L)55/MNPV
Y
	B
YY	Z
F08NR8,.+5.)+,.+U)/)5L+*S?M*?033+5+83.L+35/05L83+),?03O8/)0,/L+P<+/?30O5/MNP),<LMO8,
58OS*+5VFL+PN0/L)5QPSM//),<)/),/00,+03O03+5.)+,/)?).N8/8Q85+5UXL+3+)/)55/03+N8*0,<
X)/L),?03O8/)0,?30O0/L+35/MN)+5VG3+5+83.L+3XL0X8,/5/05/MNP/L+),?03O8/)0,OM5/8SS*P
/0/L+N8/8Q85+8,NQ+8SS30R+NVH+5+83.L+35M5+5S+.)O+,58,NN8/85/03+N),5.)+,/)?).N8/8Q85+5
/08NR8,.+5.)+,.+8,N*+83,8Q0M/L+8*/L8,NN)5+85+V
[+S*8,/0\++S50O+0?P0M35S+.)O+,58,NN8/8/L8/X+.0**+./8,NM5+/L+O?03?M/M3+3+5+83.L
8,N5L83+/L+OX)/L0/L+33+5+83.L+35V[+X)**,0/.0,/8./P0M/085\8Q0M/+8.L0?/L+5+?M/M3+
M5+5VFL+5+5S+.)O+,58,NN8/8X)**Q+5/3)SS+N0?)N+,/)?)+355M.L85,8O+U8NN3+55038..0M,/
,MOQ+3U50/L8//L+PO8PQ+M5+N?03?M/M3+3+5+83.L0,8,P/0S).8,N5L83+NQ308N*P?033+5+83.L
SM3S05+5VK0M35S+.)O+,58,NN8/8X)**Q+M5+N?033+5+83.LSM3S05+50,*P8,NX)**,0/Q+,+?)/
P0MV/)58*50S055)Q*+/L8//L+5/03+N5S+.)O+,58,NN8/8O8P,+R+3Q+M5+NVH+5M*/50?3+5+83.L
N0,+0,P0M35S+.)O+,58,NN8/8X)**,0/Q+8R8)*8Q*+/0P0M03P0M3N0./03V/O)<L/L+*SS+0S*+
XL0L8R+.8,.+38,N0/L+3N)5+85+5),/L+?M/M3+V
[+O8PSM/P0M33+5+83.LN8/8),8*83<+N8/8Q85+?03Q308N5L83),<X)/L/L+3+5+83.L.0OOM,)/PV
FL+5+N8/8Q85+583+.0OO0,*P.8**+NN8/83+S05)/03)+5VFL+5+N8/83+S05)/03)+5O)<L/03O)<L/,0/
Q+*0.8/+N8//L+VFL+),?03O8/)0,),/L)5N8/8Q85+.0M*N),.*MN+QM/)5,0/*)O)/+N/0<+,+/).
),?03O8/)0,U+/L,).)/P8,N5+]V?P0M3),N)R)NM8*3+5+83.LN8/8)5S*8.+N),0,+0?/L+5+
3+S05)/03)+5U)/X)**,0/Q+*8Q+*+NX)/LP0M3,8O+030/L+3),?03O8/)0,/L8/.0M*NQ+M5+N/0+85)*P
)N+,/)?PP0MU8,N0,*P^M8*)?)+N3+5+83.L+35X)**Q+8Q*+/0*00\8/P0M3N8/8VFL+5+3+5+83.L+35
OM5/3+.+)R+S3)038SS30R8*?30O),N)R)NM8*503.0OO)//++5/08..+55/L+N8/8V
K0M35MOO83P<+,0O).N8/8)5Q+),<S*8.+N_`b`M,3+5/3)./+NN8/8Q85+U503+5+83.L+35X)**Q+
8Q*+/08..+555MOO83P),?03O8/)0,8Q0M/8**/L+S83/).)S8,/5),.*MN+N),/L+5/MNP$),.*MN),<
P0M'U035MOO83P),?03O8/)0,.0OQ),+N?30OOM*/)S*+5/MN)+5UX)/L0M/8SS*P),<?03S+3O)55)0,V
FL+3)5\0?8,P0,+)N+,/)?P),<P0MX)/L/L)5),?03O8/)0,)5R+3P*0XV
,8NN)/)0,/0/L+M5+8,N5L83),<0?P0M35S+.)O+,58,NN8/8N+5.3)Q+N8Q0R+UX+O)<L/3+O0R+
8,P),?03O8/)0,?30OP0M35S+.)O+,58,NN8/8/L8/.8,)N+,/)?PP0M5M.L85,8O+U8NN3+55U03
O+N).8*3+.03N,MOQ+3U8,N/L+,M5+/L+5S+.)O+,58,NN8/8?038NN)/)0,8*3+5+83.L5/MN)+58//L+
030/L+3S*8.+5V?X+N0/L)5UX+O)<L/,0/.0,/8./P0M/085\P0M3S+3O)55)0,030/L+3X)5+
),?03OP0MV
?P0MN0,0/X8,/P0M35/03+N5S+.)O+,58,NN8/8M5+N?03?M/M3+3+5+83.LUS*+85+.0,/8./M5),
X3)/),<8,N*+/M5\,0X/L8/P0MN0,0/X8,/M5/0M5+P0M35S+.)O+,58,N:03N8/8VFL+,8,P
5S+.)O+,5/L8/L8R+,0/8*3+8NPQ++,M5+N035L83+NX)**Q+N+5/30P+N8,NP0M3N8/8X)**,0/Q+
M5+N?03?M/M3+3+5+83.LV0X+R+3U)/O8P,0/Q+S055)Q*+/0X)/LN38X03N+*+/+O8/+3)8*503N8/8
0,.+/L+PL8R+Q++,5L83+NX)/L0/L+33+5+83.L+35V
cdeghiejdklmnolpq
cderssdturvwrxjkoqylzy{o{l


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
	
B
LBMNBLOB
PQRST
-0U+4*),).8*4+,/+35/VW)+50??+3.0UX+,58/)0,?03X83/).)X8/)0,),3+5+83.YZFY+8U0V,/
0?.0UX+,58/)0,[)?8,\[)5<V)W+W]\X0*).)+58,W<V)W+*),+5Z
K0V^)**,0/3+.+)_+.0UX+,58/)0,?03X83/).)X8/)0,),/Y)55/VW\Z
PQR`RR`aST
-0U+4*),).8*4+,/+35/VW)+50??+33+)U]V35+U+,/03X8\U+,/?03/38_+*[*0W<),<03U+8*5
^Y)*+X83/).)X8/),<),/Y+3+5+83.YZFY+8U0V,/[)?8,\[)5<V)W+W]\X0*).)+58,W<V)W+*),+5Z
D,/Y)55/VW\[/Y+4^)**.0_+3/Y+.05/?0350U+0?\0V3+bX+,5+5Z-0U+0?/Y+5+.05/5U8\
]+X8)WW)3+./*\]\/Y+8,W50U+U8\]+3+)U]V35+W8?/+3\0VY8_+X8)WZ-0U+0,+^)**
^03c^)/Y\0V/0X30_)W+U03+),?03U8/)0,Z
PdeeT
W0+5,0/])**Y+8*/Y),5V38,.+.0UX8,)+503X83/).)X8,/5?038,\3+5+83.Y033+*8/+W.*),).8*
.83+/Y8/\0V3+.+)_+8//Y+4*),).8*4+,/+3Z
f ?50U+/+5/58,WX30.+WV3+5X+3?03U+W0V/5)W+/Y+4*),).8*4+,/+3[\0V
U8\Y8_+/0X8\?03/Y+5+.05/5)?/Y+\83+,0/.0_+3+W]\\0V3),5V38,.+
.0UX8,\Z
f g+W).),+5/Y8/83+,0/X83/0?/Y+5/VW\/3+8/U+,/^)**,0/]+X30_)W+W03X8)W
?03]\/Y+4*),).8*4+,/+3Z
f D,.+\0VY8_+.0UX*+/+W/8c),<X83/),/Y+5/VW\[U+W).8*.83+^)**,0*0,<+3
]+X30_)W+W]\/Y+4*),).8*4+,/+3Z
	C	CCh
NC
h
GW+5.3)X/)0,0?/Y)5.*),).8*/3)8*^)**]+8_8)*8]*+0,Y//X1::^^^Z4*),).8*F3)8*5Z<0_[853+iV)3+W
]\JZ-ZI8^ZFY)5j+]5)/+^)**,0/),.*VW+),?03U8/)0,/Y8/.8,)W+,/)?\\0VZG/U05/[/Y+j+]
5)/+^)**),.*VW+85VUU83\0?/Y+3+5V*/5ZK0V.8,5+83.Y/Y)5j+]5)/+8/8,\/)U+Z
	
CO
	

kaNO
PRSR`dQT
j+^)**W00V3]+5//0U8c+5V3+/Y8//Y+X+350,8*),?03U8/)0,),\0V3U+W).8*3+.03W^)**]+c+X/
X3)_8/+Z0^+_+3[^+.8,,0/<V838,/++/0/8*X3)_8.\ZD3<8,)l8/)0,5/Y8/U8\*00c8/8,W:03.0X\
\0V3U+W).8*3+.03W5?033+5+83.Y[iV8*)/\855V38,.+[8,WW8/88,8*\5)5),.*VW+1
f FY+8/)0,8*48,.+3,5/)/V/+$4'8,W0/Y+3<0_+3,U+,/8<+,.)+5[*)c+/Y+(00W8,W
73V<GWU),)5/38/)0,$(7G'[^Y).Y83+),_0*_+W),c++X),<3+5+83.Y58?+?03X+0X*+Z
f 8/)0,8*,5/)/V/+50?+8*/Y,/38UV38*,5/)/V/)0,8*H+_)+^m083W
f nV8*)?)+W3+X3+5+,/8/)_+5?30Ug+W)UUV,+:G5/38l+,+.8[/Y+XY83U8.+V/).8*.0UX8,\
^Y0X30WV.+57V3_8*VU8]8,WF3+U+*)UVU8]Z
opqstuqvpwxyz{x|}
opq~p~~vw{}x{x


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
LM+,3+5N*/50?8,3+5+83.M5/NOP83+3+Q03/+O),R+O).8*S0N3,8*5038/5.)+,/)?).R++/),<5T
/M+Q+0Q*+UM0/8V+Q83/83+,0/,8R+O8,O)O+,/)?)+OW,R05/.85+5T/M+U)**,0/3+*+85+8,P
),?03R8/)0,8X0N/P0N33+5+83.M),Y0*Y+R+,/U)/M0N/P0N3U3)//+,Q+3R)55)0,W0U+Y+3T)?P0N
5)<,83+*+85+0?),?03R8/)0,?03RT?03+Z8RQ*+T?038,),5N38,.+.0RQ8,PT/M+U)**<)Y+/M+
),5N38,.+.0RQ8,P),?03R8/)0,?30RP0N3R+O).8*3+.03OWFM)5),?03R8/)0,R)<M/8??+./$+)/M+3
?8Y038X*P03N,?8Y038X*P'/M+U)**),<,+550?/M+),5N38,.+.0RQ8,P/05+**P0N),5N38,.+W
?U+5M83+P0N35Q+.)R+,503O8/8U)/M0/M+33+5+83.M+35T),R05/.)3.NR5/8,.+5U+U)**3+R0Y+
P0N3)O+,/)?)+35X+?03+5M83),<P0N35Q+.)R+,503O8/8WK0N5M0N*OX+8U83+/M8//M+3+)585*)<M/
Q055)X)*)/P/M8/50R+0,+.0N*O?)<N3+0N//M+),?03R8/)0,)58X0N/P0NW
(N3/M+3T/M+),?03R8/)0,.0**+./+O?03/M)55/NOP)5Q30/+./+OXPN,O+384+3/)?).8/+0?
40,?)O+,/)8*)/P8,O/M+23)Y8.PG./W
	[[	[
F0M+*QN5Q30/+./P0N3Q3)Y8.PT/M+,/38RN38*230<38RM853+.+)Y+O84+3/)?).8/+0?
40,?)O+,/)8*)/P$4+3/)?).8/+'WL)/M/M)5.+3/)?).8/+T3+5+83.M+35R8P,0/3+*+85+03N5+O8/803
),?03R8/)0,8X0N/P0N+Z.+Q/),.+3/8),.)3.NR5/8,.+5W
3+5+83.M+35RN5/,0/5M83+),?03R8/)0,/M8/R8P)O+,/)?PP0N),8,P?+O+38*T5/8/+T03*0.8*
.)Y)*T.3)R),8*T8OR),)5/38/)Y+T*+<)5*8/)Y+T030/M+3Q30.++O),<5T?03+Z8RQ*+T)?3+\N+5/+OXP8
.0N3/W
FM+4+3/)?).8/+O0+5,0/Q30/+./P0N3),?03R8/)0,UM+,)/1
&W)5O)5.*05+O/0Q+0Q*+.0,,+./+OU)/M/M+3+5+83.MT?03+Z8RQ*+T),?03R8/)0,R8PX+N5+O
?038NO)/),<03Q30<38R+Y8*N8/)0,),/+3,8**PXP/M+]03
 W)53+\N)3+O/0X+O)5.*05+OXP(+O+38*T-/8/+T03*0.8**8U5T?03+Z8RQ*+TUM+,),?03R8/)0,
RN5/X+O)5.*05+O/0R++//M+*+<8*3+\N)3+R+,/50?/M+?+O+38*(00O8,O73N<
GOR),)5/38/)0,$(7G']
;W)5?030/M+33+5+83.M]
%W)5O)5.*05+OU)/MP0N3.0,5+,/W
FM+4+3/)?).8/+O0+5,0/Q3+Y+,/P0N?30RY0*N,/83)*P3+*+85),<),?03R8/)0,8X0N/P0N35+*?03P0N3
),Y0*Y+R+,/),/M)53+5+83.MW
FM+4+3/)?).8/+U)**,0/X+N5+O/0Q3+Y+,/O)5.*05N3+/05/8/+03*0.8*8N/M03)/)+50?M83R/05+*?03
0/M+35),.*NO),<T?03+Z8RQ*+T.M)*O8XN5+8,O,+<*+./T8,OXP5)<,),<X+*0UP0N.0,5+,//0/M05+
O)5.*05N3+5WD/M+3Q+3R)55)0,5?033+*+85+R8PX+R8O+XP5)<,),<?03R5T5N.M85/M+0/).+
8,OG.V,0U*+O<+R+,/0?,?03R8/)0,238./).+5.0,5+,/W
^
FM+(+O+38*23)Y8.PG./<+,+38**PQ30/+./5/M+.0,?)O+,/)8*)/P0?P0N3R+O).8*3+.03O5U+
.0**+./N,O+3/M+8N/M03)/P0?/M+2NX*).+8*/M-+3Y).+G./W,50R+.85+5T/M+23)Y8.PG./
Q30/+./)0,5O)??+3?30R/M+4+3/)?).8/+0?40,?)O+,/)8*)/PW(03+Z8RQ*+T50R+/)R+5/M+23)Y8.PG./
8**0U53+*+85+0?),?03R8/)0,?30RP0N3R+O).8*3+.03OU)/M0N/P0N3Q+3R)55)0,T?03+Z8RQ*+T)?
)/)53+\N+5/+OXP40,<3+55W,?03R8/)0,R8P8*50X+3+*+85+O?03.+3/8),3+5+83.MQN3Q05+5U)/M
ON+.0,5)O+38/)0,8,OQ30/+./)0,T/0/M05++,<8<+OXP/M+8<+,.P?033+5+83.MQN3Q05+5T/0.+3/8),
_`acdeaf`ghijkhlm
_`anoo`pqnrsntfgkmuhvuwkwh


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?@A
B	C	

4D-EFFD2GHF42GFEG4I4GIHE-EGH4-FJ7K
?+L+38*8,L5/8/+8<+,.)+5M?036N83/,+3,0/)?).8/)0,M?03),?+./)0O5L)5+85+038PO5+03,+<*+./
3+N03/),<M/0/OQ033+<)5/3)+5M?03RO8*)/S855+55Q+,/8,LQ+L).8*8OL)/5M03TU+,/U+)5
),V0*V+L),8*8T5O)/W0T+V+3MT)**0,*S3+*+85+),?03Q8/)0,?30QS0O3Q+L).8*3+.03L)?)/
)5N+3Q)//+LPSP0/U/U+4+3/)?).8/+0?40,?)L+,/)8*)/S8,L/U+23)V8.SG./W

C	XYY	Z[C\]
FU+4*),).8*4+,/+3T)**N30V)L+5U03//+3QQ+L).8*.83+?038,S),^O3S3+5O*/),<?30QS0O3
N83/).)N8/)0,),3+5+83.UU+3+W,<+,+38*M,0*0,</+3QQ+L).8*.83+03?),8,.)8*.0QN+,58/)0,?03
3+5+83.U3+*8/+L),^O3)+5T)**P+N30V)L+LPS/U+M/U+4*),).8*4+,/+3M03/U+(+L+38*
_0V+3,Q+,/W0T+V+3MS0OU8V+/U+3)<U//0NO35O+*+<8*3+Q+LS)?S0OP+*)+V+/U8/S0O3),^O3S
^O5/)?)+55O.U8./)0,W

`CB
a]

?S0OU8V+8,SN30P*+Q503RO+5/)0,58P0O//U)55/OLSM038P0O/S0O33)<U/58583+5+83.U
N83/).)N8,/M038P0O/8,S3+5+83.U3+*8/+L),^O3SM.0,/8.//U+23),.)N8*,V+5/)<8/03MF)Q_3+/+,M
bW7WM<3+/+,/?cQ8)*W,)UW<0VM %9"d9d&&%eK0OQ8S8*50.8**/U+4*),).8*4+,/+328/)+,/
H+N3+5+,/8/)V+8/;9&%!d d dM03/U+D??).+0?HfDN+38/)0,58/;9&%9 ;"&;M)?S0O
U8V+83+5+83.U3+*8/+L.0QN*8),/03.0,.+3,W
	

	]B
2*+85+g++N8.0NS0?/U)5L0.OQ+,/),.85+S0OT8,//03+8L)/8<8),W
hijlmnjoipqrstquv
hijwxxiyzw{|w}optv~q~tq


	

		
 !""$%&"'
()*+),-+./)0,%1230/0.0*40,5+,/$%'
6+35)0,78/+19%:&;: 9 &
28<+=>0?=>
@	A	

4B-CDDB2EFD42EDCE4G4EGFC-CEF4-DH7I
JK8L+3+8M/K++NO*8,8/)0,8P0Q//K)55/QMR8,MK8L+P++,<)L+,/K+0OO03/Q,)/R
/0M)5.Q55)/8,M/085STQ+5/)0,5U.0,5+,//0O83/).)O8/+),/K)55/QMRU
-)<,8/Q3+0?F+5+83.K283/).)O8,/
23),/8V+0?F+5+83.K283/).)O8,/
78/+
AWXYZA[\]^	JK8L+3+8M/K++NO*8,8/)0,
8P0Q//K)55/QMR8,MK8L+P++,<)L+,/K+0OO03/Q,)/R/0M)5.Q55)/8,M/085STQ+5/)0,5U8V*+<8**R8Q/K03)_+M
/0V8S+3+5+83.KM+.)5)0,50,P+K8*?0?/K+8MQ*/O83/).)O8,/Q,8P*+/0.0,5+,/8,MK8L+/K+8Q/K03)/R/0O30L)M+
.0,5+,//0/K)55/QMRUE58OO*).8P*+`/K+),?03V8/)0,),/K+8P0L+.0,5+,/a85M+5.3)P+M/0/K+8MQ*/O83/).)O8,/
Q,8P*+/0.0,5+,/aK08<3++5/0O83/).)O8/+),/K+5/QMRU
-)<,8/Q3+0?GEF
23),/8V+0?GEF
78/+
YWJ
-)<,8/Q3+0?,L+5/)<8/03
23),/8V+0?,L+5/)<8/03
78/+
bc\dJDK)55+./)0,)50,*R3+TQ)3+M)?R0Q83+M0),</K+038*
5K03/.0,5+,/O30.+558,M/K)5C,<*)5K.0,5+,/?03VK85P++,8OO30L+MPR/K+Fe?03Q5+85/K+P85)50?
/38,5*8/)0,U
bJ
-)<,8/Q3+0?f)/,+55g
23),/8V+0?f)/,+55
78/+
gh @i	

j	
@Akkh]

J
E,),/+3O3+/+3`030/K+3),M)L)MQ8*`aK05O+8S5C,<*)5K8,M/K+O83/).)O8,/l5O3+?+33+M*8,<Q8<+?8.)*)/8/+M
/K+8MV),)5/38/)0,0?),?03V+M.0,5+,/8,M5+3L+M858a)/,+55UDK+),L+5/)<8/030P/8),),<.0,5+,/V8R,0/
8*505+3L+85/K+a)/,+55U
E,),/+3O3+/+3`030/K+3),M)L)MQ8*`aK05O+8S5C,<*)5K8,M/K+O83/).)O8,/l5O3+?+33+M*8,<Q8<+?8.)*)/8/+M
/K+8MV),)5/38/)0,0?),?03V+M.0,5+,/PQ/M)M,0/5+3L+858a)/,+55UDK+,8V+037.0M+0?/K+O+350,
O30L)M),<),/+3O3+/)L+5QOO03/)51
U
mnoqrsotnuvwxyvz{
mno|}}n~||tuy{vyv

ICF_003.pdf: 
MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
INSTITUTE: 
National Cancer Institute 
STUDY NUMBER: 
16-C-0135 
PRINCIPAL INVESTIGATOR: 
Tim Greten, M.D. 
STUDY TITLE:  
A Pilot Study of Combined Immune Checkpoint Inhibition in Combination with 
Ablative Therapies in Subjects with Hepatocellular Carcinoma (HCC) or Biliary Tract 
Carcinomas (BTC) 
 
Continuing Review Approved by the IRB on 05/08/17 
Amendment Approved by the IRB on 06/26/17 (C) 
 
Date posted to web:  07/18/17 
Drug and Ablative Therapy 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent (2) 
 
 
INTRODUCTION 
We invite you to take part in a research study at the National Institutes of Health (NIH). 
First, we want you to know that: 
Taking part in NIH research is entirely voluntary.  
You may choose not to take part, or you may withdraw from the study at any time.  In 
either case, you will not lose any benefits to which you are otherwise entitled.  However, 
to receive care at the NIH, you must be taking part in a study or be under evaluation for 
study participation. 
You may receive no benefit from taking part.  The research may give us knowledge that 
may help people in the future. 
Second, some people have personal, religious or ethical beliefs that may limit the kinds of 
medical or research treatments they would want to receive (such as blood transfusions).  If you 
have such beliefs, please discuss them with your NIH doctors or research team before you agree 
to the study. 
Now we will describe this research study.  Before you decide to take part, please take as much 
time as you need to ask any questions and discuss this study with anyone at NIH, or with family, 
friends or your personal physician or other health professional.   
Why is this study being done?  
This research is being done to study the safety and effectiveness of the combination of 
durvalumab (formerly known as MEDI4736) and tremelimumab with and without trans-arterial 
catheter chemoembolization (TACE), radiofrequency ablation (RFA), or cryoablation. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 2 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
As you are among the second group of ~ 50 subjects enrolling on the study, you will be assigned 
to take durvalumab and tremelimumab with TACE, RFA or cryoablation. The first group of 20 
subjects will be will be assigned to take durvalumab and tremelimumab without TACE, RFA or 
cryoablation. 
Tremelimumab is an experimental drug that has not been approved by the U.S. Food and Drug 
Administration (FDA). Although tremelimumab is not approved by the FDA, it has been 
evaluated in a number of clinical studies, and over 1000 patients, most of whom had melanoma. 
Tremelimumab is similar in how it works to another drug (called ipilimumab) which was 
recently approved by the FDA. Tremelimumab has been tested in a small group of patients with 
liver cancer or hepatocellular cancer (HCC) and in general was well tolerated.  
Durvalumab is an investigational drug designed to boost the body’s immune system by targeting 
a protein on tumor cells called PDL-1. PDL-1 normally maintains the balance of the immune 
system. In cancer, PDL-1 helps tumors evade detection and elimination by the immune system. 
Durvalumab may increase the immune system’s ability to identify and destroy cancer cells. 
“Investigational” means that durvalumab has not been approved by the Food and Drug 
Administration (FDA) as either a prescription or over-the-counter drug.  
If you receive TACE a small catheter will be placed into the artery at the groin and 
chemotherapy will be injected directly into the liver. A material which closes off the vessels 
supplying blood to the tumor is also injected. If you receive RFA you will be put to sleep and a 
needle will directly be placed into the tumor and your tumor will be burnt (or part of it). If you 
receive cryoablation you will be put to sleep and a needle will be put directly into the tumor and 
the tumor will be frozen (or part of it). TACE, RFA, and cryoablation are standard procedures 
that are used to treat tumors. However, in this study RFA and cryoablation will be used in order 
to stimulate an immune response, rather than complete eradication of the lesion as per standard 
of care indication. Once it is determined which procedure you will receive your doctor will 
explain the procedure in full detail. 
This is the first study in which both drugs taken together will be tested in combination with 
TACE, RFA, or cryoablation, which is the main goal of this study. 
Why are you being asked to take part in this study? 
You are being asked to take part in this study because you have advanced hepatocellular cancer 
(HCC) or biliary tract cancer that has not responded to other types of therapy, and your doctor 
has determined that you are not a candidate for liver transplantation. 
How many people will take part in this study?  
About 90 people will take part in this study. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 3 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Description of Research Study 
Before you begin the study 
Before you begin this study, you will have several exams and tests to make sure you are eligible 
for this study.  The exams and tests are part of regular cancer care and may be done even if you 
do not join the study.  If you recently had some of the tests, they may not need to be repeated. 
The research team will explain these exams and tests to you. You will have: 
• Confirmation of diagnosis (You must provide a sample tumor tissue for an NCI lab to 
evaluate.  The tissue may be from a previous surgery or biopsy.  If none is available, we 
will ask you to undergo a biopsy to provide a fresh sample). 
• History and physical exam 
• Review of current medications and past treatments 
• Blood work 
• Urine laboratory tests 
• Tumor measurements using special x-rays called computerized tomography (CT or CAT 
scans) or magnetic resonance imaging (MRI) of your chest, stomach, and pelvis areas 
• A heart test called an electrocardiogram or ECG to check your heart 
• Urine or blood pregnancy test 
During the study 
If the exams, tests and procedures show that you can be in the study, and you choose to take part, 
then you will begin treatment.  
Before you begin treatment, you will have a biopsy of your tumor using a needle. 
In this study, study therapy will be divided into cycles, each lasting 28 days. Treatment involves 
receiving tremelimumab and durvalumab through an IV on day 1 of each cycle. On day 36 you 
will receive the TACE, RFA or cryoablation procedure. You will have two additional biopsies of 
your tumor; one during TACE, RFA or cryoablation procedure and an optional one after you 
have completed the third cycle (day 85). Once you have complete 4 cycles of study therapy you 
will continue to receive durvalumab only, until your disease worsens, you experience intolerable 
side effects or you have completed 12 months of study therapy, whichever comes first.  
 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 4 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
When you are finished taking the drugs (treatment) 
You will be seen within 60 days after completion of the study treatment to assess for possible 
delayed or ongoing side effects and overall clinical status. At this visit, you will have basic blood 
tests as well as blood collected for research purposes. 
Study Calendar 
Cycle 1 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab*  
• Tumor biopsy 
• Tremelimumab infusion 
• Durvalumab infusion 
Day 8 
• Routine and research blood tests 
Day 15 
• Routine and research blood tests 
Day 22 
• Routine blood tests 
Cycle 2 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab*  
• Tremelimumab infusion 
• Durvalumab infusion 
Day 8  
(Day 36) 
• Routine and research blood tests 
• RFA/TACE/Cryoablation (will be determined by 
your study doctor) and tumor biopsy during this 
procedure 
Day 15 
• Routine blood tests 
Day 22 
• Routine blood tests 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 5 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Cycle 3 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Tremelimumab infusion 
• Durvalumab infusion  
• CT Scan or MRI 
Day 8 
• Routine and research blood tests 
Day 15 
• Routine blood tests 
Day 22 
• Routine blood tests 
Cycle 4 
Day 1 
(Day 85) 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Research rectal swab*  
• Tumor biopsy (optional) 
• Tremelimumab infusion 
• Durvalumab infusion  
Day 8 
• Routine and research blood tests 
Day 15 
• Routine blood tests 
Day 22 
• Routine blood tests 
Subsequent Cycles 
Day 1 
• History and physical exam 
• Review of current medications and treatments 
• Routine and research blood tests 
• Durvalumab infusion 
• CT scan or MRI (every 8 weeks from third cycle) 
* Rectal swabs will be used to study microbes living in your gut, including sequence of 
microbial genes.  
Birth Control 
If you are a woman who is breast feeding or pregnant, you may not take part in the study because 
we don’t know how this medicine would affect your baby or your unborn child. If you are a 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 6 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
woman who can become pregnant, or are the partner of a woman who can become pregnant, you 
will need to practice at least two effective forms of birth control before starting study treatment, 
during study treatment, and for 6 months after you finish study treatment.  If you are a man, you 
should not donate sperm before, during and for 6 months after you finish study treatment.  If you 
think that you or your partner is pregnant, you should tell your study doctor or nurse at once.   
Effective forms of birth control include:  
• abstinence  
• intrauterine device (IUD) 
• hormonal [birth control pills, injections, or implants] 
• tubal ligation 
• vasectomy 
Risks or Discomforts of Participation 
What side effects or risks can I expect from being in this study? 
Tremelimumab 
The following are side effects that have been associated with Tremelimumab: 
• Diarrhea 
• Rash 
• Pruritus (itching) 
• Fatigue 
• Nausea 
• Vomiting 
• Anorexia (loss of appetite) 
• Headache 
• Abdominal Pain 
• Auto-immune changes to the pituitary gland leading to hormonal changes. 
• Inflammation of the part of the intestine known as the colon which can lead to infection, 
blood in the stools and abdominal pain. This is also known as ‘colitis’.  Colitis has the 
potential to be life threatening and require prolonged hospitalizations. As part of its 
management it may require treatment with steroids which may place you at increased risk 
for severe infections.  


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 7 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• Inflammation of the liver which is also known as hepatitis. In extreme cases this may 
result in liver failure and death.   
• Occasionally you can also get a skin rash related to the treatment and this can also result 
in severe and life threatening symptoms.  
• Problems related to Tremelimumab infusion 
• There is a remote chance that you may have a serious allergic reaction (anaphylaxis) to 
Tremelimumab. Anaphylaxis may cause a serious drop in blood pressure, difficulty in 
breathing, severe hives, and sometimes death. Your doctor will monitor you very closely 
after you receive the Tremelimumab, and will have medications available to treat any 
allergic reactions that might occur. Less serious allergic reactions, such as skin rash with 
or without itching and swelling, may also occur within hours to days after receiving the 
Tremelimumab. These effects usually get better without treatment.  
Durvalumab 
Likely 
• Diarrhea 
• Rash/dry itchy skin 
• Liver problems: Increases in the blood level of substances called enzymes found within 
your liver cells may occur. The enzyme changes are unlikely to make you feel unwell. 
However, if these blood enzyme levels become very high, your study doctor may need to 
stop the study medication. A patient may develop inflammation of the liver called 
hepatitis, however this is uncommon. Signs and symptoms of this include yellowing of 
the skin or whites of the eyes, dark urine, severe nausea and vomiting, pain in the upper 
right side of your abdomen, skin itchiness, not feeling hungry and bleeding or bruising 
more easily than normal. 
• Fatigue 
• Difficulty breathing 
• Nausea 
• Constipation 
• Decreased appetite 
• Vomiting 
• Fever 
• Pain in muscles and joints 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 8 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Less Likely 
• Inflammation in the lungs (pneumonitis): Symptoms may include but are not limited to a 
new or worsening cough, shortness of breath possibly with fever. Preliminary data 
suggested that there may be the tendency of higher frequency and severity in Japanese 
patients compared with non-Japanese patients: Tell your study doctor right away if you 
have any of these symptoms as it may need to be treated urgently. 
• Low thyroid (Hypothyroidism): This is when the thyroid gland produces less thyroid 
hormone than it should which causes the metabolism to run too slow. Symptoms may 
include but are not limited to fatigue, increased sensitivity to cold, constipation, dry skin, 
unexplained weight gain, puffy face, muscle weakness, slow heart rate, thinning hair, 
impaired memory. The condition can be treated with replacement thyroid hormone. 
• High thyroid (Hyperthyroidism): This is when the thyroid gland produces too much 
thyroid hormone. Symptoms include anxiety or nervousness, weight loss, frequent and 
loose bowel movements, breathlessness, feeling hot and possibly having heart 
palpitations. Depending on the severity of the symptoms treatment may include just 
monitoring the symptoms, treating the symptoms themselves and/or giving medicine to 
block the thyroid hormone. 
• Kidney problems: You may have an increase of creatinine levels in a blood test 
(creatinine is a protein marker that measures kidney function) but not have any symptoms 
or feel unwell. Less commonly a patient may experience nephritis which is an 
inflammation of the kidneys that stops the kidneys from working properly.  
• Nervous system problems: Symptoms can include unusual weakness of legs, arms, or 
face, numbness or tingling in hands or feet. In rare situations, there is the potential for the 
inflammation of the nervous system to be severe: Tell your study doctor right away if you 
have problems swallowing, if you start to feel weak very quickly and you are having 
trouble breathing. 
• Infusion Related Reactions: Reactions may occur during or after the infusion of study 
medication.  The reaction may cause fever or chills and a change in blood pressure or 
difficulty in breathing which might be serious. Tell your study doctor right away if you 
experience any of these symptoms even if it has been several days after the infusion has 
been completed.   
• Inflammation of the intestine (colitis). It may cause abdominal pain and diarrhea with or 
without blood. Fever may be present. It may require you to receive additional fluids. If 
left untreated, this may lead to a tear in the wall of the intestine which can be serious and 
life threatening. Tell your study doctor right away if you have any of these symptoms. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 9 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Rare 
• Problems with your adrenal glands (Adrenal Insufficiency): May cause stomach pains, 
vomiting, muscle weakness and fatigue, depression, low blood pressure, weight loss, 
kidney problems, and changes in mood and personality. This event can occur commonly 
in patients who receive a combination of durvalumab and tremelimumab but has been 
reported uncommonly in patients who received durvalumab on its own. These 
complications may be permanent and may require hormone replacement. 
• Inflammation of the pancreas (pancreatitis). Pancreatitis usually causes symptoms of 
persistent upper abdominal pain (sometimes made worse by eating and drinking), nausea, 
vomiting and general weakness. Pancreatitis usually settles with simple measures but it 
can be a serious condition and can be fatal. You should immediately tell your study 
doctor if you develop any unusual symptoms. You may get an increase of lipase and 
amylase levels in a blood test (related to the pancreas) but not have any symptoms or feel 
unwell. Lipase and amylase are enzymes or protein markers that measure the function of 
your pancreas. Uncommonly these increases may be associated with pancreatitis. 
• Type 1 Diabetes mellitus which may cause increased blood glucose levels (called 
‘hyperglycaemia’):  Symptoms may include weight loss, increased urination, increased 
thirst, and increased hunger. Type 1 diabetes will require replacement of insulin through 
injection. Tell your study doctor right away if you have any of these symptoms.    
• Allergic reactions: These can cause swelling of the face, lips and throat, breathing 
difficulties along with hives or nettle like rash. You should immediately tell your study 
doctor if you develop any of these symptoms.  
• Problems with the pituitary gland (hypopituitarism): Hypopituitarism refers to decreased 
output of hormones from the pituitary gland in the brain and may be caused by 
inflammation of the pituitary gland (hypophysitis). Symptoms may include headaches, 
thirstiness, and trouble seeing or double vision, leakage of breast milk or irregular periods 
in women. These complications may be permanent and may require hormone 
replacement. 
• Inflammation of the heart muscle (myocarditis). Symptoms can include chest pain, rapid 
or abnormal heart beat, shortness of breath and swelling of your legs. Tell your study 
doctor right away if you experience any of these symptoms. 
A new drug may show an increase in side effects or unexpected effects as more studies are 
conducted. For your safety, you will be followed closely by your Study Doctor and the study 
staff for any undesirable or unexpected side effects during your participation in this study and 
each time you receive durvalumab. 
There may be other side effects of durvalumab that are unknown. Other immune-mediated side 
effects are possible that have not been observed, and can result in inflammatory side effects in 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 10 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
any organ or tissue. You will be told about any new findings that develop during the course of 
this study that may affect your decision to stay in the study. 
There is a remote chance that you may develop new allergies to previously exposed substances, 
other than Durvalumab or Tremelimumab. For example, it is possible that you could develop an 
allergy to shellfish or IV contrast while taking Durvalumab or Tremelimumab. These allergies 
may be severe and life threatening. 
 
TACE Procedure 
Likely 
Less Likely 
Rare but Serious 
• Abdominal pain 
• Fever 
• Nausea and/or vomiting 
• Abdominal fluid buildup 
(Ascites) 
• Bleeding 
(at 
catheter 
insertion site) 
• Allergy to iodine contrast 
agent  
• Liver failure 
• Kidney failure 
• Liver abscess formation  
• Stomach or duodenal ulcer 
• Pancreatitis 
• Cholecystitis (irritation of 
the gall bladder) 
• Arterial injury at catheter 
insertion site 
 
RFA Procedure 
The risks from the radiofrequency or microwave ablation procedure itself include a small chance 
of bleeding, injury to the normal liver tissue, and re-growth of the tumor.  An infection, called an 
abscess, can develop in the treated tumor, and may require antibiotics and/or putting a temporary 
tube in the abscess to drain it.  There should be minimal discomfort from the ablation procedure 
itself during the ablation procedure, because you will be “asleep” under general anesthesia.  The 
length of time you will need to be in the hospital will vary but will be estimated by your doctors. 
This will be discussed with you in greater detail prior to the procedure. It is the intent of this trial 
to use RFA to stimulate the immune system. RFA will intentionally treat only part of the 
tumor(s), even if that particular tumor can technically be eradicated. 
Cryoablation 
The risks from cryoablation procedure itself include a small chance of bleeding, injury to the 
normal liver tissue, and re-growth of the tumor.  Nerve damage may result. Completely frozen 
nerves can cause motor weakness or numbness in the area supplied by the nerves.  There should 
be minimal discomfort from the cryoablation procedure itself during the procedure, because you 
will be “asleep” under general anesthesia.  Following percutaneous cryotherapy, you should be 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 11 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
able to resume your usual activities within one to three days. If you have had open cryoablation, 
you should be able to resume your usual activities within seven to 10 days. You should avoid 
lifting heavy objects for at least 72 hours. This will be discussed with you in greater detail prior 
to the procedure. It is the intent of this trial to use Cryoablation to stimulate the immune system. 
Cryoablation will intentionally treat only part of the tumor(s), even if that particular tumor can 
technically be eradicated. 
Blood Sampling  
Bruising or bleeding at the needle site; rarely infection. This is treated with bandages, pressure 
and, if infection, antibiotic medicines. For more information about risks and side effects, ask 
your study team. 
Tumor Biopsy 
If your doctor determines it is safe we will obtain a piece of your tumor (biopsy) before you 
begin any study therapy, on day 36 and day 85 using a needle with minimal risk to you.  You 
will be given local anesthesia (numbing medicine) and a sedative prior to the biopsy.  The biopsy 
will be taken through a needle put through the skin into your tumor.  After the procedure, the 
nurses will watch your blood pressure and other vital signs.  The baseline biopsy is mandatory 
and you cannot participate in this study if you do not agree to this biopsy. The day 36 biopsy will 
be performed during TACE/RFA/Cryoablation procedure. The day 85 biopsy is optional. If the 
first biopsy is too difficult or if you experience too much discomfort as a result of it, you will be 
able to continue on the protocol without undergoing the additional biopsy. However, an attempt 
at the first biopsy is needed to enter this study. There are other studies at NIH which may also be 
options for you and which do not involve biopsies. 
Radiation  
TACE/RFA/Cryoablation and Tumor biopsies will be done by a specialist using the CT scanner 
or ultrasound machine to guide any of these procedures to ensure accuracy. Thus, you might be 
exposed to three CT scans. This radiation exposure is not required for your medical care and is 
for research purposes only. The amount of radiation you will receive in these procedures is 3.0 
rem which is below the guideline of 5 rem per year allowed for research subjects by the NIH 
Radiation Safety Committee.  The average person in the United States receives a radiation 
exposure of 0.3 rem per year from natural sources, such as the sun, outer space, and the earth's 
air and soil.  If you would like more information about radiation, please ask the investigator for a 
copy of the pamphlet, An Introduction to Radiation for NIH Research Subjects.  
Potential Benefits of Participation 
Are there benefits to taking part in this study? 
The aim of this study is to see if this experimental treatment will cause your tumors to shrink.  
We do not know if you will receive personal, medical benefit from taking part in this study.  
These potential benefits could include shrinking of your tumor or lessening of your symptoms, 
such as pain, that are caused by the cancer.  Because there is not much information about the 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 12 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
drug’s effect on your cancer, we do not know if you will benefit from taking part in this study, 
although the knowledge gained from this study may help others in the future who have cancer.   
Alternative Approaches or Treatments 
Instead of being in this study, you have these options: 
• Getting treatment or care for your cancer without being in a study 
• Taking part in another study 
• Getting comfort care, also called palliative care.  This type of care helps reduce pain, 
tiredness, appetite problems and other problems caused by the cancer.  It does not treat 
the cancer directly.  Instead, it tries to improve how you feel.  Comfort care tries to keep 
you as active and comfortable as possible. 
Please talk to your doctor about these and other options. 
Research Subject’s Rights 
What are the costs of taking part in this study?  
If you choose to take part in the study, the following will apply, in keeping with the NIH policy: 
• 
You will receive study treatment at no charge to you. This may include 
surgery, medicines, laboratory testing, x-rays or scans done at the 
Clinical Center, National Institutes of Health (NIH), or arranged for you 
by the research team to be done outside the Clinical Center, NIH if the 
study related treatment is not available at the NIH.  
• 
There are limited funds available to cover the cost of some tests and 
procedures performed outside the Clinical Center, NIH.  You may have 
to pay for these costs if they are not covered by your insurance company. 
• 
Medicines that are not part of the study treatment will not be provided or 
paid for by the Clinical Center, NIH. 
• 
Once you have completed taking part in the study, medical care will no 
longer be provided by the Clinical Center, NIH. 
Will your medical information be kept private? 
We will do our best to make sure that the personal information in your medical record will be 
kept private.  However, we cannot guarantee total privacy.  Organizations that may look at 
and/or copy your medical records for research, quality assurance, and data analysis include: 
• The National Cancer Institute (NCI) and other government agencies, like the Food and 
Drug Administration (FDA), which are involved in keeping research safe for people. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 13 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
• National Cancer Institute Institutional Review Board 
• Qualified representatives from MedImmune, Inc, the pharmaceutical company who 
produces tremelimumab and durvalumab. 
A description of this clinical trial will be available on http://www.Clinicaltrials.gov, as required 
by U.S. Law.  This Web site will not include information that can identify you.  At most the 
Web site will include a summary of the results.  You can search this Web site at any time.  
Genomic data of your microbes and your health information will be put in a controlled-access 
database.  This means that only researchers who apply for and get permission to use the 
information for a specific research project will be able to access the information.  Your 
microbial genomic data and health information will not be labeled with your name or other 
information that could be used to identify you.  Researchers approved to access information in 
the database have agreed not to attempt to identify you. 
Stopping Therapy  
Your doctor may decide to stop your therapy for the following reasons: 
• if he/she believes that it is in your best interest 
• if your disease comes back during treatment 
• if you have side effects from the treatment that your doctor thinks are too severe 
•  if new information shows that another treatment would be better for you 
In this case, you will be informed of the reason therapy is being stopped. 
You can stop taking part in the study at any time. However, if you decide to stop taking part in 
the study, we would like you to talk to the study doctor and your regular doctor first. 
If you decide at any time to withdraw your consent to participate in the trial, we will not collect 
any additional medical information about you. However, according to FDA guidelines, 
information collected on you up to that point may still be provided to MedImmune, Inc. or 
designated representatives. If you withdraw your consent and leave the trial, any samples of 
yours that have been obtained for the study and stored at the NCI can be destroyed upon request. 
However, any samples and data generated from the samples that have already been distributed to 
other researchers or placed in the research databases cannot be recalled and destroyed. 


MEDICAL RECORD 
CONTINUATION SHEET for either: 
NIH 2514-1, Consent to Participate in A Clinical Research Study 
NIH 2514-2, Minor Patient’s Assent to Participate In A Clinical Research Study 
STUDY NUMBER: 16-C-0135 
CONTINUATION: page 14 of 16 pages 
 
PATIENT IDENTIFICATION 
CONTINUATION SHEET for either: 
NIH-2514-1 (07-09) 
NIH-2514-2 (10-84) 
P.A.:  09-25-0099 
File in Section 4:  Protocol Consent 
 
Conflict of Interest  
The National Institutes of Health (NIH) reviews NIH staff researchers at least yearly for conflicts 
of interest.  This process is detailed in a Protocol Review Guide.  You may ask your research 
team for a copy of the Protocol Review Guide or for more information.  Members of the research 
team who do not work for NIH are expected to follow these guidelines but they do not need to 
report their personal finances to the NIH. 
Members of the research team working on this study may have up to $15,000 of stock in the 
companies that make products used in this study.  This is allowed under federal rules and is not a 
conflict of interest.  
The National Institutes of Health and the research team for this study are using tremelimumab 
and durvalumab developed by MedImmune, Inc. through a joint study with your researchers and 
the company.   The company also provides financial support for this study.  
Use of Specimens and Data for Future Research 
To advance science, it is helpful for researchers to share information they get from studying 
human samples.  They do this by putting it into one or more scientific databases, where it is 
stored along with information from other studies. A researcher who wants to study the 
information must apply to the database and be approved.  Researchers use specimens and data 
stored in scientific databases to advance science and learn about health and disease.   
We plan to keep some of your specimens and data that we collect and use them for future 
research and share them with other researchers. We will not contact you to ask about each of 
these future uses.  These specimens and data will be stripped of identifiers such as name, address 
or account number, so that they may be used for future research on any topic and shared broadly 
for research purposes. Your specimens and data will be used for research purposes only and will 
not benefit you.  It is also possible that the stored specimens and data may never be used.  
Results of research done on your specimens and data will not be available to you or your doctor.  
It might help people who have cancer and other diseases in the future.   
If you do not want your stored specimens and data used for future research, please contact us in 
writing and let us know that you do not want us to use your specimens and/or data.  Then any 
specimens that have not already been used or shared will be destroyed and your data will not be 
used for future research. However, it may not be possible to withdraw or delete materials or data 
once they have been shared with other researchers. 
 


MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 15 of 16 pages 
 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH 
STUDY (Continuation Sheet) 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
 
File in Section 4:  Protocol Consent 
 
 
 
OTHER PERTINENT INFORMATION 
1. 
Confidentiality.  When results of an NIH research study are reported in medical journals 
or at scientific meetings, the people who take part are not named and identified.  In most cases, 
the NIH will not release any information about your research involvement without your written 
permission.  However, if you sign a release of information form, for example, for an insurance 
company, the NIH will give the insurance company information from your medical record.  This 
information might affect (either favorably or unfavorably) the willingness of the insurance 
company to sell you insurance. 
The Federal Privacy Act protects the confidentiality of your NIH medical records.  However, you 
should know that the Act allows release of some information from your medical record without 
your permission, for example, if it is required by the Food and Drug Administration (FDA), 
members of Congress, law enforcement officials, or authorized hospital accreditation 
organizations. 
2. 
Policy Regarding Research-Related Injuries.  The Clinical Center will provide short-
term medical care for any injury resulting from your participation in research here.  In general, 
no long-term medical care or financial compensation for research-related injuries will be 
provided by the National Institutes of Health, the Clinical Center, or the Federal Government.  
However, you have the right to pursue legal remedy if you believe that your injury justifies such 
action. 
3. 
Payments.  The amount of payment to research volunteers is guided by the National 
Institutes of Health policies.  In general, patients are not paid for taking part in research studies at 
the National Institutes of Health.  Reimbursement of travel and subsistence will be offered 
consistent with NIH guidelines. 
4. 
Problems or Questions.  If you have any problems or questions about this study, or 
about your rights as a research participant, or about any research-related injury, contact the 
Principal Investigator, Tim Greten, M.D., Building 10, Room 12N226, Telephone:  240-760-
6114. You may also call the Clinical Center Patient Representative at 301-496-2626. If you have 
any questions about the use of your specimens or data for future research studies, you may also 
contact the Office of the Clinical Director, Telephone:  240-760-6070.  
5. 
Consent Document.  Please keep a copy of this document in case you want to read it 
again. 


MEDICAL RECORD 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH STUDY 
• 
Adult Patient or 
• Parent, for Minor Patient 
STUDY NUMBER:  16-C-0135 
CONTINUATION: page 16 of 16 pages 
 
PATIENT IDENTIFICATION 
CONSENT TO PARTICIPATE IN A CLINICAL RESEARCH 
STUDY (Continuation Sheet) 
• 
Adult Patient or 
• Parent, for Minor Patient 
NIH-2514-1 (07-09) 
P.A.:  09-25-0099 
 
File in Section 4:  Protocol Consent 
 
 
 
 
COMPLETE APPROPRIATE ITEM(S) BELOW: 
A. Adult Patient’s Consent 
B. Parent’s Permission for Minor Patient. 
I have read the explanation about this study 
and have been given the opportunity to discuss 
it and to ask questions.  I hereby consent to 
take part in this study. 
I have read the explanation about this study 
and have been given the opportunity to discuss 
it and to ask questions.  I hereby give 
permission for my child to take part in this 
study.   
(Attach NIH 2514-2, Minor’s Assent, if 
applicable.) 
 
  
  
 
 
 
Signature of Adult Patient/ 
Legal Representative 
Date 
Signature of Parent(s)/ Guardian Date 
 
 
Print Name 
 
 
Print Name 
C. Child’s Verbal Assent (If Applicable) 
The information in the above consent was described to my child and my child agrees to 
participate in the study. 
 
  
  
 
Signature of Parent(s)/Guardian 
Date 
Print Name 
THIS CONSENT DOCUMENT HAS BEEN APPROVED FOR USE  
FROM MAY 8, 2017 THROUGH MAY 7, 2018.  
 
 
 
 
 
 
 
 
Signature of Investigator 
Date 
Signature of Witness 
Date 
 
 
Print Name 
 
 
Print Name